id	sid	tid	token	lemma	pos
cord-314500-89ovdnxl	1	1	key	key	NN
cord-314500-89ovdnxl	1	2	:	:	:
cord-314500-89ovdnxl	2	1	cord-314500	cord-314500	NNP
cord-314500-89ovdnxl	2	2	-	-	HYPH
cord-314500-89ovdnxl	2	3	89ovdnxl	89ovdnxl	CD
cord-314500-89ovdnxl	2	4	authors	author	NNS
cord-314500-89ovdnxl	2	5	:	:	:
cord-314500-89ovdnxl	2	6	Dunachie	Dunachie	NNP
cord-314500-89ovdnxl	2	7	,	,	,
cord-314500-89ovdnxl	2	8	Susanna	Susanna	NNP
cord-314500-89ovdnxl	2	9	;	;	:
cord-314500-89ovdnxl	2	10	Chamnan	Chamnan	NNP
cord-314500-89ovdnxl	2	11	,	,	,
cord-314500-89ovdnxl	2	12	Parinya	Parinya	NNP
cord-314500-89ovdnxl	2	13	title	title	NN
cord-314500-89ovdnxl	2	14	:	:	:
cord-314500-89ovdnxl	2	15	The	the	DT
cord-314500-89ovdnxl	2	16	double	double	JJ
cord-314500-89ovdnxl	2	17	burden	burden	NN
cord-314500-89ovdnxl	2	18	of	of	IN
cord-314500-89ovdnxl	2	19	diabetes	diabetes	NN
cord-314500-89ovdnxl	2	20	and	and	CC
cord-314500-89ovdnxl	2	21	global	global	JJ
cord-314500-89ovdnxl	2	22	infection	infection	NN
cord-314500-89ovdnxl	2	23	in	in	IN
cord-314500-89ovdnxl	2	24	low	low	JJ
cord-314500-89ovdnxl	2	25	and	and	CC
cord-314500-89ovdnxl	2	26	middle	middle	JJ
cord-314500-89ovdnxl	2	27	-	-	HYPH
cord-314500-89ovdnxl	2	28	income	income	NN
cord-314500-89ovdnxl	2	29	countries	country	NNS
cord-314500-89ovdnxl	2	30	date	date	NN
cord-314500-89ovdnxl	2	31	:	:	:
cord-314500-89ovdnxl	2	32	2018	2018	CD
cord-314500-89ovdnxl	2	33	-	-	SYM
cord-314500-89ovdnxl	2	34	12	12	CD
cord-314500-89ovdnxl	2	35	-	-	HYPH
cord-314500-89ovdnxl	2	36	04	04	CD
cord-314500-89ovdnxl	2	37	journal	journal	NN
cord-314500-89ovdnxl	2	38	:	:	:
cord-314500-89ovdnxl	3	1	Trans	Trans	NNP
cord-314500-89ovdnxl	3	2	R	R	NNP
cord-314500-89ovdnxl	3	3	Soc	Soc	NNP
cord-314500-89ovdnxl	4	1	Trop	Trop	NNP
cord-314500-89ovdnxl	4	2	Med	Med	NNP
cord-314500-89ovdnxl	4	3	Hyg	Hyg	NNP
cord-314500-89ovdnxl	5	1	DOI	DOI	NNP
cord-314500-89ovdnxl	5	2	:	:	:
cord-314500-89ovdnxl	6	1	10.1093	10.1093	CD
cord-314500-89ovdnxl	6	2	/	/	SYM
cord-314500-89ovdnxl	6	3	trstmh	trstmh	NNP
cord-314500-89ovdnxl	6	4	/	/	SYM
cord-314500-89ovdnxl	6	5	try124	try124	NNP
cord-314500-89ovdnxl	6	6	sha	sha	NNP
cord-314500-89ovdnxl	6	7	:	:	:
cord-314500-89ovdnxl	6	8	3ddc728885c89c86d141cc470752c9b740894e53	3ddc728885c89c86d141cc470752c9b740894e53	NNP
cord-314500-89ovdnxl	6	9	doc_id	doc_id	CD
cord-314500-89ovdnxl	6	10	:	:	:
cord-314500-89ovdnxl	6	11	314500	314500	CD
cord-314500-89ovdnxl	6	12	cord_uid	cord_uid	NNS
cord-314500-89ovdnxl	6	13	:	:	:
cord-314500-89ovdnxl	7	1	89ovdnxl	89ovdnxl	CD
cord-314500-89ovdnxl	7	2	Four	four	CD
cord-314500-89ovdnxl	7	3	out	out	IN
cord-314500-89ovdnxl	7	4	of	of	IN
cord-314500-89ovdnxl	7	5	five	five	CD
cord-314500-89ovdnxl	7	6	people	people	NNS
cord-314500-89ovdnxl	7	7	in	in	IN
cord-314500-89ovdnxl	7	8	the	the	DT
cord-314500-89ovdnxl	7	9	world	world	NN
cord-314500-89ovdnxl	7	10	with	with	IN
cord-314500-89ovdnxl	7	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	7	12	now	now	RB
cord-314500-89ovdnxl	7	13	live	live	VBP
cord-314500-89ovdnxl	7	14	in	in	IN
cord-314500-89ovdnxl	7	15	low-	low-	NN
cord-314500-89ovdnxl	8	1	and	and	CC
cord-314500-89ovdnxl	8	2	middle	middle	JJ
cord-314500-89ovdnxl	8	3	-	-	HYPH
cord-314500-89ovdnxl	8	4	income	income	NN
cord-314500-89ovdnxl	8	5	countries	country	NNS
cord-314500-89ovdnxl	8	6	(	(	-LRB-
cord-314500-89ovdnxl	8	7	LMIC	LMIC	NNP
cord-314500-89ovdnxl	8	8	)	)	-RRB-
cord-314500-89ovdnxl	8	9	,	,	,
cord-314500-89ovdnxl	8	10	and	and	CC
cord-314500-89ovdnxl	8	11	the	the	DT
cord-314500-89ovdnxl	8	12	incidence	incidence	NN
cord-314500-89ovdnxl	8	13	of	of	IN
cord-314500-89ovdnxl	8	14	diabetes	diabetes	NN
cord-314500-89ovdnxl	8	15	is	be	VBZ
cord-314500-89ovdnxl	8	16	accelerating	accelerate	VBG
cord-314500-89ovdnxl	8	17	in	in	IN
cord-314500-89ovdnxl	8	18	poorer	poor	JJR
cord-314500-89ovdnxl	8	19	communities	community	NNS
cord-314500-89ovdnxl	8	20	.	.	.
cord-314500-89ovdnxl	9	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	9	2	increases	increase	VBZ
cord-314500-89ovdnxl	9	3	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	9	4	to	to	IN
cord-314500-89ovdnxl	9	5	infection	infection	NN
cord-314500-89ovdnxl	9	6	and	and	CC
cord-314500-89ovdnxl	9	7	worsens	worsen	VBZ
cord-314500-89ovdnxl	9	8	outcomes	outcome	NNS
cord-314500-89ovdnxl	9	9	for	for	IN
cord-314500-89ovdnxl	9	10	some	some	DT
cord-314500-89ovdnxl	9	11	of	of	IN
cord-314500-89ovdnxl	9	12	the	the	DT
cord-314500-89ovdnxl	9	13	world	world	NN
cord-314500-89ovdnxl	9	14	’s	’s	POS
cord-314500-89ovdnxl	9	15	major	major	JJ
cord-314500-89ovdnxl	9	16	infectious	infectious	JJ
cord-314500-89ovdnxl	9	17	diseases	disease	NNS
cord-314500-89ovdnxl	9	18	such	such	JJ
cord-314500-89ovdnxl	9	19	as	as	IN
cord-314500-89ovdnxl	9	20	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	9	21	,	,	,
cord-314500-89ovdnxl	9	22	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	9	23	and	and	CC
cord-314500-89ovdnxl	9	24	dengue	dengue	NN
cord-314500-89ovdnxl	9	25	,	,	,
cord-314500-89ovdnxl	9	26	but	but	CC
cord-314500-89ovdnxl	9	27	the	the	DT
cord-314500-89ovdnxl	9	28	relationship	relationship	NN
cord-314500-89ovdnxl	9	29	between	between	IN
cord-314500-89ovdnxl	9	30	diabetes	diabetes	NN
cord-314500-89ovdnxl	9	31	and	and	CC
cord-314500-89ovdnxl	9	32	many	many	JJ
cord-314500-89ovdnxl	9	33	neglected	neglect	VBN
cord-314500-89ovdnxl	9	34	tropical	tropical	JJ
cord-314500-89ovdnxl	9	35	diseases	disease	NNS
cord-314500-89ovdnxl	9	36	is	be	VBZ
cord-314500-89ovdnxl	9	37	yet	yet	RB
cord-314500-89ovdnxl	9	38	to	to	TO
cord-314500-89ovdnxl	9	39	be	be	VB
cord-314500-89ovdnxl	9	40	accurately	accurately	RB
cord-314500-89ovdnxl	9	41	characterised	characterise	VBN
cord-314500-89ovdnxl	9	42	.	.	.
cord-314500-89ovdnxl	10	1	There	there	EX
cord-314500-89ovdnxl	10	2	is	be	VBZ
cord-314500-89ovdnxl	10	3	some	some	DT
cord-314500-89ovdnxl	10	4	evidence	evidence	NN
cord-314500-89ovdnxl	10	5	that	that	IN
cord-314500-89ovdnxl	10	6	chronic	chronic	JJ
cord-314500-89ovdnxl	10	7	viral	viral	JJ
cord-314500-89ovdnxl	10	8	infections	infection	NNS
cord-314500-89ovdnxl	10	9	such	such	JJ
cord-314500-89ovdnxl	10	10	as	as	IN
cord-314500-89ovdnxl	10	11	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	10	12	B	B	NNP
cord-314500-89ovdnxl	10	13	and	and	CC
cord-314500-89ovdnxl	10	14	HIV	HIV	NNP
cord-314500-89ovdnxl	10	15	may	may	MD
cord-314500-89ovdnxl	10	16	predispose	predispose	VB
cord-314500-89ovdnxl	10	17	to	to	IN
cord-314500-89ovdnxl	10	18	the	the	DT
cord-314500-89ovdnxl	10	19	development	development	NN
cord-314500-89ovdnxl	10	20	of	of	IN
cord-314500-89ovdnxl	10	21	type	type	NN
cord-314500-89ovdnxl	10	22	2	2	CD
cord-314500-89ovdnxl	10	23	diabetes	diabete	NNS
cord-314500-89ovdnxl	10	24	by	by	IN
cord-314500-89ovdnxl	10	25	chronic	chronic	JJ
cord-314500-89ovdnxl	10	26	inflammatory	inflammatory	JJ
cord-314500-89ovdnxl	10	27	and	and	CC
cord-314500-89ovdnxl	10	28	immunometabolic	immunometabolic	JJ
cord-314500-89ovdnxl	10	29	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	10	30	.	.	.
cord-314500-89ovdnxl	11	1	Helminth	helminth	JJ
cord-314500-89ovdnxl	11	2	infections	infection	NNS
cord-314500-89ovdnxl	11	3	such	such	JJ
cord-314500-89ovdnxl	11	4	as	as	IN
cord-314500-89ovdnxl	11	5	schistosomiasis	schistosomiasis	NN
cord-314500-89ovdnxl	11	6	may	may	MD
cord-314500-89ovdnxl	11	7	be	be	VB
cord-314500-89ovdnxl	11	8	protective	protective	JJ
cord-314500-89ovdnxl	11	9	against	against	IN
cord-314500-89ovdnxl	11	10	the	the	DT
cord-314500-89ovdnxl	11	11	development	development	NN
cord-314500-89ovdnxl	11	12	of	of	IN
cord-314500-89ovdnxl	11	13	diabetes	diabetes	NN
cord-314500-89ovdnxl	11	14	,	,	,
cord-314500-89ovdnxl	11	15	and	and	CC
cord-314500-89ovdnxl	11	16	this	this	DT
cord-314500-89ovdnxl	11	17	finding	finding	NN
cord-314500-89ovdnxl	11	18	opens	open	VBZ
cord-314500-89ovdnxl	11	19	up	up	RP
cord-314500-89ovdnxl	11	20	new	new	JJ
cord-314500-89ovdnxl	11	21	territory	territory	NN
cord-314500-89ovdnxl	11	22	for	for	IN
cord-314500-89ovdnxl	11	23	discovery	discovery	NN
cord-314500-89ovdnxl	11	24	of	of	IN
cord-314500-89ovdnxl	11	25	novel	novel	JJ
cord-314500-89ovdnxl	11	26	therapeutics	therapeutic	NNS
cord-314500-89ovdnxl	11	27	for	for	IN
cord-314500-89ovdnxl	11	28	the	the	DT
cord-314500-89ovdnxl	11	29	prevention	prevention	NN
cord-314500-89ovdnxl	11	30	and	and	CC
cord-314500-89ovdnxl	11	31	treatment	treatment	NN
cord-314500-89ovdnxl	11	32	of	of	IN
cord-314500-89ovdnxl	11	33	diabetes	diabete	NNS
cord-314500-89ovdnxl	11	34	.	.	.
cord-314500-89ovdnxl	12	1	A	a	DT
cord-314500-89ovdnxl	12	2	greater	great	JJR
cord-314500-89ovdnxl	12	3	understanding	understanding	NN
cord-314500-89ovdnxl	12	4	of	of	IN
cord-314500-89ovdnxl	12	5	the	the	DT
cord-314500-89ovdnxl	12	6	impact	impact	NN
cord-314500-89ovdnxl	12	7	of	of	IN
cord-314500-89ovdnxl	12	8	diabetes	diabetes	NN
cord-314500-89ovdnxl	12	9	on	on	IN
cord-314500-89ovdnxl	12	10	risks	risk	NNS
cord-314500-89ovdnxl	12	11	and	and	CC
cord-314500-89ovdnxl	12	12	outcomes	outcome	NNS
cord-314500-89ovdnxl	12	13	for	for	IN
cord-314500-89ovdnxl	12	14	infections	infection	NNS
cord-314500-89ovdnxl	12	15	causing	cause	VBG
cord-314500-89ovdnxl	12	16	significant	significant	JJ
cord-314500-89ovdnxl	12	17	diseases	disease	NNS
cord-314500-89ovdnxl	12	18	in	in	IN
cord-314500-89ovdnxl	12	19	LMIC	LMIC	NNP
cord-314500-89ovdnxl	12	20	is	be	VBZ
cord-314500-89ovdnxl	12	21	essential	essential	JJ
cord-314500-89ovdnxl	12	22	in	in	IN
cord-314500-89ovdnxl	12	23	order	order	NN
cord-314500-89ovdnxl	12	24	to	to	TO
cord-314500-89ovdnxl	12	25	develop	develop	VB
cord-314500-89ovdnxl	12	26	vaccines	vaccine	NNS
cord-314500-89ovdnxl	12	27	and	and	CC
cord-314500-89ovdnxl	12	28	therapies	therapy	NNS
cord-314500-89ovdnxl	12	29	for	for	IN
cord-314500-89ovdnxl	12	30	the	the	DT
cord-314500-89ovdnxl	12	31	growing	grow	VBG
cord-314500-89ovdnxl	12	32	number	number	NN
cord-314500-89ovdnxl	12	33	of	of	IN
cord-314500-89ovdnxl	12	34	people	people	NNS
cord-314500-89ovdnxl	12	35	with	with	IN
cord-314500-89ovdnxl	12	36	diabetes	diabete	NNS
cord-314500-89ovdnxl	12	37	at	at	IN
cord-314500-89ovdnxl	12	38	risk	risk	NN
cord-314500-89ovdnxl	12	39	of	of	IN
cord-314500-89ovdnxl	12	40	infection	infection	NN
cord-314500-89ovdnxl	12	41	,	,	,
cord-314500-89ovdnxl	12	42	and	and	CC
cord-314500-89ovdnxl	12	43	to	to	TO
cord-314500-89ovdnxl	12	44	prioritise	prioritise	VB
cord-314500-89ovdnxl	12	45	research	research	NN
cord-314500-89ovdnxl	12	46	agendas	agenda	NNS
cord-314500-89ovdnxl	12	47	,	,	,
cord-314500-89ovdnxl	12	48	public	public	JJ
cord-314500-89ovdnxl	12	49	health	health	NN
cord-314500-89ovdnxl	12	50	interventions	intervention	NNS
cord-314500-89ovdnxl	12	51	and	and	CC
cord-314500-89ovdnxl	12	52	policy	policy	NN
cord-314500-89ovdnxl	12	53	.	.	.
cord-314500-89ovdnxl	13	1	This	this	DT
cord-314500-89ovdnxl	13	2	review	review	NN
cord-314500-89ovdnxl	13	3	seeks	seek	VBZ
cord-314500-89ovdnxl	13	4	to	to	TO
cord-314500-89ovdnxl	13	5	give	give	VB
cord-314500-89ovdnxl	13	6	an	an	DT
cord-314500-89ovdnxl	13	7	overview	overview	NN
cord-314500-89ovdnxl	13	8	of	of	IN
cord-314500-89ovdnxl	13	9	the	the	DT
cord-314500-89ovdnxl	13	10	current	current	JJ
cord-314500-89ovdnxl	13	11	international	international	JJ
cord-314500-89ovdnxl	13	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	13	13	burden	burden	NN
cord-314500-89ovdnxl	13	14	,	,	,
cord-314500-89ovdnxl	13	15	the	the	DT
cord-314500-89ovdnxl	13	16	evidence	evidence	NN
cord-314500-89ovdnxl	13	17	for	for	IN
cord-314500-89ovdnxl	13	18	interactions	interaction	NNS
cord-314500-89ovdnxl	13	19	between	between	IN
cord-314500-89ovdnxl	13	20	diabetes	diabetes	NN
cord-314500-89ovdnxl	13	21	and	and	CC
cord-314500-89ovdnxl	13	22	infection	infection	NN
cord-314500-89ovdnxl	13	23	,	,	,
cord-314500-89ovdnxl	13	24	immune	immune	JJ
cord-314500-89ovdnxl	13	25	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	13	26	for	for	IN
cord-314500-89ovdnxl	13	27	the	the	DT
cord-314500-89ovdnxl	13	28	interaction	interaction	NN
cord-314500-89ovdnxl	13	29	,	,	,
cord-314500-89ovdnxl	13	30	and	and	CC
cord-314500-89ovdnxl	13	31	potential	potential	JJ
cord-314500-89ovdnxl	13	32	interventions	intervention	NNS
cord-314500-89ovdnxl	13	33	to	to	TO
cord-314500-89ovdnxl	13	34	tackle	tackle	VB
cord-314500-89ovdnxl	13	35	the	the	DT
cord-314500-89ovdnxl	13	36	dual	dual	JJ
cord-314500-89ovdnxl	13	37	burden	burden	NN
cord-314500-89ovdnxl	13	38	of	of	IN
cord-314500-89ovdnxl	13	39	diabetes	diabetes	NN
cord-314500-89ovdnxl	13	40	and	and	CC
cord-314500-89ovdnxl	13	41	infection	infection	NN
cord-314500-89ovdnxl	13	42	.	.	.
cord-314500-89ovdnxl	14	1	There	there	EX
cord-314500-89ovdnxl	14	2	are	be	VBP
cord-314500-89ovdnxl	14	3	now	now	RB
cord-314500-89ovdnxl	14	4	336	336	CD
cord-314500-89ovdnxl	14	5	million	million	CD
cord-314500-89ovdnxl	14	6	people	people	NNS
cord-314500-89ovdnxl	14	7	with	with	IN
cord-314500-89ovdnxl	14	8	diabetes	diabete	NNS
cord-314500-89ovdnxl	14	9	living	live	VBG
cord-314500-89ovdnxl	14	10	in	in	IN
cord-314500-89ovdnxl	14	11	low	low	JJ
cord-314500-89ovdnxl	14	12	-	-	HYPH
cord-314500-89ovdnxl	14	13	and	and	CC
cord-314500-89ovdnxl	14	14	middle	middle	JJ
cord-314500-89ovdnxl	14	15	-	-	HYPH
cord-314500-89ovdnxl	14	16	income	income	NN
cord-314500-89ovdnxl	14	17	countries	country	NNS
cord-314500-89ovdnxl	14	18	(	(	-LRB-
cord-314500-89ovdnxl	14	19	LMIC	LMIC	NNP
cord-314500-89ovdnxl	14	20	)	)	-RRB-
cord-314500-89ovdnxl	14	21	.	.	.
cord-314500-89ovdnxl	15	1	1	1	CD
cord-314500-89ovdnxl	15	2	,	,	,
cord-314500-89ovdnxl	15	3	2	2	CD
cord-314500-89ovdnxl	15	4	Diabetes	diabetes	NN
cord-314500-89ovdnxl	15	5	increases	increase	VBZ
cord-314500-89ovdnxl	15	6	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	15	7	to	to	IN
cord-314500-89ovdnxl	15	8	infection	infection	NN
cord-314500-89ovdnxl	15	9	and	and	CC
cord-314500-89ovdnxl	15	10	worsens	worsen	VBZ
cord-314500-89ovdnxl	15	11	outcomes	outcome	NNS
cord-314500-89ovdnxl	15	12	for	for	IN
cord-314500-89ovdnxl	15	13	diseases	disease	NNS
cord-314500-89ovdnxl	15	14	such	such	JJ
cord-314500-89ovdnxl	15	15	as	as	IN
cord-314500-89ovdnxl	15	16	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	15	17	(	(	-LRB-
cord-314500-89ovdnxl	15	18	TB	TB	NNP
cord-314500-89ovdnxl	15	19	)	)	-RRB-
cord-314500-89ovdnxl	15	20	,	,	,
cord-314500-89ovdnxl	15	21	3	3	CD
cord-314500-89ovdnxl	15	22	and	and	CC
cord-314500-89ovdnxl	15	23	the	the	DT
cord-314500-89ovdnxl	15	24	under	under	RB
cord-314500-89ovdnxl	15	25	-	-	HYPH
cord-314500-89ovdnxl	15	26	recognised	recognise	VBN
cord-314500-89ovdnxl	15	27	tropical	tropical	JJ
cord-314500-89ovdnxl	15	28	disease	disease	NN
cord-314500-89ovdnxl	15	29	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	15	30	.	.	.
cord-314500-89ovdnxl	16	1	4	4	LS
cord-314500-89ovdnxl	16	2	,	,	,
cord-314500-89ovdnxl	16	3	5	5	CD
cord-314500-89ovdnxl	16	4	Current	current	JJ
cord-314500-89ovdnxl	16	5	international	international	JJ
cord-314500-89ovdnxl	16	6	treatment	treatment	NN
cord-314500-89ovdnxl	16	7	guidelines	guideline	NNS
cord-314500-89ovdnxl	16	8	for	for	IN
cord-314500-89ovdnxl	16	9	diabetes	diabete	NNS
cord-314500-89ovdnxl	16	10	are	be	VBP
cord-314500-89ovdnxl	16	11	based	base	VBN
cord-314500-89ovdnxl	16	12	on	on	IN
cord-314500-89ovdnxl	16	13	research	research	NN
cord-314500-89ovdnxl	16	14	conducted	conduct	VBN
cord-314500-89ovdnxl	16	15	in	in	IN
cord-314500-89ovdnxl	16	16	high	high	JJ
cord-314500-89ovdnxl	16	17	-	-	HYPH
cord-314500-89ovdnxl	16	18	income	income	NN
cord-314500-89ovdnxl	16	19	countries	country	NNS
cord-314500-89ovdnxl	16	20	focussed	focusse	VBN
cord-314500-89ovdnxl	16	21	on	on	IN
cord-314500-89ovdnxl	16	22	preventing	prevent	VBG
cord-314500-89ovdnxl	16	23	adverse	adverse	JJ
cord-314500-89ovdnxl	16	24	cardiovascular	cardiovascular	JJ
cord-314500-89ovdnxl	16	25	outcomes	outcome	NNS
cord-314500-89ovdnxl	16	26	and	and	CC
cord-314500-89ovdnxl	16	27	early	early	JJ
cord-314500-89ovdnxl	16	28	death	death	NN
cord-314500-89ovdnxl	16	29	.	.	.
cord-314500-89ovdnxl	17	1	There	there	EX
cord-314500-89ovdnxl	17	2	is	be	VBZ
cord-314500-89ovdnxl	17	3	a	a	DT
cord-314500-89ovdnxl	17	4	lack	lack	NN
cord-314500-89ovdnxl	17	5	of	of	IN
cord-314500-89ovdnxl	17	6	evidence	evidence	NN
cord-314500-89ovdnxl	17	7	upon	upon	IN
cord-314500-89ovdnxl	17	8	which	which	WDT
cord-314500-89ovdnxl	17	9	to	to	TO
cord-314500-89ovdnxl	17	10	base	base	VB
cord-314500-89ovdnxl	17	11	guidelines	guideline	NNS
cord-314500-89ovdnxl	17	12	for	for	IN
cord-314500-89ovdnxl	17	13	people	people	NNS
cord-314500-89ovdnxl	17	14	living	live	VBG
cord-314500-89ovdnxl	17	15	in	in	IN
cord-314500-89ovdnxl	17	16	LMIC	LMIC	NNP
cord-314500-89ovdnxl	17	17	,	,	,
cord-314500-89ovdnxl	17	18	where	where	WRB
cord-314500-89ovdnxl	17	19	there	there	EX
cord-314500-89ovdnxl	17	20	is	be	VBZ
cord-314500-89ovdnxl	17	21	an	an	DT
cord-314500-89ovdnxl	17	22	increased	increase	VBN
cord-314500-89ovdnxl	17	23	burden	burden	NN
cord-314500-89ovdnxl	17	24	of	of	IN
cord-314500-89ovdnxl	17	25	infectious	infectious	JJ
cord-314500-89ovdnxl	17	26	diseases	disease	NNS
cord-314500-89ovdnxl	17	27	compared	compare	VBN
cord-314500-89ovdnxl	17	28	with	with	IN
cord-314500-89ovdnxl	17	29	high	high	JJ
cord-314500-89ovdnxl	17	30	income	income	NN
cord-314500-89ovdnxl	17	31	countries	country	NNS
cord-314500-89ovdnxl	17	32	.	.	.
cord-314500-89ovdnxl	18	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	18	2	has	have	VBZ
cord-314500-89ovdnxl	18	3	traditionally	traditionally	RB
cord-314500-89ovdnxl	18	4	been	be	VBN
cord-314500-89ovdnxl	18	5	viewed	view	VBN
cord-314500-89ovdnxl	18	6	as	as	IN
cord-314500-89ovdnxl	18	7	a	a	DT
cord-314500-89ovdnxl	18	8	'	'	``
cord-314500-89ovdnxl	18	9	disease	disease	NN
cord-314500-89ovdnxl	18	10	of	of	IN
cord-314500-89ovdnxl	18	11	the	the	DT
cord-314500-89ovdnxl	18	12	wealthy	wealthy	JJ
cord-314500-89ovdnxl	18	13	'	'	''
cord-314500-89ovdnxl	18	14	,	,	,
cord-314500-89ovdnxl	18	15	mostly	mostly	RB
cord-314500-89ovdnxl	18	16	found	find	VBN
cord-314500-89ovdnxl	18	17	among	among	IN
cord-314500-89ovdnxl	18	18	elderly	elderly	JJ
cord-314500-89ovdnxl	18	19	people	people	NNS
cord-314500-89ovdnxl	18	20	in	in	IN
cord-314500-89ovdnxl	18	21	developed	develop	VBN
cord-314500-89ovdnxl	18	22	countries	country	NNS
cord-314500-89ovdnxl	18	23	.	.	.
cord-314500-89ovdnxl	19	1	Now	now	RB
cord-314500-89ovdnxl	19	2	,	,	,
cord-314500-89ovdnxl	19	3	however	however	RB
cord-314500-89ovdnxl	19	4	,	,	,
cord-314500-89ovdnxl	19	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	19	6	affects	affect	VBZ
cord-314500-89ovdnxl	19	7	every	every	DT
cord-314500-89ovdnxl	19	8	strata	strata	NN
cord-314500-89ovdnxl	19	9	of	of	IN
cord-314500-89ovdnxl	19	10	society	society	NN
cord-314500-89ovdnxl	19	11	,	,	,
cord-314500-89ovdnxl	19	12	and	and	CC
cord-314500-89ovdnxl	19	13	has	have	VBZ
cord-314500-89ovdnxl	19	14	become	become	VBN
cord-314500-89ovdnxl	19	15	a	a	DT
cord-314500-89ovdnxl	19	16	fast	fast	RB
cord-314500-89ovdnxl	19	17	-	-	HYPH
cord-314500-89ovdnxl	19	18	growing	grow	VBG
cord-314500-89ovdnxl	19	19	problem	problem	NN
cord-314500-89ovdnxl	19	20	in	in	IN
cord-314500-89ovdnxl	19	21	poorer	poor	JJR
cord-314500-89ovdnxl	19	22	communities	community	NNS
cord-314500-89ovdnxl	19	23	.	.	.
cord-314500-89ovdnxl	20	1	The	the	DT
cord-314500-89ovdnxl	20	2	Global	Global	NNP
cord-314500-89ovdnxl	20	3	Burden	Burden	NNP
cord-314500-89ovdnxl	20	4	of	of	IN
cord-314500-89ovdnxl	20	5	Disease	Disease	NNP
cord-314500-89ovdnxl	20	6	(	(	-LRB-
cord-314500-89ovdnxl	20	7	GBD	GBD	NNP
cord-314500-89ovdnxl	20	8	)	)	-RRB-
cord-314500-89ovdnxl	20	9	study	study	NN
cord-314500-89ovdnxl	20	10	estimated	estimate	VBN
cord-314500-89ovdnxl	21	1	there	there	EX
cord-314500-89ovdnxl	21	2	were	be	VBD
cord-314500-89ovdnxl	21	3	1.4	1.4	CD
cord-314500-89ovdnxl	21	4	million	million	CD
cord-314500-89ovdnxl	21	5	deaths	death	NNS
cord-314500-89ovdnxl	21	6	worldwide	worldwide	RB
cord-314500-89ovdnxl	21	7	from	from	IN
cord-314500-89ovdnxl	21	8	diabetes	diabetes	NN
cord-314500-89ovdnxl	21	9	in	in	IN
cord-314500-89ovdnxl	21	10	2016	2016	CD
cord-314500-89ovdnxl	21	11	,	,	,
cord-314500-89ovdnxl	21	12	6	6	CD
cord-314500-89ovdnxl	21	13	representing	represent	VBG
cord-314500-89ovdnxl	21	14	a	a	DT
cord-314500-89ovdnxl	21	15	31	31	CD
cord-314500-89ovdnxl	21	16	%	%	NN
cord-314500-89ovdnxl	21	17	increase	increase	NN
cord-314500-89ovdnxl	21	18	from	from	IN
cord-314500-89ovdnxl	21	19	2006	2006	CD
cord-314500-89ovdnxl	21	20	.	.	.
cord-314500-89ovdnxl	22	1	Of	of	IN
cord-314500-89ovdnxl	22	2	the	the	DT
cord-314500-89ovdnxl	22	3	estimated	estimate	VBN
cord-314500-89ovdnxl	22	4	425	425	CD
cord-314500-89ovdnxl	22	5	million	million	CD
cord-314500-89ovdnxl	22	6	people	people	NNS
cord-314500-89ovdnxl	22	7	with	with	IN
cord-314500-89ovdnxl	22	8	diabetes	diabetes	NN
cord-314500-89ovdnxl	22	9	worldwide	worldwide	RB
cord-314500-89ovdnxl	22	10	,	,	,
cord-314500-89ovdnxl	22	11	four	four	CD
cord-314500-89ovdnxl	22	12	-	-	HYPH
cord-314500-89ovdnxl	22	13	fifths	fifth	NNS
cord-314500-89ovdnxl	22	14	currently	currently	RB
cord-314500-89ovdnxl	22	15	live	live	VBP
cord-314500-89ovdnxl	22	16	in	in	IN
cord-314500-89ovdnxl	22	17	LMIC	LMIC	NNP
cord-314500-89ovdnxl	22	18	and	and	CC
cord-314500-89ovdnxl	22	19	increasing	increase	VBG
cord-314500-89ovdnxl	22	20	numbers	number	NNS
cord-314500-89ovdnxl	22	21	of	of	IN
cord-314500-89ovdnxl	22	22	children	child	NNS
cord-314500-89ovdnxl	22	23	and	and	CC
cord-314500-89ovdnxl	22	24	young	young	JJ
cord-314500-89ovdnxl	22	25	adults	adult	NNS
cord-314500-89ovdnxl	22	26	have	have	VBP
cord-314500-89ovdnxl	22	27	been	be	VBN
cord-314500-89ovdnxl	22	28	diagnosed	diagnose	VBN
cord-314500-89ovdnxl	22	29	with	with	IN
cord-314500-89ovdnxl	22	30	the	the	DT
cord-314500-89ovdnxl	22	31	disease	disease	NN
cord-314500-89ovdnxl	22	32	.	.	.
cord-314500-89ovdnxl	23	1	1	1	LS
cord-314500-89ovdnxl	24	1	This	this	DT
cord-314500-89ovdnxl	24	2	number	number	NN
cord-314500-89ovdnxl	24	3	is	be	VBZ
cord-314500-89ovdnxl	24	4	projected	project	VBN
cord-314500-89ovdnxl	24	5	to	to	TO
cord-314500-89ovdnxl	24	6	increase	increase	VB
cord-314500-89ovdnxl	24	7	to	to	IN
cord-314500-89ovdnxl	24	8	629	629	CD
cord-314500-89ovdnxl	24	9	million	million	CD
cord-314500-89ovdnxl	24	10	by	by	IN
cord-314500-89ovdnxl	24	11	2045	2045	CD
cord-314500-89ovdnxl	24	12	,	,	,
cord-314500-89ovdnxl	24	13	and	and	CC
cord-314500-89ovdnxl	24	14	most	most	JJS
cord-314500-89ovdnxl	24	15	of	of	IN
cord-314500-89ovdnxl	24	16	the	the	DT
cord-314500-89ovdnxl	24	17	rising	rise	VBG
cord-314500-89ovdnxl	24	18	burden	burden	NN
cord-314500-89ovdnxl	24	19	will	will	MD
cord-314500-89ovdnxl	24	20	occur	occur	VB
cord-314500-89ovdnxl	24	21	in	in	IN
cord-314500-89ovdnxl	24	22	LMIC	LMIC	NNP
cord-314500-89ovdnxl	24	23	(	(	-LRB-
cord-314500-89ovdnxl	24	24	Figure	figure	NN
cord-314500-89ovdnxl	24	25	1	1	CD
cord-314500-89ovdnxl	24	26	)	)	-RRB-
cord-314500-89ovdnxl	24	27	.	.	.
cord-314500-89ovdnxl	25	1	In	in	IN
cord-314500-89ovdnxl	25	2	addition	addition	NN
cord-314500-89ovdnxl	25	3	,	,	,
cord-314500-89ovdnxl	25	4	diabetes	diabetes	NN
cord-314500-89ovdnxl	25	5	is	be	VBZ
cord-314500-89ovdnxl	25	6	more	more	RBR
cord-314500-89ovdnxl	25	7	likely	likely	JJ
cord-314500-89ovdnxl	25	8	to	to	TO
cord-314500-89ovdnxl	25	9	be	be	VB
cord-314500-89ovdnxl	25	10	undiagnosed	undiagnosed	JJ
cord-314500-89ovdnxl	25	11	or	or	CC
cord-314500-89ovdnxl	25	12	poorly	poorly	RB
cord-314500-89ovdnxl	25	13	treated	treat	VBN
cord-314500-89ovdnxl	25	14	in	in	IN
cord-314500-89ovdnxl	25	15	LMIC	LMIC	NNP
cord-314500-89ovdnxl	25	16	.	.	.
cord-314500-89ovdnxl	26	1	1	1	CD
cord-314500-89ovdnxl	26	2	Data	datum	NNS
cord-314500-89ovdnxl	26	3	from	from	IN
cord-314500-89ovdnxl	26	4	the	the	DT
cord-314500-89ovdnxl	26	5	NCD	NCD	NNP
cord-314500-89ovdnxl	26	6	Risk	Risk	NNP
cord-314500-89ovdnxl	26	7	Factor	Factor	NNP
cord-314500-89ovdnxl	26	8	Collaboration	Collaboration	NNP
cord-314500-89ovdnxl	26	9	2	2	CD
cord-314500-89ovdnxl	26	10	show	show	VBP
cord-314500-89ovdnxl	26	11	that	that	IN
cord-314500-89ovdnxl	26	12	agestandardised	agestandardised	JJ
cord-314500-89ovdnxl	26	13	diabetes	diabetes	NN
cord-314500-89ovdnxl	26	14	prevalence	prevalence	NN
cord-314500-89ovdnxl	26	15	in	in	IN
cord-314500-89ovdnxl	26	16	adults	adult	NNS
cord-314500-89ovdnxl	26	17	has	have	VBZ
cord-314500-89ovdnxl	26	18	increased	increase	VBN
cord-314500-89ovdnxl	26	19	or	or	CC
cord-314500-89ovdnxl	26	20	remained	remain	VBD
cord-314500-89ovdnxl	26	21	unchanged	unchanged	JJ
cord-314500-89ovdnxl	26	22	since	since	IN
cord-314500-89ovdnxl	26	23	1980	1980	CD
cord-314500-89ovdnxl	26	24	in	in	IN
cord-314500-89ovdnxl	26	25	every	every	DT
cord-314500-89ovdnxl	26	26	country	country	NN
cord-314500-89ovdnxl	26	27	.	.	.
cord-314500-89ovdnxl	27	1	2	2	LS
cord-314500-89ovdnxl	28	1	Importantly	importantly	RB
cord-314500-89ovdnxl	28	2	,	,	,
cord-314500-89ovdnxl	28	3	the	the	DT
cord-314500-89ovdnxl	28	4	burden	burden	NN
cord-314500-89ovdnxl	28	5	of	of	IN
cord-314500-89ovdnxl	28	6	diabetes	diabetes	NN
cord-314500-89ovdnxl	28	7	has	have	VBZ
cord-314500-89ovdnxl	28	8	increased	increase	VBN
cord-314500-89ovdnxl	28	9	faster	fast	RBR
cord-314500-89ovdnxl	28	10	in	in	IN
cord-314500-89ovdnxl	28	11	LMIC	LMIC	NNP
cord-314500-89ovdnxl	28	12	than	than	IN
cord-314500-89ovdnxl	28	13	in	in	IN
cord-314500-89ovdnxl	28	14	high	high	JJ
cord-314500-89ovdnxl	28	15	-	-	HYPH
cord-314500-89ovdnxl	28	16	income	income	NN
cord-314500-89ovdnxl	28	17	countries	country	NNS
cord-314500-89ovdnxl	28	18	.	.	.
cord-314500-89ovdnxl	29	1	2	2	LS
cord-314500-89ovdnxl	30	1	This	this	DT
cord-314500-89ovdnxl	30	2	rising	rise	VBG
cord-314500-89ovdnxl	30	3	prevalence	prevalence	NN
cord-314500-89ovdnxl	30	4	of	of	IN
cord-314500-89ovdnxl	30	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	30	6	in	in	IN
cord-314500-89ovdnxl	30	7	LMIC	LMIC	NNP
cord-314500-89ovdnxl	30	8	is	be	VBZ
cord-314500-89ovdnxl	30	9	believed	believe	VBN
cord-314500-89ovdnxl	30	10	to	to	TO
cord-314500-89ovdnxl	30	11	be	be	VB
cord-314500-89ovdnxl	30	12	associated	associate	VBN
cord-314500-89ovdnxl	30	13	with	with	IN
cord-314500-89ovdnxl	30	14	many	many	JJ
cord-314500-89ovdnxl	30	15	factors	factor	NNS
cord-314500-89ovdnxl	30	16	,	,	,
cord-314500-89ovdnxl	30	17	including	include	VBG
cord-314500-89ovdnxl	30	18	ageing	age	VBG
cord-314500-89ovdnxl	30	19	populations	population	NNS
cord-314500-89ovdnxl	30	20	,	,	,
cord-314500-89ovdnxl	30	21	urbanisation	urbanisation	NN
cord-314500-89ovdnxl	30	22	,	,	,
cord-314500-89ovdnxl	30	23	cultural	cultural	JJ
cord-314500-89ovdnxl	30	24	and	and	CC
cord-314500-89ovdnxl	30	25	social	social	JJ
cord-314500-89ovdnxl	30	26	changes	change	NNS
cord-314500-89ovdnxl	30	27	,	,	,
cord-314500-89ovdnxl	30	28	dietary	dietary	JJ
cord-314500-89ovdnxl	30	29	changes	change	NNS
cord-314500-89ovdnxl	30	30	,	,	,
cord-314500-89ovdnxl	30	31	physical	physical	JJ
cord-314500-89ovdnxl	30	32	inactivity	inactivity	NN
cord-314500-89ovdnxl	30	33	,	,	,
cord-314500-89ovdnxl	30	34	changes	change	NNS
cord-314500-89ovdnxl	30	35	in	in	IN
cord-314500-89ovdnxl	30	36	diagnostic	diagnostic	JJ
cord-314500-89ovdnxl	30	37	criteria	criterion	NNS
cord-314500-89ovdnxl	30	38	and	and	CC
cord-314500-89ovdnxl	30	39	screening	screening	NN
cord-314500-89ovdnxl	30	40	practices	practice	NNS
cord-314500-89ovdnxl	30	41	,	,	,
cord-314500-89ovdnxl	30	42	better	well	JJR
cord-314500-89ovdnxl	30	43	treatment	treatment	NN
cord-314500-89ovdnxl	30	44	and	and	CC
cord-314500-89ovdnxl	30	45	survival	survival	NN
cord-314500-89ovdnxl	30	46	,	,	,
cord-314500-89ovdnxl	30	47	and	and	CC
cord-314500-89ovdnxl	30	48	increasing	increase	VBG
cord-314500-89ovdnxl	30	49	trends	trend	NNS
cord-314500-89ovdnxl	30	50	in	in	IN
cord-314500-89ovdnxl	30	51	overweight	overweight	NN
cord-314500-89ovdnxl	30	52	and	and	CC
cord-314500-89ovdnxl	30	53	obesity	obesity	NN
cord-314500-89ovdnxl	30	54	.	.	.
cord-314500-89ovdnxl	31	1	Classification	classification	NN
cord-314500-89ovdnxl	31	2	of	of	IN
cord-314500-89ovdnxl	31	3	diabetes	diabetes	NN
cord-314500-89ovdnxl	31	4	Table	Table	NNP
cord-314500-89ovdnxl	31	5	1	1	CD
cord-314500-89ovdnxl	31	6	shows	show	VBZ
cord-314500-89ovdnxl	31	7	the	the	DT
cord-314500-89ovdnxl	31	8	current	current	JJ
cord-314500-89ovdnxl	31	9	classification	classification	NN
cord-314500-89ovdnxl	31	10	of	of	IN
cord-314500-89ovdnxl	31	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	31	12	by	by	IN
cord-314500-89ovdnxl	31	13	WHO	WHO	NNP
cord-314500-89ovdnxl	31	14	and	and	CC
cord-314500-89ovdnxl	31	15	the	the	DT
cord-314500-89ovdnxl	31	16	American	American	NNP
cord-314500-89ovdnxl	31	17	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	31	18	Association	Association	NNP
cord-314500-89ovdnxl	31	19	(	(	-LRB-
cord-314500-89ovdnxl	31	20	ADA	ADA	NNP
cord-314500-89ovdnxl	31	21	)	)	-RRB-
cord-314500-89ovdnxl	31	22	,	,	,
cord-314500-89ovdnxl	31	23	7	7	CD
cord-314500-89ovdnxl	31	24	,	,	,
cord-314500-89ovdnxl	31	25	8	8	CD
cord-314500-89ovdnxl	31	26	which	which	WDT
cord-314500-89ovdnxl	31	27	includes	include	VBZ
cord-314500-89ovdnxl	31	28	four	four	CD
cord-314500-89ovdnxl	31	29	clinical	clinical	JJ
cord-314500-89ovdnxl	31	30	and	and	CC
cord-314500-89ovdnxl	31	31	aetiological	aetiological	JJ
cord-314500-89ovdnxl	31	32	classes	class	NNS
cord-314500-89ovdnxl	31	33	:	:	:
cord-314500-89ovdnxl	31	34	type	type	NN
cord-314500-89ovdnxl	31	35	1	1	CD
cord-314500-89ovdnxl	31	36	diabetes	diabetes	NN
cord-314500-89ovdnxl	31	37	(	(	-LRB-
cord-314500-89ovdnxl	31	38	T1DM	T1DM	NNP
cord-314500-89ovdnxl	31	39	)	)	-RRB-
cord-314500-89ovdnxl	31	40	,	,	,
cord-314500-89ovdnxl	31	41	type	type	NN
cord-314500-89ovdnxl	31	42	2	2	CD
cord-314500-89ovdnxl	31	43	diabetes	diabetes	NN
cord-314500-89ovdnxl	31	44	(	(	-LRB-
cord-314500-89ovdnxl	31	45	T2DM	T2DM	NNP
cord-314500-89ovdnxl	31	46	)	)	-RRB-
cord-314500-89ovdnxl	31	47	,	,	,
cord-314500-89ovdnxl	31	48	gestational	gestational	JJ
cord-314500-89ovdnxl	31	49	diabetes	diabetes	NN
cord-314500-89ovdnxl	31	50	mellitus	mellitus	NN
cord-314500-89ovdnxl	31	51	,	,	,
cord-314500-89ovdnxl	31	52	and	and	CC
cord-314500-89ovdnxl	31	53	other	other	JJ
cord-314500-89ovdnxl	31	54	specific	specific	JJ
cord-314500-89ovdnxl	31	55	types	type	NNS
cord-314500-89ovdnxl	31	56	of	of	IN
cord-314500-89ovdnxl	31	57	diabetes	diabete	NNS
cord-314500-89ovdnxl	31	58	due	due	IN
cord-314500-89ovdnxl	31	59	to	to	IN
cord-314500-89ovdnxl	31	60	other	other	JJ
cord-314500-89ovdnxl	31	61	causes	cause	NNS
cord-314500-89ovdnxl	31	62	.	.	.
cord-314500-89ovdnxl	32	1	T1DM	T1DM	NNP
cord-314500-89ovdnxl	32	2	is	be	VBZ
cord-314500-89ovdnxl	32	3	caused	cause	VBN
cord-314500-89ovdnxl	32	4	by	by	IN
cord-314500-89ovdnxl	32	5	an	an	DT
cord-314500-89ovdnxl	32	6	autoimmune	autoimmune	JJ
cord-314500-89ovdnxl	32	7	reaction	reaction	NN
cord-314500-89ovdnxl	32	8	which	which	WDT
cord-314500-89ovdnxl	32	9	destroys	destroy	VBZ
cord-314500-89ovdnxl	32	10	the	the	DT
cord-314500-89ovdnxl	32	11	insulin	insulin	NN
cord-314500-89ovdnxl	32	12	-	-	HYPH
cord-314500-89ovdnxl	32	13	producing	produce	VBG
cord-314500-89ovdnxl	32	14	beta	beta	NN
cord-314500-89ovdnxl	32	15	cells	cell	NNS
cord-314500-89ovdnxl	32	16	in	in	IN
cord-314500-89ovdnxl	32	17	the	the	DT
cord-314500-89ovdnxl	32	18	islets	islet	NNS
cord-314500-89ovdnxl	32	19	of	of	IN
cord-314500-89ovdnxl	32	20	the	the	DT
cord-314500-89ovdnxl	32	21	pancreas	pancrea	NNS
cord-314500-89ovdnxl	32	22	,	,	,
cord-314500-89ovdnxl	32	23	leading	lead	VBG
cord-314500-89ovdnxl	32	24	to	to	IN
cord-314500-89ovdnxl	32	25	no	no	DT
cord-314500-89ovdnxl	32	26	or	or	CC
cord-314500-89ovdnxl	32	27	low	low	JJ
cord-314500-89ovdnxl	32	28	production	production	NN
cord-314500-89ovdnxl	32	29	of	of	IN
cord-314500-89ovdnxl	32	30	insulin	insulin	NN
cord-314500-89ovdnxl	32	31	.	.	.
cord-314500-89ovdnxl	33	1	T2DM	T2DM	NNP
cord-314500-89ovdnxl	33	2	is	be	VBZ
cord-314500-89ovdnxl	33	3	the	the	DT
cord-314500-89ovdnxl	33	4	most	most	RBS
cord-314500-89ovdnxl	33	5	common	common	JJ
cord-314500-89ovdnxl	33	6	type	type	NN
cord-314500-89ovdnxl	33	7	of	of	IN
cord-314500-89ovdnxl	33	8	diabetes	diabetes	NN
cord-314500-89ovdnxl	33	9	,	,	,
cord-314500-89ovdnxl	33	10	accounting	account	VBG
cord-314500-89ovdnxl	33	11	for	for	IN
cord-314500-89ovdnxl	33	12	approximately	approximately	RB
cord-314500-89ovdnxl	33	13	90	90	CD
cord-314500-89ovdnxl	33	14	%	%	NN
cord-314500-89ovdnxl	33	15	of	of	IN
cord-314500-89ovdnxl	33	16	all	all	DT
cord-314500-89ovdnxl	33	17	cases	case	NNS
cord-314500-89ovdnxl	33	18	of	of	IN
cord-314500-89ovdnxl	33	19	diabetes	diabetes	NN
cord-314500-89ovdnxl	33	20	worldwide	worldwide	RB
cord-314500-89ovdnxl	33	21	.	.	.
cord-314500-89ovdnxl	34	1	1	1	LS
cord-314500-89ovdnxl	35	1	It	-PRON-	PRP
cord-314500-89ovdnxl	35	2	is	be	VBZ
cord-314500-89ovdnxl	35	3	characterised	characterise	VBN
cord-314500-89ovdnxl	35	4	by	by	IN
cord-314500-89ovdnxl	35	5	an	an	DT
cord-314500-89ovdnxl	35	6	inadequate	inadequate	JJ
cord-314500-89ovdnxl	35	7	production	production	NN
cord-314500-89ovdnxl	35	8	of	of	IN
cord-314500-89ovdnxl	35	9	insulin	insulin	NN
cord-314500-89ovdnxl	35	10	and	and	CC
cord-314500-89ovdnxl	35	11	an	an	DT
cord-314500-89ovdnxl	35	12	inability	inability	NN
cord-314500-89ovdnxl	35	13	of	of	IN
cord-314500-89ovdnxl	35	14	the	the	DT
cord-314500-89ovdnxl	35	15	body	body	NN
cord-314500-89ovdnxl	35	16	to	to	TO
cord-314500-89ovdnxl	35	17	respond	respond	VB
cord-314500-89ovdnxl	35	18	fully	fully	RB
cord-314500-89ovdnxl	35	19	to	to	IN
cord-314500-89ovdnxl	35	20	insulin	insulin	NN
cord-314500-89ovdnxl	35	21	,	,	,
cord-314500-89ovdnxl	35	22	defined	define	VBN
cord-314500-89ovdnxl	35	23	as	as	IN
cord-314500-89ovdnxl	35	24	insulin	insulin	NN
cord-314500-89ovdnxl	35	25	resistance	resistance	NN
cord-314500-89ovdnxl	35	26	.	.	.
cord-314500-89ovdnxl	36	1	It	-PRON-	PRP
cord-314500-89ovdnxl	36	2	is	be	VBZ
cord-314500-89ovdnxl	36	3	important	important	JJ
cord-314500-89ovdnxl	36	4	to	to	TO
cord-314500-89ovdnxl	36	5	note	note	VB
cord-314500-89ovdnxl	36	6	that	that	IN
cord-314500-89ovdnxl	36	7	assigning	assign	VBG
cord-314500-89ovdnxl	36	8	a	a	DT
cord-314500-89ovdnxl	36	9	type	type	NN
cord-314500-89ovdnxl	36	10	of	of	IN
cord-314500-89ovdnxl	36	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	36	12	to	to	IN
cord-314500-89ovdnxl	36	13	an	an	DT
cord-314500-89ovdnxl	36	14	individual	individual	NN
cord-314500-89ovdnxl	36	15	is	be	VBZ
cord-314500-89ovdnxl	36	16	often	often	RB
cord-314500-89ovdnxl	36	17	reliant	reliant	JJ
cord-314500-89ovdnxl	36	18	on	on	IN
cord-314500-89ovdnxl	36	19	the	the	DT
cord-314500-89ovdnxl	36	20	circumstances	circumstance	NNS
cord-314500-89ovdnxl	36	21	present	present	JJ
cord-314500-89ovdnxl	36	22	and	and	CC
cord-314500-89ovdnxl	36	23	additional	additional	JJ
cord-314500-89ovdnxl	36	24	testing	testing	NN
cord-314500-89ovdnxl	36	25	at	at	IN
cord-314500-89ovdnxl	36	26	the	the	DT
cord-314500-89ovdnxl	36	27	time	time	NN
cord-314500-89ovdnxl	36	28	of	of	IN
cord-314500-89ovdnxl	36	29	diagnosis	diagnosis	NN
cord-314500-89ovdnxl	36	30	,	,	,
cord-314500-89ovdnxl	36	31	and	and	CC
cord-314500-89ovdnxl	36	32	that	that	IN
cord-314500-89ovdnxl	36	33	many	many	JJ
cord-314500-89ovdnxl	36	34	patients	patient	NNS
cord-314500-89ovdnxl	36	35	with	with	IN
cord-314500-89ovdnxl	36	36	diabetes	diabete	NNS
cord-314500-89ovdnxl	36	37	do	do	VBP
cord-314500-89ovdnxl	36	38	not	not	RB
cord-314500-89ovdnxl	36	39	easily	easily	RB
cord-314500-89ovdnxl	36	40	fit	fit	VB
cord-314500-89ovdnxl	36	41	into	into	IN
cord-314500-89ovdnxl	36	42	a	a	DT
cord-314500-89ovdnxl	36	43	single	single	JJ
cord-314500-89ovdnxl	36	44	class	class	NN
cord-314500-89ovdnxl	36	45	.	.	.
cord-314500-89ovdnxl	37	1	In	in	IN
cord-314500-89ovdnxl	37	2	LMIC	LMIC	NNP
cord-314500-89ovdnxl	37	3	,	,	,
cord-314500-89ovdnxl	37	4	it	-PRON-	PRP
cord-314500-89ovdnxl	37	5	is	be	VBZ
cord-314500-89ovdnxl	37	6	often	often	RB
cord-314500-89ovdnxl	37	7	unknown	unknown	JJ
cord-314500-89ovdnxl	37	8	which	which	WDT
cord-314500-89ovdnxl	37	9	type	type	NN
cord-314500-89ovdnxl	37	10	of	of	IN
cord-314500-89ovdnxl	37	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	37	12	a	a	DT
cord-314500-89ovdnxl	37	13	person	person	NN
cord-314500-89ovdnxl	37	14	has	have	VBZ
cord-314500-89ovdnxl	37	15	,	,	,
cord-314500-89ovdnxl	37	16	and	and	CC
cord-314500-89ovdnxl	37	17	therefore	therefore	RB
cord-314500-89ovdnxl	37	18	this	this	DT
cord-314500-89ovdnxl	37	19	review	review	NN
cord-314500-89ovdnxl	37	20	will	will	MD
cord-314500-89ovdnxl	37	21	use	use	VB
cord-314500-89ovdnxl	37	22	the	the	DT
cord-314500-89ovdnxl	37	23	general	general	JJ
cord-314500-89ovdnxl	37	24	term	term	NN
cord-314500-89ovdnxl	37	25	'	'	``
cord-314500-89ovdnxl	37	26	diabetes	diabetes	NN
cord-314500-89ovdnxl	37	27	'	'	''
cord-314500-89ovdnxl	37	28	,	,	,
cord-314500-89ovdnxl	37	29	but	but	CC
cord-314500-89ovdnxl	37	30	>	>	XX
cord-314500-89ovdnxl	38	1	90	90	CD
cord-314500-89ovdnxl	38	2	%	%	NN
cord-314500-89ovdnxl	38	3	of	of	IN
cord-314500-89ovdnxl	38	4	patients	patient	NNS
cord-314500-89ovdnxl	38	5	with	with	IN
cord-314500-89ovdnxl	38	6	diabetes	diabete	NNS
cord-314500-89ovdnxl	38	7	in	in	IN
cord-314500-89ovdnxl	38	8	LMIC	LMIC	NNP
cord-314500-89ovdnxl	38	9	are	be	VBP
cord-314500-89ovdnxl	38	10	believed	believe	VBN
cord-314500-89ovdnxl	38	11	to	to	TO
cord-314500-89ovdnxl	38	12	have	have	VB
cord-314500-89ovdnxl	38	13	T2DM	T2DM	NNP
cord-314500-89ovdnxl	38	14	.	.	.
cord-314500-89ovdnxl	39	1	1	1	CD
cord-314500-89ovdnxl	39	2	Table	Table	NNP
cord-314500-89ovdnxl	39	3	2	2	CD
cord-314500-89ovdnxl	39	4	summarises	summarise	VBZ
cord-314500-89ovdnxl	39	5	the	the	DT
cord-314500-89ovdnxl	39	6	modifiable	modifiable	JJ
cord-314500-89ovdnxl	39	7	and	and	CC
cord-314500-89ovdnxl	39	8	non	non	JJ
cord-314500-89ovdnxl	39	9	-	-	JJ
cord-314500-89ovdnxl	39	10	modifiable	modifiable	JJ
cord-314500-89ovdnxl	39	11	risk	risk	NN
cord-314500-89ovdnxl	39	12	factors	factor	NNS
cord-314500-89ovdnxl	39	13	for	for	IN
cord-314500-89ovdnxl	39	14	T2DM	T2DM	NNP
cord-314500-89ovdnxl	39	15	,	,	,
cord-314500-89ovdnxl	39	16	which	which	WDT
cord-314500-89ovdnxl	39	17	is	be	VBZ
cord-314500-89ovdnxl	39	18	a	a	DT
cord-314500-89ovdnxl	39	19	disease	disease	NN
cord-314500-89ovdnxl	39	20	caused	cause	VBN
cord-314500-89ovdnxl	39	21	by	by	IN
cord-314500-89ovdnxl	39	22	a	a	DT
cord-314500-89ovdnxl	39	23	complex	complex	JJ
cord-314500-89ovdnxl	39	24	interplay	interplay	NN
cord-314500-89ovdnxl	39	25	between	between	IN
cord-314500-89ovdnxl	39	26	genetic	genetic	JJ
cord-314500-89ovdnxl	39	27	and	and	CC
cord-314500-89ovdnxl	39	28	environmental	environmental	JJ
cord-314500-89ovdnxl	39	29	factors	factor	NNS
cord-314500-89ovdnxl	39	30	.	.	.
cord-314500-89ovdnxl	40	1	9	9	CD
cord-314500-89ovdnxl	41	1	The	the	DT
cord-314500-89ovdnxl	41	2	rapid	rapid	JJ
cord-314500-89ovdnxl	41	3	increase	increase	NN
cord-314500-89ovdnxl	41	4	in	in	IN
cord-314500-89ovdnxl	41	5	the	the	DT
cord-314500-89ovdnxl	41	6	prevalence	prevalence	NN
cord-314500-89ovdnxl	41	7	of	of	IN
cord-314500-89ovdnxl	41	8	diabetes	diabetes	NN
cord-314500-89ovdnxl	41	9	over	over	IN
cord-314500-89ovdnxl	41	10	recent	recent	JJ
cord-314500-89ovdnxl	41	11	decades	decade	NNS
cord-314500-89ovdnxl	41	12	suggests	suggest	VBZ
cord-314500-89ovdnxl	41	13	that	that	IN
cord-314500-89ovdnxl	41	14	environmental	environmental	JJ
cord-314500-89ovdnxl	41	15	and	and	CC
cord-314500-89ovdnxl	41	16	lifestyle	lifestyle	NN
cord-314500-89ovdnxl	41	17	factors	factor	NNS
cord-314500-89ovdnxl	41	18	might	may	MD
cord-314500-89ovdnxl	41	19	play	play	VB
cord-314500-89ovdnxl	41	20	an	an	DT
cord-314500-89ovdnxl	41	21	increasingly	increasingly	RB
cord-314500-89ovdnxl	41	22	important	important	JJ
cord-314500-89ovdnxl	41	23	role	role	NN
cord-314500-89ovdnxl	41	24	in	in	IN
cord-314500-89ovdnxl	41	25	the	the	DT
cord-314500-89ovdnxl	41	26	development	development	NN
cord-314500-89ovdnxl	41	27	of	of	IN
cord-314500-89ovdnxl	41	28	the	the	DT
cord-314500-89ovdnxl	41	29	disease	disease	NN
cord-314500-89ovdnxl	41	30	.	.	.
cord-314500-89ovdnxl	42	1	It	-PRON-	PRP
cord-314500-89ovdnxl	42	2	is	be	VBZ
cord-314500-89ovdnxl	42	3	generally	generally	RB
cord-314500-89ovdnxl	42	4	recognised	recognise	VBN
cord-314500-89ovdnxl	42	5	that	that	IN
cord-314500-89ovdnxl	42	6	people	people	NNS
cord-314500-89ovdnxl	42	7	with	with	IN
cord-314500-89ovdnxl	42	8	diabetes	diabete	NNS
cord-314500-89ovdnxl	42	9	are	be	VBP
cord-314500-89ovdnxl	42	10	at	at	IN
cord-314500-89ovdnxl	42	11	increased	increase	VBN
cord-314500-89ovdnxl	42	12	risk	risk	NN
cord-314500-89ovdnxl	42	13	of	of	IN
cord-314500-89ovdnxl	42	14	infection	infection	NN
cord-314500-89ovdnxl	42	15	and	and	CC
cord-314500-89ovdnxl	42	16	worse	bad	JJR
cord-314500-89ovdnxl	42	17	outcomes	outcome	NNS
cord-314500-89ovdnxl	42	18	,	,	,
cord-314500-89ovdnxl	42	19	10	10	CD
cord-314500-89ovdnxl	42	20	,	,	,
cord-314500-89ovdnxl	42	21	11	11	CD
cord-314500-89ovdnxl	42	22	including	include	VBG
cord-314500-89ovdnxl	42	23	diabetic	diabetic	JJ
cord-314500-89ovdnxl	42	24	foot	foot	NN
cord-314500-89ovdnxl	42	25	infection	infection	NN
cord-314500-89ovdnxl	42	26	,	,	,
cord-314500-89ovdnxl	42	27	urinary	urinary	JJ
cord-314500-89ovdnxl	42	28	tract	tract	NN
cord-314500-89ovdnxl	42	29	infections	infection	NNS
cord-314500-89ovdnxl	42	30	(	(	-LRB-
cord-314500-89ovdnxl	42	31	especially	especially	RB
cord-314500-89ovdnxl	42	32	from	from	IN
cord-314500-89ovdnxl	42	33	 	 	_SP
cord-314500-89ovdnxl	42	34	Tuberculosis	Tuberculosis	NNP
cord-314500-89ovdnxl	42	35	(	(	-LRB-
cord-314500-89ovdnxl	42	36	TB	TB	NNP
cord-314500-89ovdnxl	42	37	)	)	-RRB-
cord-314500-89ovdnxl	42	38	is	be	VBZ
cord-314500-89ovdnxl	42	39	a	a	DT
cord-314500-89ovdnxl	42	40	leading	leading	JJ
cord-314500-89ovdnxl	42	41	cause	cause	NN
cord-314500-89ovdnxl	42	42	of	of	IN
cord-314500-89ovdnxl	42	43	disease	disease	NN
cord-314500-89ovdnxl	42	44	and	and	CC
cord-314500-89ovdnxl	42	45	death	death	NN
cord-314500-89ovdnxl	42	46	worldwide	worldwide	RB
cord-314500-89ovdnxl	42	47	,	,	,
cord-314500-89ovdnxl	42	48	with	with	IN
cord-314500-89ovdnxl	42	49	an	an	DT
cord-314500-89ovdnxl	42	50	estimated	estimate	VBN
cord-314500-89ovdnxl	42	51	9	9	CD
cord-314500-89ovdnxl	42	52	million	million	CD
cord-314500-89ovdnxl	42	53	cases	case	NNS
cord-314500-89ovdnxl	42	54	of	of	IN
cord-314500-89ovdnxl	42	55	TB	TB	NNP
cord-314500-89ovdnxl	42	56	and	and	CC
cord-314500-89ovdnxl	42	57	1.2	1.2	CD
cord-314500-89ovdnxl	42	58	million	million	CD
cord-314500-89ovdnxl	42	59	deaths	death	NNS
cord-314500-89ovdnxl	42	60	in	in	IN
cord-314500-89ovdnxl	42	61	2017	2017	CD
cord-314500-89ovdnxl	42	62	.	.	.
cord-314500-89ovdnxl	43	1	6	6	CD
cord-314500-89ovdnxl	43	2	Diabetes	diabetes	NN
cord-314500-89ovdnxl	43	3	is	be	VBZ
cord-314500-89ovdnxl	43	4	associated	associate	VBN
cord-314500-89ovdnxl	43	5	with	with	IN
cord-314500-89ovdnxl	43	6	a	a	DT
cord-314500-89ovdnxl	43	7	threefold	threefold	JJ
cord-314500-89ovdnxl	43	8	increased	increase	VBN
cord-314500-89ovdnxl	43	9	risk	risk	NN
cord-314500-89ovdnxl	43	10	of	of	IN
cord-314500-89ovdnxl	43	11	developing	develop	VBG
cord-314500-89ovdnxl	43	12	TB	TB	NNP
cord-314500-89ovdnxl	43	13	,	,	,
cord-314500-89ovdnxl	43	14	3	3	CD
cord-314500-89ovdnxl	43	15	and	and	CC
cord-314500-89ovdnxl	43	16	increased	increase	VBN
cord-314500-89ovdnxl	43	17	risk	risk	NN
cord-314500-89ovdnxl	43	18	of	of	IN
cord-314500-89ovdnxl	43	19	death	death	NN
cord-314500-89ovdnxl	43	20	or	or	CC
cord-314500-89ovdnxl	43	21	treatment	treatment	NN
cord-314500-89ovdnxl	43	22	failure	failure	NN
cord-314500-89ovdnxl	43	23	in	in	IN
cord-314500-89ovdnxl	43	24	TB	TB	NNP
cord-314500-89ovdnxl	43	25	.	.	.
cord-314500-89ovdnxl	44	1	12	12	CD
cord-314500-89ovdnxl	45	1	The	the	DT
cord-314500-89ovdnxl	45	2	GBD	GBD	NNP
cord-314500-89ovdnxl	45	3	group	group	NN
cord-314500-89ovdnxl	45	4	reported	report	VBD
cord-314500-89ovdnxl	45	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	45	6	accounting	account	VBG
cord-314500-89ovdnxl	45	7	for	for	IN
cord-314500-89ovdnxl	45	8	10.6	10.6	CD
cord-314500-89ovdnxl	45	9	%	%	NN
cord-314500-89ovdnxl	45	10	of	of	IN
cord-314500-89ovdnxl	45	11	the	the	DT
cord-314500-89ovdnxl	45	12	TB	TB	NNP
cord-314500-89ovdnxl	45	13	mortality	mortality	NN
cord-314500-89ovdnxl	45	14	in	in	IN
cord-314500-89ovdnxl	45	15	HIV	HIV	NNP
cord-314500-89ovdnxl	45	16	-	-	HYPH
cord-314500-89ovdnxl	45	17	negative	negative	JJ
cord-314500-89ovdnxl	45	18	people	people	NNS
cord-314500-89ovdnxl	45	19	.	.	.
cord-314500-89ovdnxl	46	1	13	13	CD
cord-314500-89ovdnxl	47	1	In	in	IN
cord-314500-89ovdnxl	47	2	2017	2017	CD
cord-314500-89ovdnxl	47	3	,	,	,
cord-314500-89ovdnxl	47	4	790	790	CD
cord-314500-89ovdnxl	47	5	000	000	CD
cord-314500-89ovdnxl	47	6	cases	case	NNS
cord-314500-89ovdnxl	47	7	of	of	IN
cord-314500-89ovdnxl	47	8	TB	TB	NNP
cord-314500-89ovdnxl	47	9	were	be	VBD
cord-314500-89ovdnxl	47	10	attributable	attributable	JJ
cord-314500-89ovdnxl	47	11	to	to	IN
cord-314500-89ovdnxl	47	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	47	13	,	,	,
cord-314500-89ovdnxl	47	14	14	14	CD
cord-314500-89ovdnxl	47	15	and	and	CC
cord-314500-89ovdnxl	47	16	the	the	DT
cord-314500-89ovdnxl	47	17	absolute	absolute	JJ
cord-314500-89ovdnxl	47	18	numbers	number	NNS
cord-314500-89ovdnxl	47	19	of	of	IN
cord-314500-89ovdnxl	47	20	people	people	NNS
cord-314500-89ovdnxl	47	21	with	with	IN
cord-314500-89ovdnxl	47	22	TB	TB	NNP
cord-314500-89ovdnxl	47	23	-	-	HYPH
cord-314500-89ovdnxl	47	24	diabetes	diabetes	NN
cord-314500-89ovdnxl	47	25	co	co	NN
cord-314500-89ovdnxl	47	26	-	-	NN
cord-314500-89ovdnxl	47	27	morbidity	morbidity	NN
cord-314500-89ovdnxl	47	28	is	be	VBZ
cord-314500-89ovdnxl	47	29	now	now	RB
cord-314500-89ovdnxl	47	30	similar	similar	JJ
cord-314500-89ovdnxl	47	31	to	to	IN
cord-314500-89ovdnxl	47	32	people	people	NNS
cord-314500-89ovdnxl	47	33	with	with	IN
cord-314500-89ovdnxl	47	34	TB	TB	NNP
cord-314500-89ovdnxl	47	35	-	-	HYPH
cord-314500-89ovdnxl	47	36	HIV	HIV	NNP
cord-314500-89ovdnxl	47	37	co	co	NN
cord-314500-89ovdnxl	47	38	-	-	NN
cord-314500-89ovdnxl	47	39	infection	infection	NN
cord-314500-89ovdnxl	47	40	.	.	.
cord-314500-89ovdnxl	48	1	More	More	JJR
cord-314500-89ovdnxl	48	2	than	than	IN
cord-314500-89ovdnxl	48	3	half	half	NN
cord-314500-89ovdnxl	48	4	of	of	IN
cord-314500-89ovdnxl	48	5	the	the	DT
cord-314500-89ovdnxl	48	6	world	world	NN
cord-314500-89ovdnxl	48	7	's	's	POS
cord-314500-89ovdnxl	48	8	TB	TB	NNP
cord-314500-89ovdnxl	48	9	cases	case	NNS
cord-314500-89ovdnxl	48	10	occur	occur	VBP
cord-314500-89ovdnxl	48	11	in	in	IN
cord-314500-89ovdnxl	48	12	five	five	CD
cord-314500-89ovdnxl	48	13	countries	country	NNS
cord-314500-89ovdnxl	48	14	,	,	,
cord-314500-89ovdnxl	48	15	15	15	CD
cord-314500-89ovdnxl	48	16	which	which	WDT
cord-314500-89ovdnxl	48	17	have	have	VBP
cord-314500-89ovdnxl	48	18	significant	significant	JJ
cord-314500-89ovdnxl	48	19	prevalence	prevalence	NN
cord-314500-89ovdnxl	48	20	rates	rate	NNS
cord-314500-89ovdnxl	48	21	and	and	CC
cord-314500-89ovdnxl	48	22	total	total	JJ
cord-314500-89ovdnxl	48	23	numbers	number	NNS
cord-314500-89ovdnxl	48	24	of	of	IN
cord-314500-89ovdnxl	48	25	diabetes	diabetes	NN
cord-314500-89ovdnxl	48	26	cases	case	NNS
cord-314500-89ovdnxl	48	27	in	in	IN
cord-314500-89ovdnxl	48	28	adults	adult	NNS
cord-314500-89ovdnxl	48	29	aged	age	VBN
cord-314500-89ovdnxl	48	30	20	20	CD
cord-314500-89ovdnxl	48	31	-	-	SYM
cord-314500-89ovdnxl	48	32	79	79	CD
cord-314500-89ovdnxl	48	33	years	year	NNS
cord-314500-89ovdnxl	48	34	as	as	IN
cord-314500-89ovdnxl	48	35	follows	follow	VBZ
cord-314500-89ovdnxl	48	36	:	:	:
cord-314500-89ovdnxl	48	37	China	China	NNP
cord-314500-89ovdnxl	48	38	(	(	-LRB-
cord-314500-89ovdnxl	48	39	10.9	10.9	CD
cord-314500-89ovdnxl	48	40	%	%	NN
cord-314500-89ovdnxl	48	41	,	,	,
cord-314500-89ovdnxl	48	42	114	114	CD
cord-314500-89ovdnxl	48	43	million	million	CD
cord-314500-89ovdnxl	48	44	)	)	-RRB-
cord-314500-89ovdnxl	48	45	,	,	,
cord-314500-89ovdnxl	48	46	India	India	NNP
cord-314500-89ovdnxl	48	47	(	(	-LRB-
cord-314500-89ovdnxl	48	48	8.8	8.8	CD
cord-314500-89ovdnxl	48	49	%	%	NN
cord-314500-89ovdnxl	48	50	,	,	,
cord-314500-89ovdnxl	48	51	73	73	CD
cord-314500-89ovdnxl	48	52	million	million	CD
cord-314500-89ovdnxl	48	53	)	)	-RRB-
cord-314500-89ovdnxl	48	54	,	,	,
cord-314500-89ovdnxl	48	55	Indonesia	Indonesia	NNP
cord-314500-89ovdnxl	48	56	(	(	-LRB-
cord-314500-89ovdnxl	48	57	6.2	6.2	CD
cord-314500-89ovdnxl	48	58	%	%	NN
cord-314500-89ovdnxl	48	59	,	,	,
cord-314500-89ovdnxl	48	60	10	10	CD
cord-314500-89ovdnxl	48	61	million	million	CD
cord-314500-89ovdnxl	48	62	)	)	-RRB-
cord-314500-89ovdnxl	48	63	,	,	,
cord-314500-89ovdnxl	48	64	Philippines	Philippines	NNP
cord-314500-89ovdnxl	48	65	(	(	-LRB-
cord-314500-89ovdnxl	48	66	6.2	6.2	CD
cord-314500-89ovdnxl	48	67	%	%	NN
cord-314500-89ovdnxl	48	68	,	,	,
cord-314500-89ovdnxl	48	69	3.7	3.7	CD
cord-314500-89ovdnxl	48	70	million	million	CD
cord-314500-89ovdnxl	48	71	)	)	-RRB-
cord-314500-89ovdnxl	48	72	and	and	CC
cord-314500-89ovdnxl	48	73	Pakistan	Pakistan	NNP
cord-314500-89ovdnxl	48	74	(	(	-LRB-
cord-314500-89ovdnxl	48	75	6.9	6.9	CD
cord-314500-89ovdnxl	48	76	%	%	NN
cord-314500-89ovdnxl	48	77	,	,	,
cord-314500-89ovdnxl	48	78	7.5	7.5	CD
cord-314500-89ovdnxl	48	79	million	million	CD
cord-314500-89ovdnxl	48	80	)	)	-RRB-
cord-314500-89ovdnxl	48	81	.	.	.
cord-314500-89ovdnxl	49	1	1	1	LS
cord-314500-89ovdnxl	50	1	There	there	EX
cord-314500-89ovdnxl	50	2	is	be	VBZ
cord-314500-89ovdnxl	50	3	evidence	evidence	NN
cord-314500-89ovdnxl	50	4	that	that	IN
cord-314500-89ovdnxl	50	5	the	the	DT
cord-314500-89ovdnxl	50	6	presence	presence	NN
cord-314500-89ovdnxl	50	7	of	of	IN
cord-314500-89ovdnxl	50	8	clinical	clinical	JJ
cord-314500-89ovdnxl	50	9	TB	TB	NNP
cord-314500-89ovdnxl	50	10	disease	disease	NN
cord-314500-89ovdnxl	50	11	drives	drive	VBZ
cord-314500-89ovdnxl	50	12	stress	stress	NN
cord-314500-89ovdnxl	50	13	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	50	14	,	,	,
cord-314500-89ovdnxl	50	15	impacting	impact	VBG
cord-314500-89ovdnxl	50	16	on	on	IN
cord-314500-89ovdnxl	50	17	clinical	clinical	JJ
cord-314500-89ovdnxl	50	18	outcomes	outcome	NNS
cord-314500-89ovdnxl	50	19	and	and	CC
cord-314500-89ovdnxl	50	20	response	response	NN
cord-314500-89ovdnxl	50	21	to	to	IN
cord-314500-89ovdnxl	50	22	treatment	treatment	NN
cord-314500-89ovdnxl	50	23	.	.	.
cord-314500-89ovdnxl	51	1	16	16	CD
cord-314500-89ovdnxl	52	1	As	as	IN
cord-314500-89ovdnxl	52	2	rates	rate	NNS
cord-314500-89ovdnxl	52	3	of	of	IN
cord-314500-89ovdnxl	52	4	diabetes	diabete	NNS
cord-314500-89ovdnxl	52	5	continue	continue	VBP
cord-314500-89ovdnxl	52	6	to	to	TO
cord-314500-89ovdnxl	52	7	rise	rise	VB
cord-314500-89ovdnxl	52	8	,	,	,
cord-314500-89ovdnxl	52	9	and	and	CC
cord-314500-89ovdnxl	52	10	the	the	DT
cord-314500-89ovdnxl	52	11	TB	TB	NNP
cord-314500-89ovdnxl	52	12	epidemic	epidemic	NN
cord-314500-89ovdnxl	52	13	continues	continue	VBZ
cord-314500-89ovdnxl	52	14	,	,	,
cord-314500-89ovdnxl	52	15	there	there	EX
cord-314500-89ovdnxl	52	16	is	be	VBZ
cord-314500-89ovdnxl	52	17	a	a	DT
cord-314500-89ovdnxl	52	18	pressing	press	VBG
cord-314500-89ovdnxl	52	19	need	need	NN
cord-314500-89ovdnxl	52	20	for	for	IN
cord-314500-89ovdnxl	52	21	bidirectional	bidirectional	JJ
cord-314500-89ovdnxl	52	22	screening	screening	NN
cord-314500-89ovdnxl	52	23	in	in	IN
cord-314500-89ovdnxl	52	24	countries	country	NNS
cord-314500-89ovdnxl	52	25	facing	face	VBG
cord-314500-89ovdnxl	52	26	the	the	DT
cord-314500-89ovdnxl	52	27	double	double	JJ
cord-314500-89ovdnxl	52	28	burden	burden	NN
cord-314500-89ovdnxl	52	29	of	of	IN
cord-314500-89ovdnxl	52	30	TB	TB	NNP
cord-314500-89ovdnxl	52	31	and	and	CC
cord-314500-89ovdnxl	52	32	diabetes	diabetes	NN
cord-314500-89ovdnxl	52	33	.	.	.
cord-314500-89ovdnxl	53	1	Work	work	VB
cord-314500-89ovdnxl	53	2	in	in	IN
cord-314500-89ovdnxl	53	3	India	India	NNP
cord-314500-89ovdnxl	53	4	has	have	VBZ
cord-314500-89ovdnxl	53	5	shown	show	VBN
cord-314500-89ovdnxl	53	6	success	success	NN
cord-314500-89ovdnxl	53	7	at	at	IN
cord-314500-89ovdnxl	53	8	screening	screening	NN
cord-314500-89ovdnxl	53	9	newly	newly	RB
cord-314500-89ovdnxl	53	10	diagnosed	diagnose	VBN
cord-314500-89ovdnxl	53	11	TB	TB	NNP
cord-314500-89ovdnxl	53	12	cases	case	NNS
cord-314500-89ovdnxl	53	13	for	for	IN
cord-314500-89ovdnxl	53	14	diabetes	diabetes	NN
cord-314500-89ovdnxl	53	15	,	,	,
cord-314500-89ovdnxl	53	16	17	17	CD
cord-314500-89ovdnxl	53	17	due	due	IN
cord-314500-89ovdnxl	53	18	to	to	IN
cord-314500-89ovdnxl	53	19	the	the	DT
cord-314500-89ovdnxl	53	20	availability	availability	NN
cord-314500-89ovdnxl	53	21	of	of	IN
cord-314500-89ovdnxl	53	22	a	a	DT
cord-314500-89ovdnxl	53	23	simple	simple	JJ
cord-314500-89ovdnxl	53	24	screening	screening	NN
cord-314500-89ovdnxl	53	25	blood	blood	NN
cord-314500-89ovdnxl	53	26	test	test	NN
cord-314500-89ovdnxl	53	27	(	(	-LRB-
cord-314500-89ovdnxl	53	28	HbA1c	HbA1c	NNP
cord-314500-89ovdnxl	53	29	)	)	-RRB-
cord-314500-89ovdnxl	53	30	and	and	CC
cord-314500-89ovdnxl	53	31	the	the	DT
cord-314500-89ovdnxl	53	32	use	use	NN
cord-314500-89ovdnxl	53	33	of	of	IN
cord-314500-89ovdnxl	53	34	existing	exist	VBG
cord-314500-89ovdnxl	53	35	systems	system	NNS
cord-314500-89ovdnxl	53	36	established	establish	VBN
cord-314500-89ovdnxl	53	37	to	to	TO
cord-314500-89ovdnxl	53	38	screen	screen	VB
cord-314500-89ovdnxl	53	39	TB	TB	NNP
cord-314500-89ovdnxl	53	40	cases	case	NNS
cord-314500-89ovdnxl	53	41	for	for	IN
cord-314500-89ovdnxl	53	42	HIV	HIV	NNP
cord-314500-89ovdnxl	53	43	.	.	.
cord-314500-89ovdnxl	54	1	Screening	screen	VBG
cord-314500-89ovdnxl	54	2	people	people	NNS
cord-314500-89ovdnxl	54	3	with	with	IN
cord-314500-89ovdnxl	54	4	diabetes	diabete	NNS
cord-314500-89ovdnxl	54	5	for	for	IN
cord-314500-89ovdnxl	54	6	TB	TB	NNP
cord-314500-89ovdnxl	54	7	is	be	VBZ
cord-314500-89ovdnxl	54	8	more	more	RBR
cord-314500-89ovdnxl	54	9	difficult	difficult	JJ
cord-314500-89ovdnxl	54	10	due	due	IN
cord-314500-89ovdnxl	54	11	to	to	IN
cord-314500-89ovdnxl	54	12	the	the	DT
cord-314500-89ovdnxl	54	13	reliance	reliance	NN
cord-314500-89ovdnxl	54	14	on	on	IN
cord-314500-89ovdnxl	54	15	symptom	symptom	NN
cord-314500-89ovdnxl	54	16	questionnaires	questionnaire	NNS
cord-314500-89ovdnxl	54	17	followed	follow	VBN
cord-314500-89ovdnxl	54	18	by	by	IN
cord-314500-89ovdnxl	54	19	chest	chest	NN
cord-314500-89ovdnxl	54	20	xray	xray	NNP
cord-314500-89ovdnxl	54	21	.	.	.
cord-314500-89ovdnxl	55	1	A	a	DT
cord-314500-89ovdnxl	55	2	blood	blood	NN
cord-314500-89ovdnxl	55	3	test	test	NN
cord-314500-89ovdnxl	55	4	to	to	TO
cord-314500-89ovdnxl	55	5	diagnose	diagnose	VB
cord-314500-89ovdnxl	55	6	TB	TB	NNP
cord-314500-89ovdnxl	55	7	in	in	IN
cord-314500-89ovdnxl	55	8	this	this	DT
cord-314500-89ovdnxl	55	9	setting	setting	NN
cord-314500-89ovdnxl	55	10	is	be	VBZ
cord-314500-89ovdnxl	55	11	highly	highly	RB
cord-314500-89ovdnxl	55	12	desirable	desirable	JJ
cord-314500-89ovdnxl	55	13	,	,	,
cord-314500-89ovdnxl	55	14	but	but	CC
cord-314500-89ovdnxl	55	15	current	current	JJ
cord-314500-89ovdnxl	55	16	interferon	interferon	NN
cord-314500-89ovdnxl	55	17	gamma	gamma	NN
cord-314500-89ovdnxl	55	18	release	release	NN
cord-314500-89ovdnxl	55	19	assays	assay	NNS
cord-314500-89ovdnxl	55	20	(	(	-LRB-
cord-314500-89ovdnxl	55	21	IGRAs	igra	NNS
cord-314500-89ovdnxl	55	22	)	)	-RRB-
cord-314500-89ovdnxl	55	23	do	do	VBP
cord-314500-89ovdnxl	55	24	not	not	RB
cord-314500-89ovdnxl	55	25	have	have	VB
cord-314500-89ovdnxl	55	26	sufficient	sufficient	JJ
cord-314500-89ovdnxl	55	27	sensitivity	sensitivity	NN
cord-314500-89ovdnxl	55	28	and	and	CC
cord-314500-89ovdnxl	55	29	specificity	specificity	NN
cord-314500-89ovdnxl	55	30	for	for	IN
cord-314500-89ovdnxl	55	31	this	this	DT
cord-314500-89ovdnxl	55	32	purpose	purpose	NN
cord-314500-89ovdnxl	55	33	.	.	.
cord-314500-89ovdnxl	56	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	56	2	is	be	VBZ
cord-314500-89ovdnxl	56	3	also	also	RB
cord-314500-89ovdnxl	56	4	associated	associate	VBN
cord-314500-89ovdnxl	56	5	with	with	IN
cord-314500-89ovdnxl	56	6	higher	high	JJR
cord-314500-89ovdnxl	56	7	rates	rate	NNS
cord-314500-89ovdnxl	56	8	of	of	IN
cord-314500-89ovdnxl	56	9	Mycobacterium	Mycobacterium	NNP
cord-314500-89ovdnxl	56	10	leprae	leprae	NNP
cord-314500-89ovdnxl	56	11	.	.	.
cord-314500-89ovdnxl	57	1	18	18	CD
cord-314500-89ovdnxl	57	2	,	,	,
cord-314500-89ovdnxl	57	3	19	19	CD
cord-314500-89ovdnxl	58	1	The	the	DT
cord-314500-89ovdnxl	58	2	greatest	great	JJS
cord-314500-89ovdnxl	58	3	increased	increase	VBN
cord-314500-89ovdnxl	58	4	risk	risk	NN
cord-314500-89ovdnxl	58	5	for	for	IN
cord-314500-89ovdnxl	58	6	infection	infection	NN
cord-314500-89ovdnxl	58	7	in	in	IN
cord-314500-89ovdnxl	58	8	people	people	NNS
cord-314500-89ovdnxl	58	9	with	with	IN
cord-314500-89ovdnxl	58	10	diabetes	diabetes	NN
cord-314500-89ovdnxl	58	11	is	be	VBZ
cord-314500-89ovdnxl	58	12	seen	see	VBN
cord-314500-89ovdnxl	58	13	for	for	IN
cord-314500-89ovdnxl	58	14	the	the	DT
cord-314500-89ovdnxl	58	15	grossly	grossly	RB
cord-314500-89ovdnxl	58	16	under	under	RB
cord-314500-89ovdnxl	58	17	-	-	HYPH
cord-314500-89ovdnxl	58	18	recognised	recognise	VBN
cord-314500-89ovdnxl	58	19	tropical	tropical	JJ
cord-314500-89ovdnxl	58	20	disease	disease	NN
cord-314500-89ovdnxl	58	21	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	58	22	,	,	,
cord-314500-89ovdnxl	58	23	which	which	WDT
cord-314500-89ovdnxl	58	24	is	be	VBZ
cord-314500-89ovdnxl	58	25	caused	cause	VBN
cord-314500-89ovdnxl	58	26	by	by	IN
cord-314500-89ovdnxl	58	27	the	the	DT
cord-314500-89ovdnxl	58	28	Gram	gram	NN
cord-314500-89ovdnxl	58	29	-	-	HYPH
cord-314500-89ovdnxl	58	30	negative	negative	JJ
cord-314500-89ovdnxl	58	31	bacterium	bacterium	NN
cord-314500-89ovdnxl	58	32	Burkholderia	Burkholderia	NNP
cord-314500-89ovdnxl	58	33	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	58	34	.	.	.
cord-314500-89ovdnxl	59	1	People	People	NNS
cord-314500-89ovdnxl	59	2	with	with	IN
cord-314500-89ovdnxl	59	3	diabetes	diabete	NNS
cord-314500-89ovdnxl	59	4	have	have	VBP
cord-314500-89ovdnxl	59	5	a	a	DT
cord-314500-89ovdnxl	59	6	twelvefold	twelvefold	JJ
cord-314500-89ovdnxl	59	7	increased	increase	VBN
cord-314500-89ovdnxl	59	8	risk	risk	NN
cord-314500-89ovdnxl	59	9	of	of	IN
cord-314500-89ovdnxl	59	10	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	59	11	,	,	,
cord-314500-89ovdnxl	59	12	and	and	CC
cord-314500-89ovdnxl	59	13	over	over	IN
cord-314500-89ovdnxl	59	14	half	half	NN
cord-314500-89ovdnxl	59	15	of	of	IN
cord-314500-89ovdnxl	59	16	all	all	DT
cord-314500-89ovdnxl	59	17	cases	case	NNS
cord-314500-89ovdnxl	59	18	of	of	IN
cord-314500-89ovdnxl	59	19	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	59	20	have	have	VBP
cord-314500-89ovdnxl	59	21	diabetes	diabete	NNS
cord-314500-89ovdnxl	59	22	.	.	.
cord-314500-89ovdnxl	60	1	20	20	CD
cord-314500-89ovdnxl	60	2	B.	B.	NNP
cord-314500-89ovdnxl	60	3	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	60	4	is	be	VBZ
cord-314500-89ovdnxl	60	5	an	an	DT
cord-314500-89ovdnxl	60	6	environmental	environmental	JJ
cord-314500-89ovdnxl	60	7	saprophyte	saprophyte	NN
cord-314500-89ovdnxl	60	8	with	with	IN
cord-314500-89ovdnxl	60	9	a	a	DT
cord-314500-89ovdnxl	60	10	predilection	predilection	NN
cord-314500-89ovdnxl	60	11	for	for	IN
cord-314500-89ovdnxl	60	12	rice	rice	NN
cord-314500-89ovdnxl	60	13	paddy	paddy	NN
cord-314500-89ovdnxl	60	14	fields	field	NNS
cord-314500-89ovdnxl	60	15	,	,	,
cord-314500-89ovdnxl	60	16	and	and	CC
cord-314500-89ovdnxl	60	17	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	60	18	is	be	VBZ
cord-314500-89ovdnxl	60	19	typically	typically	RB
cord-314500-89ovdnxl	60	20	seen	see	VBN
cord-314500-89ovdnxl	60	21	in	in	IN
cord-314500-89ovdnxl	60	22	adults	adult	NNS
cord-314500-89ovdnxl	60	23	in	in	IN
cord-314500-89ovdnxl	60	24	middle	middle	JJ
cord-314500-89ovdnxl	60	25	age	age	NN
cord-314500-89ovdnxl	60	26	and	and	CC
cord-314500-89ovdnxl	60	27	above	above	RB
cord-314500-89ovdnxl	60	28	,	,	,
cord-314500-89ovdnxl	60	29	often	often	RB
cord-314500-89ovdnxl	60	30	in	in	IN
cord-314500-89ovdnxl	60	31	rice	rice	NN
cord-314500-89ovdnxl	60	32	-	-	HYPH
cord-314500-89ovdnxl	60	33	farming	farm	VBG
cord-314500-89ovdnxl	60	34	communities	community	NNS
cord-314500-89ovdnxl	60	35	.	.	.
cord-314500-89ovdnxl	61	1	A	a	DT
cord-314500-89ovdnxl	61	2	broad	broad	JJ
cord-314500-89ovdnxl	61	3	range	range	NN
cord-314500-89ovdnxl	61	4	of	of	IN
cord-314500-89ovdnxl	61	5	clinical	clinical	JJ
cord-314500-89ovdnxl	61	6	presentations	presentation	NNS
cord-314500-89ovdnxl	61	7	are	be	VBP
cord-314500-89ovdnxl	61	8	seen	see	VBN
cord-314500-89ovdnxl	61	9	,	,	,
cord-314500-89ovdnxl	61	10	including	include	VBG
cord-314500-89ovdnxl	61	11	pneumonia	pneumonia	NN
cord-314500-89ovdnxl	61	12	,	,	,
cord-314500-89ovdnxl	61	13	acute	acute	JJ
cord-314500-89ovdnxl	61	14	sepsis	sepsis	NN
cord-314500-89ovdnxl	61	15	with	with	IN
cord-314500-89ovdnxl	61	16	bacteraemia	bacteraemia	NN
cord-314500-89ovdnxl	61	17	,	,	,
cord-314500-89ovdnxl	61	18	abscess	abscess	NN
cord-314500-89ovdnxl	61	19	formation	formation	NN
cord-314500-89ovdnxl	61	20	in	in	IN
cord-314500-89ovdnxl	61	21	any	any	DT
cord-314500-89ovdnxl	61	22	organ	organ	NN
cord-314500-89ovdnxl	61	23	site	site	NN
cord-314500-89ovdnxl	61	24	,	,	,
cord-314500-89ovdnxl	61	25	chronic	chronic	JJ
cord-314500-89ovdnxl	61	26	subacute	subacute	JJ
cord-314500-89ovdnxl	61	27	disease	disease	NN
cord-314500-89ovdnxl	61	28	and	and	CC
cord-314500-89ovdnxl	61	29	latency	latency	NN
cord-314500-89ovdnxl	61	30	.	.	.
cord-314500-89ovdnxl	62	1	21	21	CD
cord-314500-89ovdnxl	62	2	,	,	,
cord-314500-89ovdnxl	62	3	22	22	CD
cord-314500-89ovdnxl	62	4	Transmission	transmission	NN
cord-314500-89ovdnxl	62	5	of	of	IN
cord-314500-89ovdnxl	62	6	the	the	DT
cord-314500-89ovdnxl	62	7	bacterium	bacterium	NN
cord-314500-89ovdnxl	62	8	to	to	IN
cord-314500-89ovdnxl	62	9	humans	human	NNS
cord-314500-89ovdnxl	62	10	occurs	occur	VBZ
cord-314500-89ovdnxl	62	11	via	via	IN
cord-314500-89ovdnxl	62	12	three	three	CD
cord-314500-89ovdnxl	62	13	routes	route	NNS
cord-314500-89ovdnxl	62	14	:	:	:
cord-314500-89ovdnxl	62	15	inhalational	inhalational	JJ
cord-314500-89ovdnxl	62	16	,	,	,
cord-314500-89ovdnxl	62	17	cutaneous	cutaneous	JJ
cord-314500-89ovdnxl	62	18	via	via	IN
cord-314500-89ovdnxl	62	19	skin	skin	NN
cord-314500-89ovdnxl	62	20	abrasions	abrasion	NNS
cord-314500-89ovdnxl	62	21	and	and	CC
cord-314500-89ovdnxl	62	22	ingestion	ingestion	NN
cord-314500-89ovdnxl	62	23	of	of	IN
cord-314500-89ovdnxl	62	24	contaminated	contaminated	JJ
cord-314500-89ovdnxl	62	25	drinking	drinking	NN
cord-314500-89ovdnxl	62	26	water	water	NN
cord-314500-89ovdnxl	62	27	.	.	.
cord-314500-89ovdnxl	63	1	23	23	CD
cord-314500-89ovdnxl	64	1	The	the	DT
cord-314500-89ovdnxl	64	2	disease	disease	NN
cord-314500-89ovdnxl	64	3	is	be	VBZ
cord-314500-89ovdnxl	64	4	commonly	commonly	RB
cord-314500-89ovdnxl	64	5	diagnosed	diagnose	VBN
cord-314500-89ovdnxl	64	6	in	in	IN
cord-314500-89ovdnxl	64	7	Southeast	Southeast	NNP
cord-314500-89ovdnxl	64	8	Asia	Asia	NNP
cord-314500-89ovdnxl	64	9	and	and	CC
cord-314500-89ovdnxl	64	10	Northern	Northern	NNP
cord-314500-89ovdnxl	64	11	Australia	Australia	NNP
cord-314500-89ovdnxl	64	12	,	,	,
cord-314500-89ovdnxl	64	13	but	but	CC
cord-314500-89ovdnxl	64	14	is	be	VBZ
cord-314500-89ovdnxl	64	15	now	now	RB
cord-314500-89ovdnxl	64	16	known	know	VBN
cord-314500-89ovdnxl	64	17	to	to	TO
cord-314500-89ovdnxl	64	18	be	be	VB
cord-314500-89ovdnxl	64	19	present	present	JJ
cord-314500-89ovdnxl	64	20	in	in	IN
cord-314500-89ovdnxl	64	21	45	45	CD
cord-314500-89ovdnxl	64	22	countries	country	NNS
cord-314500-89ovdnxl	64	23	across	across	IN
cord-314500-89ovdnxl	64	24	tropical	tropical	JJ
cord-314500-89ovdnxl	64	25	regions	region	NNS
cord-314500-89ovdnxl	64	26	,	,	,
cord-314500-89ovdnxl	64	27	with	with	IN
cord-314500-89ovdnxl	64	28	an	an	DT
cord-314500-89ovdnxl	64	29	estimated	estimate	VBN
cord-314500-89ovdnxl	64	30	annual	annual	JJ
cord-314500-89ovdnxl	64	31	165	165	CD
cord-314500-89ovdnxl	64	32	000	000	CD
cord-314500-89ovdnxl	64	33	cases	case	NNS
cord-314500-89ovdnxl	64	34	and	and	CC
cord-314500-89ovdnxl	64	35	89	89	CD
cord-314500-89ovdnxl	64	36	000	000	CD
cord-314500-89ovdnxl	64	37	deaths	death	NNS
cord-314500-89ovdnxl	64	38	.	.	.
cord-314500-89ovdnxl	65	1	24	24	CD
cord-314500-89ovdnxl	66	1	If	if	IN
cord-314500-89ovdnxl	66	2	rates	rate	NNS
cord-314500-89ovdnxl	66	3	of	of	IN
cord-314500-89ovdnxl	66	4	diabetes	diabete	NNS
cord-314500-89ovdnxl	66	5	continue	continue	VBP
cord-314500-89ovdnxl	66	6	to	to	TO
cord-314500-89ovdnxl	66	7	rise	rise	VB
cord-314500-89ovdnxl	66	8	as	as	IN
cord-314500-89ovdnxl	66	9	predicted	predict	VBN
cord-314500-89ovdnxl	66	10	,	,	,
cord-314500-89ovdnxl	66	11	coupled	couple	VBN
cord-314500-89ovdnxl	66	12	with	with	IN
cord-314500-89ovdnxl	66	13	an	an	DT
cord-314500-89ovdnxl	66	14	increased	increase	VBN
cord-314500-89ovdnxl	66	15	reliance	reliance	NN
cord-314500-89ovdnxl	66	16	on	on	IN
cord-314500-89ovdnxl	66	17	older	old	JJR
cord-314500-89ovdnxl	66	18	people	people	NNS
cord-314500-89ovdnxl	66	19	for	for	IN
cord-314500-89ovdnxl	66	20	rice	rice	NN
cord-314500-89ovdnxl	66	21	farming	farming	NN
cord-314500-89ovdnxl	66	22	due	due	IN
cord-314500-89ovdnxl	66	23	to	to	IN
cord-314500-89ovdnxl	66	24	exodus	exodus	NN
cord-314500-89ovdnxl	66	25	of	of	IN
cord-314500-89ovdnxl	66	26	the	the	DT
cord-314500-89ovdnxl	66	27	younger	young	JJR
cord-314500-89ovdnxl	66	28	generation	generation	NN
cord-314500-89ovdnxl	66	29	to	to	IN
cord-314500-89ovdnxl	66	30	urban	urban	JJ
cord-314500-89ovdnxl	66	31	areas	area	NNS
cord-314500-89ovdnxl	66	32	,	,	,
cord-314500-89ovdnxl	66	33	then	then	RB
cord-314500-89ovdnxl	66	34	the	the	DT
cord-314500-89ovdnxl	66	35	burden	burden	NN
cord-314500-89ovdnxl	66	36	of	of	IN
cord-314500-89ovdnxl	66	37	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	66	38	will	will	MD
cord-314500-89ovdnxl	66	39	also	also	RB
cord-314500-89ovdnxl	66	40	rise	rise	VB
cord-314500-89ovdnxl	66	41	.	.	.
cord-314500-89ovdnxl	67	1	Studies	study	NNS
cord-314500-89ovdnxl	67	2	in	in	IN
cord-314500-89ovdnxl	67	3	high	high	JJ
cord-314500-89ovdnxl	67	4	-	-	HYPH
cord-314500-89ovdnxl	67	5	income	income	NN
cord-314500-89ovdnxl	67	6	countries	country	NNS
cord-314500-89ovdnxl	67	7	have	have	VBP
cord-314500-89ovdnxl	67	8	shown	show	VBN
cord-314500-89ovdnxl	67	9	that	that	IN
cord-314500-89ovdnxl	67	10	people	people	NNS
cord-314500-89ovdnxl	67	11	with	with	IN
cord-314500-89ovdnxl	67	12	diabetes	diabete	NNS
cord-314500-89ovdnxl	67	13	have	have	VBP
cord-314500-89ovdnxl	67	14	high	high	JJ
cord-314500-89ovdnxl	67	15	rates	rate	NNS
cord-314500-89ovdnxl	67	16	of	of	IN
cord-314500-89ovdnxl	67	17	infection	infection	NN
cord-314500-89ovdnxl	67	18	from	from	IN
cord-314500-89ovdnxl	67	19	many	many	JJ
cord-314500-89ovdnxl	67	20	common	common	JJ
cord-314500-89ovdnxl	67	21	bacteria	bacteria	NNS
cord-314500-89ovdnxl	67	22	,	,	,
cord-314500-89ovdnxl	67	23	25	25	CD
cord-314500-89ovdnxl	67	24	but	but	CC
cord-314500-89ovdnxl	67	25	some	some	DT
cord-314500-89ovdnxl	67	26	bacterial	bacterial	JJ
cord-314500-89ovdnxl	67	27	species	specie	NNS
cord-314500-89ovdnxl	67	28	are	be	VBP
cord-314500-89ovdnxl	67	29	more	more	RBR
cord-314500-89ovdnxl	67	30	frequently	frequently	RB
cord-314500-89ovdnxl	67	31	reported	report	VBN
cord-314500-89ovdnxl	67	32	in	in	IN
cord-314500-89ovdnxl	67	33	association	association	NN
cord-314500-89ovdnxl	67	34	with	with	IN
cord-314500-89ovdnxl	67	35	diabetes	diabete	NNS
cord-314500-89ovdnxl	67	36	.	.	.
cord-314500-89ovdnxl	68	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	68	2	is	be	VBZ
cord-314500-89ovdnxl	68	3	an	an	DT
cord-314500-89ovdnxl	68	4	established	establish	VBN
cord-314500-89ovdnxl	68	5	risk	risk	NN
cord-314500-89ovdnxl	68	6	factor	factor	NN
cord-314500-89ovdnxl	68	7	for	for	IN
cord-314500-89ovdnxl	68	8	invasive	invasive	JJ
cord-314500-89ovdnxl	68	9	infection	infection	NN
cord-314500-89ovdnxl	68	10	with	with	IN
cord-314500-89ovdnxl	68	11	Staphylococcus	Staphylococcus	NNP
cord-314500-89ovdnxl	68	12	aureus	aureus	NN
cord-314500-89ovdnxl	68	13	.	.	.
cord-314500-89ovdnxl	69	1	26	26	CD
cord-314500-89ovdnxl	69	2	S.	S.	NNP
cord-314500-89ovdnxl	69	3	aureus	aureus	NN
cord-314500-89ovdnxl	69	4	is	be	VBZ
cord-314500-89ovdnxl	69	5	the	the	DT
cord-314500-89ovdnxl	69	6	commonest	common	JJS
cord-314500-89ovdnxl	69	7	cause	cause	NN
cord-314500-89ovdnxl	69	8	of	of	IN
cord-314500-89ovdnxl	69	9	tropical	tropical	JJ
cord-314500-89ovdnxl	69	10	pyomyositis	pyomyositis	NN
cord-314500-89ovdnxl	69	11	,	,	,
cord-314500-89ovdnxl	69	12	an	an	DT
cord-314500-89ovdnxl	69	13	infection	infection	NN
cord-314500-89ovdnxl	69	14	of	of	IN
cord-314500-89ovdnxl	69	15	skeletal	skeletal	JJ
cord-314500-89ovdnxl	69	16	muscle	muscle	NN
cord-314500-89ovdnxl	69	17	featuring	feature	VBG
cord-314500-89ovdnxl	69	18	intramuscular	intramuscular	JJ
cord-314500-89ovdnxl	69	19	abscesses	abscess	NNS
cord-314500-89ovdnxl	69	20	that	that	WDT
cord-314500-89ovdnxl	69	21	is	be	VBZ
cord-314500-89ovdnxl	69	22	commonly	commonly	RB
cord-314500-89ovdnxl	69	23	seen	see	VBN
cord-314500-89ovdnxl	69	24	in	in	IN
cord-314500-89ovdnxl	69	25	tropical	tropical	JJ
cord-314500-89ovdnxl	69	26	regions	region	NNS
cord-314500-89ovdnxl	69	27	and	and	CC
cord-314500-89ovdnxl	69	28	can	can	MD
cord-314500-89ovdnxl	69	29	account	account	VB
cord-314500-89ovdnxl	69	30	for	for	IN
cord-314500-89ovdnxl	69	31	1	1	CD
cord-314500-89ovdnxl	69	32	-	-	SYM
cord-314500-89ovdnxl	69	33	4	4	CD
cord-314500-89ovdnxl	69	34	%	%	NN
cord-314500-89ovdnxl	69	35	of	of	IN
cord-314500-89ovdnxl	69	36	acute	acute	JJ
cord-314500-89ovdnxl	69	37	admissions	admission	NNS
cord-314500-89ovdnxl	69	38	.	.	.
cord-314500-89ovdnxl	70	1	27	27	CD
cord-314500-89ovdnxl	70	2	Pyomyositis	Pyomyositis	NNP
cord-314500-89ovdnxl	70	3	occurs	occur	VBZ
cord-314500-89ovdnxl	70	4	less	less	RBR
cord-314500-89ovdnxl	70	5	frequently	frequently	RB
cord-314500-89ovdnxl	70	6	in	in	IN
cord-314500-89ovdnxl	70	7	temperate	temperate	JJ
cord-314500-89ovdnxl	70	8	zones	zone	NNS
cord-314500-89ovdnxl	70	9	,	,	,
cord-314500-89ovdnxl	70	10	where	where	WRB
cord-314500-89ovdnxl	70	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	70	12	is	be	VBZ
cord-314500-89ovdnxl	70	13	a	a	DT
cord-314500-89ovdnxl	70	14	known	know	VBN
cord-314500-89ovdnxl	70	15	risk	risk	NN
cord-314500-89ovdnxl	70	16	factor	factor	NN
cord-314500-89ovdnxl	70	17	.	.	.
cord-314500-89ovdnxl	71	1	28	28	CD
cord-314500-89ovdnxl	71	2	,	,	,
cord-314500-89ovdnxl	71	3	29	29	CD
cord-314500-89ovdnxl	71	4	While	while	IN
cord-314500-89ovdnxl	71	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	71	6	has	have	VBZ
cord-314500-89ovdnxl	71	7	been	be	VBN
cord-314500-89ovdnxl	71	8	reported	report	VBN
cord-314500-89ovdnxl	71	9	in	in	IN
cord-314500-89ovdnxl	71	10	some	some	DT
cord-314500-89ovdnxl	71	11	case	case	NN
cord-314500-89ovdnxl	71	12	reports	report	NNS
cord-314500-89ovdnxl	71	13	of	of	IN
cord-314500-89ovdnxl	71	14	tropical	tropical	JJ
cord-314500-89ovdnxl	71	15	pyomyositis	pyomyositis	NN
cord-314500-89ovdnxl	71	16	,	,	,
cord-314500-89ovdnxl	71	17	30	30	CD
cord-314500-89ovdnxl	71	18	further	further	JJ
cord-314500-89ovdnxl	71	19	research	research	NN
cord-314500-89ovdnxl	71	20	is	be	VBZ
cord-314500-89ovdnxl	71	21	needed	need	VBN
cord-314500-89ovdnxl	71	22	to	to	TO
cord-314500-89ovdnxl	71	23	establish	establish	VB
cord-314500-89ovdnxl	71	24	the	the	DT
cord-314500-89ovdnxl	71	25	Box	Box	NNP
cord-314500-89ovdnxl	71	26	1	1	CD
cord-314500-89ovdnxl	71	27	.	.	.
cord-314500-89ovdnxl	72	1	Relationship	relationship	NN
cord-314500-89ovdnxl	72	2	between	between	IN
cord-314500-89ovdnxl	72	3	diabetes	diabetes	NN
cord-314500-89ovdnxl	72	4	and	and	CC
cord-314500-89ovdnxl	72	5	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	72	6	/	/	SYM
cord-314500-89ovdnxl	72	7	increased	increase	VBN
cord-314500-89ovdnxl	72	8	disease	disease	NN
cord-314500-89ovdnxl	72	9	severity	severity	NN
cord-314500-89ovdnxl	72	10	for	for	IN
cord-314500-89ovdnxl	72	11	significant	significant	JJ
cord-314500-89ovdnxl	72	12	pathogens	pathogen	NNS
cord-314500-89ovdnxl	72	13	in	in	IN
cord-314500-89ovdnxl	72	14	low	low	JJ
cord-314500-89ovdnxl	72	15	-	-	HYPH
cord-314500-89ovdnxl	72	16	and	and	CC
cord-314500-89ovdnxl	72	17	middle	middle	JJ
cord-314500-89ovdnxl	72	18	-	-	HYPH
cord-314500-89ovdnxl	72	19	income	income	NN
cord-314500-89ovdnxl	72	20	countries	country	NNS
cord-314500-89ovdnxl	72	21	.	.	.
cord-314500-89ovdnxl	73	1	See	see	VB
cord-314500-89ovdnxl	73	2	text	text	NN
cord-314500-89ovdnxl	73	3	for	for	IN
cord-314500-89ovdnxl	73	4	discussion	discussion	NN
cord-314500-89ovdnxl	73	5	of	of	IN
cord-314500-89ovdnxl	73	6	evidence	evidence	NN
cord-314500-89ovdnxl	73	7	.	.	.
cord-314500-89ovdnxl	74	1	31	31	CD
cord-314500-89ovdnxl	74	2	Diabetes	diabetes	NN
cord-314500-89ovdnxl	74	3	was	be	VBD
cord-314500-89ovdnxl	74	4	associated	associate	VBN
cord-314500-89ovdnxl	74	5	with	with	IN
cord-314500-89ovdnxl	74	6	around	around	IN
cord-314500-89ovdnxl	74	7	a	a	DT
cord-314500-89ovdnxl	74	8	threefold	threefold	JJ
cord-314500-89ovdnxl	74	9	increased	increase	VBN
cord-314500-89ovdnxl	74	10	risk	risk	NN
cord-314500-89ovdnxl	74	11	of	of	IN
cord-314500-89ovdnxl	74	12	infection	infection	NN
cord-314500-89ovdnxl	74	13	with	with	IN
cord-314500-89ovdnxl	74	14	S.	S.	NNP
cord-314500-89ovdnxl	74	15	enteritidis	enteritidis	NN
cord-314500-89ovdnxl	74	16	following	follow	VBG
cord-314500-89ovdnxl	74	17	exposure	exposure	NN
cord-314500-89ovdnxl	74	18	in	in	IN
cord-314500-89ovdnxl	74	19	a	a	DT
cord-314500-89ovdnxl	74	20	US	US	NNP
cord-314500-89ovdnxl	74	21	hospital	hospital	NN
cord-314500-89ovdnxl	74	22	outbreak	outbreak	NN
cord-314500-89ovdnxl	74	23	.	.	.
cord-314500-89ovdnxl	75	1	32	32	CD
cord-314500-89ovdnxl	75	2	People	People	NNS
cord-314500-89ovdnxl	75	3	with	with	IN
cord-314500-89ovdnxl	75	4	diabetes	diabete	NNS
cord-314500-89ovdnxl	75	5	have	have	VBP
cord-314500-89ovdnxl	75	6	an	an	DT
cord-314500-89ovdnxl	75	7	increased	increase	VBN
cord-314500-89ovdnxl	75	8	risk	risk	NN
cord-314500-89ovdnxl	75	9	of	of	IN
cord-314500-89ovdnxl	75	10	Klebsiella	Klebsiella	NNP
cord-314500-89ovdnxl	75	11	infections	infection	NNS
cord-314500-89ovdnxl	75	12	,	,	,
cord-314500-89ovdnxl	75	13	33	33	CD
cord-314500-89ovdnxl	75	14	especially	especially	RB
cord-314500-89ovdnxl	75	15	Klebsiella	Klebsiella	NNP
cord-314500-89ovdnxl	75	16	liver	liver	NN
cord-314500-89ovdnxl	75	17	abscess	abscess	NN
cord-314500-89ovdnxl	75	18	in	in	IN
cord-314500-89ovdnxl	75	19	Asia	Asia	NNP
cord-314500-89ovdnxl	75	20	.	.	.
cord-314500-89ovdnxl	76	1	34	34	CD
cord-314500-89ovdnxl	76	2	,	,	,
cord-314500-89ovdnxl	76	3	35	35	CD
cord-314500-89ovdnxl	76	4	Scrub	Scrub	NNP
cord-314500-89ovdnxl	76	5	typhus	typhus	NN
cord-314500-89ovdnxl	76	6	is	be	VBZ
cord-314500-89ovdnxl	76	7	a	a	DT
cord-314500-89ovdnxl	76	8	febrile	febrile	JJ
cord-314500-89ovdnxl	76	9	illness	illness	NN
cord-314500-89ovdnxl	76	10	caused	cause	VBN
cord-314500-89ovdnxl	76	11	by	by	IN
cord-314500-89ovdnxl	76	12	the	the	DT
cord-314500-89ovdnxl	76	13	Rickettsial	Rickettsial	NNP
cord-314500-89ovdnxl	76	14	group	group	NN
cord-314500-89ovdnxl	76	15	intracellular	intracellular	JJ
cord-314500-89ovdnxl	76	16	pathogen	pathogen	NN
cord-314500-89ovdnxl	76	17	Orientia	Orientia	NNP
cord-314500-89ovdnxl	76	18	tsutsugamushi	tsutsugamushi	NNP
cord-314500-89ovdnxl	76	19	.	.	.
cord-314500-89ovdnxl	77	1	Around	around	IN
cord-314500-89ovdnxl	77	2	a	a	DT
cord-314500-89ovdnxl	77	3	million	million	CD
cord-314500-89ovdnxl	77	4	cases	case	NNS
cord-314500-89ovdnxl	77	5	a	a	DT
cord-314500-89ovdnxl	77	6	year	year	NN
cord-314500-89ovdnxl	77	7	occur	occur	VBP
cord-314500-89ovdnxl	77	8	in	in	IN
cord-314500-89ovdnxl	77	9	Asia	Asia	NNP
cord-314500-89ovdnxl	77	10	,	,	,
cord-314500-89ovdnxl	77	11	36	36	CD
cord-314500-89ovdnxl	77	12	and	and	CC
cord-314500-89ovdnxl	77	13	it	-PRON-	PRP
cord-314500-89ovdnxl	77	14	is	be	VBZ
cord-314500-89ovdnxl	77	15	believed	believe	VBN
cord-314500-89ovdnxl	77	16	to	to	TO
cord-314500-89ovdnxl	77	17	exist	exist	VB
cord-314500-89ovdnxl	77	18	in	in	IN
cord-314500-89ovdnxl	77	19	other	other	JJ
cord-314500-89ovdnxl	77	20	tropical	tropical	JJ
cord-314500-89ovdnxl	77	21	regions	region	NNS
cord-314500-89ovdnxl	77	22	outside	outside	IN
cord-314500-89ovdnxl	77	23	Asia	Asia	NNP
cord-314500-89ovdnxl	77	24	.	.	.
cord-314500-89ovdnxl	78	1	37	37	CD
cord-314500-89ovdnxl	78	2	Diabetes	diabetes	NN
cord-314500-89ovdnxl	78	3	was	be	VBD
cord-314500-89ovdnxl	78	4	an	an	DT
cord-314500-89ovdnxl	78	5	independent	independent	JJ
cord-314500-89ovdnxl	78	6	risk	risk	NN
cord-314500-89ovdnxl	78	7	factor	factor	NN
cord-314500-89ovdnxl	78	8	for	for	IN
cord-314500-89ovdnxl	78	9	more	more	RBR
cord-314500-89ovdnxl	78	10	severe	severe	JJ
cord-314500-89ovdnxl	78	11	disease	disease	NN
cord-314500-89ovdnxl	78	12	in	in	IN
cord-314500-89ovdnxl	78	13	a	a	DT
cord-314500-89ovdnxl	78	14	prospective	prospective	JJ
cord-314500-89ovdnxl	78	15	study	study	NN
cord-314500-89ovdnxl	78	16	of	of	IN
cord-314500-89ovdnxl	78	17	eschar	eschar	NN
cord-314500-89ovdnxl	78	18	-	-	HYPH
cord-314500-89ovdnxl	78	19	positive	positive	JJ
cord-314500-89ovdnxl	78	20	scrub	scrub	NN
cord-314500-89ovdnxl	78	21	typhus	typhus	NN
cord-314500-89ovdnxl	78	22	.	.	.
cord-314500-89ovdnxl	79	1	38	38	CD
cord-314500-89ovdnxl	80	1	It	-PRON-	PRP
cord-314500-89ovdnxl	80	2	remains	remain	VBZ
cord-314500-89ovdnxl	80	3	to	to	TO
cord-314500-89ovdnxl	80	4	be	be	VB
cord-314500-89ovdnxl	80	5	established	establish	VBN
cord-314500-89ovdnxl	80	6	why	why	WRB
cord-314500-89ovdnxl	80	7	diabetes	diabetes	NN
cord-314500-89ovdnxl	80	8	confers	confer	VBZ
cord-314500-89ovdnxl	80	9	much	much	RB
cord-314500-89ovdnxl	80	10	greater	great	JJR
cord-314500-89ovdnxl	80	11	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	80	12	to	to	IN
cord-314500-89ovdnxl	80	13	,	,	,
cord-314500-89ovdnxl	80	14	and	and	CC
cord-314500-89ovdnxl	80	15	worse	bad	JJR
cord-314500-89ovdnxl	80	16	outcomes	outcome	NNS
cord-314500-89ovdnxl	80	17	for	for	IN
cord-314500-89ovdnxl	80	18	some	some	DT
cord-314500-89ovdnxl	80	19	bacteria	bacteria	NNS
cord-314500-89ovdnxl	80	20	than	than	IN
cord-314500-89ovdnxl	80	21	to	to	IN
cord-314500-89ovdnxl	80	22	others	other	NNS
cord-314500-89ovdnxl	80	23	.	.	.
cord-314500-89ovdnxl	81	1	Several	several	JJ
cord-314500-89ovdnxl	81	2	of	of	IN
cord-314500-89ovdnxl	81	3	the	the	DT
cord-314500-89ovdnxl	81	4	bacteria	bacteria	NNS
cord-314500-89ovdnxl	81	5	most	most	RBS
cord-314500-89ovdnxl	81	6	closely	closely	RB
cord-314500-89ovdnxl	81	7	associated	associate	VBN
cord-314500-89ovdnxl	81	8	with	with	IN
cord-314500-89ovdnxl	81	9	diabetes	diabete	NNS
cord-314500-89ovdnxl	81	10	,	,	,
cord-314500-89ovdnxl	81	11	such	such	JJ
cord-314500-89ovdnxl	81	12	as	as	IN
cord-314500-89ovdnxl	81	13	M.	M.	NNP
cord-314500-89ovdnxl	81	14	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	81	15	and	and	CC
cord-314500-89ovdnxl	81	16	B.	B.	NNP
cord-314500-89ovdnxl	81	17	pseudomallei	pseudomallei	NNP
cord-314500-89ovdnxl	81	18	,	,	,
cord-314500-89ovdnxl	81	19	are	be	VBP
cord-314500-89ovdnxl	81	20	predominantly	predominantly	RB
cord-314500-89ovdnxl	81	21	intracellular	intracellular	JJ
cord-314500-89ovdnxl	81	22	bacteria	bacteria	NNS
cord-314500-89ovdnxl	81	23	.	.	.
cord-314500-89ovdnxl	82	1	Impairments	impairment	NNS
cord-314500-89ovdnxl	82	2	in	in	IN
cord-314500-89ovdnxl	82	3	phagocyte	phagocyte	NNP
cord-314500-89ovdnxl	82	4	function	function	NN
cord-314500-89ovdnxl	82	5	and	and	CC
cord-314500-89ovdnxl	82	6	adaptive	adaptive	JJ
cord-314500-89ovdnxl	82	7	T	t	NN
cord-314500-89ovdnxl	82	8	cell	cell	NN
cord-314500-89ovdnxl	82	9	immunity	immunity	NN
cord-314500-89ovdnxl	82	10	in	in	IN
cord-314500-89ovdnxl	82	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	82	12	may	may	MD
cord-314500-89ovdnxl	82	13	contribute	contribute	VB
cord-314500-89ovdnxl	82	14	to	to	IN
cord-314500-89ovdnxl	82	15	increased	increase	VBN
cord-314500-89ovdnxl	82	16	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	82	17	to	to	IN
cord-314500-89ovdnxl	82	18	intracellular	intracellular	JJ
cord-314500-89ovdnxl	82	19	pathogens	pathogen	NNS
cord-314500-89ovdnxl	82	20	.	.	.
cord-314500-89ovdnxl	83	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	83	2	is	be	VBZ
cord-314500-89ovdnxl	83	3	associated	associate	VBN
cord-314500-89ovdnxl	83	4	with	with	IN
cord-314500-89ovdnxl	83	5	antimicrobial	antimicrobial	JJ
cord-314500-89ovdnxl	83	6	resistance	resistance	NN
cord-314500-89ovdnxl	83	7	(	(	-LRB-
cord-314500-89ovdnxl	83	8	AMR	AMR	NNP
cord-314500-89ovdnxl	83	9	)	)	-RRB-
cord-314500-89ovdnxl	83	10	.	.	.
cord-314500-89ovdnxl	84	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	84	2	status	status	NN
cord-314500-89ovdnxl	84	3	is	be	VBZ
cord-314500-89ovdnxl	84	4	associated	associate	VBN
cord-314500-89ovdnxl	84	5	with	with	IN
cord-314500-89ovdnxl	84	6	increased	increase	VBN
cord-314500-89ovdnxl	84	7	rates	rate	NNS
cord-314500-89ovdnxl	84	8	of	of	IN
cord-314500-89ovdnxl	84	9	drug	drug	NN
cord-314500-89ovdnxl	84	10	resistance	resistance	NN
cord-314500-89ovdnxl	84	11	in	in	IN
cord-314500-89ovdnxl	84	12	TB	TB	NNP
cord-314500-89ovdnxl	84	13	,	,	,
cord-314500-89ovdnxl	84	14	including	include	VBG
cord-314500-89ovdnxl	84	15	multidrug	multidrug	NN
cord-314500-89ovdnxl	84	16	-	-	HYPH
cord-314500-89ovdnxl	84	17	resistant	resistant	JJ
cord-314500-89ovdnxl	84	18	TB	TB	NNP
cord-314500-89ovdnxl	84	19	.	.	.
cord-314500-89ovdnxl	85	1	39	39	CD
cord-314500-89ovdnxl	85	2	,	,	,
cord-314500-89ovdnxl	85	3	40	40	CD
cord-314500-89ovdnxl	86	1	Besides	besides	IN
cord-314500-89ovdnxl	86	2	TB	TB	NNP
cord-314500-89ovdnxl	86	3	,	,	,
cord-314500-89ovdnxl	86	4	people	people	NNS
cord-314500-89ovdnxl	86	5	with	with	IN
cord-314500-89ovdnxl	86	6	diabetes	diabete	NNS
cord-314500-89ovdnxl	86	7	are	be	VBP
cord-314500-89ovdnxl	86	8	over	over	RB
cord-314500-89ovdnxl	86	9	-	-	HYPH
cord-314500-89ovdnxl	86	10	represented	represent	VBN
cord-314500-89ovdnxl	86	11	in	in	IN
cord-314500-89ovdnxl	86	12	cohorts	cohort	NNS
cord-314500-89ovdnxl	86	13	with	with	IN
cord-314500-89ovdnxl	86	14	multi	multi	JJ
cord-314500-89ovdnxl	86	15	-	-	JJ
cord-314500-89ovdnxl	86	16	drugresistant	drugresistant	JJ
cord-314500-89ovdnxl	86	17	infections	infection	NNS
cord-314500-89ovdnxl	86	18	,	,	,
cord-314500-89ovdnxl	86	19	41	41	CD
cord-314500-89ovdnxl	87	1	but	but	CC
cord-314500-89ovdnxl	87	2	there	there	EX
cord-314500-89ovdnxl	87	3	is	be	VBZ
cord-314500-89ovdnxl	87	4	a	a	DT
cord-314500-89ovdnxl	87	5	lack	lack	NN
cord-314500-89ovdnxl	87	6	of	of	IN
cord-314500-89ovdnxl	87	7	evidence	evidence	NN
cord-314500-89ovdnxl	87	8	at	at	IN
cord-314500-89ovdnxl	87	9	present	present	NN
cord-314500-89ovdnxl	87	10	of	of	IN
cord-314500-89ovdnxl	87	11	higher	high	JJR
cord-314500-89ovdnxl	87	12	rates	rate	NNS
cord-314500-89ovdnxl	87	13	of	of	IN
cord-314500-89ovdnxl	87	14	AMR	AMR	NNP
cord-314500-89ovdnxl	87	15	in	in	IN
cord-314500-89ovdnxl	87	16	bacterial	bacterial	JJ
cord-314500-89ovdnxl	87	17	isolates	isolate	NNS
cord-314500-89ovdnxl	87	18	from	from	IN
cord-314500-89ovdnxl	87	19	people	people	NNS
cord-314500-89ovdnxl	87	20	with	with	IN
cord-314500-89ovdnxl	87	21	diabetes	diabete	NNS
cord-314500-89ovdnxl	87	22	compared	compare	VBN
cord-314500-89ovdnxl	87	23	with	with	IN
cord-314500-89ovdnxl	87	24	isolates	isolate	NNS
cord-314500-89ovdnxl	87	25	from	from	IN
cord-314500-89ovdnxl	87	26	non	non	JJ
cord-314500-89ovdnxl	87	27	-	-	NNS
cord-314500-89ovdnxl	87	28	diabetics	diabetic	NNS
cord-314500-89ovdnxl	87	29	.	.	.
cord-314500-89ovdnxl	88	1	What	what	WP
cord-314500-89ovdnxl	88	2	is	be	VBZ
cord-314500-89ovdnxl	88	3	clear	clear	JJ
cord-314500-89ovdnxl	88	4	is	be	VBZ
cord-314500-89ovdnxl	88	5	that	that	IN
cord-314500-89ovdnxl	88	6	increasing	increase	VBG
cord-314500-89ovdnxl	88	7	rates	rate	NNS
cord-314500-89ovdnxl	88	8	of	of	IN
cord-314500-89ovdnxl	88	9	AMR	AMR	NNP
cord-314500-89ovdnxl	88	10	will	will	MD
cord-314500-89ovdnxl	88	11	have	have	VB
cord-314500-89ovdnxl	88	12	a	a	DT
cord-314500-89ovdnxl	88	13	larger	large	JJR
cord-314500-89ovdnxl	88	14	impact	impact	NN
cord-314500-89ovdnxl	88	15	on	on	IN
cord-314500-89ovdnxl	88	16	people	people	NNS
cord-314500-89ovdnxl	88	17	with	with	IN
cord-314500-89ovdnxl	88	18	diabetes	diabete	NNS
cord-314500-89ovdnxl	88	19	,	,	,
cord-314500-89ovdnxl	88	20	due	due	IN
cord-314500-89ovdnxl	88	21	to	to	IN
cord-314500-89ovdnxl	88	22	their	-PRON-	PRP$
cord-314500-89ovdnxl	88	23	higher	high	JJR
cord-314500-89ovdnxl	88	24	risk	risk	NN
cord-314500-89ovdnxl	88	25	of	of	IN
cord-314500-89ovdnxl	88	26	infection	infection	NN
cord-314500-89ovdnxl	88	27	and	and	CC
cord-314500-89ovdnxl	88	28	increased	increase	VBN
cord-314500-89ovdnxl	88	29	need	need	NN
cord-314500-89ovdnxl	88	30	for	for	IN
cord-314500-89ovdnxl	88	31	healthcare	healthcare	NN
cord-314500-89ovdnxl	88	32	exposure	exposure	NN
cord-314500-89ovdnxl	88	33	and	and	CC
cord-314500-89ovdnxl	88	34	interventions	intervention	NNS
cord-314500-89ovdnxl	88	35	.	.	.
cord-314500-89ovdnxl	89	1	Dengue	dengue	NN
cord-314500-89ovdnxl	89	2	causes	cause	VBZ
cord-314500-89ovdnxl	89	3	an	an	DT
cord-314500-89ovdnxl	89	4	estimated	estimate	VBN
cord-314500-89ovdnxl	89	5	101	101	CD
cord-314500-89ovdnxl	89	6	million	million	CD
cord-314500-89ovdnxl	89	7	clinical	clinical	JJ
cord-314500-89ovdnxl	89	8	cases	case	NNS
cord-314500-89ovdnxl	89	9	per	per	IN
cord-314500-89ovdnxl	89	10	year	year	NN
cord-314500-89ovdnxl	89	11	and	and	CC
cord-314500-89ovdnxl	89	12	37	37	CD
cord-314500-89ovdnxl	89	13	800	800	CD
cord-314500-89ovdnxl	89	14	deaths	death	NNS
cord-314500-89ovdnxl	89	15	.	.	.
cord-314500-89ovdnxl	90	1	6	6	CD
cord-314500-89ovdnxl	91	1	An	an	DT
cord-314500-89ovdnxl	91	2	association	association	NN
cord-314500-89ovdnxl	91	3	between	between	IN
cord-314500-89ovdnxl	91	4	diabetes	diabetes	NN
cord-314500-89ovdnxl	91	5	and	and	CC
cord-314500-89ovdnxl	91	6	severe	severe	JJ
cord-314500-89ovdnxl	91	7	presentations	presentation	NNS
cord-314500-89ovdnxl	91	8	of	of	IN
cord-314500-89ovdnxl	91	9	dengue	dengue	NN
cord-314500-89ovdnxl	91	10	is	be	VBZ
cord-314500-89ovdnxl	91	11	now	now	RB
cord-314500-89ovdnxl	91	12	broadly	broadly	RB
cord-314500-89ovdnxl	91	13	accepted	accept	VBN
cord-314500-89ovdnxl	91	14	.	.	.
cord-314500-89ovdnxl	92	1	42	42	CD
cord-314500-89ovdnxl	93	1	However	however	RB
cord-314500-89ovdnxl	93	2	,	,	,
cord-314500-89ovdnxl	93	3	studies	study	NNS
cord-314500-89ovdnxl	93	4	are	be	VBP
cord-314500-89ovdnxl	93	5	typically	typically	RB
cord-314500-89ovdnxl	93	6	retrospective	retrospective	JJ
cord-314500-89ovdnxl	93	7	,	,	,
cord-314500-89ovdnxl	93	8	often	often	RB
cord-314500-89ovdnxl	93	9	small	small	JJ
cord-314500-89ovdnxl	93	10	in	in	IN
cord-314500-89ovdnxl	93	11	nature	nature	NN
cord-314500-89ovdnxl	93	12	,	,	,
cord-314500-89ovdnxl	93	13	and	and	CC
cord-314500-89ovdnxl	93	14	use	use	VB
cord-314500-89ovdnxl	93	15	varying	varying	JJ
cord-314500-89ovdnxl	93	16	definitions	definition	NNS
cord-314500-89ovdnxl	93	17	of	of	IN
cord-314500-89ovdnxl	93	18	severe	severe	JJ
cord-314500-89ovdnxl	93	19	dengue	dengue	NN
cord-314500-89ovdnxl	93	20	.	.	.
cord-314500-89ovdnxl	94	1	In	in	IN
cord-314500-89ovdnxl	94	2	a	a	DT
cord-314500-89ovdnxl	94	3	metaanalysis	metaanalysis	NN
cord-314500-89ovdnxl	94	4	of	of	IN
cord-314500-89ovdnxl	94	5	five	five	CD
cord-314500-89ovdnxl	94	6	case	case	NN
cord-314500-89ovdnxl	94	7	-	-	HYPH
cord-314500-89ovdnxl	94	8	control	control	NN
cord-314500-89ovdnxl	94	9	studies	study	NNS
cord-314500-89ovdnxl	94	10	of	of	IN
cord-314500-89ovdnxl	94	11	acute	acute	JJ
cord-314500-89ovdnxl	94	12	dengue	dengue	NN
cord-314500-89ovdnxl	94	13	,	,	,
cord-314500-89ovdnxl	94	14	diabetes	diabetes	NN
cord-314500-89ovdnxl	94	15	was	be	VBD
cord-314500-89ovdnxl	94	16	associated	associate	VBN
cord-314500-89ovdnxl	94	17	with	with	IN
cord-314500-89ovdnxl	94	18	an	an	DT
cord-314500-89ovdnxl	94	19	increased	increase	VBN
cord-314500-89ovdnxl	94	20	risk	risk	NN
cord-314500-89ovdnxl	94	21	of	of	IN
cord-314500-89ovdnxl	94	22	a	a	DT
cord-314500-89ovdnxl	94	23	severe	severe	JJ
cord-314500-89ovdnxl	94	24	clinical	clinical	JJ
cord-314500-89ovdnxl	94	25	presentation	presentation	NN
cord-314500-89ovdnxl	94	26	of	of	IN
cord-314500-89ovdnxl	94	27	dengue	dengue	NN
cord-314500-89ovdnxl	94	28	compared	compare	VBN
cord-314500-89ovdnxl	94	29	with	with	IN
cord-314500-89ovdnxl	94	30	either	either	CC
cord-314500-89ovdnxl	94	31	asymptomatic	asymptomatic	JJ
cord-314500-89ovdnxl	94	32	infection	infection	NN
cord-314500-89ovdnxl	94	33	or	or	CC
cord-314500-89ovdnxl	94	34	non	non	JJ
cord-314500-89ovdnxl	94	35	-	-	JJ
cord-314500-89ovdnxl	94	36	severe	severe	JJ
cord-314500-89ovdnxl	94	37	acute	acute	JJ
cord-314500-89ovdnxl	94	38	dengue	dengue	NN
cord-314500-89ovdnxl	94	39	,	,	,
cord-314500-89ovdnxl	94	40	43	43	CD
cord-314500-89ovdnxl	94	41	although	although	IN
cord-314500-89ovdnxl	94	42	given	give	VBN
cord-314500-89ovdnxl	94	43	the	the	DT
cord-314500-89ovdnxl	94	44	limited	limited	JJ
cord-314500-89ovdnxl	94	45	data	datum	NNS
cord-314500-89ovdnxl	94	46	,	,	,
cord-314500-89ovdnxl	94	47	the	the	DT
cord-314500-89ovdnxl	94	48	authors	author	NNS
cord-314500-89ovdnxl	94	49	emphasised	emphasise	VBD
cord-314500-89ovdnxl	94	50	this	this	DT
cord-314500-89ovdnxl	94	51	was	be	VBD
cord-314500-89ovdnxl	94	52	only	only	RB
cord-314500-89ovdnxl	94	53	suggestive	suggestive	JJ
cord-314500-89ovdnxl	94	54	of	of	IN
cord-314500-89ovdnxl	94	55	a	a	DT
cord-314500-89ovdnxl	94	56	link	link	NN
cord-314500-89ovdnxl	94	57	.	.	.
cord-314500-89ovdnxl	95	1	This	this	DT
cord-314500-89ovdnxl	95	2	finding	finding	NN
cord-314500-89ovdnxl	95	3	has	have	VBZ
cord-314500-89ovdnxl	95	4	been	be	VBN
cord-314500-89ovdnxl	95	5	supported	support	VBN
cord-314500-89ovdnxl	95	6	by	by	IN
cord-314500-89ovdnxl	95	7	further	further	JJ
cord-314500-89ovdnxl	95	8	studies	study	NNS
cord-314500-89ovdnxl	95	9	in	in	IN
cord-314500-89ovdnxl	95	10	Malaysia	Malaysia	NNP
cord-314500-89ovdnxl	95	11	44	44	CD
cord-314500-89ovdnxl	95	12	and	and	CC
cord-314500-89ovdnxl	95	13	China	China	NNP
cord-314500-89ovdnxl	95	14	.	.	.
cord-314500-89ovdnxl	96	1	45	45	CD
cord-314500-89ovdnxl	97	1	A	a	DT
cord-314500-89ovdnxl	97	2	systematic	systematic	JJ
cord-314500-89ovdnxl	97	3	review	review	NN
cord-314500-89ovdnxl	97	4	46	46	CD
cord-314500-89ovdnxl	97	5	to	to	TO
cord-314500-89ovdnxl	97	6	evaluate	evaluate	VB
cord-314500-89ovdnxl	97	7	the	the	DT
cord-314500-89ovdnxl	97	8	contribution	contribution	NN
cord-314500-89ovdnxl	97	9	of	of	IN
cord-314500-89ovdnxl	97	10	non	non	JJ
cord-314500-89ovdnxl	97	11	-	-	JJ
cord-314500-89ovdnxl	97	12	communicable	communicable	JJ
cord-314500-89ovdnxl	97	13	diseases	disease	NNS
cord-314500-89ovdnxl	97	14	(	(	-LRB-
cord-314500-89ovdnxl	97	15	NCDs	ncd	NNS
cord-314500-89ovdnxl	97	16	)	)	-RRB-
cord-314500-89ovdnxl	97	17	to	to	IN
cord-314500-89ovdnxl	97	18	the	the	DT
cord-314500-89ovdnxl	97	19	development	development	NN
cord-314500-89ovdnxl	97	20	of	of	IN
cord-314500-89ovdnxl	97	21	severe	severe	JJ
cord-314500-89ovdnxl	97	22	dengue	dengue	NN
cord-314500-89ovdnxl	97	23	identified	identify	VBD
cord-314500-89ovdnxl	97	24	16	16	CD
cord-314500-89ovdnxl	97	25	relevant	relevant	JJ
cord-314500-89ovdnxl	97	26	publications	publication	NNS
cord-314500-89ovdnxl	97	27	and	and	CC
cord-314500-89ovdnxl	97	28	gives	give	VBZ
cord-314500-89ovdnxl	97	29	a	a	DT
cord-314500-89ovdnxl	97	30	clear	clear	JJ
cord-314500-89ovdnxl	97	31	overview	overview	NN
cord-314500-89ovdnxl	97	32	of	of	IN
cord-314500-89ovdnxl	97	33	this	this	DT
cord-314500-89ovdnxl	97	34	literature	literature	NN
cord-314500-89ovdnxl	97	35	,	,	,
cord-314500-89ovdnxl	97	36	but	but	CC
cord-314500-89ovdnxl	97	37	given	give	VBN
cord-314500-89ovdnxl	97	38	the	the	DT
cord-314500-89ovdnxl	97	39	heterogeneity	heterogeneity	NN
cord-314500-89ovdnxl	97	40	of	of	IN
cord-314500-89ovdnxl	97	41	the	the	DT
cord-314500-89ovdnxl	97	42	studies	study	NNS
cord-314500-89ovdnxl	97	43	the	the	DT
cord-314500-89ovdnxl	97	44	authors	author	NNS
cord-314500-89ovdnxl	97	45	concluded	conclude	VBD
cord-314500-89ovdnxl	97	46	that	that	IN
cord-314500-89ovdnxl	97	47	the	the	DT
cord-314500-89ovdnxl	97	48	existing	exist	VBG
cord-314500-89ovdnxl	97	49	literature	literature	NN
cord-314500-89ovdnxl	97	50	was	be	VBD
cord-314500-89ovdnxl	97	51	inadequate	inadequate	JJ
cord-314500-89ovdnxl	97	52	for	for	IN
cord-314500-89ovdnxl	97	53	meaningful	meaningful	JJ
cord-314500-89ovdnxl	97	54	estimation	estimation	NN
cord-314500-89ovdnxl	97	55	of	of	IN
cord-314500-89ovdnxl	97	56	the	the	DT
cord-314500-89ovdnxl	97	57	impact	impact	NN
cord-314500-89ovdnxl	97	58	of	of	IN
cord-314500-89ovdnxl	97	59	diabetes	diabetes	NN
cord-314500-89ovdnxl	97	60	and	and	CC
cord-314500-89ovdnxl	97	61	other	other	JJ
cord-314500-89ovdnxl	97	62	NCDs	ncd	NNS
cord-314500-89ovdnxl	97	63	on	on	IN
cord-314500-89ovdnxl	97	64	dengue	dengue	NN
cord-314500-89ovdnxl	97	65	severity	severity	NN
cord-314500-89ovdnxl	97	66	.	.	.
cord-314500-89ovdnxl	98	1	The	the	DT
cord-314500-89ovdnxl	98	2	following	following	JJ
cord-314500-89ovdnxl	98	3	year	year	NN
cord-314500-89ovdnxl	98	4	a	a	DT
cord-314500-89ovdnxl	98	5	Canadian	canadian	JJ
cord-314500-89ovdnxl	98	6	group	group	NN
cord-314500-89ovdnxl	98	7	47	47	CD
cord-314500-89ovdnxl	98	8	reported	report	VBD
cord-314500-89ovdnxl	98	9	a	a	DT
cord-314500-89ovdnxl	98	10	nearly	nearly	RB
cord-314500-89ovdnxl	98	11	three	three	CD
cord-314500-89ovdnxl	98	12	-	-	HYPH
cord-314500-89ovdnxl	98	13	fold	fold	VB
cord-314500-89ovdnxl	98	14	higher	high	JJR
cord-314500-89ovdnxl	98	15	prevalence	prevalence	NN
cord-314500-89ovdnxl	98	16	of	of	IN
cord-314500-89ovdnxl	98	17	diabetes	diabete	NNS
cord-314500-89ovdnxl	98	18	in	in	IN
cord-314500-89ovdnxl	98	19	3236	3236	CD
cord-314500-89ovdnxl	98	20	patients	patient	NNS
cord-314500-89ovdnxl	98	21	in	in	IN
cord-314500-89ovdnxl	98	22	22	22	CD
cord-314500-89ovdnxl	98	23	studies	study	NNS
cord-314500-89ovdnxl	98	24	with	with	IN
cord-314500-89ovdnxl	98	25	severe	severe	JJ
cord-314500-89ovdnxl	98	26	dengue	dengue	NN
cord-314500-89ovdnxl	98	27	than	than	IN
cord-314500-89ovdnxl	98	28	the	the	DT
cord-314500-89ovdnxl	98	29	prevalence	prevalence	NN
cord-314500-89ovdnxl	98	30	of	of	IN
cord-314500-89ovdnxl	98	31	diabetes	diabete	NNS
cord-314500-89ovdnxl	98	32	in	in	IN
cord-314500-89ovdnxl	98	33	9067	9067	CD
cord-314500-89ovdnxl	98	34	subjects	subject	NNS
cord-314500-89ovdnxl	98	35	in	in	IN
cord-314500-89ovdnxl	98	36	13	13	CD
cord-314500-89ovdnxl	98	37	studies	study	NNS
cord-314500-89ovdnxl	98	38	with	with	IN
cord-314500-89ovdnxl	98	39	non	non	JJ
cord-314500-89ovdnxl	98	40	-	-	JJ
cord-314500-89ovdnxl	98	41	severe	severe	JJ
cord-314500-89ovdnxl	98	42	dengue	dengue	NN
cord-314500-89ovdnxl	98	43	.	.	.
cord-314500-89ovdnxl	99	1	The	the	DT
cord-314500-89ovdnxl	99	2	same	same	JJ
cord-314500-89ovdnxl	99	3	analysis	analysis	NN
cord-314500-89ovdnxl	99	4	found	find	VBD
cord-314500-89ovdnxl	99	5	hypertension	hypertension	NN
cord-314500-89ovdnxl	99	6	,	,	,
cord-314500-89ovdnxl	99	7	heart	heart	NN
cord-314500-89ovdnxl	99	8	disease	disease	NN
cord-314500-89ovdnxl	99	9	and	and	CC
cord-314500-89ovdnxl	99	10	obesity	obesity	NN
cord-314500-89ovdnxl	99	11	(	(	-LRB-
cord-314500-89ovdnxl	99	12	conditions	condition	NNS
cord-314500-89ovdnxl	99	13	interrelated	interrelate	VBN
cord-314500-89ovdnxl	99	14	with	with	IN
cord-314500-89ovdnxl	99	15	diabetes	diabetes	NN
cord-314500-89ovdnxl	99	16	)	)	-RRB-
cord-314500-89ovdnxl	99	17	to	to	TO
cord-314500-89ovdnxl	99	18	be	be	VB
cord-314500-89ovdnxl	99	19	significantly	significantly	RB
cord-314500-89ovdnxl	99	20	more	more	RBR
cord-314500-89ovdnxl	99	21	prevalent	prevalent	JJ
cord-314500-89ovdnxl	99	22	in	in	IN
cord-314500-89ovdnxl	99	23	severe	severe	JJ
cord-314500-89ovdnxl	99	24	dengue	dengue	NN
cord-314500-89ovdnxl	99	25	,	,	,
cord-314500-89ovdnxl	99	26	and	and	CC
cord-314500-89ovdnxl	99	27	also	also	RB
cord-314500-89ovdnxl	99	28	reported	report	VBD
cord-314500-89ovdnxl	99	29	a	a	DT
cord-314500-89ovdnxl	99	30	four	four	CD
cord-314500-89ovdnxl	99	31	-	-	HYPH
cord-314500-89ovdnxl	99	32	fold	fold	JJ
cord-314500-89ovdnxl	99	33	increased	increase	VBN
cord-314500-89ovdnxl	99	34	prevalence	prevalence	NN
cord-314500-89ovdnxl	99	35	of	of	IN
cord-314500-89ovdnxl	99	36	diabetes	diabetes	NN
cord-314500-89ovdnxl	99	37	in	in	IN
cord-314500-89ovdnxl	99	38	severe	severe	JJ
cord-314500-89ovdnxl	99	39	West	West	NNP
cord-314500-89ovdnxl	99	40	Nile	Nile	NNP
cord-314500-89ovdnxl	99	41	fever	fever	NN
cord-314500-89ovdnxl	99	42	cases	case	NNS
cord-314500-89ovdnxl	99	43	by	by	IN
cord-314500-89ovdnxl	99	44	the	the	DT
cord-314500-89ovdnxl	99	45	same	same	JJ
cord-314500-89ovdnxl	99	46	methodology	methodology	NN
cord-314500-89ovdnxl	99	47	,	,	,
cord-314500-89ovdnxl	99	48	supporting	support	VBG
cord-314500-89ovdnxl	99	49	an	an	DT
cord-314500-89ovdnxl	99	50	earlier	early	JJR
cord-314500-89ovdnxl	99	51	study	study	NN
cord-314500-89ovdnxl	99	52	48	48	CD
cord-314500-89ovdnxl	99	53	.	.	.
cord-314500-89ovdnxl	100	1	The	the	DT
cord-314500-89ovdnxl	100	2	authors	author	NNS
cord-314500-89ovdnxl	100	3	acknowledge	acknowledge	VBP
cord-314500-89ovdnxl	100	4	the	the	DT
cord-314500-89ovdnxl	100	5	multiple	multiple	JJ
cord-314500-89ovdnxl	100	6	limitations	limitation	NNS
cord-314500-89ovdnxl	100	7	of	of	IN
cord-314500-89ovdnxl	100	8	this	this	DT
cord-314500-89ovdnxl	100	9	approach	approach	NN
cord-314500-89ovdnxl	100	10	,	,	,
cord-314500-89ovdnxl	100	11	including	include	VBG
cord-314500-89ovdnxl	100	12	the	the	DT
cord-314500-89ovdnxl	100	13	heterogeneity	heterogeneity	NN
cord-314500-89ovdnxl	100	14	of	of	IN
cord-314500-89ovdnxl	100	15	the	the	DT
cord-314500-89ovdnxl	100	16	studies	study	NNS
cord-314500-89ovdnxl	100	17	and	and	CC
cord-314500-89ovdnxl	100	18	publication	publication	NN
cord-314500-89ovdnxl	100	19	bias	bias	NN
cord-314500-89ovdnxl	100	20	for	for	IN
cord-314500-89ovdnxl	100	21	studies	study	NNS
cord-314500-89ovdnxl	100	22	included	include	VBN
cord-314500-89ovdnxl	100	23	.	.	.
cord-314500-89ovdnxl	101	1	There	there	EX
cord-314500-89ovdnxl	101	2	is	be	VBZ
cord-314500-89ovdnxl	101	3	clearly	clearly	RB
cord-314500-89ovdnxl	101	4	a	a	DT
cord-314500-89ovdnxl	101	5	need	need	NN
cord-314500-89ovdnxl	101	6	for	for	IN
cord-314500-89ovdnxl	101	7	further	further	JJ
cord-314500-89ovdnxl	101	8	high	high	JJ
cord-314500-89ovdnxl	101	9	-	-	HYPH
cord-314500-89ovdnxl	101	10	quality	quality	NN
cord-314500-89ovdnxl	101	11	epidemiological	epidemiological	JJ
cord-314500-89ovdnxl	101	12	studies	study	NNS
cord-314500-89ovdnxl	101	13	to	to	TO
cord-314500-89ovdnxl	101	14	further	further	RB
cord-314500-89ovdnxl	101	15	define	define	VB
cord-314500-89ovdnxl	101	16	the	the	DT
cord-314500-89ovdnxl	101	17	association	association	NN
cord-314500-89ovdnxl	101	18	.	.	.
cord-314500-89ovdnxl	102	1	There	there	EX
cord-314500-89ovdnxl	102	2	is	be	VBZ
cord-314500-89ovdnxl	102	3	some	some	DT
cord-314500-89ovdnxl	102	4	evidence	evidence	NN
cord-314500-89ovdnxl	102	5	that	that	IN
cord-314500-89ovdnxl	102	6	diabetes	diabetes	NN
cord-314500-89ovdnxl	102	7	is	be	VBZ
cord-314500-89ovdnxl	102	8	associated	associate	VBN
cord-314500-89ovdnxl	102	9	with	with	IN
cord-314500-89ovdnxl	102	10	more	more	RBR
cord-314500-89ovdnxl	102	11	severe	severe	JJ
cord-314500-89ovdnxl	102	12	disease	disease	NN
cord-314500-89ovdnxl	102	13	in	in	IN
cord-314500-89ovdnxl	102	14	chikungunya	chikungunya	NN
cord-314500-89ovdnxl	102	15	disease	disease	NN
cord-314500-89ovdnxl	102	16	,	,	,
cord-314500-89ovdnxl	102	17	49	49	CD
cord-314500-89ovdnxl	103	1	but	but	CC
cord-314500-89ovdnxl	103	2	there	there	EX
cord-314500-89ovdnxl	103	3	is	be	VBZ
cord-314500-89ovdnxl	103	4	a	a	DT
cord-314500-89ovdnxl	103	5	current	current	JJ
cord-314500-89ovdnxl	103	6	lack	lack	NN
cord-314500-89ovdnxl	103	7	of	of	IN
cord-314500-89ovdnxl	103	8	data	datum	NNS
cord-314500-89ovdnxl	103	9	for	for	IN
cord-314500-89ovdnxl	103	10	analysing	analyse	VBG
cord-314500-89ovdnxl	103	11	the	the	DT
cord-314500-89ovdnxl	103	12	relationship	relationship	NN
cord-314500-89ovdnxl	103	13	with	with	IN
cord-314500-89ovdnxl	103	14	Zika	Zika	NNP
cord-314500-89ovdnxl	103	15	virus	virus	NN
cord-314500-89ovdnxl	103	16	.	.	.
cord-314500-89ovdnxl	104	1	Other	other	JJ
cord-314500-89ovdnxl	104	2	viral	viral	JJ
cord-314500-89ovdnxl	104	3	infections	infection	NNS
cord-314500-89ovdnxl	104	4	may	may	MD
cord-314500-89ovdnxl	104	5	be	be	VB
cord-314500-89ovdnxl	104	6	associated	associate	VBN
cord-314500-89ovdnxl	104	7	with	with	IN
cord-314500-89ovdnxl	104	8	diabetes	diabete	NNS
cord-314500-89ovdnxl	104	9	.	.	.
cord-314500-89ovdnxl	105	1	People	People	NNS
cord-314500-89ovdnxl	105	2	with	with	IN
cord-314500-89ovdnxl	105	3	diabetes	diabete	NNS
cord-314500-89ovdnxl	105	4	are	be	VBP
cord-314500-89ovdnxl	105	5	an	an	DT
cord-314500-89ovdnxl	105	6	at	at	IN
cord-314500-89ovdnxl	105	7	-	-	HYPH
cord-314500-89ovdnxl	105	8	risk	risk	NN
cord-314500-89ovdnxl	105	9	group	group	NN
cord-314500-89ovdnxl	105	10	for	for	IN
cord-314500-89ovdnxl	105	11	clinical	clinical	JJ
cord-314500-89ovdnxl	105	12	illness	illness	NN
cord-314500-89ovdnxl	105	13	,	,	,
cord-314500-89ovdnxl	105	14	disease	disease	NN
cord-314500-89ovdnxl	105	15	severity	severity	NN
cord-314500-89ovdnxl	105	16	and	and	CC
cord-314500-89ovdnxl	105	17	death	death	NN
cord-314500-89ovdnxl	105	18	from	from	IN
cord-314500-89ovdnxl	105	19	influenza	influenza	NN
cord-314500-89ovdnxl	105	20	,	,	,
cord-314500-89ovdnxl	105	21	50	50	CD
cord-314500-89ovdnxl	105	22	with	with	IN
cord-314500-89ovdnxl	105	23	a	a	DT
cord-314500-89ovdnxl	105	24	meta	meta	JJ
cord-314500-89ovdnxl	105	25	-	-	HYPH
cord-314500-89ovdnxl	105	26	analysis	analysis	NN
cord-314500-89ovdnxl	105	27	of	of	IN
cord-314500-89ovdnxl	105	28	234	234	CD
cord-314500-89ovdnxl	105	29	articles	article	NNS
cord-314500-89ovdnxl	105	30	51	51	CD
cord-314500-89ovdnxl	105	31	showing	show	VBG
cord-314500-89ovdnxl	105	32	diabetes	diabetes	NN
cord-314500-89ovdnxl	105	33	to	to	TO
cord-314500-89ovdnxl	105	34	be	be	VB
cord-314500-89ovdnxl	105	35	a	a	DT
cord-314500-89ovdnxl	105	36	risk	risk	NN
cord-314500-89ovdnxl	105	37	factor	factor	NN
cord-314500-89ovdnxl	105	38	for	for	IN
cord-314500-89ovdnxl	105	39	death	death	NN
cord-314500-89ovdnxl	105	40	from	from	IN
cord-314500-89ovdnxl	105	41	pandemic	pandemic	NN
cord-314500-89ovdnxl	105	42	influenza	influenza	NN
cord-314500-89ovdnxl	105	43	(	(	-LRB-
cord-314500-89ovdnxl	105	44	predominantly	predominantly	RB
cord-314500-89ovdnxl	105	45	H1N1	H1N1	NNP
cord-314500-89ovdnxl	105	46	)	)	-RRB-
cord-314500-89ovdnxl	105	47	,	,	,
cord-314500-89ovdnxl	105	48	although	although	IN
cord-314500-89ovdnxl	105	49	there	there	EX
cord-314500-89ovdnxl	105	50	was	be	VBD
cord-314500-89ovdnxl	105	51	a	a	DT
cord-314500-89ovdnxl	105	52	lack	lack	NN
cord-314500-89ovdnxl	105	53	of	of	IN
cord-314500-89ovdnxl	105	54	high	high	JJ
cord-314500-89ovdnxl	105	55	-	-	HYPH
cord-314500-89ovdnxl	105	56	quality	quality	NN
cord-314500-89ovdnxl	105	57	cohort	cohort	NN
cord-314500-89ovdnxl	105	58	studies	study	NNS
cord-314500-89ovdnxl	105	59	to	to	TO
cord-314500-89ovdnxl	105	60	demonstrate	demonstrate	VB
cord-314500-89ovdnxl	105	61	this	this	DT
cord-314500-89ovdnxl	105	62	in	in	IN
cord-314500-89ovdnxl	105	63	seasonal	seasonal	JJ
cord-314500-89ovdnxl	105	64	influenza	influenza	NN
cord-314500-89ovdnxl	105	65	.	.	.
cord-314500-89ovdnxl	106	1	It	-PRON-	PRP
cord-314500-89ovdnxl	106	2	is	be	VBZ
cord-314500-89ovdnxl	106	3	estimated	estimate	VBN
cord-314500-89ovdnxl	106	4	that	that	IN
cord-314500-89ovdnxl	106	5	260	260	CD
cord-314500-89ovdnxl	106	6	million	million	CD
cord-314500-89ovdnxl	106	7	people	people	NNS
cord-314500-89ovdnxl	106	8	are	be	VBP
cord-314500-89ovdnxl	106	9	chronic	chronic	JJ
cord-314500-89ovdnxl	106	10	carriers	carrier	NNS
cord-314500-89ovdnxl	106	11	of	of	IN
cord-314500-89ovdnxl	106	12	the	the	DT
cord-314500-89ovdnxl	106	13	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	106	14	B	B	NNP
cord-314500-89ovdnxl	106	15	virus	virus	NN
cord-314500-89ovdnxl	106	16	(	(	-LRB-
cord-314500-89ovdnxl	106	17	HBV	HBV	NNP
cord-314500-89ovdnxl	106	18	)	)	-RRB-
cord-314500-89ovdnxl	106	19	,	,	,
cord-314500-89ovdnxl	106	20	52	52	CD
cord-314500-89ovdnxl	106	21	and	and	CC
cord-314500-89ovdnxl	106	22	HBV	HBV	NNP
cord-314500-89ovdnxl	106	23	has	have	VBZ
cord-314500-89ovdnxl	106	24	recently	recently	RB
cord-314500-89ovdnxl	106	25	been	be	VBN
cord-314500-89ovdnxl	106	26	described	describe	VBN
cord-314500-89ovdnxl	106	27	as	as	IN
cord-314500-89ovdnxl	106	28	a	a	DT
cord-314500-89ovdnxl	106	29	neglected	neglect	VBN
cord-314500-89ovdnxl	106	30	tropical	tropical	JJ
cord-314500-89ovdnxl	106	31	disease	disease	NN
cord-314500-89ovdnxl	106	32	.	.	.
cord-314500-89ovdnxl	107	1	53	53	CD
cord-314500-89ovdnxl	108	1	A	a	DT
cord-314500-89ovdnxl	108	2	number	number	NN
cord-314500-89ovdnxl	108	3	of	of	IN
cord-314500-89ovdnxl	108	4	studies	study	NNS
cord-314500-89ovdnxl	108	5	have	have	VBP
cord-314500-89ovdnxl	108	6	shown	show	VBN
cord-314500-89ovdnxl	108	7	a	a	DT
cord-314500-89ovdnxl	108	8	higher	high	JJR
cord-314500-89ovdnxl	108	9	prevalence	prevalence	NN
cord-314500-89ovdnxl	108	10	of	of	IN
cord-314500-89ovdnxl	108	11	HBV	HBV	NNP
cord-314500-89ovdnxl	108	12	in	in	IN
cord-314500-89ovdnxl	108	13	people	people	NNS
cord-314500-89ovdnxl	108	14	with	with	IN
cord-314500-89ovdnxl	108	15	diabetes	diabete	NNS
cord-314500-89ovdnxl	108	16	,	,	,
cord-314500-89ovdnxl	108	17	[	[	-LRB-
cord-314500-89ovdnxl	108	18	54	54	CD
cord-314500-89ovdnxl	108	19	]	]	-RRB-
cord-314500-89ovdnxl	108	20	[	[	-LRB-
cord-314500-89ovdnxl	108	21	55	55	CD
cord-314500-89ovdnxl	108	22	]	]	-RRB-
cord-314500-89ovdnxl	108	23	[	[	-LRB-
cord-314500-89ovdnxl	108	24	56	56	CD
cord-314500-89ovdnxl	108	25	]	]	-RRB-
cord-314500-89ovdnxl	108	26	and	and	CC
cord-314500-89ovdnxl	108	27	people	people	NNS
cord-314500-89ovdnxl	108	28	with	with	IN
cord-314500-89ovdnxl	108	29	chronic	chronic	JJ
cord-314500-89ovdnxl	108	30	HBV	HBV	NNP
cord-314500-89ovdnxl	108	31	are	be	VBP
cord-314500-89ovdnxl	108	32	reported	report	VBN
cord-314500-89ovdnxl	108	33	to	to	TO
cord-314500-89ovdnxl	108	34	have	have	VB
cord-314500-89ovdnxl	108	35	an	an	DT
cord-314500-89ovdnxl	108	36	increased	increase	VBN
cord-314500-89ovdnxl	108	37	risk	risk	NN
cord-314500-89ovdnxl	108	38	of	of	IN
cord-314500-89ovdnxl	108	39	developing	develop	VBG
cord-314500-89ovdnxl	108	40	diabetes	diabete	NNS
cord-314500-89ovdnxl	108	41	,	,	,
cord-314500-89ovdnxl	108	42	57	57	CD
cord-314500-89ovdnxl	108	43	although	although	IN
cord-314500-89ovdnxl	108	44	this	this	DT
cord-314500-89ovdnxl	108	45	has	have	VBZ
cord-314500-89ovdnxl	108	46	not	not	RB
cord-314500-89ovdnxl	108	47	been	be	VBN
cord-314500-89ovdnxl	108	48	demonstrated	demonstrate	VBN
cord-314500-89ovdnxl	108	49	to	to	IN
cord-314500-89ovdnxl	108	50	date	date	NN
cord-314500-89ovdnxl	108	51	in	in	IN
cord-314500-89ovdnxl	108	52	sub	sub	JJ
cord-314500-89ovdnxl	108	53	-	-	JJ
cord-314500-89ovdnxl	108	54	Saharan	saharan	JJ
cord-314500-89ovdnxl	108	55	Africa	Africa	NNP
cord-314500-89ovdnxl	108	56	.	.	.
cord-314500-89ovdnxl	109	1	58	58	CD
cord-314500-89ovdnxl	109	2	,	,	,
cord-314500-89ovdnxl	109	3	59	59	CD
cord-314500-89ovdnxl	110	1	In	in	IN
cord-314500-89ovdnxl	110	2	addition	addition	NN
cord-314500-89ovdnxl	110	3	,	,	,
cord-314500-89ovdnxl	110	4	diabetes	diabetes	NN
cord-314500-89ovdnxl	110	5	is	be	VBZ
cord-314500-89ovdnxl	110	6	associated	associate	VBN
cord-314500-89ovdnxl	110	7	with	with	IN
cord-314500-89ovdnxl	110	8	disease	disease	NN
cord-314500-89ovdnxl	110	9	progression	progression	NN
cord-314500-89ovdnxl	110	10	of	of	IN
cord-314500-89ovdnxl	110	11	HBV	HBV	NNP
cord-314500-89ovdnxl	110	12	,	,	,
cord-314500-89ovdnxl	110	13	60	60	CD
cord-314500-89ovdnxl	110	14	-	-	SYM
cord-314500-89ovdnxl	110	15	62	62	CD
cord-314500-89ovdnxl	110	16	which	which	WDT
cord-314500-89ovdnxl	110	17	has	have	VBZ
cord-314500-89ovdnxl	110	18	also	also	RB
cord-314500-89ovdnxl	110	19	been	be	VBN
cord-314500-89ovdnxl	110	20	reported	report	VBN
cord-314500-89ovdnxl	110	21	for	for	IN
cord-314500-89ovdnxl	110	22	hepatitis	hepatitis	NNP
cord-314500-89ovdnxl	110	23	C.	C.	NNP
cord-314500-89ovdnxl	110	24	63	63	CD
cord-314500-89ovdnxl	110	25	Varicella	Varicella	NNP
cord-314500-89ovdnxl	110	26	zoster	zoster	NN
cord-314500-89ovdnxl	110	27	virus	virus	NN
cord-314500-89ovdnxl	110	28	(	(	-LRB-
cord-314500-89ovdnxl	110	29	VZV	VZV	NNP
cord-314500-89ovdnxl	110	30	)	)	-RRB-
cord-314500-89ovdnxl	110	31	causes	cause	VBZ
cord-314500-89ovdnxl	110	32	chickenpox	chickenpox	NN
cord-314500-89ovdnxl	110	33	as	as	IN
cord-314500-89ovdnxl	110	34	a	a	DT
cord-314500-89ovdnxl	110	35	primary	primary	JJ
cord-314500-89ovdnxl	110	36	infection	infection	NN
cord-314500-89ovdnxl	110	37	which	which	WDT
cord-314500-89ovdnxl	110	38	can	can	MD
cord-314500-89ovdnxl	110	39	reactivate	reactivate	VB
cord-314500-89ovdnxl	110	40	as	as	IN
cord-314500-89ovdnxl	110	41	herpes	herpes	NN
cord-314500-89ovdnxl	110	42	-	-	HYPH
cord-314500-89ovdnxl	110	43	zoster	zoster	NN
cord-314500-89ovdnxl	110	44	(	(	-LRB-
cord-314500-89ovdnxl	110	45	shingles	shingle	NNS
cord-314500-89ovdnxl	110	46	)	)	-RRB-
cord-314500-89ovdnxl	110	47	,	,	,
cord-314500-89ovdnxl	110	48	especially	especially	RB
cord-314500-89ovdnxl	110	49	in	in	IN
cord-314500-89ovdnxl	110	50	older	old	JJR
cord-314500-89ovdnxl	110	51	people	people	NNS
cord-314500-89ovdnxl	110	52	.	.	.
cord-314500-89ovdnxl	111	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	111	2	is	be	VBZ
cord-314500-89ovdnxl	111	3	an	an	DT
cord-314500-89ovdnxl	111	4	established	establish	VBN
cord-314500-89ovdnxl	111	5	risk	risk	NN
cord-314500-89ovdnxl	111	6	factor	factor	NN
cord-314500-89ovdnxl	111	7	for	for	IN
cord-314500-89ovdnxl	111	8	shingles	shingle	NNS
cord-314500-89ovdnxl	111	9	.	.	.
cord-314500-89ovdnxl	112	1	64	64	CD
cord-314500-89ovdnxl	112	2	,	,	,
cord-314500-89ovdnxl	112	3	65	65	CD
cord-314500-89ovdnxl	112	4	Diabetes	diabetes	NN
cord-314500-89ovdnxl	112	5	is	be	VBZ
cord-314500-89ovdnxl	112	6	considered	consider	VBN
cord-314500-89ovdnxl	112	7	a	a	DT
cord-314500-89ovdnxl	112	8	risk	risk	NN
cord-314500-89ovdnxl	112	9	factor	factor	NN
cord-314500-89ovdnxl	112	10	for	for	IN
cord-314500-89ovdnxl	112	11	Middle	Middle	NNP
cord-314500-89ovdnxl	112	12	East	East	NNP
cord-314500-89ovdnxl	112	13	Respiratory	Respiratory	NNP
cord-314500-89ovdnxl	112	14	Syndrome	Syndrome	NNP
cord-314500-89ovdnxl	112	15	(	(	-LRB-
cord-314500-89ovdnxl	112	16	MERS	MERS	NNP
cord-314500-89ovdnxl	112	17	)	)	-RRB-
cord-314500-89ovdnxl	112	18	.	.	.
cord-314500-89ovdnxl	113	1	A	a	DT
cord-314500-89ovdnxl	113	2	recent	recent	JJ
cord-314500-89ovdnxl	113	3	systematic	systematic	JJ
cord-314500-89ovdnxl	113	4	review	review	NN
cord-314500-89ovdnxl	113	5	66	66	CD
cord-314500-89ovdnxl	113	6	identified	identify	VBD
cord-314500-89ovdnxl	113	7	58	58	CD
cord-314500-89ovdnxl	113	8	published	publish	VBN
cord-314500-89ovdnxl	113	9	works	work	NNS
cord-314500-89ovdnxl	113	10	for	for	IN
cord-314500-89ovdnxl	113	11	analysis	analysis	NN
cord-314500-89ovdnxl	113	12	,	,	,
cord-314500-89ovdnxl	113	13	with	with	IN
cord-314500-89ovdnxl	113	14	several	several	JJ
cord-314500-89ovdnxl	113	15	reporting	report	VBG
cord-314500-89ovdnxl	113	16	diabetes	diabetes	NN
cord-314500-89ovdnxl	113	17	as	as	IN
cord-314500-89ovdnxl	113	18	a	a	DT
cord-314500-89ovdnxl	113	19	risk	risk	NN
cord-314500-89ovdnxl	113	20	factor	factor	NN
cord-314500-89ovdnxl	113	21	for	for	IN
cord-314500-89ovdnxl	113	22	infection	infection	NN
cord-314500-89ovdnxl	113	23	and	and	CC
cord-314500-89ovdnxl	113	24	death	death	NN
cord-314500-89ovdnxl	113	25	,	,	,
cord-314500-89ovdnxl	113	26	but	but	CC
cord-314500-89ovdnxl	113	27	meta	meta	NN
cord-314500-89ovdnxl	113	28	-	-	HYPH
cord-314500-89ovdnxl	113	29	analysis	analysis	NN
cord-314500-89ovdnxl	113	30	to	to	TO
cord-314500-89ovdnxl	113	31	quantitate	quantitate	VB
cord-314500-89ovdnxl	113	32	the	the	DT
cord-314500-89ovdnxl	113	33	increased	increase	VBN
cord-314500-89ovdnxl	113	34	risk	risk	NN
cord-314500-89ovdnxl	113	35	of	of	IN
cord-314500-89ovdnxl	113	36	diabetes	diabetes	NN
cord-314500-89ovdnxl	113	37	across	across	IN
cord-314500-89ovdnxl	113	38	the	the	DT
cord-314500-89ovdnxl	113	39	studies	study	NNS
cord-314500-89ovdnxl	113	40	was	be	VBD
cord-314500-89ovdnxl	113	41	not	not	RB
cord-314500-89ovdnxl	113	42	possible	possible	JJ
cord-314500-89ovdnxl	113	43	due	due	IN
cord-314500-89ovdnxl	113	44	to	to	IN
cord-314500-89ovdnxl	113	45	the	the	DT
cord-314500-89ovdnxl	113	46	small	small	JJ
cord-314500-89ovdnxl	113	47	number	number	NN
cord-314500-89ovdnxl	113	48	of	of	IN
cord-314500-89ovdnxl	113	49	studies	study	NNS
cord-314500-89ovdnxl	113	50	addressing	address	VBG
cord-314500-89ovdnxl	113	51	this	this	DT
cord-314500-89ovdnxl	113	52	risk	risk	NN
cord-314500-89ovdnxl	113	53	factor	factor	NN
cord-314500-89ovdnxl	113	54	.	.	.
cord-314500-89ovdnxl	114	1	People	People	NNS
cord-314500-89ovdnxl	114	2	living	live	VBG
cord-314500-89ovdnxl	114	3	with	with	IN
cord-314500-89ovdnxl	114	4	HIV	HIV	NNP
cord-314500-89ovdnxl	114	5	(	(	-LRB-
cord-314500-89ovdnxl	114	6	PLHIV	PLHIV	NNP
cord-314500-89ovdnxl	114	7	)	)	-RRB-
cord-314500-89ovdnxl	114	8	who	who	WP
cord-314500-89ovdnxl	114	9	receive	receive	VBP
cord-314500-89ovdnxl	114	10	combined	combine	VBN
cord-314500-89ovdnxl	114	11	antiretroviral	antiretroviral	JJ
cord-314500-89ovdnxl	114	12	therapy	therapy	NN
cord-314500-89ovdnxl	114	13	(	(	-LRB-
cord-314500-89ovdnxl	114	14	ART	art	NN
cord-314500-89ovdnxl	114	15	)	)	-RRB-
cord-314500-89ovdnxl	114	16	now	now	RB
cord-314500-89ovdnxl	114	17	have	have	VBP
cord-314500-89ovdnxl	114	18	excellent	excellent	JJ
cord-314500-89ovdnxl	114	19	long	long	JJ
cord-314500-89ovdnxl	114	20	-	-	HYPH
cord-314500-89ovdnxl	114	21	term	term	NN
cord-314500-89ovdnxl	114	22	survival	survival	NN
cord-314500-89ovdnxl	114	23	,	,	,
cord-314500-89ovdnxl	114	24	but	but	CC
cord-314500-89ovdnxl	114	25	increased	increase	VBN
cord-314500-89ovdnxl	114	26	rates	rate	NNS
cord-314500-89ovdnxl	114	27	of	of	IN
cord-314500-89ovdnxl	114	28	metabolic	metabolic	JJ
cord-314500-89ovdnxl	114	29	disorders	disorder	NNS
cord-314500-89ovdnxl	114	30	such	such	JJ
cord-314500-89ovdnxl	114	31	as	as	IN
cord-314500-89ovdnxl	114	32	impaired	impaired	JJ
cord-314500-89ovdnxl	114	33	glucose	glucose	NN
cord-314500-89ovdnxl	114	34	tolerance	tolerance	NN
cord-314500-89ovdnxl	114	35	,	,	,
cord-314500-89ovdnxl	114	36	hyperlipidaemia	hyperlipidaemia	NN
cord-314500-89ovdnxl	114	37	and	and	CC
cord-314500-89ovdnxl	114	38	body	body	NN
cord-314500-89ovdnxl	114	39	morphological	morphological	JJ
cord-314500-89ovdnxl	114	40	changes	change	NNS
cord-314500-89ovdnxl	114	41	(	(	-LRB-
cord-314500-89ovdnxl	114	42	lipodystrophy	lipodystrophy	NNP
cord-314500-89ovdnxl	114	43	syndrome	syndrome	NNP
cord-314500-89ovdnxl	114	44	)	)	-RRB-
cord-314500-89ovdnxl	114	45	have	have	VBP
cord-314500-89ovdnxl	114	46	been	be	VBN
cord-314500-89ovdnxl	114	47	reported	report	VBN
cord-314500-89ovdnxl	114	48	.	.	.
cord-314500-89ovdnxl	115	1	67	67	CD
cord-314500-89ovdnxl	115	2	Increased	increase	VBN
cord-314500-89ovdnxl	115	3	rates	rate	NNS
cord-314500-89ovdnxl	115	4	of	of	IN
cord-314500-89ovdnxl	115	5	insulin	insulin	NN
cord-314500-89ovdnxl	115	6	resistance	resistance	NN
cord-314500-89ovdnxl	115	7	in	in	IN
cord-314500-89ovdnxl	115	8	PLHIV	PLHIV	NNP
cord-314500-89ovdnxl	115	9	could	could	MD
cord-314500-89ovdnxl	115	10	occur	occur	VB
cord-314500-89ovdnxl	115	11	due	due	IN
cord-314500-89ovdnxl	115	12	to	to	IN
cord-314500-89ovdnxl	115	13	the	the	DT
cord-314500-89ovdnxl	115	14	proinflammatory	proinflammatory	JJ
cord-314500-89ovdnxl	115	15	effects	effect	NNS
cord-314500-89ovdnxl	115	16	of	of	IN
cord-314500-89ovdnxl	115	17	chronic	chronic	JJ
cord-314500-89ovdnxl	115	18	viral	viral	JJ
cord-314500-89ovdnxl	115	19	infection	infection	NN
cord-314500-89ovdnxl	115	20	,	,	,
cord-314500-89ovdnxl	115	21	direct	direct	JJ
cord-314500-89ovdnxl	115	22	effects	effect	NNS
cord-314500-89ovdnxl	115	23	of	of	IN
cord-314500-89ovdnxl	115	24	ART	art	NN
cord-314500-89ovdnxl	115	25	,	,	,
cord-314500-89ovdnxl	115	26	and	and	CC
cord-314500-89ovdnxl	115	27	also	also	RB
cord-314500-89ovdnxl	115	28	indirect	indirect	JJ
cord-314500-89ovdnxl	115	29	effects	effect	NNS
cord-314500-89ovdnxl	115	30	of	of	IN
cord-314500-89ovdnxl	115	31	ART	art	NN
cord-314500-89ovdnxl	115	32	such	such	JJ
cord-314500-89ovdnxl	115	33	as	as	IN
cord-314500-89ovdnxl	115	34	dyslipidaemia	dyslipidaemia	NN
cord-314500-89ovdnxl	115	35	and	and	CC
cord-314500-89ovdnxl	115	36	body	body	NN
cord-314500-89ovdnxl	115	37	fat	fat	NN
cord-314500-89ovdnxl	115	38	distribution	distribution	NN
cord-314500-89ovdnxl	115	39	changes	change	NNS
cord-314500-89ovdnxl	115	40	.	.	.
cord-314500-89ovdnxl	116	1	Although	although	IN
cord-314500-89ovdnxl	116	2	studies	study	NNS
cord-314500-89ovdnxl	116	3	in	in	IN
cord-314500-89ovdnxl	116	4	high	high	JJ
cord-314500-89ovdnxl	116	5	-	-	HYPH
cord-314500-89ovdnxl	116	6	income	income	NN
cord-314500-89ovdnxl	116	7	Western	western	JJ
cord-314500-89ovdnxl	116	8	countries	country	NNS
cord-314500-89ovdnxl	116	9	have	have	VBP
cord-314500-89ovdnxl	116	10	shown	show	VBN
cord-314500-89ovdnxl	116	11	inconsistent	inconsistent	JJ
cord-314500-89ovdnxl	116	12	results	result	NNS
cord-314500-89ovdnxl	116	13	as	as	IN
cord-314500-89ovdnxl	116	14	to	to	IN
cord-314500-89ovdnxl	116	15	whether	whether	IN
cord-314500-89ovdnxl	116	16	HIV	HIV	NNP
cord-314500-89ovdnxl	116	17	infection	infection	NN
cord-314500-89ovdnxl	116	18	increases	increase	VBZ
cord-314500-89ovdnxl	116	19	the	the	DT
cord-314500-89ovdnxl	116	20	risk	risk	NN
cord-314500-89ovdnxl	116	21	of	of	IN
cord-314500-89ovdnxl	116	22	T2DM	T2DM	NNP
cord-314500-89ovdnxl	116	23	or	or	CC
cord-314500-89ovdnxl	116	24	merely	merely	RB
cord-314500-89ovdnxl	116	25	represents	represent	VBZ
cord-314500-89ovdnxl	116	26	earlier	early	JJR
cord-314500-89ovdnxl	116	27	diagnosis	diagnosis	NN
cord-314500-89ovdnxl	116	28	in	in	IN
cord-314500-89ovdnxl	116	29	a	a	DT
cord-314500-89ovdnxl	116	30	closely	closely	RB
cord-314500-89ovdnxl	116	31	monitored	monitor	VBN
cord-314500-89ovdnxl	116	32	population	population	NN
cord-314500-89ovdnxl	116	33	,	,	,
cord-314500-89ovdnxl	116	34	68	68	CD
cord-314500-89ovdnxl	116	35	there	there	EX
cord-314500-89ovdnxl	116	36	is	be	VBZ
cord-314500-89ovdnxl	116	37	evidence	evidence	NN
cord-314500-89ovdnxl	116	38	that	that	IN
cord-314500-89ovdnxl	116	39	HIV	HIV	NNP
cord-314500-89ovdnxl	116	40	increases	increase	VBZ
cord-314500-89ovdnxl	116	41	the	the	DT
cord-314500-89ovdnxl	116	42	risk	risk	NN
cord-314500-89ovdnxl	116	43	of	of	IN
cord-314500-89ovdnxl	116	44	diabetes	diabetes	NN
cord-314500-89ovdnxl	116	45	in	in	IN
cord-314500-89ovdnxl	116	46	Asian	asian	JJ
cord-314500-89ovdnxl	116	47	and	and	CC
cord-314500-89ovdnxl	116	48	African	african	JJ
cord-314500-89ovdnxl	116	49	populations	population	NNS
cord-314500-89ovdnxl	116	50	.	.	.
cord-314500-89ovdnxl	117	1	A	a	DT
cord-314500-89ovdnxl	117	2	study	study	NN
cord-314500-89ovdnxl	117	3	in	in	IN
cord-314500-89ovdnxl	117	4	Taiwan	Taiwan	NNP
cord-314500-89ovdnxl	117	5	suggested	suggest	VBD
cord-314500-89ovdnxl	117	6	PLHIV	PLHIV	NNP
cord-314500-89ovdnxl	117	7	to	to	TO
cord-314500-89ovdnxl	117	8	be	be	VB
cord-314500-89ovdnxl	117	9	as	as	RB
cord-314500-89ovdnxl	117	10	much	much	JJ
cord-314500-89ovdnxl	117	11	as	as	IN
cord-314500-89ovdnxl	117	12	sixfold	sixfold	RB
cord-314500-89ovdnxl	117	13	more	more	RBR
cord-314500-89ovdnxl	117	14	likely	likely	JJ
cord-314500-89ovdnxl	117	15	to	to	TO
cord-314500-89ovdnxl	117	16	develop	develop	VB
cord-314500-89ovdnxl	117	17	diabetes	diabete	NNS
cord-314500-89ovdnxl	117	18	than	than	IN
cord-314500-89ovdnxl	117	19	the	the	DT
cord-314500-89ovdnxl	117	20	rest	rest	NN
cord-314500-89ovdnxl	117	21	of	of	IN
cord-314500-89ovdnxl	117	22	the	the	DT
cord-314500-89ovdnxl	117	23	population	population	NN
cord-314500-89ovdnxl	117	24	,	,	,
cord-314500-89ovdnxl	117	25	69	69	CD
cord-314500-89ovdnxl	117	26	and	and	CC
cord-314500-89ovdnxl	117	27	a	a	DT
cord-314500-89ovdnxl	117	28	recent	recent	JJ
cord-314500-89ovdnxl	117	29	Thai	thai	JJ
cord-314500-89ovdnxl	117	30	study	study	NN
cord-314500-89ovdnxl	117	31	of	of	IN
cord-314500-89ovdnxl	117	32	PLHIV	PLHIV	NNP
cord-314500-89ovdnxl	117	33	showed	show	VBD
cord-314500-89ovdnxl	117	34	diabetes	diabetes	NN
cord-314500-89ovdnxl	117	35	developed	develop	VBN
cord-314500-89ovdnxl	117	36	at	at	IN
cord-314500-89ovdnxl	117	37	a	a	DT
cord-314500-89ovdnxl	117	38	younger	young	JJR
cord-314500-89ovdnxl	117	39	age	age	NN
cord-314500-89ovdnxl	117	40	compared	compare	VBN
cord-314500-89ovdnxl	117	41	with	with	IN
cord-314500-89ovdnxl	117	42	the	the	DT
cord-314500-89ovdnxl	117	43	general	general	JJ
cord-314500-89ovdnxl	117	44	population	population	NN
cord-314500-89ovdnxl	117	45	.	.	.
cord-314500-89ovdnxl	118	1	70	70	CD
cord-314500-89ovdnxl	118	2	Increased	increase	VBN
cord-314500-89ovdnxl	118	3	rates	rate	NNS
cord-314500-89ovdnxl	118	4	of	of	IN
cord-314500-89ovdnxl	118	5	diabetes	diabete	NNS
cord-314500-89ovdnxl	118	6	have	have	VBP
cord-314500-89ovdnxl	118	7	also	also	RB
cord-314500-89ovdnxl	118	8	been	be	VBN
cord-314500-89ovdnxl	118	9	reported	report	VBN
cord-314500-89ovdnxl	118	10	in	in	IN
cord-314500-89ovdnxl	118	11	PLHIV	PLHIV	NNP
cord-314500-89ovdnxl	118	12	in	in	IN
cord-314500-89ovdnxl	118	13	South	South	NNP
cord-314500-89ovdnxl	118	14	Africa	Africa	NNP
cord-314500-89ovdnxl	118	15	,	,	,
cord-314500-89ovdnxl	118	16	71	71	CD
cord-314500-89ovdnxl	118	17	Tanzania	Tanzania	NNP
cord-314500-89ovdnxl	118	18	72	72	CD
cord-314500-89ovdnxl	118	19	and	and	CC
cord-314500-89ovdnxl	118	20	Ethiopia	Ethiopia	NNP
cord-314500-89ovdnxl	118	21	.	.	.
cord-314500-89ovdnxl	119	1	71	71	CD
cord-314500-89ovdnxl	119	2	Older	old	JJR
cord-314500-89ovdnxl	119	3	ART	art	NN
cord-314500-89ovdnxl	119	4	drugs	drug	NNS
cord-314500-89ovdnxl	119	5	such	such	JJ
cord-314500-89ovdnxl	119	6	as	as	IN
cord-314500-89ovdnxl	119	7	stavudine	stavudine	NNP
cord-314500-89ovdnxl	119	8	and	and	CC
cord-314500-89ovdnxl	119	9	zidovudine	zidovudine	NN
cord-314500-89ovdnxl	119	10	are	be	VBP
cord-314500-89ovdnxl	119	11	known	know	VBN
cord-314500-89ovdnxl	119	12	to	to	TO
cord-314500-89ovdnxl	119	13	increase	increase	VB
cord-314500-89ovdnxl	119	14	the	the	DT
cord-314500-89ovdnxl	119	15	risk	risk	NN
cord-314500-89ovdnxl	119	16	of	of	IN
cord-314500-89ovdnxl	119	17	metabolic	metabolic	JJ
cord-314500-89ovdnxl	119	18	syndrome	syndrome	NN
cord-314500-89ovdnxl	119	19	and	and	CC
cord-314500-89ovdnxl	119	20	diabetes	diabetes	NN
cord-314500-89ovdnxl	119	21	,	,	,
cord-314500-89ovdnxl	119	22	and	and	CC
cord-314500-89ovdnxl	119	23	are	be	VBP
cord-314500-89ovdnxl	119	24	used	use	VBN
cord-314500-89ovdnxl	119	25	less	less	RBR
cord-314500-89ovdnxl	119	26	now	now	RB
cord-314500-89ovdnxl	119	27	,	,	,
cord-314500-89ovdnxl	119	28	so	so	RB
cord-314500-89ovdnxl	119	29	future	future	JJ
cord-314500-89ovdnxl	119	30	studies	study	NNS
cord-314500-89ovdnxl	119	31	may	may	MD
cord-314500-89ovdnxl	119	32	not	not	RB
cord-314500-89ovdnxl	119	33	confirm	confirm	VB
cord-314500-89ovdnxl	119	34	this	this	DT
cord-314500-89ovdnxl	119	35	relationship	relationship	NN
cord-314500-89ovdnxl	119	36	.	.	.
cord-314500-89ovdnxl	120	1	Parasitic	Parasitic	NNP
cord-314500-89ovdnxl	120	2	Malaria	Malaria	NNP
cord-314500-89ovdnxl	120	3	remains	remain	VBZ
cord-314500-89ovdnxl	120	4	one	one	CD
cord-314500-89ovdnxl	120	5	of	of	IN
cord-314500-89ovdnxl	120	6	the	the	DT
cord-314500-89ovdnxl	120	7	world	world	NN
cord-314500-89ovdnxl	120	8	's	's	POS
cord-314500-89ovdnxl	120	9	largest	large	JJS
cord-314500-89ovdnxl	120	10	causes	cause	NNS
cord-314500-89ovdnxl	120	11	of	of	IN
cord-314500-89ovdnxl	120	12	mortality	mortality	NN
cord-314500-89ovdnxl	120	13	from	from	IN
cord-314500-89ovdnxl	120	14	infectious	infectious	JJ
cord-314500-89ovdnxl	120	15	diseases	disease	NNS
cord-314500-89ovdnxl	120	16	,	,	,
cord-314500-89ovdnxl	120	17	with	with	IN
cord-314500-89ovdnxl	120	18	an	an	DT
cord-314500-89ovdnxl	120	19	estimated	estimate	VBN
cord-314500-89ovdnxl	120	20	213	213	CD
cord-314500-89ovdnxl	120	21	million	million	CD
cord-314500-89ovdnxl	120	22	cases	case	NNS
cord-314500-89ovdnxl	120	23	and	and	CC
cord-314500-89ovdnxl	120	24	720	720	CD
cord-314500-89ovdnxl	120	25	000	000	CD
cord-314500-89ovdnxl	120	26	deaths	death	NNS
cord-314500-89ovdnxl	120	27	per	per	IN
cord-314500-89ovdnxl	120	28	annum	annum	NN
cord-314500-89ovdnxl	120	29	.	.	.
cord-314500-89ovdnxl	121	1	6	6	CD
cord-314500-89ovdnxl	122	1	In	in	IN
cord-314500-89ovdnxl	122	2	2010	2010	CD
cord-314500-89ovdnxl	122	3	,	,	,
cord-314500-89ovdnxl	122	4	researchers	researcher	NNS
cord-314500-89ovdnxl	122	5	reported	report	VBD
cord-314500-89ovdnxl	122	6	a	a	DT
cord-314500-89ovdnxl	122	7	46	46	CD
cord-314500-89ovdnxl	122	8	%	%	NN
cord-314500-89ovdnxl	122	9	increased	increase	VBN
cord-314500-89ovdnxl	122	10	risk	risk	NN
cord-314500-89ovdnxl	122	11	of	of	IN
cord-314500-89ovdnxl	122	12	malaria	malaria	NN
cord-314500-89ovdnxl	122	13	in	in	IN
cord-314500-89ovdnxl	122	14	people	people	NNS
cord-314500-89ovdnxl	122	15	with	with	IN
cord-314500-89ovdnxl	122	16	diabetes	diabetes	NN
cord-314500-89ovdnxl	122	17	73	73	CD
cord-314500-89ovdnxl	122	18	in	in	IN
cord-314500-89ovdnxl	122	19	a	a	DT
cord-314500-89ovdnxl	122	20	case	case	NN
cord-314500-89ovdnxl	122	21	-	-	HYPH
cord-314500-89ovdnxl	122	22	control	control	NN
cord-314500-89ovdnxl	122	23	study	study	NN
cord-314500-89ovdnxl	122	24	in	in	IN
cord-314500-89ovdnxl	122	25	an	an	DT
cord-314500-89ovdnxl	122	26	urban	urban	JJ
cord-314500-89ovdnxl	122	27	setting	setting	NN
cord-314500-89ovdnxl	122	28	in	in	IN
cord-314500-89ovdnxl	122	29	Ghana	Ghana	NNP
cord-314500-89ovdnxl	122	30	.	.	.
cord-314500-89ovdnxl	123	1	The	the	DT
cord-314500-89ovdnxl	123	2	malaria	malaria	NN
cord-314500-89ovdnxl	123	3	was	be	VBD
cord-314500-89ovdnxl	123	4	predominantly	predominantly	RB
cord-314500-89ovdnxl	123	5	P.	P.	NNP
cord-314500-89ovdnxl	123	6	falciparum	falciparum	NN
cord-314500-89ovdnxl	123	7	,	,	,
cord-314500-89ovdnxl	123	8	asymptomatic	asymptomatic	JJ
cord-314500-89ovdnxl	123	9	and	and	CC
cord-314500-89ovdnxl	123	10	diagnosed	diagnose	VBN
cord-314500-89ovdnxl	123	11	by	by	IN
cord-314500-89ovdnxl	123	12	PCR	PCR	NNP
cord-314500-89ovdnxl	123	13	.	.	.
cord-314500-89ovdnxl	124	1	The	the	DT
cord-314500-89ovdnxl	124	2	comparison	comparison	NN
cord-314500-89ovdnxl	124	3	of	of	IN
cord-314500-89ovdnxl	124	4	probability	probability	NN
cord-314500-89ovdnxl	124	5	of	of	IN
cord-314500-89ovdnxl	124	6	malaria	malaria	NN
cord-314500-89ovdnxl	124	7	infection	infection	NN
cord-314500-89ovdnxl	124	8	was	be	VBD
cord-314500-89ovdnxl	124	9	made	make	VBN
cord-314500-89ovdnxl	124	10	between	between	IN
cord-314500-89ovdnxl	124	11	patients	patient	NNS
cord-314500-89ovdnxl	124	12	with	with	IN
cord-314500-89ovdnxl	124	13	diabetes	diabete	NNS
cord-314500-89ovdnxl	124	14	(	(	-LRB-
cord-314500-89ovdnxl	124	15	n=675	n=675	NNP
cord-314500-89ovdnxl	124	16	)	)	-RRB-
cord-314500-89ovdnxl	124	17	and	and	CC
cord-314500-89ovdnxl	124	18	a	a	DT
cord-314500-89ovdnxl	124	19	control	control	NN
cord-314500-89ovdnxl	124	20	group	group	NN
cord-314500-89ovdnxl	124	21	(	(	-LRB-
cord-314500-89ovdnxl	124	22	n=791	n=791	NNP
cord-314500-89ovdnxl	124	23	)	)	-RRB-
cord-314500-89ovdnxl	124	24	comprising	comprise	VBG
cord-314500-89ovdnxl	124	25	patients	patient	NNS
cord-314500-89ovdnxl	124	26	attending	attend	VBG
cord-314500-89ovdnxl	124	27	hypertension	hypertension	NN
cord-314500-89ovdnxl	124	28	clinics	clinic	NNS
cord-314500-89ovdnxl	124	29	,	,	,
cord-314500-89ovdnxl	124	30	patients	patient	NNS
cord-314500-89ovdnxl	124	31	attending	attend	VBG
cord-314500-89ovdnxl	124	32	other	other	JJ
cord-314500-89ovdnxl	124	33	hospital	hospital	NN
cord-314500-89ovdnxl	124	34	clinics	clinic	NNS
cord-314500-89ovdnxl	124	35	,	,	,
cord-314500-89ovdnxl	124	36	and	and	CC
cord-314500-89ovdnxl	124	37	hospital	hospital	NN
cord-314500-89ovdnxl	124	38	staff	staff	NN
cord-314500-89ovdnxl	124	39	.	.	.
cord-314500-89ovdnxl	125	1	The	the	DT
cord-314500-89ovdnxl	125	2	groups	group	NNS
cord-314500-89ovdnxl	125	3	were	be	VBD
cord-314500-89ovdnxl	125	4	not	not	RB
cord-314500-89ovdnxl	125	5	matched	match	VBN
cord-314500-89ovdnxl	125	6	in	in	IN
cord-314500-89ovdnxl	125	7	that	that	IN
cord-314500-89ovdnxl	125	8	the	the	DT
cord-314500-89ovdnxl	125	9	diabetes	diabetes	NN
cord-314500-89ovdnxl	125	10	group	group	NN
cord-314500-89ovdnxl	125	11	were	be	VBD
cord-314500-89ovdnxl	125	12	older	old	JJR
cord-314500-89ovdnxl	125	13	by	by	IN
cord-314500-89ovdnxl	125	14	a	a	DT
cord-314500-89ovdnxl	125	15	mean	mean	NN
cord-314500-89ovdnxl	125	16	of	of	IN
cord-314500-89ovdnxl	125	17	7.6	7.6	CD
cord-314500-89ovdnxl	125	18	years	year	NNS
cord-314500-89ovdnxl	125	19	and	and	CC
cord-314500-89ovdnxl	125	20	had	have	VBD
cord-314500-89ovdnxl	125	21	a	a	DT
cord-314500-89ovdnxl	125	22	socio	socio	JJ
cord-314500-89ovdnxl	125	23	-	-	JJ
cord-314500-89ovdnxl	125	24	economic	economic	JJ
cord-314500-89ovdnxl	125	25	profile	profile	NN
cord-314500-89ovdnxl	125	26	associated	associate	VBN
cord-314500-89ovdnxl	125	27	with	with	IN
cord-314500-89ovdnxl	125	28	greater	great	JJR
cord-314500-89ovdnxl	125	29	poverty	poverty	NN
cord-314500-89ovdnxl	125	30	,	,	,
cord-314500-89ovdnxl	125	31	and	and	CC
cord-314500-89ovdnxl	125	32	the	the	DT
cord-314500-89ovdnxl	125	33	adjusted	adjust	VBN
cord-314500-89ovdnxl	125	34	odds	odd	NNS
cord-314500-89ovdnxl	125	35	ratio	ratio	NN
cord-314500-89ovdnxl	125	36	for	for	IN
cord-314500-89ovdnxl	125	37	diabetes	diabete	NNS
cord-314500-89ovdnxl	125	38	as	as	IN
cord-314500-89ovdnxl	125	39	a	a	DT
cord-314500-89ovdnxl	125	40	risk	risk	NN
cord-314500-89ovdnxl	125	41	factor	factor	NN
cord-314500-89ovdnxl	125	42	for	for	IN
cord-314500-89ovdnxl	125	43	P.	p.	NN
cord-314500-89ovdnxl	125	44	falciparum	falciparum	NN
cord-314500-89ovdnxl	125	45	infection	infection	NN
cord-314500-89ovdnxl	125	46	was	be	VBD
cord-314500-89ovdnxl	125	47	just	just	RB
cord-314500-89ovdnxl	125	48	outside	outside	JJ
cord-314500-89ovdnxl	125	49	significance	significance	NN
cord-314500-89ovdnxl	125	50	in	in	IN
cord-314500-89ovdnxl	125	51	a	a	DT
cord-314500-89ovdnxl	125	52	multivariate	multivariate	JJ
cord-314500-89ovdnxl	125	53	analysis	analysis	NN
cord-314500-89ovdnxl	125	54	adjusting	adjust	VBG
cord-314500-89ovdnxl	125	55	for	for	IN
cord-314500-89ovdnxl	125	56	these	these	DT
cord-314500-89ovdnxl	125	57	parameters	parameter	NNS
cord-314500-89ovdnxl	125	58	(	(	-LRB-
cord-314500-89ovdnxl	125	59	adjusted	adjust	VBN
cord-314500-89ovdnxl	125	60	OR	or	CC
cord-314500-89ovdnxl	125	61	1.36	1.36	CD
cord-314500-89ovdnxl	125	62	,	,	,
cord-314500-89ovdnxl	125	63	95	95	CD
cord-314500-89ovdnxl	125	64	%	%	NN
cord-314500-89ovdnxl	125	65	CI	ci	NN
cord-314500-89ovdnxl	125	66	0	0	CD
cord-314500-89ovdnxl	125	67	.	.	.
cord-314500-89ovdnxl	126	1	98	98	CD
cord-314500-89ovdnxl	126	2	-	-	SYM
cord-314500-89ovdnxl	126	3	1.90	1.90	CD
cord-314500-89ovdnxl	126	4	)	)	-RRB-
cord-314500-89ovdnxl	126	5	.	.	.
cord-314500-89ovdnxl	127	1	This	this	DT
cord-314500-89ovdnxl	127	2	report	report	NN
cord-314500-89ovdnxl	127	3	is	be	VBZ
cord-314500-89ovdnxl	127	4	very	very	RB
cord-314500-89ovdnxl	127	5	interesting	interesting	JJ
cord-314500-89ovdnxl	127	6	,	,	,
cord-314500-89ovdnxl	127	7	but	but	CC
cord-314500-89ovdnxl	127	8	there	there	EX
cord-314500-89ovdnxl	127	9	have	have	VBP
cord-314500-89ovdnxl	127	10	been	be	VBN
cord-314500-89ovdnxl	127	11	no	no	RB
cord-314500-89ovdnxl	127	12	further	further	RB
cord-314500-89ovdnxl	127	13	published	publish	VBN
cord-314500-89ovdnxl	127	14	clinical	clinical	JJ
cord-314500-89ovdnxl	127	15	studies	study	NNS
cord-314500-89ovdnxl	127	16	addressing	address	VBG
cord-314500-89ovdnxl	127	17	the	the	DT
cord-314500-89ovdnxl	127	18	relationship	relationship	NN
cord-314500-89ovdnxl	127	19	between	between	IN
cord-314500-89ovdnxl	127	20	diabetes	diabetes	NN
cord-314500-89ovdnxl	127	21	and	and	CC
cord-314500-89ovdnxl	127	22	malaria	malaria	NN
cord-314500-89ovdnxl	127	23	.	.	.
cord-314500-89ovdnxl	128	1	If	if	IN
cord-314500-89ovdnxl	128	2	diabetes	diabetes	NN
cord-314500-89ovdnxl	128	3	increases	increase	VBZ
cord-314500-89ovdnxl	128	4	the	the	DT
cord-314500-89ovdnxl	128	5	risk	risk	NN
cord-314500-89ovdnxl	128	6	of	of	IN
cord-314500-89ovdnxl	128	7	malaria	malaria	NN
cord-314500-89ovdnxl	128	8	this	this	DT
cord-314500-89ovdnxl	128	9	would	would	MD
cord-314500-89ovdnxl	128	10	be	be	VB
cord-314500-89ovdnxl	128	11	of	of	IN
cord-314500-89ovdnxl	128	12	huge	huge	JJ
cord-314500-89ovdnxl	128	13	significance	significance	NN
cord-314500-89ovdnxl	128	14	on	on	IN
cord-314500-89ovdnxl	128	15	a	a	DT
cord-314500-89ovdnxl	128	16	global	global	JJ
cord-314500-89ovdnxl	128	17	scale	scale	NN
cord-314500-89ovdnxl	128	18	.	.	.
cord-314500-89ovdnxl	129	1	As	as	IN
cord-314500-89ovdnxl	129	2	India	India	NNP
cord-314500-89ovdnxl	129	3	is	be	VBZ
cord-314500-89ovdnxl	129	4	a	a	DT
cord-314500-89ovdnxl	129	5	country	country	NN
cord-314500-89ovdnxl	129	6	with	with	IN
cord-314500-89ovdnxl	129	7	a	a	DT
cord-314500-89ovdnxl	129	8	high	high	JJ
cord-314500-89ovdnxl	129	9	burden	burden	NN
cord-314500-89ovdnxl	129	10	of	of	IN
cord-314500-89ovdnxl	129	11	both	both	DT
cord-314500-89ovdnxl	129	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	129	13	and	and	CC
cord-314500-89ovdnxl	129	14	P.	p.	NN
cord-314500-89ovdnxl	129	15	vivax	vivax	JJ
cord-314500-89ovdnxl	129	16	malaria	malaria	NN
cord-314500-89ovdnxl	129	17	,	,	,
cord-314500-89ovdnxl	129	18	74	74	CD
cord-314500-89ovdnxl	129	19	one	one	PRP
cord-314500-89ovdnxl	129	20	might	may	MD
cord-314500-89ovdnxl	129	21	expect	expect	VB
cord-314500-89ovdnxl	129	22	evidence	evidence	NN
cord-314500-89ovdnxl	129	23	of	of	IN
cord-314500-89ovdnxl	129	24	a	a	DT
cord-314500-89ovdnxl	129	25	relationship	relationship	NN
cord-314500-89ovdnxl	129	26	between	between	IN
cord-314500-89ovdnxl	129	27	diabetes	diabetes	NN
cord-314500-89ovdnxl	129	28	and	and	CC
cord-314500-89ovdnxl	129	29	vivax	vivax	JJ
cord-314500-89ovdnxl	129	30	malaria	malaria	NN
cord-314500-89ovdnxl	129	31	to	to	TO
cord-314500-89ovdnxl	129	32	emerge	emerge	VB
cord-314500-89ovdnxl	129	33	from	from	IN
cord-314500-89ovdnxl	129	34	research	research	NN
cord-314500-89ovdnxl	129	35	in	in	IN
cord-314500-89ovdnxl	129	36	this	this	DT
cord-314500-89ovdnxl	129	37	region	region	NN
cord-314500-89ovdnxl	129	38	.	.	.
cord-314500-89ovdnxl	130	1	Further	further	JJ
cord-314500-89ovdnxl	130	2	prospective	prospective	JJ
cord-314500-89ovdnxl	130	3	studies	study	NNS
cord-314500-89ovdnxl	130	4	with	with	IN
cord-314500-89ovdnxl	130	5	well	well	RB
cord-314500-89ovdnxl	130	6	-	-	HYPH
cord-314500-89ovdnxl	130	7	matched	match	VBN
cord-314500-89ovdnxl	130	8	cohorts	cohort	NNS
cord-314500-89ovdnxl	130	9	,	,	,
cord-314500-89ovdnxl	130	10	and	and	CC
cord-314500-89ovdnxl	130	11	research	research	VB
cord-314500-89ovdnxl	130	12	into	into	IN
cord-314500-89ovdnxl	130	13	the	the	DT
cord-314500-89ovdnxl	130	14	effect	effect	NN
cord-314500-89ovdnxl	130	15	on	on	IN
cord-314500-89ovdnxl	130	16	outcomes	outcome	NNS
cord-314500-89ovdnxl	130	17	for	for	IN
cord-314500-89ovdnxl	130	18	people	people	NNS
cord-314500-89ovdnxl	130	19	with	with	IN
cord-314500-89ovdnxl	130	20	malaria	malaria	NN
cord-314500-89ovdnxl	130	21	is	be	VBZ
cord-314500-89ovdnxl	130	22	needed	need	VBN
cord-314500-89ovdnxl	130	23	.	.	.
cord-314500-89ovdnxl	131	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	131	2	has	have	VBZ
cord-314500-89ovdnxl	131	3	been	be	VBN
cord-314500-89ovdnxl	131	4	linked	link	VBN
cord-314500-89ovdnxl	131	5	to	to	IN
cord-314500-89ovdnxl	131	6	increased	increase	VBN
cord-314500-89ovdnxl	131	7	risk	risk	NN
cord-314500-89ovdnxl	131	8	of	of	IN
cord-314500-89ovdnxl	131	9	cutaneous	cutaneous	JJ
cord-314500-89ovdnxl	131	10	75,76	75,76	CD
cord-314500-89ovdnxl	131	11	and	and	CC
cord-314500-89ovdnxl	131	12	visceral	visceral	JJ
cord-314500-89ovdnxl	131	13	leishmaniasis	leishmaniasis	NN
cord-314500-89ovdnxl	131	14	,	,	,
cord-314500-89ovdnxl	131	15	77	77	CD
cord-314500-89ovdnxl	131	16	and	and	CC
cord-314500-89ovdnxl	131	17	diabetes	diabetes	NN
cord-314500-89ovdnxl	131	18	and	and	CC
cord-314500-89ovdnxl	131	19	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	131	20	were	be	VBD
cord-314500-89ovdnxl	131	21	more	more	RBR
cord-314500-89ovdnxl	131	22	frequently	frequently	RB
cord-314500-89ovdnxl	131	23	reported	report	VBN
cord-314500-89ovdnxl	131	24	in	in	IN
cord-314500-89ovdnxl	131	25	cardiomyopathy	cardiomyopathy	NN
cord-314500-89ovdnxl	131	26	caused	cause	VBN
cord-314500-89ovdnxl	131	27	by	by	IN
cord-314500-89ovdnxl	131	28	Trypanosoma	Trypanosoma	NNP
cord-314500-89ovdnxl	131	29	cruzi	cruzi	NNP
cord-314500-89ovdnxl	131	30	(	(	-LRB-
cord-314500-89ovdnxl	131	31	Chagas	Chagas	NNP
cord-314500-89ovdnxl	131	32	disease	disease	NN
cord-314500-89ovdnxl	131	33	)	)	-RRB-
cord-314500-89ovdnxl	131	34	than	than	IN
cord-314500-89ovdnxl	131	35	in	in	IN
cord-314500-89ovdnxl	131	36	controls	control	NNS
cord-314500-89ovdnxl	131	37	.	.	.
cord-314500-89ovdnxl	132	1	78	78	CD
cord-314500-89ovdnxl	133	1	There	there	EX
cord-314500-89ovdnxl	133	2	are	be	VBP
cord-314500-89ovdnxl	133	3	a	a	DT
cord-314500-89ovdnxl	133	4	lack	lack	NN
cord-314500-89ovdnxl	133	5	of	of	IN
cord-314500-89ovdnxl	133	6	data	datum	NNS
cord-314500-89ovdnxl	133	7	on	on	IN
cord-314500-89ovdnxl	133	8	the	the	DT
cord-314500-89ovdnxl	133	9	relationship	relationship	NN
cord-314500-89ovdnxl	133	10	between	between	IN
cord-314500-89ovdnxl	133	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	133	12	and	and	CC
cord-314500-89ovdnxl	133	13	most	most	RBS
cord-314500-89ovdnxl	133	14	neglected	neglect	VBN
cord-314500-89ovdnxl	133	15	tropical	tropical	JJ
cord-314500-89ovdnxl	133	16	diseases	disease	NNS
cord-314500-89ovdnxl	133	17	(	(	-LRB-
cord-314500-89ovdnxl	133	18	reviewed	review	VBN
cord-314500-89ovdnxl	133	19	79	79	CD
cord-314500-89ovdnxl	133	20	)	)	-RRB-
cord-314500-89ovdnxl	133	21	and	and	CC
cord-314500-89ovdnxl	133	22	prospective	prospective	JJ
cord-314500-89ovdnxl	133	23	studies	study	NNS
cord-314500-89ovdnxl	133	24	of	of	IN
cord-314500-89ovdnxl	133	25	people	people	NNS
cord-314500-89ovdnxl	133	26	with	with	IN
cord-314500-89ovdnxl	133	27	diabetes	diabete	NNS
cord-314500-89ovdnxl	133	28	in	in	IN
cord-314500-89ovdnxl	133	29	tropical	tropical	JJ
cord-314500-89ovdnxl	133	30	regions	region	NNS
cord-314500-89ovdnxl	133	31	are	be	VBP
cord-314500-89ovdnxl	133	32	needed	need	VBN
cord-314500-89ovdnxl	133	33	to	to	TO
cord-314500-89ovdnxl	133	34	evaluate	evaluate	VB
cord-314500-89ovdnxl	133	35	this	this	DT
cord-314500-89ovdnxl	133	36	.	.	.
cord-314500-89ovdnxl	134	1	Some	some	DT
cord-314500-89ovdnxl	134	2	interesting	interesting	JJ
cord-314500-89ovdnxl	134	3	findings	finding	NNS
cord-314500-89ovdnxl	134	4	have	have	VBP
cord-314500-89ovdnxl	134	5	been	be	VBN
cord-314500-89ovdnxl	134	6	reported	report	VBN
cord-314500-89ovdnxl	134	7	for	for	IN
cord-314500-89ovdnxl	134	8	a	a	DT
cord-314500-89ovdnxl	134	9	lower	low	JJR
cord-314500-89ovdnxl	134	10	risk	risk	NN
cord-314500-89ovdnxl	134	11	of	of	IN
cord-314500-89ovdnxl	134	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	134	13	following	follow	VBG
cord-314500-89ovdnxl	134	14	helminth	helminth	JJ
cord-314500-89ovdnxl	134	15	infections	infection	NNS
cord-314500-89ovdnxl	134	16	including	include	VBG
cord-314500-89ovdnxl	134	17	schistosomiasis	schistosomiasis	NN
cord-314500-89ovdnxl	134	18	,	,	,
cord-314500-89ovdnxl	134	19	strongyloides	strongyloide	NNS
cord-314500-89ovdnxl	134	20	and	and	CC
cord-314500-89ovdnxl	134	21	filariasis	filariasis	NN
cord-314500-89ovdnxl	134	22	,	,	,
cord-314500-89ovdnxl	134	23	as	as	IN
cord-314500-89ovdnxl	134	24	reviewed	review	VBN
cord-314500-89ovdnxl	134	25	by	by	IN
cord-314500-89ovdnxl	134	26	Berbudi	Berbudi	NNP
cord-314500-89ovdnxl	134	27	and	and	CC
cord-314500-89ovdnxl	134	28	colleagues	colleague	NNS
cord-314500-89ovdnxl	134	29	.	.	.
cord-314500-89ovdnxl	135	1	80	80	CD
cord-314500-89ovdnxl	136	1	The	the	DT
cord-314500-89ovdnxl	136	2	mechanism	mechanism	NN
cord-314500-89ovdnxl	136	3	for	for	IN
cord-314500-89ovdnxl	136	4	such	such	PDT
cord-314500-89ovdnxl	136	5	a	a	DT
cord-314500-89ovdnxl	136	6	protective	protective	JJ
cord-314500-89ovdnxl	136	7	effect	effect	NN
cord-314500-89ovdnxl	136	8	could	could	MD
cord-314500-89ovdnxl	136	9	be	be	VB
cord-314500-89ovdnxl	136	10	by	by	IN
cord-314500-89ovdnxl	136	11	helminth	helminth	JJ
cord-314500-89ovdnxl	136	12	infection	infection	NN
cord-314500-89ovdnxl	136	13	inducing	induce	VBG
cord-314500-89ovdnxl	136	14	a	a	DT
cord-314500-89ovdnxl	136	15	shift	shift	NN
cord-314500-89ovdnxl	136	16	towards	towards	IN
cord-314500-89ovdnxl	136	17	type	type	NN
cord-314500-89ovdnxl	136	18	2	2	CD
cord-314500-89ovdnxl	136	19	(	(	-LRB-
cord-314500-89ovdnxl	136	20	anti	anti	JJ
cord-314500-89ovdnxl	136	21	-	-	JJ
cord-314500-89ovdnxl	136	22	inflammatory	inflammatory	JJ
cord-314500-89ovdnxl	136	23	)	)	-RRB-
cord-314500-89ovdnxl	136	24	immune	immune	JJ
cord-314500-89ovdnxl	136	25	responses	response	NNS
cord-314500-89ovdnxl	136	26	,	,	,
cord-314500-89ovdnxl	136	27	and	and	CC
cord-314500-89ovdnxl	136	28	reducing	reduce	VBG
cord-314500-89ovdnxl	136	29	chronic	chronic	JJ
cord-314500-89ovdnxl	136	30	low	low	JJ
cord-314500-89ovdnxl	136	31	-	-	HYPH
cord-314500-89ovdnxl	136	32	grade	grade	NN
cord-314500-89ovdnxl	136	33	inflammation	inflammation	NN
cord-314500-89ovdnxl	136	34	.	.	.
cord-314500-89ovdnxl	137	1	A	a	DT
cord-314500-89ovdnxl	137	2	mouse	mouse	NN
cord-314500-89ovdnxl	137	3	model	model	NN
cord-314500-89ovdnxl	137	4	81	81	CD
cord-314500-89ovdnxl	137	5	demonstrated	demonstrate	VBD
cord-314500-89ovdnxl	137	6	greater	great	JJR
cord-314500-89ovdnxl	137	7	insulin	insulin	NN
cord-314500-89ovdnxl	137	8	sensitivity	sensitivity	NN
cord-314500-89ovdnxl	137	9	following	follow	VBG
cord-314500-89ovdnxl	137	10	S.	S.	NNP
cord-314500-89ovdnxl	137	11	mansoni	mansoni	NN
cord-314500-89ovdnxl	137	12	infection	infection	NN
cord-314500-89ovdnxl	137	13	in	in	IN
cord-314500-89ovdnxl	137	14	mice	mouse	NNS
cord-314500-89ovdnxl	137	15	fed	feed	VBD
cord-314500-89ovdnxl	137	16	a	a	DT
cord-314500-89ovdnxl	137	17	high	high	JJ
cord-314500-89ovdnxl	137	18	-	-	HYPH
cord-314500-89ovdnxl	137	19	fat	fat	NN
cord-314500-89ovdnxl	137	20	diet	diet	NN
cord-314500-89ovdnxl	137	21	,	,	,
cord-314500-89ovdnxl	137	22	with	with	IN
cord-314500-89ovdnxl	137	23	an	an	DT
cord-314500-89ovdnxl	137	24	increase	increase	NN
cord-314500-89ovdnxl	137	25	in	in	IN
cord-314500-89ovdnxl	137	26	type	type	NN
cord-314500-89ovdnxl	137	27	2	2	CD
cord-314500-89ovdnxl	137	28	cytokines	cytokine	NNS
cord-314500-89ovdnxl	137	29	and	and	CC
cord-314500-89ovdnxl	137	30	the	the	DT
cord-314500-89ovdnxl	137	31	ratio	ratio	NN
cord-314500-89ovdnxl	137	32	of	of	IN
cord-314500-89ovdnxl	137	33	M2	M2	NNP
cord-314500-89ovdnxl	137	34	to	to	IN
cord-314500-89ovdnxl	137	35	M1	M1	NNP
cord-314500-89ovdnxl	137	36	macrophages	macrophage	NNS
cord-314500-89ovdnxl	137	37	in	in	IN
cord-314500-89ovdnxl	137	38	white	white	JJ
cord-314500-89ovdnxl	137	39	adipose	adipose	JJ
cord-314500-89ovdnxl	137	40	tissue	tissue	NN
cord-314500-89ovdnxl	137	41	.	.	.
cord-314500-89ovdnxl	138	1	Further	further	JJ
cord-314500-89ovdnxl	138	2	research	research	NN
cord-314500-89ovdnxl	138	3	is	be	VBZ
cord-314500-89ovdnxl	138	4	evaluating	evaluate	VBG
cord-314500-89ovdnxl	138	5	whether	whether	IN
cord-314500-89ovdnxl	138	6	helminth	helminth	NN
cord-314500-89ovdnxl	138	7	-	-	HYPH
cord-314500-89ovdnxl	138	8	derived	derive	VBN
cord-314500-89ovdnxl	138	9	molecules	molecule	NNS
cord-314500-89ovdnxl	138	10	could	could	MD
cord-314500-89ovdnxl	138	11	be	be	VB
cord-314500-89ovdnxl	138	12	developed	develop	VBN
cord-314500-89ovdnxl	138	13	as	as	IN
cord-314500-89ovdnxl	138	14	novel	novel	JJ
cord-314500-89ovdnxl	138	15	therapeutic	therapeutic	JJ
cord-314500-89ovdnxl	138	16	approaches	approach	NNS
cord-314500-89ovdnxl	138	17	to	to	IN
cord-314500-89ovdnxl	138	18	diabetes	diabetes	NN
cord-314500-89ovdnxl	138	19	and	and	CC
cord-314500-89ovdnxl	138	20	metabolic	metabolic	JJ
cord-314500-89ovdnxl	138	21	syndrome	syndrome	NN
cord-314500-89ovdnxl	138	22	.	.	.
cord-314500-89ovdnxl	139	1	82	82	CD
cord-314500-89ovdnxl	140	1	In	in	IN
cord-314500-89ovdnxl	140	2	addition	addition	NN
cord-314500-89ovdnxl	140	3	,	,	,
cord-314500-89ovdnxl	140	4	a	a	DT
cord-314500-89ovdnxl	140	5	prospective	prospective	JJ
cord-314500-89ovdnxl	140	6	randomised	randomised	JJ
cord-314500-89ovdnxl	140	7	-	-	HYPH
cord-314500-89ovdnxl	140	8	control	control	NN
cord-314500-89ovdnxl	140	9	trial	trial	NN
cord-314500-89ovdnxl	140	10	of	of	IN
cord-314500-89ovdnxl	140	11	helminth	helminth	JJ
cord-314500-89ovdnxl	140	12	eradiation	eradiation	NN
cord-314500-89ovdnxl	140	13	by	by	IN
cord-314500-89ovdnxl	140	14	albendazole	albendazole	NNP
cord-314500-89ovdnxl	140	15	therapy	therapy	NN
cord-314500-89ovdnxl	140	16	in	in	IN
cord-314500-89ovdnxl	140	17	Indonesia	Indonesia	NNP
cord-314500-89ovdnxl	140	18	83	83	CD
cord-314500-89ovdnxl	140	19	is	be	VBZ
cord-314500-89ovdnxl	140	20	underway	underway	JJ
cord-314500-89ovdnxl	140	21	evaluating	evaluate	VBG
cord-314500-89ovdnxl	140	22	the	the	DT
cord-314500-89ovdnxl	140	23	impact	impact	NN
cord-314500-89ovdnxl	140	24	of	of	IN
cord-314500-89ovdnxl	140	25	helminth	helminth	JJ
cord-314500-89ovdnxl	140	26	infections	infection	NNS
cord-314500-89ovdnxl	140	27	on	on	IN
cord-314500-89ovdnxl	140	28	insulin	insulin	NN
cord-314500-89ovdnxl	140	29	resistance	resistance	NN
cord-314500-89ovdnxl	140	30	.	.	.
cord-314500-89ovdnxl	141	1	The	the	DT
cord-314500-89ovdnxl	141	2	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	141	3	by	by	IN
cord-314500-89ovdnxl	141	4	which	which	WDT
cord-314500-89ovdnxl	141	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	141	6	confers	confer	VBZ
cord-314500-89ovdnxl	141	7	altered	alter	VBN
cord-314500-89ovdnxl	141	8	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	141	9	to	to	IN
cord-314500-89ovdnxl	141	10	infections	infection	NNS
cord-314500-89ovdnxl	141	11	are	be	VBP
cord-314500-89ovdnxl	141	12	likely	likely	JJ
cord-314500-89ovdnxl	141	13	to	to	TO
cord-314500-89ovdnxl	141	14	be	be	VB
cord-314500-89ovdnxl	141	15	via	via	IN
cord-314500-89ovdnxl	141	16	multiple	multiple	JJ
cord-314500-89ovdnxl	141	17	effects	effect	NNS
cord-314500-89ovdnxl	141	18	on	on	IN
cord-314500-89ovdnxl	141	19	the	the	DT
cord-314500-89ovdnxl	141	20	human	human	JJ
cord-314500-89ovdnxl	141	21	immune	immune	NN
cord-314500-89ovdnxl	141	22	system	system	NN
cord-314500-89ovdnxl	141	23	.	.	.
cord-314500-89ovdnxl	142	1	People	People	NNS
cord-314500-89ovdnxl	142	2	with	with	IN
cord-314500-89ovdnxl	142	3	diabetes	diabete	NNS
cord-314500-89ovdnxl	142	4	have	have	VBP
cord-314500-89ovdnxl	142	5	altered	alter	VBN
cord-314500-89ovdnxl	142	6	skin	skin	NN
cord-314500-89ovdnxl	142	7	flora	flora	NNS
cord-314500-89ovdnxl	142	8	,	,	,
cord-314500-89ovdnxl	142	9	including	include	VBG
cord-314500-89ovdnxl	142	10	increased	increase	VBN
cord-314500-89ovdnxl	142	11	colonisation	colonisation	NN
cord-314500-89ovdnxl	142	12	with	with	IN
cord-314500-89ovdnxl	142	13	S.	S.	NNP
cord-314500-89ovdnxl	142	14	aureus	aureus	NN
cord-314500-89ovdnxl	142	15	.	.	.
cord-314500-89ovdnxl	143	1	84	84	CD
cord-314500-89ovdnxl	143	2	Breaches	breach	NNS
cord-314500-89ovdnxl	143	3	in	in	IN
cord-314500-89ovdnxl	143	4	the	the	DT
cord-314500-89ovdnxl	143	5	skin	skin	NN
cord-314500-89ovdnxl	143	6	's	's	POS
cord-314500-89ovdnxl	143	7	integrity	integrity	NN
cord-314500-89ovdnxl	143	8	as	as	IN
cord-314500-89ovdnxl	143	9	a	a	DT
cord-314500-89ovdnxl	143	10	physical	physical	JJ
cord-314500-89ovdnxl	143	11	barrier	barrier	NN
cord-314500-89ovdnxl	143	12	to	to	IN
cord-314500-89ovdnxl	143	13	infection	infection	NN
cord-314500-89ovdnxl	143	14	occur	occur	VBP
cord-314500-89ovdnxl	143	15	more	more	RBR
cord-314500-89ovdnxl	143	16	commonly	commonly	RB
cord-314500-89ovdnxl	143	17	in	in	IN
cord-314500-89ovdnxl	143	18	diabetes	diabetes	NN
cord-314500-89ovdnxl	143	19	due	due	IN
cord-314500-89ovdnxl	143	20	to	to	IN
cord-314500-89ovdnxl	143	21	the	the	DT
cord-314500-89ovdnxl	143	22	impact	impact	NN
cord-314500-89ovdnxl	143	23	of	of	IN
cord-314500-89ovdnxl	143	24	chronic	chronic	JJ
cord-314500-89ovdnxl	143	25	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	143	26	on	on	IN
cord-314500-89ovdnxl	143	27	peripheral	peripheral	JJ
cord-314500-89ovdnxl	143	28	nerves	nerve	NNS
cord-314500-89ovdnxl	143	29	and	and	CC
cord-314500-89ovdnxl	143	30	vascular	vascular	JJ
cord-314500-89ovdnxl	143	31	supply	supply	NN
cord-314500-89ovdnxl	143	32	.	.	.
cord-314500-89ovdnxl	144	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	144	2	and	and	CC
cord-314500-89ovdnxl	144	3	its	-PRON-	PRP$
cord-314500-89ovdnxl	144	4	treatment	treatment	NN
cord-314500-89ovdnxl	144	5	has	have	VBZ
cord-314500-89ovdnxl	144	6	an	an	DT
cord-314500-89ovdnxl	144	7	impact	impact	NN
cord-314500-89ovdnxl	144	8	on	on	IN
cord-314500-89ovdnxl	144	9	the	the	DT
cord-314500-89ovdnxl	144	10	composition	composition	NN
cord-314500-89ovdnxl	144	11	of	of	IN
cord-314500-89ovdnxl	144	12	the	the	DT
cord-314500-89ovdnxl	144	13	gut	gut	NN
cord-314500-89ovdnxl	144	14	microbiome	microbiome	NN
cord-314500-89ovdnxl	144	15	,	,	,
cord-314500-89ovdnxl	144	16	85	85	CD
cord-314500-89ovdnxl	144	17	and	and	CC
cord-314500-89ovdnxl	144	18	the	the	DT
cord-314500-89ovdnxl	144	19	pivotal	pivotal	JJ
cord-314500-89ovdnxl	144	20	role	role	NN
cord-314500-89ovdnxl	144	21	of	of	IN
cord-314500-89ovdnxl	144	22	the	the	DT
cord-314500-89ovdnxl	144	23	gut	gut	NN
cord-314500-89ovdnxl	144	24	microbiome	microbiome	NN
cord-314500-89ovdnxl	144	25	in	in	IN
cord-314500-89ovdnxl	144	26	modulating	modulate	VBG
cord-314500-89ovdnxl	144	27	human	human	JJ
cord-314500-89ovdnxl	144	28	innate	innate	JJ
cord-314500-89ovdnxl	144	29	and	and	CC
cord-314500-89ovdnxl	144	30	adaptive	adaptive	JJ
cord-314500-89ovdnxl	144	31	responses	response	NNS
cord-314500-89ovdnxl	144	32	via	via	IN
cord-314500-89ovdnxl	144	33	pathogen	pathogen	NN
cord-314500-89ovdnxl	144	34	recognition	recognition	NN
cord-314500-89ovdnxl	144	35	receptor	receptor	NN
cord-314500-89ovdnxl	144	36	pathways	pathway	NNS
cord-314500-89ovdnxl	144	37	and	and	CC
cord-314500-89ovdnxl	144	38	secretion	secretion	NN
cord-314500-89ovdnxl	144	39	of	of	IN
cord-314500-89ovdnxl	144	40	immunomodulatory	immunomodulatory	JJ
cord-314500-89ovdnxl	144	41	molecules	molecule	NNS
cord-314500-89ovdnxl	144	42	by	by	IN
cord-314500-89ovdnxl	144	43	gut	gut	NN
cord-314500-89ovdnxl	144	44	bacteria	bacteria	NNS
cord-314500-89ovdnxl	144	45	is	be	VBZ
cord-314500-89ovdnxl	144	46	now	now	RB
cord-314500-89ovdnxl	144	47	emerging	emerge	VBG
cord-314500-89ovdnxl	144	48	.	.	.
cord-314500-89ovdnxl	145	1	86	86	CD
cord-314500-89ovdnxl	146	1	In	in	IN
cord-314500-89ovdnxl	146	2	vitro	vitro	FW
cord-314500-89ovdnxl	146	3	,	,	,
cord-314500-89ovdnxl	146	4	mild	mild	JJ
cord-314500-89ovdnxl	146	5	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	146	6	may	may	MD
cord-314500-89ovdnxl	146	7	favour	favour	VB
cord-314500-89ovdnxl	146	8	pathogen	pathogen	NN
cord-314500-89ovdnxl	146	9	growth	growth	NN
cord-314500-89ovdnxl	146	10	,	,	,
cord-314500-89ovdnxl	146	11	and	and	CC
cord-314500-89ovdnxl	146	12	while	while	IN
cord-314500-89ovdnxl	146	13	the	the	DT
cord-314500-89ovdnxl	146	14	contribution	contribution	NN
cord-314500-89ovdnxl	146	15	of	of	IN
cord-314500-89ovdnxl	146	16	this	this	DT
cord-314500-89ovdnxl	146	17	to	to	IN
cord-314500-89ovdnxl	146	18	human	human	JJ
cord-314500-89ovdnxl	146	19	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	146	20	to	to	IN
cord-314500-89ovdnxl	146	21	infection	infection	NN
cord-314500-89ovdnxl	146	22	is	be	VBZ
cord-314500-89ovdnxl	146	23	unknown	unknown	JJ
cord-314500-89ovdnxl	146	24	,	,	,
cord-314500-89ovdnxl	146	25	glycosuria	glycosuria	NNP
cord-314500-89ovdnxl	146	26	favours	favour	VBZ
cord-314500-89ovdnxl	146	27	urinary	urinary	JJ
cord-314500-89ovdnxl	146	28	tract	tract	JJ
cord-314500-89ovdnxl	146	29	infections	infection	NNS
cord-314500-89ovdnxl	146	30	.	.	.
cord-314500-89ovdnxl	147	1	In	in	IN
cord-314500-89ovdnxl	147	2	addition	addition	NN
cord-314500-89ovdnxl	147	3	,	,	,
cord-314500-89ovdnxl	147	4	hyperglycaemia	hyperglycaemia	NNP
cord-314500-89ovdnxl	147	5	has	have	VBZ
cord-314500-89ovdnxl	147	6	a	a	DT
cord-314500-89ovdnxl	147	7	number	number	NN
cord-314500-89ovdnxl	147	8	of	of	IN
cord-314500-89ovdnxl	147	9	immunosuppressive	immunosuppressive	JJ
cord-314500-89ovdnxl	147	10	effects	effect	NNS
cord-314500-89ovdnxl	147	11	,	,	,
cord-314500-89ovdnxl	147	12	including	include	VBG
cord-314500-89ovdnxl	147	13	impairment	impairment	NN
cord-314500-89ovdnxl	147	14	of	of	IN
cord-314500-89ovdnxl	147	15	neutrophil	neutrophil	NN
cord-314500-89ovdnxl	147	16	degranulation	degranulation	NN
cord-314500-89ovdnxl	147	17	,	,	,
cord-314500-89ovdnxl	147	18	complement	complement	NN
cord-314500-89ovdnxl	147	19	activation	activation	NN
cord-314500-89ovdnxl	147	20	and	and	CC
cord-314500-89ovdnxl	147	21	phagocytosis	phagocytosis	NN
cord-314500-89ovdnxl	147	22	.	.	.
cord-314500-89ovdnxl	148	1	50	50	CD
cord-314500-89ovdnxl	148	2	Hyperglycaemia	Hyperglycaemia	NNP
cord-314500-89ovdnxl	148	3	does	do	VBZ
cord-314500-89ovdnxl	148	4	not	not	RB
cord-314500-89ovdnxl	148	5	,	,	,
cord-314500-89ovdnxl	148	6	however	however	RB
cord-314500-89ovdnxl	148	7	,	,	,
cord-314500-89ovdnxl	148	8	appear	appear	VBP
cord-314500-89ovdnxl	148	9	to	to	TO
cord-314500-89ovdnxl	148	10	be	be	VB
cord-314500-89ovdnxl	148	11	a	a	DT
cord-314500-89ovdnxl	148	12	key	key	JJ
cord-314500-89ovdnxl	148	13	mechanism	mechanism	NN
cord-314500-89ovdnxl	148	14	for	for	IN
cord-314500-89ovdnxl	148	15	the	the	DT
cord-314500-89ovdnxl	148	16	increased	increase	VBN
cord-314500-89ovdnxl	148	17	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	148	18	to	to	IN
cord-314500-89ovdnxl	148	19	TB	TB	NNP
cord-314500-89ovdnxl	148	20	.	.	.
cord-314500-89ovdnxl	149	1	87	87	CD
cord-314500-89ovdnxl	149	2	Diabetes	diabetes	NN
cord-314500-89ovdnxl	149	3	is	be	VBZ
cord-314500-89ovdnxl	149	4	associated	associate	VBN
cord-314500-89ovdnxl	149	5	with	with	IN
cord-314500-89ovdnxl	149	6	endothelial	endothelial	JJ
cord-314500-89ovdnxl	149	7	dysfunction	dysfunction	NN
cord-314500-89ovdnxl	149	8	,	,	,
cord-314500-89ovdnxl	149	9	oxidative	oxidative	JJ
cord-314500-89ovdnxl	149	10	stress	stress	NN
cord-314500-89ovdnxl	149	11	and	and	CC
cord-314500-89ovdnxl	149	12	chronic	chronic	JJ
cord-314500-89ovdnxl	149	13	inflammation	inflammation	NN
cord-314500-89ovdnxl	149	14	.	.	.
cord-314500-89ovdnxl	150	1	88	88	CD
cord-314500-89ovdnxl	151	1	In	in	IN
cord-314500-89ovdnxl	151	2	infections	infection	NNS
cord-314500-89ovdnxl	151	3	like	like	IN
cord-314500-89ovdnxl	151	4	dengue	dengue	NN
cord-314500-89ovdnxl	151	5	,	,	,
cord-314500-89ovdnxl	151	6	this	this	DT
cord-314500-89ovdnxl	151	7	may	may	MD
cord-314500-89ovdnxl	151	8	support	support	VB
cord-314500-89ovdnxl	151	9	a	a	DT
cord-314500-89ovdnxl	151	10	shift	shift	NN
cord-314500-89ovdnxl	151	11	towards	towards	IN
cord-314500-89ovdnxl	151	12	an	an	DT
cord-314500-89ovdnxl	151	13	excessive	excessive	JJ
cord-314500-89ovdnxl	151	14	pro	pro	JJ
cord-314500-89ovdnxl	151	15	-	-	JJ
cord-314500-89ovdnxl	151	16	inflammatory	inflammatory	JJ
cord-314500-89ovdnxl	151	17	response	response	NN
cord-314500-89ovdnxl	151	18	,	,	,
cord-314500-89ovdnxl	151	19	leading	lead	VBG
cord-314500-89ovdnxl	151	20	to	to	IN
cord-314500-89ovdnxl	151	21	the	the	DT
cord-314500-89ovdnxl	151	22	cytokine	cytokine	NN
cord-314500-89ovdnxl	151	23	storm	storm	NN
cord-314500-89ovdnxl	151	24	,	,	,
cord-314500-89ovdnxl	151	25	shock	shock	NN
cord-314500-89ovdnxl	151	26	,	,	,
cord-314500-89ovdnxl	151	27	vasculopathy	vasculopathy	NNP
cord-314500-89ovdnxl	151	28	and	and	CC
cord-314500-89ovdnxl	151	29	coagulopathy	coagulopathy	NN
cord-314500-89ovdnxl	151	30	that	that	WDT
cord-314500-89ovdnxl	151	31	feature	feature	VBP
cord-314500-89ovdnxl	151	32	in	in	IN
cord-314500-89ovdnxl	151	33	severe	severe	JJ
cord-314500-89ovdnxl	151	34	dengue	dengue	NN
cord-314500-89ovdnxl	151	35	.	.	.
cord-314500-89ovdnxl	152	1	47	47	CD
cord-314500-89ovdnxl	152	2	Finally	finally	RB
cord-314500-89ovdnxl	152	3	,	,	,
cord-314500-89ovdnxl	152	4	people	people	NNS
cord-314500-89ovdnxl	152	5	with	with	IN
cord-314500-89ovdnxl	152	6	diabetes	diabete	NNS
cord-314500-89ovdnxl	152	7	have	have	VBP
cord-314500-89ovdnxl	152	8	higher	high	JJR
cord-314500-89ovdnxl	152	9	rates	rate	NNS
cord-314500-89ovdnxl	152	10	of	of	IN
cord-314500-89ovdnxl	152	11	hospital	hospital	NN
cord-314500-89ovdnxl	152	12	admissions	admission	NNS
cord-314500-89ovdnxl	152	13	,	,	,
cord-314500-89ovdnxl	152	14	1	1	CD
cord-314500-89ovdnxl	152	15	which	which	WDT
cord-314500-89ovdnxl	152	16	exposes	expose	VBZ
cord-314500-89ovdnxl	152	17	them	-PRON-	PRP
cord-314500-89ovdnxl	152	18	to	to	IN
cord-314500-89ovdnxl	152	19	hospital	hospital	NN
cord-314500-89ovdnxl	152	20	-	-	HYPH
cord-314500-89ovdnxl	152	21	acquired	acquire	VBN
cord-314500-89ovdnxl	152	22	infections	infection	NNS
cord-314500-89ovdnxl	152	23	and	and	CC
cord-314500-89ovdnxl	152	24	the	the	DT
cord-314500-89ovdnxl	152	25	risk	risk	NN
cord-314500-89ovdnxl	152	26	of	of	IN
cord-314500-89ovdnxl	152	27	AMR	AMR	NNP
cord-314500-89ovdnxl	152	28	.	.	.
cord-314500-89ovdnxl	153	1	There	there	EX
cord-314500-89ovdnxl	153	2	is	be	VBZ
cord-314500-89ovdnxl	153	3	overlap	overlap	NN
cord-314500-89ovdnxl	153	4	between	between	IN
cord-314500-89ovdnxl	153	5	the	the	DT
cord-314500-89ovdnxl	153	6	spectrum	spectrum	NN
cord-314500-89ovdnxl	153	7	of	of	IN
cord-314500-89ovdnxl	153	8	pathogens	pathogen	NNS
cord-314500-89ovdnxl	153	9	that	that	WDT
cord-314500-89ovdnxl	153	10	people	people	NNS
cord-314500-89ovdnxl	153	11	with	with	IN
cord-314500-89ovdnxl	153	12	diabetes	diabete	NNS
cord-314500-89ovdnxl	153	13	have	have	VBP
cord-314500-89ovdnxl	153	14	,	,	,
cord-314500-89ovdnxl	153	15	notably	notably	RB
cord-314500-89ovdnxl	153	16	increased	increase	VBN
cord-314500-89ovdnxl	153	17	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	153	18	to	to	IN
cord-314500-89ovdnxl	153	19	such	such	JJ
cord-314500-89ovdnxl	153	20	as	as	IN
cord-314500-89ovdnxl	153	21	S.	S.	NNP
cord-314500-89ovdnxl	153	22	aureus	aureus	NN
cord-314500-89ovdnxl	153	23	and	and	CC
cord-314500-89ovdnxl	153	24	invasive	invasive	JJ
cord-314500-89ovdnxl	153	25	fungi	fungus	NNS
cord-314500-89ovdnxl	153	26	,	,	,
cord-314500-89ovdnxl	153	27	and	and	CC
cord-314500-89ovdnxl	153	28	the	the	DT
cord-314500-89ovdnxl	153	29	infections	infection	NNS
cord-314500-89ovdnxl	153	30	seen	see	VBN
cord-314500-89ovdnxl	153	31	in	in	IN
cord-314500-89ovdnxl	153	32	chronic	chronic	JJ
cord-314500-89ovdnxl	153	33	granulomatous	granulomatous	JJ
cord-314500-89ovdnxl	153	34	disease	disease	NN
cord-314500-89ovdnxl	153	35	(	(	-LRB-
cord-314500-89ovdnxl	153	36	CGD	CGD	NNP
cord-314500-89ovdnxl	153	37	)	)	-RRB-
cord-314500-89ovdnxl	153	38	,	,	,
cord-314500-89ovdnxl	153	39	89	89	CD
cord-314500-89ovdnxl	153	40	which	which	WDT
cord-314500-89ovdnxl	153	41	is	be	VBZ
cord-314500-89ovdnxl	153	42	congenital	congenital	JJ
cord-314500-89ovdnxl	153	43	deficiency	deficiency	NN
cord-314500-89ovdnxl	153	44	in	in	IN
cord-314500-89ovdnxl	153	45	phagocytic	phagocytic	JJ
cord-314500-89ovdnxl	153	46	function	function	NN
cord-314500-89ovdnxl	153	47	.	.	.
cord-314500-89ovdnxl	154	1	This	this	DT
cord-314500-89ovdnxl	154	2	suggests	suggest	VBZ
cord-314500-89ovdnxl	154	3	impairment	impairment	NN
cord-314500-89ovdnxl	154	4	of	of	IN
cord-314500-89ovdnxl	154	5	neutrophil	neutrophil	NN
cord-314500-89ovdnxl	154	6	and	and	CC
cord-314500-89ovdnxl	154	7	macrophage	macrophage	NN
cord-314500-89ovdnxl	154	8	function	function	NN
cord-314500-89ovdnxl	154	9	in	in	IN
cord-314500-89ovdnxl	154	10	people	people	NNS
cord-314500-89ovdnxl	154	11	with	with	IN
cord-314500-89ovdnxl	154	12	diabetes	diabete	NNS
cord-314500-89ovdnxl	154	13	as	as	IN
cord-314500-89ovdnxl	154	14	a	a	DT
cord-314500-89ovdnxl	154	15	key	key	JJ
cord-314500-89ovdnxl	154	16	mechanism	mechanism	NN
cord-314500-89ovdnxl	154	17	of	of	IN
cord-314500-89ovdnxl	154	18	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	154	19	.	.	.
cord-314500-89ovdnxl	155	1	This	this	DT
cord-314500-89ovdnxl	155	2	is	be	VBZ
cord-314500-89ovdnxl	155	3	supported	support	VBN
cord-314500-89ovdnxl	155	4	by	by	IN
cord-314500-89ovdnxl	155	5	studies	study	NNS
cord-314500-89ovdnxl	155	6	showing	show	VBG
cord-314500-89ovdnxl	155	7	impaired	impaired	JJ
cord-314500-89ovdnxl	155	8	neutrophil	neutrophil	NN
cord-314500-89ovdnxl	155	9	migration	migration	NN
cord-314500-89ovdnxl	155	10	,	,	,
cord-314500-89ovdnxl	155	11	phagocytosis	phagocytosis	NN
cord-314500-89ovdnxl	155	12	and	and	CC
cord-314500-89ovdnxl	155	13	intracellular	intracellular	JJ
cord-314500-89ovdnxl	155	14	killing	killing	NN
cord-314500-89ovdnxl	155	15	in	in	IN
cord-314500-89ovdnxl	155	16	the	the	DT
cord-314500-89ovdnxl	155	17	host	host	NN
cord-314500-89ovdnxl	155	18	response	response	NN
cord-314500-89ovdnxl	155	19	to	to	IN
cord-314500-89ovdnxl	155	20	B.	B.	NNP
cord-314500-89ovdnxl	155	21	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	155	22	in	in	IN
cord-314500-89ovdnxl	155	23	people	people	NNS
cord-314500-89ovdnxl	155	24	with	with	IN
cord-314500-89ovdnxl	155	25	diabetes	diabete	NNS
cord-314500-89ovdnxl	155	26	.	.	.
cord-314500-89ovdnxl	156	1	90	90	CD
cord-314500-89ovdnxl	157	1	However	however	RB
cord-314500-89ovdnxl	157	2	,	,	,
cord-314500-89ovdnxl	157	3	people	people	NNS
cord-314500-89ovdnxl	157	4	with	with	IN
cord-314500-89ovdnxl	157	5	CGD	CGD	NNP
cord-314500-89ovdnxl	157	6	are	be	VBP
cord-314500-89ovdnxl	157	7	not	not	RB
cord-314500-89ovdnxl	157	8	known	know	VBN
cord-314500-89ovdnxl	157	9	to	to	TO
cord-314500-89ovdnxl	157	10	have	have	VB
cord-314500-89ovdnxl	157	11	increased	increase	VBN
cord-314500-89ovdnxl	157	12	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	157	13	to	to	IN
cord-314500-89ovdnxl	157	14	viral	viral	JJ
cord-314500-89ovdnxl	157	15	infections	infection	NNS
cord-314500-89ovdnxl	157	16	,	,	,
cord-314500-89ovdnxl	157	17	and	and	CC
cord-314500-89ovdnxl	157	18	therefore	therefore	RB
cord-314500-89ovdnxl	157	19	this	this	DT
cord-314500-89ovdnxl	157	20	impairment	impairment	NN
cord-314500-89ovdnxl	157	21	of	of	IN
cord-314500-89ovdnxl	157	22	phagocyte	phagocyte	NNP
cord-314500-89ovdnxl	157	23	function	function	NN
cord-314500-89ovdnxl	157	24	is	be	VBZ
cord-314500-89ovdnxl	157	25	unlikely	unlikely	JJ
cord-314500-89ovdnxl	157	26	to	to	TO
cord-314500-89ovdnxl	157	27	be	be	VB
cord-314500-89ovdnxl	157	28	the	the	DT
cord-314500-89ovdnxl	157	29	only	only	JJ
cord-314500-89ovdnxl	157	30	cause	cause	NN
cord-314500-89ovdnxl	157	31	of	of	IN
cord-314500-89ovdnxl	157	32	increased	increase	VBN
cord-314500-89ovdnxl	157	33	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	157	34	to	to	IN
cord-314500-89ovdnxl	157	35	infection	infection	NN
cord-314500-89ovdnxl	157	36	in	in	IN
cord-314500-89ovdnxl	157	37	diabetes	diabetes	NN
cord-314500-89ovdnxl	157	38	.	.	.
cord-314500-89ovdnxl	158	1	The	the	DT
cord-314500-89ovdnxl	158	2	literature	literature	NN
cord-314500-89ovdnxl	158	3	on	on	IN
cord-314500-89ovdnxl	158	4	humeral	humeral	JJ
cord-314500-89ovdnxl	158	5	responses	response	NNS
cord-314500-89ovdnxl	158	6	to	to	IN
cord-314500-89ovdnxl	158	7	infection	infection	NN
cord-314500-89ovdnxl	158	8	in	in	IN
cord-314500-89ovdnxl	158	9	people	people	NNS
cord-314500-89ovdnxl	158	10	with	with	IN
cord-314500-89ovdnxl	158	11	diabetes	diabetes	NN
cord-314500-89ovdnxl	158	12	does	do	VBZ
cord-314500-89ovdnxl	158	13	not	not	RB
cord-314500-89ovdnxl	158	14	suggest	suggest	VB
cord-314500-89ovdnxl	158	15	that	that	IN
cord-314500-89ovdnxl	158	16	poor	poor	JJ
cord-314500-89ovdnxl	158	17	antibody	antibody	NN
cord-314500-89ovdnxl	158	18	response	response	NN
cord-314500-89ovdnxl	158	19	is	be	VBZ
cord-314500-89ovdnxl	158	20	a	a	DT
cord-314500-89ovdnxl	158	21	dominant	dominant	JJ
cord-314500-89ovdnxl	158	22	mechanism	mechanism	NN
cord-314500-89ovdnxl	158	23	for	for	IN
cord-314500-89ovdnxl	158	24	the	the	DT
cord-314500-89ovdnxl	158	25	increased	increase	VBN
cord-314500-89ovdnxl	158	26	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	158	27	to	to	IN
cord-314500-89ovdnxl	158	28	infection	infection	NN
cord-314500-89ovdnxl	158	29	seen	see	VBN
cord-314500-89ovdnxl	158	30	in	in	IN
cord-314500-89ovdnxl	158	31	diabetes	diabetes	NN
cord-314500-89ovdnxl	158	32	.	.	.
cord-314500-89ovdnxl	159	1	Most	Most	JJS
cord-314500-89ovdnxl	159	2	studies	study	NNS
cord-314500-89ovdnxl	159	3	support	support	VBP
cord-314500-89ovdnxl	159	4	adequate	adequate	JJ
cord-314500-89ovdnxl	159	5	induction	induction	NN
cord-314500-89ovdnxl	159	6	of	of	IN
cord-314500-89ovdnxl	159	7	antibodies	antibody	NNS
cord-314500-89ovdnxl	159	8	in	in	IN
cord-314500-89ovdnxl	159	9	response	response	NN
cord-314500-89ovdnxl	159	10	to	to	IN
cord-314500-89ovdnxl	159	11	licenced	licenced	JJ
cord-314500-89ovdnxl	159	12	antibody	antibody	NN
cord-314500-89ovdnxl	159	13	-	-	HYPH
cord-314500-89ovdnxl	159	14	inducing	induce	VBG
cord-314500-89ovdnxl	159	15	vaccines	vaccine	NNS
cord-314500-89ovdnxl	159	16	in	in	IN
cord-314500-89ovdnxl	159	17	people	people	NNS
cord-314500-89ovdnxl	159	18	with	with	IN
cord-314500-89ovdnxl	159	19	diabetes	diabete	NNS
cord-314500-89ovdnxl	159	20	[	[	-LRB-
cord-314500-89ovdnxl	159	21	91	91	CD
cord-314500-89ovdnxl	159	22	]	]	-RRB-
cord-314500-89ovdnxl	159	23	[	[	-LRB-
cord-314500-89ovdnxl	159	24	92	92	CD
cord-314500-89ovdnxl	159	25	]	]	-RRB-
cord-314500-89ovdnxl	159	26	[	[	-LRB-
cord-314500-89ovdnxl	159	27	93	93	CD
cord-314500-89ovdnxl	159	28	]	]	-RRB-
cord-314500-89ovdnxl	159	29	.	.	.
cord-314500-89ovdnxl	160	1	Higher	high	JJR
cord-314500-89ovdnxl	160	2	antibody	antibody	NN
cord-314500-89ovdnxl	160	3	responses	response	NNS
cord-314500-89ovdnxl	160	4	to	to	IN
cord-314500-89ovdnxl	160	5	influenza	influenza	NN
cord-314500-89ovdnxl	160	6	vaccine	vaccine	NN
cord-314500-89ovdnxl	160	7	were	be	VBD
cord-314500-89ovdnxl	160	8	seen	see	VBN
cord-314500-89ovdnxl	160	9	in	in	IN
cord-314500-89ovdnxl	160	10	a	a	DT
cord-314500-89ovdnxl	160	11	US	US	NNP
cord-314500-89ovdnxl	160	12	study	study	NN
cord-314500-89ovdnxl	160	13	of	of	IN
cord-314500-89ovdnxl	160	14	elderly	elderly	JJ
cord-314500-89ovdnxl	160	15	people	people	NNS
cord-314500-89ovdnxl	160	16	with	with	IN
cord-314500-89ovdnxl	160	17	diabetes	diabete	NNS
cord-314500-89ovdnxl	160	18	compared	compare	VBN
cord-314500-89ovdnxl	160	19	with	with	IN
cord-314500-89ovdnxl	160	20	elderly	elderly	JJ
cord-314500-89ovdnxl	160	21	non	non	JJ
cord-314500-89ovdnxl	160	22	-	-	JJ
cord-314500-89ovdnxl	160	23	diabetic	diabetic	JJ
cord-314500-89ovdnxl	160	24	people	people	NNS
cord-314500-89ovdnxl	160	25	,	,	,
cord-314500-89ovdnxl	160	26	94	94	CD
cord-314500-89ovdnxl	160	27	and	and	CC
cord-314500-89ovdnxl	160	28	antibodies	antibody	NNS
cord-314500-89ovdnxl	160	29	induced	induce	VBN
cord-314500-89ovdnxl	160	30	by	by	IN
cord-314500-89ovdnxl	160	31	natural	natural	JJ
cord-314500-89ovdnxl	160	32	exposure	exposure	NN
cord-314500-89ovdnxl	160	33	to	to	IN
cord-314500-89ovdnxl	160	34	melioidosis	melioidosis	NNP
cord-314500-89ovdnxl	160	35	were	be	VBD
cord-314500-89ovdnxl	160	36	higher	high	JJR
cord-314500-89ovdnxl	160	37	in	in	IN
cord-314500-89ovdnxl	160	38	those	those	DT
cord-314500-89ovdnxl	160	39	with	with	IN
cord-314500-89ovdnxl	160	40	diabetes	diabete	NNS
cord-314500-89ovdnxl	160	41	.	.	.
cord-314500-89ovdnxl	161	1	95	95	CD
cord-314500-89ovdnxl	162	1	Such	such	JJ
cord-314500-89ovdnxl	162	2	higher	high	JJR
cord-314500-89ovdnxl	162	3	responses	response	NNS
cord-314500-89ovdnxl	162	4	in	in	IN
cord-314500-89ovdnxl	162	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	162	6	could	could	MD
cord-314500-89ovdnxl	162	7	be	be	VB
cord-314500-89ovdnxl	162	8	due	due	JJ
cord-314500-89ovdnxl	162	9	to	to	IN
cord-314500-89ovdnxl	162	10	chronic	chronic	JJ
cord-314500-89ovdnxl	162	11	hyperactivation	hyperactivation	NN
cord-314500-89ovdnxl	162	12	of	of	IN
cord-314500-89ovdnxl	162	13	the	the	DT
cord-314500-89ovdnxl	162	14	innate	innate	JJ
cord-314500-89ovdnxl	162	15	immune	immune	JJ
cord-314500-89ovdnxl	162	16	response	response	NN
cord-314500-89ovdnxl	162	17	in	in	IN
cord-314500-89ovdnxl	162	18	T2DM	T2DM	NNP
cord-314500-89ovdnxl	162	19	resulting	result	VBG
cord-314500-89ovdnxl	162	20	in	in	IN
cord-314500-89ovdnxl	162	21	polyclonal	polyclonal	JJ
cord-314500-89ovdnxl	162	22	B	b	NN
cord-314500-89ovdnxl	162	23	-	-	HYPH
cord-314500-89ovdnxl	162	24	cell	cell	NN
cord-314500-89ovdnxl	162	25	stimulation	stimulation	NN
cord-314500-89ovdnxl	162	26	and	and	CC
cord-314500-89ovdnxl	162	27	enhanced	enhanced	JJ
cord-314500-89ovdnxl	162	28	antibody	antibody	NN
cord-314500-89ovdnxl	162	29	production	production	NN
cord-314500-89ovdnxl	162	30	to	to	IN
cord-314500-89ovdnxl	162	31	stimuli	stimulus	NNS
cord-314500-89ovdnxl	162	32	.	.	.
cord-314500-89ovdnxl	163	1	96	96	CD
cord-314500-89ovdnxl	163	2	 	 	_SP
cord-314500-89ovdnxl	164	1	Beyond	beyond	IN
cord-314500-89ovdnxl	164	2	neutrophil	neutrophil	NN
cord-314500-89ovdnxl	164	3	changes	change	NNS
cord-314500-89ovdnxl	164	4	,	,	,
cord-314500-89ovdnxl	164	5	people	people	NNS
cord-314500-89ovdnxl	164	6	with	with	IN
cord-314500-89ovdnxl	164	7	diabetes	diabete	NNS
cord-314500-89ovdnxl	164	8	have	have	VBP
cord-314500-89ovdnxl	164	9	alterations	alteration	NNS
cord-314500-89ovdnxl	164	10	in	in	IN
cord-314500-89ovdnxl	164	11	the	the	DT
cord-314500-89ovdnxl	164	12	function	function	NN
cord-314500-89ovdnxl	164	13	of	of	IN
cord-314500-89ovdnxl	164	14	several	several	JJ
cord-314500-89ovdnxl	164	15	cell	cell	NN
cord-314500-89ovdnxl	164	16	types	type	NNS
cord-314500-89ovdnxl	164	17	including	include	VBG
cord-314500-89ovdnxl	164	18	macrophages	macrophage	NNS
cord-314500-89ovdnxl	164	19	,	,	,
cord-314500-89ovdnxl	164	20	S.	S.	NNP
cord-314500-89ovdnxl	164	21	Dunachie	Dunachie	NNP
cord-314500-89ovdnxl	164	22	and	and	CC
cord-314500-89ovdnxl	164	23	P.	P.	NNP
cord-314500-89ovdnxl	164	24	Chamnan	Chamnan	NNP
cord-314500-89ovdnxl	164	25	Natural	Natural	NNP
cord-314500-89ovdnxl	164	26	Killer	Killer	NNP
cord-314500-89ovdnxl	164	27	cells	cell	NNS
cord-314500-89ovdnxl	164	28	,	,	,
cord-314500-89ovdnxl	164	29	CD4	CD4	NNP
cord-314500-89ovdnxl	164	30	T	T	NNP
cord-314500-89ovdnxl	164	31	cells	cell	NNS
cord-314500-89ovdnxl	164	32	and	and	CC
cord-314500-89ovdnxl	164	33	CD8	CD8	NNP
cord-314500-89ovdnxl	164	34	T	T	NNP
cord-314500-89ovdnxl	164	35	cells	cell	NNS
cord-314500-89ovdnxl	164	36	function	function	VBP
cord-314500-89ovdnxl	164	37	.	.	.
cord-314500-89ovdnxl	165	1	97	97	CD
cord-314500-89ovdnxl	165	2	T	t	NN
cord-314500-89ovdnxl	165	3	cell	cell	NN
cord-314500-89ovdnxl	165	4	responses	response	NNS
cord-314500-89ovdnxl	165	5	are	be	VBP
cord-314500-89ovdnxl	165	6	known	know	VBN
cord-314500-89ovdnxl	165	7	to	to	TO
cord-314500-89ovdnxl	165	8	be	be	VB
cord-314500-89ovdnxl	165	9	important	important	JJ
cord-314500-89ovdnxl	165	10	in	in	IN
cord-314500-89ovdnxl	165	11	host	host	NN
cord-314500-89ovdnxl	165	12	defence	defence	NN
cord-314500-89ovdnxl	165	13	against	against	IN
cord-314500-89ovdnxl	165	14	intracellular	intracellular	JJ
cord-314500-89ovdnxl	165	15	pathogens	pathogen	NNS
cord-314500-89ovdnxl	165	16	,	,	,
cord-314500-89ovdnxl	165	17	with	with	IN
cord-314500-89ovdnxl	165	18	intracellular	intracellular	JJ
cord-314500-89ovdnxl	165	19	antigens	antigen	NNS
cord-314500-89ovdnxl	165	20	presented	present	VBN
cord-314500-89ovdnxl	165	21	to	to	IN
cord-314500-89ovdnxl	165	22	CD8	CD8	NNP
cord-314500-89ovdnxl	165	23	T	T	NNP
cord-314500-89ovdnxl	165	24	cells	cell	NNS
cord-314500-89ovdnxl	165	25	via	via	IN
cord-314500-89ovdnxl	165	26	the	the	DT
cord-314500-89ovdnxl	165	27	MHC	MHC	NNP
cord-314500-89ovdnxl	165	28	Class	Class	NNP
cord-314500-89ovdnxl	165	29	1	1	CD
cord-314500-89ovdnxl	165	30	antigen	antigen	NN
cord-314500-89ovdnxl	165	31	presentation	presentation	NN
cord-314500-89ovdnxl	165	32	pathway	pathway	NN
cord-314500-89ovdnxl	165	33	,	,	,
cord-314500-89ovdnxl	165	34	and	and	CC
cord-314500-89ovdnxl	165	35	digested	digest	VBN
cord-314500-89ovdnxl	165	36	antigens	antigen	NNS
cord-314500-89ovdnxl	165	37	from	from	IN
cord-314500-89ovdnxl	165	38	both	both	CC
cord-314500-89ovdnxl	165	39	extracellular	extracellular	JJ
cord-314500-89ovdnxl	165	40	and	and	CC
cord-314500-89ovdnxl	165	41	intracellular	intracellular	JJ
cord-314500-89ovdnxl	165	42	sources	source	NNS
cord-314500-89ovdnxl	165	43	presented	present	VBN
cord-314500-89ovdnxl	165	44	to	to	IN
cord-314500-89ovdnxl	165	45	CD4	CD4	NNP
cord-314500-89ovdnxl	165	46	T	T	NNP
cord-314500-89ovdnxl	165	47	cells	cell	NNS
cord-314500-89ovdnxl	165	48	via	via	IN
cord-314500-89ovdnxl	165	49	the	the	DT
cord-314500-89ovdnxl	165	50	MHC	MHC	NNP
cord-314500-89ovdnxl	165	51	Class	Class	NNP
cord-314500-89ovdnxl	165	52	2	2	CD
cord-314500-89ovdnxl	165	53	system	system	NN
cord-314500-89ovdnxl	165	54	.	.	.
cord-314500-89ovdnxl	166	1	HIV	HIV	NNP
cord-314500-89ovdnxl	166	2	results	result	VBZ
cord-314500-89ovdnxl	166	3	in	in	IN
cord-314500-89ovdnxl	166	4	reduction	reduction	NN
cord-314500-89ovdnxl	166	5	of	of	IN
cord-314500-89ovdnxl	166	6	CD4	CD4	NNP
cord-314500-89ovdnxl	166	7	T	T	NNP
cord-314500-89ovdnxl	166	8	cells	cell	NNS
cord-314500-89ovdnxl	166	9	,	,	,
cord-314500-89ovdnxl	166	10	and	and	CC
cord-314500-89ovdnxl	166	11	the	the	DT
cord-314500-89ovdnxl	166	12	huge	huge	JJ
cord-314500-89ovdnxl	166	13	increased	increased	JJ
cord-314500-89ovdnxl	166	14	risk	risk	NN
cord-314500-89ovdnxl	166	15	of	of	IN
cord-314500-89ovdnxl	166	16	TB	TB	NNP
cord-314500-89ovdnxl	166	17	seen	see	VBN
cord-314500-89ovdnxl	166	18	in	in	IN
cord-314500-89ovdnxl	166	19	advanced	advanced	JJ
cord-314500-89ovdnxl	166	20	HIV	HIV	NNP
cord-314500-89ovdnxl	166	21	demonstrates	demonstrate	VBZ
cord-314500-89ovdnxl	166	22	the	the	DT
cord-314500-89ovdnxl	166	23	importance	importance	NN
cord-314500-89ovdnxl	166	24	of	of	IN
cord-314500-89ovdnxl	166	25	CD4	CD4	NNP
cord-314500-89ovdnxl	166	26	cells	cell	NNS
cord-314500-89ovdnxl	166	27	in	in	IN
cord-314500-89ovdnxl	166	28	defence	defence	NN
cord-314500-89ovdnxl	166	29	against	against	IN
cord-314500-89ovdnxl	166	30	TB	TB	NNP
cord-314500-89ovdnxl	166	31	.	.	.
cord-314500-89ovdnxl	167	1	There	there	EX
cord-314500-89ovdnxl	167	2	is	be	VBZ
cord-314500-89ovdnxl	167	3	evidence	evidence	NN
cord-314500-89ovdnxl	167	4	of	of	IN
cord-314500-89ovdnxl	167	5	impaired	impaired	JJ
cord-314500-89ovdnxl	167	6	antigenspecific	antigenspecific	NNP
cord-314500-89ovdnxl	167	7	T	t	CD
cord-314500-89ovdnxl	167	8	cell	cell	NN
cord-314500-89ovdnxl	167	9	responses	response	NNS
cord-314500-89ovdnxl	167	10	in	in	IN
cord-314500-89ovdnxl	167	11	people	people	NNS
cord-314500-89ovdnxl	167	12	with	with	IN
cord-314500-89ovdnxl	167	13	diabetes	diabete	NNS
cord-314500-89ovdnxl	167	14	in	in	IN
cord-314500-89ovdnxl	167	15	response	response	NN
cord-314500-89ovdnxl	167	16	to	to	IN
cord-314500-89ovdnxl	167	17	early	early	JJ
cord-314500-89ovdnxl	167	18	TB	TB	NNP
cord-314500-89ovdnxl	167	19	97	97	CD
cord-314500-89ovdnxl	167	20	,	,	,
cord-314500-89ovdnxl	167	21	B.	B.	NNP
cord-314500-89ovdnxl	167	22	pseudomallei	pseudomallei	NNP
cord-314500-89ovdnxl	167	23	20	20	CD
cord-314500-89ovdnxl	167	24	and	and	CC
cord-314500-89ovdnxl	167	25	VZV	VZV	NNP
cord-314500-89ovdnxl	167	26	98	98	CD
cord-314500-89ovdnxl	167	27	,	,	,
cord-314500-89ovdnxl	167	28	although	although	IN
cord-314500-89ovdnxl	167	29	in	in	IN
cord-314500-89ovdnxl	167	30	established	establish	VBN
cord-314500-89ovdnxl	167	31	TB	TB	NNP
cord-314500-89ovdnxl	167	32	the	the	DT
cord-314500-89ovdnxl	167	33	cellular	cellular	JJ
cord-314500-89ovdnxl	167	34	response	response	NN
cord-314500-89ovdnxl	167	35	appears	appear	VBZ
cord-314500-89ovdnxl	167	36	to	to	TO
cord-314500-89ovdnxl	167	37	be	be	VB
cord-314500-89ovdnxl	167	38	higher	high	JJR
cord-314500-89ovdnxl	167	39	in	in	IN
cord-314500-89ovdnxl	167	40	diabetes	diabetes	NN
cord-314500-89ovdnxl	167	41	.	.	.
cord-314500-89ovdnxl	168	1	97	97	CD
cord-314500-89ovdnxl	169	1	In	in	IN
cord-314500-89ovdnxl	169	2	addition	addition	NN
cord-314500-89ovdnxl	169	3	,	,	,
cord-314500-89ovdnxl	169	4	differences	difference	NNS
cord-314500-89ovdnxl	169	5	in	in	IN
cord-314500-89ovdnxl	169	6	the	the	DT
cord-314500-89ovdnxl	169	7	regulation	regulation	NN
cord-314500-89ovdnxl	169	8	and	and	CC
cord-314500-89ovdnxl	169	9	orchestration	orchestration	NN
cord-314500-89ovdnxl	169	10	of	of	IN
cord-314500-89ovdnxl	169	11	the	the	DT
cord-314500-89ovdnxl	169	12	immune	immune	JJ
cord-314500-89ovdnxl	169	13	response	response	NN
cord-314500-89ovdnxl	169	14	are	be	VBP
cord-314500-89ovdnxl	169	15	seen	see	VBN
cord-314500-89ovdnxl	169	16	in	in	IN
cord-314500-89ovdnxl	169	17	dengue	dengue	NN
cord-314500-89ovdnxl	169	18	.	.	.
cord-314500-89ovdnxl	170	1	99	99	CD
cord-314500-89ovdnxl	171	1	For	for	IN
cord-314500-89ovdnxl	171	2	further	further	JJ
cord-314500-89ovdnxl	171	3	detailed	detailed	JJ
cord-314500-89ovdnxl	171	4	discussion	discussion	NN
cord-314500-89ovdnxl	171	5	of	of	IN
cord-314500-89ovdnxl	171	6	immune	immune	JJ
cord-314500-89ovdnxl	171	7	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	171	8	,	,	,
cord-314500-89ovdnxl	171	9	the	the	DT
cord-314500-89ovdnxl	171	10	reader	reader	NN
cord-314500-89ovdnxl	171	11	is	be	VBZ
cord-314500-89ovdnxl	171	12	referred	refer	VBN
cord-314500-89ovdnxl	171	13	to	to	IN
cord-314500-89ovdnxl	171	14	a	a	DT
cord-314500-89ovdnxl	171	15	number	number	NN
cord-314500-89ovdnxl	171	16	of	of	IN
cord-314500-89ovdnxl	171	17	excellent	excellent	JJ
cord-314500-89ovdnxl	171	18	reviews	review	NNS
cord-314500-89ovdnxl	171	19	of	of	IN
cord-314500-89ovdnxl	171	20	immune	immune	JJ
cord-314500-89ovdnxl	171	21	impairment	impairment	NN
cord-314500-89ovdnxl	171	22	in	in	IN
cord-314500-89ovdnxl	171	23	diabetes	diabetes	NN
cord-314500-89ovdnxl	171	24	.	.	.
cord-314500-89ovdnxl	172	1	97	97	CD
cord-314500-89ovdnxl	173	1	,	,	,
cord-314500-89ovdnxl	173	2	100	100	CD
cord-314500-89ovdnxl	173	3	Overall	Overall	NNP
cord-314500-89ovdnxl	173	4	,	,	,
cord-314500-89ovdnxl	173	5	diabetes	diabete	NNS
cord-314500-89ovdnxl	173	6	can	can	MD
cord-314500-89ovdnxl	173	7	impair	impair	VB
cord-314500-89ovdnxl	173	8	the	the	DT
cord-314500-89ovdnxl	173	9	immune	immune	JJ
cord-314500-89ovdnxl	173	10	system	system	NN
cord-314500-89ovdnxl	173	11	at	at	IN
cord-314500-89ovdnxl	173	12	a	a	DT
cord-314500-89ovdnxl	173	13	systemic	systemic	JJ
cord-314500-89ovdnxl	173	14	,	,	,
cord-314500-89ovdnxl	173	15	cellular	cellular	JJ
cord-314500-89ovdnxl	173	16	and	and	CC
cord-314500-89ovdnxl	173	17	molecular	molecular	JJ
cord-314500-89ovdnxl	173	18	level	level	NN
cord-314500-89ovdnxl	173	19	,	,	,
cord-314500-89ovdnxl	173	20	but	but	CC
cord-314500-89ovdnxl	173	21	it	-PRON-	PRP
cord-314500-89ovdnxl	173	22	is	be	VBZ
cord-314500-89ovdnxl	173	23	the	the	DT
cord-314500-89ovdnxl	173	24	alteration	alteration	NN
cord-314500-89ovdnxl	173	25	of	of	IN
cord-314500-89ovdnxl	173	26	T	T	NNP
cord-314500-89ovdnxl	173	27	cell	cell	NN
cord-314500-89ovdnxl	173	28	function	function	NN
cord-314500-89ovdnxl	173	29	that	that	WDT
cord-314500-89ovdnxl	173	30	is	be	VBZ
cord-314500-89ovdnxl	173	31	most	most	RBS
cord-314500-89ovdnxl	173	32	amenable	amenable	JJ
cord-314500-89ovdnxl	173	33	to	to	IN
cord-314500-89ovdnxl	173	34	boosting	boost	VBG
cord-314500-89ovdnxl	173	35	with	with	IN
cord-314500-89ovdnxl	173	36	targeted	target	VBN
cord-314500-89ovdnxl	173	37	vaccination	vaccination	NN
cord-314500-89ovdnxl	173	38	strategies	strategy	NNS
cord-314500-89ovdnxl	173	39	.	.	.
cord-314500-89ovdnxl	174	1	Acute	acute	JJ
cord-314500-89ovdnxl	174	2	infection	infection	NN
cord-314500-89ovdnxl	174	3	is	be	VBZ
cord-314500-89ovdnxl	174	4	known	know	VBN
cord-314500-89ovdnxl	174	5	to	to	TO
cord-314500-89ovdnxl	174	6	lead	lead	VB
cord-314500-89ovdnxl	174	7	to	to	IN
cord-314500-89ovdnxl	174	8	hyperglycaemia	hyperglycaemia	NNP
cord-314500-89ovdnxl	174	9	as	as	IN
cord-314500-89ovdnxl	174	10	a	a	DT
cord-314500-89ovdnxl	174	11	consequence	consequence	NN
cord-314500-89ovdnxl	174	12	of	of	IN
cord-314500-89ovdnxl	174	13	the	the	DT
cord-314500-89ovdnxl	174	14	stress	stress	NN
cord-314500-89ovdnxl	174	15	-	-	HYPH
cord-314500-89ovdnxl	174	16	response	response	NN
cord-314500-89ovdnxl	174	17	activation	activation	NN
cord-314500-89ovdnxl	174	18	of	of	IN
cord-314500-89ovdnxl	174	19	the	the	DT
cord-314500-89ovdnxl	174	20	hypothalamicpituitary	hypothalamicpituitary	JJ
cord-314500-89ovdnxl	174	21	-	-	HYPH
cord-314500-89ovdnxl	174	22	adrenal	adrenal	JJ
cord-314500-89ovdnxl	174	23	axis	axis	NN
cord-314500-89ovdnxl	174	24	to	to	TO
cord-314500-89ovdnxl	174	25	increase	increase	VB
cord-314500-89ovdnxl	174	26	secretion	secretion	NN
cord-314500-89ovdnxl	174	27	of	of	IN
cord-314500-89ovdnxl	174	28	cortisol	cortisol	NN
cord-314500-89ovdnxl	174	29	and	and	CC
cord-314500-89ovdnxl	174	30	other	other	JJ
cord-314500-89ovdnxl	174	31	hormones	hormone	NNS
cord-314500-89ovdnxl	174	32	which	which	WDT
cord-314500-89ovdnxl	174	33	promote	promote	VBP
cord-314500-89ovdnxl	174	34	peripheral	peripheral	JJ
cord-314500-89ovdnxl	174	35	insulin	insulin	NN
cord-314500-89ovdnxl	174	36	resistance	resistance	NN
cord-314500-89ovdnxl	174	37	,	,	,
cord-314500-89ovdnxl	174	38	alongside	alongside	IN
cord-314500-89ovdnxl	174	39	alteration	alteration	NN
cord-314500-89ovdnxl	174	40	of	of	IN
cord-314500-89ovdnxl	174	41	insulin	insulin	NN
cord-314500-89ovdnxl	174	42	-	-	HYPH
cord-314500-89ovdnxl	174	43	receptor	receptor	NN
cord-314500-89ovdnxl	174	44	signalling	signalling	NN
cord-314500-89ovdnxl	174	45	by	by	IN
cord-314500-89ovdnxl	174	46	pro	pro	JJ
cord-314500-89ovdnxl	174	47	-	-	JJ
cord-314500-89ovdnxl	174	48	inflammatory	inflammatory	JJ
cord-314500-89ovdnxl	174	49	cytokines	cytokine	NNS
cord-314500-89ovdnxl	174	50	(	(	-LRB-
cord-314500-89ovdnxl	174	51	reviewed	review	VBN
cord-314500-89ovdnxl	174	52	101	101	CD
cord-314500-89ovdnxl	174	53	)	)	-RRB-
cord-314500-89ovdnxl	174	54	.	.	.
cord-314500-89ovdnxl	175	1	Sepsis	sepsis	NN
cord-314500-89ovdnxl	175	2	-	-	HYPH
cord-314500-89ovdnxl	175	3	related	relate	VBN
cord-314500-89ovdnxl	175	4	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	175	5	may	may	MD
cord-314500-89ovdnxl	175	6	be	be	VB
cord-314500-89ovdnxl	175	7	a	a	DT
cord-314500-89ovdnxl	175	8	risk	risk	NN
cord-314500-89ovdnxl	175	9	factor	factor	NN
cord-314500-89ovdnxl	175	10	for	for	IN
cord-314500-89ovdnxl	175	11	future	future	JJ
cord-314500-89ovdnxl	175	12	development	development	NN
cord-314500-89ovdnxl	175	13	of	of	IN
cord-314500-89ovdnxl	175	14	T2DM	T2DM	NNP
cord-314500-89ovdnxl	175	15	,	,	,
cord-314500-89ovdnxl	175	16	101	101	CD
cord-314500-89ovdnxl	175	17	and	and	CC
cord-314500-89ovdnxl	175	18	stress	stress	NN
cord-314500-89ovdnxl	175	19	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	175	20	induced	induce	VBN
cord-314500-89ovdnxl	175	21	by	by	IN
cord-314500-89ovdnxl	175	22	chronic	chronic	JJ
cord-314500-89ovdnxl	175	23	infections	infection	NNS
cord-314500-89ovdnxl	175	24	such	such	JJ
cord-314500-89ovdnxl	175	25	as	as	IN
cord-314500-89ovdnxl	175	26	TB	TB	NNP
cord-314500-89ovdnxl	175	27	may	may	MD
cord-314500-89ovdnxl	175	28	contribute	contribute	VB
cord-314500-89ovdnxl	175	29	to	to	IN
cord-314500-89ovdnxl	175	30	the	the	DT
cord-314500-89ovdnxl	175	31	global	global	JJ
cord-314500-89ovdnxl	175	32	burden	burden	NN
cord-314500-89ovdnxl	175	33	of	of	IN
cord-314500-89ovdnxl	175	34	diabetes	diabete	NNS
cord-314500-89ovdnxl	175	35	.	.	.
cord-314500-89ovdnxl	176	1	16	16	CD
cord-314500-89ovdnxl	176	2	 	 	_SP
cord-314500-89ovdnxl	177	1	Concerted	concerted	JJ
cord-314500-89ovdnxl	177	2	international	international	JJ
cord-314500-89ovdnxl	177	3	efforts	effort	NNS
cord-314500-89ovdnxl	177	4	to	to	TO
cord-314500-89ovdnxl	177	5	stem	stem	VB
cord-314500-89ovdnxl	177	6	the	the	DT
cord-314500-89ovdnxl	177	7	tide	tide	NN
cord-314500-89ovdnxl	177	8	of	of	IN
cord-314500-89ovdnxl	177	9	advancing	advance	VBG
cord-314500-89ovdnxl	177	10	diabetes	diabetes	NN
cord-314500-89ovdnxl	177	11	in	in	IN
cord-314500-89ovdnxl	177	12	LMIC	LMIC	NNP
cord-314500-89ovdnxl	177	13	are	be	VBP
cord-314500-89ovdnxl	177	14	urgently	urgently	RB
cord-314500-89ovdnxl	177	15	required	require	VBN
cord-314500-89ovdnxl	177	16	.	.	.
cord-314500-89ovdnxl	178	1	Implementation	implementation	NN
cord-314500-89ovdnxl	178	2	of	of	IN
cord-314500-89ovdnxl	178	3	evidencebased	evidencebased	JJ
cord-314500-89ovdnxl	178	4	approaches	approach	NNS
cord-314500-89ovdnxl	178	5	that	that	WDT
cord-314500-89ovdnxl	178	6	are	be	VBP
cord-314500-89ovdnxl	178	7	effective	effective	JJ
cord-314500-89ovdnxl	178	8	at	at	IN
cord-314500-89ovdnxl	178	9	both	both	DT
cord-314500-89ovdnxl	178	10	prevention	prevention	NN
cord-314500-89ovdnxl	178	11	and	and	CC
cord-314500-89ovdnxl	178	12	early	early	JJ
cord-314500-89ovdnxl	178	13	intervention	intervention	NN
cord-314500-89ovdnxl	178	14	for	for	IN
cord-314500-89ovdnxl	178	15	diabetes	diabete	NNS
cord-314500-89ovdnxl	178	16	are	be	VBP
cord-314500-89ovdnxl	178	17	needed	need	VBN
cord-314500-89ovdnxl	178	18	.	.	.
cord-314500-89ovdnxl	179	1	Such	such	JJ
cord-314500-89ovdnxl	179	2	approaches	approach	NNS
cord-314500-89ovdnxl	179	3	require	require	VBP
cord-314500-89ovdnxl	179	4	behavioural	behavioural	JJ
cord-314500-89ovdnxl	179	5	changes	change	NNS
cord-314500-89ovdnxl	179	6	in	in	IN
cord-314500-89ovdnxl	179	7	diet	diet	NN
cord-314500-89ovdnxl	179	8	and	and	CC
cord-314500-89ovdnxl	179	9	physical	physical	JJ
cord-314500-89ovdnxl	179	10	inactivity	inactivity	NN
cord-314500-89ovdnxl	179	11	,	,	,
cord-314500-89ovdnxl	179	12	raising	raise	VBG
cord-314500-89ovdnxl	179	13	public	public	JJ
cord-314500-89ovdnxl	179	14	awareness	awareness	NN
cord-314500-89ovdnxl	179	15	of	of	IN
cord-314500-89ovdnxl	179	16	diabetes	diabetes	NN
cord-314500-89ovdnxl	179	17	,	,	,
cord-314500-89ovdnxl	179	18	and	and	CC
cord-314500-89ovdnxl	179	19	convincing	convincing	JJ
cord-314500-89ovdnxl	179	20	policy	policy	NN
cord-314500-89ovdnxl	179	21	-	-	HYPH
cord-314500-89ovdnxl	179	22	makers	maker	NNS
cord-314500-89ovdnxl	179	23	and	and	CC
cord-314500-89ovdnxl	179	24	the	the	DT
cord-314500-89ovdnxl	179	25	public	public	NN
cord-314500-89ovdnxl	179	26	alike	alike	RB
cord-314500-89ovdnxl	179	27	of	of	IN
cord-314500-89ovdnxl	179	28	the	the	DT
cord-314500-89ovdnxl	179	29	benefits	benefit	NNS
cord-314500-89ovdnxl	179	30	of	of	IN
cord-314500-89ovdnxl	179	31	early	early	JJ
cord-314500-89ovdnxl	179	32	diagnosis	diagnosis	NN
cord-314500-89ovdnxl	179	33	for	for	IN
cord-314500-89ovdnxl	179	34	disease	disease	NN
cord-314500-89ovdnxl	179	35	reversal	reversal	NN
cord-314500-89ovdnxl	179	36	and	and	CC
cord-314500-89ovdnxl	179	37	management	management	NN
cord-314500-89ovdnxl	179	38	.	.	.
cord-314500-89ovdnxl	180	1	One	one	CD
cord-314500-89ovdnxl	180	2	of	of	IN
cord-314500-89ovdnxl	180	3	the	the	DT
cord-314500-89ovdnxl	180	4	targets	target	NNS
cord-314500-89ovdnxl	180	5	for	for	IN
cord-314500-89ovdnxl	180	6	the	the	DT
cord-314500-89ovdnxl	180	7	UN	UN	NNP
cord-314500-89ovdnxl	180	8	's	's	POS
cord-314500-89ovdnxl	180	9	Sustainable	Sustainable	NNP
cord-314500-89ovdnxl	180	10	Development	Development	NNP
cord-314500-89ovdnxl	180	11	Goal	Goal	NNP
cord-314500-89ovdnxl	180	12	3	3	CD
cord-314500-89ovdnxl	180	13	(	(	-LRB-
cord-314500-89ovdnxl	180	14	Good	Good	NNP
cord-314500-89ovdnxl	180	15	Health	Health	NNP
cord-314500-89ovdnxl	180	16	and	and	CC
cord-314500-89ovdnxl	180	17	Well	Well	NNP
cord-314500-89ovdnxl	180	18	-	-	HYPH
cord-314500-89ovdnxl	180	19	being	being	NN
cord-314500-89ovdnxl	180	20	)	)	-RRB-
cord-314500-89ovdnxl	180	21	is	be	VBZ
cord-314500-89ovdnxl	180	22	to	to	TO
cord-314500-89ovdnxl	180	23	reduce	reduce	VB
cord-314500-89ovdnxl	180	24	by	by	IN
cord-314500-89ovdnxl	180	25	one	one	CD
cord-314500-89ovdnxl	180	26	-	-	HYPH
cord-314500-89ovdnxl	180	27	third	third	NN
cord-314500-89ovdnxl	180	28	premature	premature	JJ
cord-314500-89ovdnxl	180	29	mortality	mortality	NN
cord-314500-89ovdnxl	180	30	from	from	IN
cord-314500-89ovdnxl	180	31	NCDs	ncd	NNS
cord-314500-89ovdnxl	180	32	through	through	IN
cord-314500-89ovdnxl	180	33	prevention	prevention	NN
cord-314500-89ovdnxl	180	34	and	and	CC
cord-314500-89ovdnxl	180	35	treatment	treatment	NN
cord-314500-89ovdnxl	180	36	by	by	IN
cord-314500-89ovdnxl	180	37	2030	2030	CD
cord-314500-89ovdnxl	180	38	,	,	,
cord-314500-89ovdnxl	180	39	with	with	IN
cord-314500-89ovdnxl	180	40	action	action	NN
cord-314500-89ovdnxl	180	41	on	on	IN
cord-314500-89ovdnxl	180	42	diabetes	diabetes	NN
cord-314500-89ovdnxl	180	43	essential	essential	JJ
cord-314500-89ovdnxl	180	44	.	.	.
cord-314500-89ovdnxl	181	1	Actions	action	NNS
cord-314500-89ovdnxl	181	2	include	include	VBP
cord-314500-89ovdnxl	181	3	implementation	implementation	NN
cord-314500-89ovdnxl	181	4	of	of	IN
cord-314500-89ovdnxl	181	5	National	National	NNP
cord-314500-89ovdnxl	181	6	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	181	7	programmes	programme	NNS
cord-314500-89ovdnxl	181	8	and	and	CC
cord-314500-89ovdnxl	181	9	extension	extension	NN
cord-314500-89ovdnxl	181	10	of	of	IN
cord-314500-89ovdnxl	181	11	health	health	NN
cord-314500-89ovdnxl	181	12	promotion	promotion	NN
cord-314500-89ovdnxl	181	13	activities	activity	NNS
cord-314500-89ovdnxl	181	14	.	.	.
cord-314500-89ovdnxl	182	1	1	1	LS
cord-314500-89ovdnxl	183	1	Tackling	tackle	VBG
cord-314500-89ovdnxl	183	2	the	the	DT
cord-314500-89ovdnxl	183	3	interaction	interaction	NN
cord-314500-89ovdnxl	183	4	between	between	IN
cord-314500-89ovdnxl	183	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	183	6	and	and	CC
cord-314500-89ovdnxl	183	7	infection	infection	NN
cord-314500-89ovdnxl	183	8	requires	require	VBZ
cord-314500-89ovdnxl	183	9	a	a	DT
cord-314500-89ovdnxl	183	10	greater	great	JJR
cord-314500-89ovdnxl	183	11	understanding	understanding	NN
cord-314500-89ovdnxl	183	12	of	of	IN
cord-314500-89ovdnxl	183	13	the	the	DT
cord-314500-89ovdnxl	183	14	immune	immune	JJ
cord-314500-89ovdnxl	183	15	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	183	16	underlying	underlie	VBG
cord-314500-89ovdnxl	183	17	the	the	DT
cord-314500-89ovdnxl	183	18	altered	altered	JJ
cord-314500-89ovdnxl	183	19	susceptibility	susceptibility	NN
cord-314500-89ovdnxl	183	20	to	to	IN
cord-314500-89ovdnxl	183	21	infection	infection	NN
cord-314500-89ovdnxl	183	22	seen	see	VBN
cord-314500-89ovdnxl	183	23	in	in	IN
cord-314500-89ovdnxl	183	24	diabetes	diabetes	NN
cord-314500-89ovdnxl	183	25	,	,	,
cord-314500-89ovdnxl	183	26	and	and	CC
cord-314500-89ovdnxl	183	27	knowledge	knowledge	NN
cord-314500-89ovdnxl	183	28	of	of	IN
cord-314500-89ovdnxl	183	29	how	how	WRB
cord-314500-89ovdnxl	183	30	therapeutic	therapeutic	JJ
cord-314500-89ovdnxl	183	31	management	management	NN
cord-314500-89ovdnxl	183	32	of	of	IN
cord-314500-89ovdnxl	183	33	diabetes	diabetes	NN
cord-314500-89ovdnxl	183	34	impacts	impact	NNS
cord-314500-89ovdnxl	183	35	on	on	IN
cord-314500-89ovdnxl	183	36	risk	risk	NN
cord-314500-89ovdnxl	183	37	of	of	IN
cord-314500-89ovdnxl	183	38	infection	infection	NN
cord-314500-89ovdnxl	183	39	.	.	.
cord-314500-89ovdnxl	184	1	It	-PRON-	PRP
cord-314500-89ovdnxl	184	2	is	be	VBZ
cord-314500-89ovdnxl	184	3	likely	likely	JJ
cord-314500-89ovdnxl	184	4	that	that	IN
cord-314500-89ovdnxl	184	5	tight	tight	JJ
cord-314500-89ovdnxl	184	6	control	control	NN
cord-314500-89ovdnxl	184	7	of	of	IN
cord-314500-89ovdnxl	184	8	hyperglycaemia	hyperglycaemia	NNP
cord-314500-89ovdnxl	184	9	lowers	lower	VBZ
cord-314500-89ovdnxl	184	10	the	the	DT
cord-314500-89ovdnxl	184	11	risk	risk	NN
cord-314500-89ovdnxl	184	12	of	of	IN
cord-314500-89ovdnxl	184	13	infection	infection	NN
cord-314500-89ovdnxl	184	14	,	,	,
cord-314500-89ovdnxl	184	15	although	although	IN
cord-314500-89ovdnxl	184	16	this	this	DT
cord-314500-89ovdnxl	184	17	has	have	VBZ
cord-314500-89ovdnxl	184	18	yet	yet	RB
cord-314500-89ovdnxl	184	19	to	to	TO
cord-314500-89ovdnxl	184	20	be	be	VB
cord-314500-89ovdnxl	184	21	comprehensively	comprehensively	RB
cord-314500-89ovdnxl	184	22	demonstrated	demonstrate	VBN
cord-314500-89ovdnxl	184	23	in	in	IN
cord-314500-89ovdnxl	184	24	prospective	prospective	JJ
cord-314500-89ovdnxl	184	25	studies	study	NNS
cord-314500-89ovdnxl	184	26	.	.	.
cord-314500-89ovdnxl	185	1	Current	current	JJ
cord-314500-89ovdnxl	185	2	international	international	JJ
cord-314500-89ovdnxl	185	3	treatment	treatment	NN
cord-314500-89ovdnxl	185	4	guidelines	guideline	NNS
cord-314500-89ovdnxl	185	5	for	for	IN
cord-314500-89ovdnxl	185	6	T2DM	T2DM	NNP
cord-314500-89ovdnxl	185	7	are	be	VBP
cord-314500-89ovdnxl	185	8	based	base	VBN
cord-314500-89ovdnxl	185	9	on	on	IN
cord-314500-89ovdnxl	185	10	research	research	NN
cord-314500-89ovdnxl	185	11	conducted	conduct	VBN
cord-314500-89ovdnxl	185	12	in	in	IN
cord-314500-89ovdnxl	185	13	high	high	JJ
cord-314500-89ovdnxl	185	14	-	-	HYPH
cord-314500-89ovdnxl	185	15	income	income	NN
cord-314500-89ovdnxl	185	16	countries	country	NNS
cord-314500-89ovdnxl	185	17	focussed	focusse	VBN
cord-314500-89ovdnxl	185	18	on	on	IN
cord-314500-89ovdnxl	185	19	preventing	prevent	VBG
cord-314500-89ovdnxl	185	20	adverse	adverse	JJ
cord-314500-89ovdnxl	185	21	cardiovascular	cardiovascular	JJ
cord-314500-89ovdnxl	185	22	outcomes	outcome	NNS
cord-314500-89ovdnxl	185	23	and	and	CC
cord-314500-89ovdnxl	185	24	early	early	JJ
cord-314500-89ovdnxl	185	25	death	death	NN
cord-314500-89ovdnxl	185	26	.	.	.
cord-314500-89ovdnxl	186	1	There	there	EX
cord-314500-89ovdnxl	186	2	is	be	VBZ
cord-314500-89ovdnxl	186	3	a	a	DT
cord-314500-89ovdnxl	186	4	lack	lack	NN
cord-314500-89ovdnxl	186	5	of	of	IN
cord-314500-89ovdnxl	186	6	evidence	evidence	NN
cord-314500-89ovdnxl	186	7	on	on	IN
cord-314500-89ovdnxl	186	8	which	which	WDT
cord-314500-89ovdnxl	186	9	to	to	TO
cord-314500-89ovdnxl	186	10	base	base	VB
cord-314500-89ovdnxl	186	11	guidelines	guideline	NNS
cord-314500-89ovdnxl	186	12	for	for	IN
cord-314500-89ovdnxl	186	13	people	people	NNS
cord-314500-89ovdnxl	186	14	living	live	VBG
cord-314500-89ovdnxl	186	15	in	in	IN
cord-314500-89ovdnxl	186	16	LMIC	LMIC	NNP
cord-314500-89ovdnxl	186	17	,	,	,
cord-314500-89ovdnxl	186	18	and	and	CC
cord-314500-89ovdnxl	186	19	choice	choice	NN
cord-314500-89ovdnxl	186	20	of	of	IN
cord-314500-89ovdnxl	186	21	glucose	glucose	NN
cord-314500-89ovdnxl	186	22	-	-	HYPH
cord-314500-89ovdnxl	186	23	lowering	lower	VBG
cord-314500-89ovdnxl	186	24	therapy	therapy	NN
cord-314500-89ovdnxl	186	25	may	may	MD
cord-314500-89ovdnxl	186	26	impact	impact	VB
cord-314500-89ovdnxl	186	27	on	on	IN
cord-314500-89ovdnxl	186	28	infection	infection	NN
cord-314500-89ovdnxl	186	29	risk	risk	NN
cord-314500-89ovdnxl	186	30	and	and	CC
cord-314500-89ovdnxl	186	31	outcomes	outcome	NNS
cord-314500-89ovdnxl	186	32	.	.	.
cord-314500-89ovdnxl	187	1	For	for	IN
cord-314500-89ovdnxl	187	2	example	example	NN
cord-314500-89ovdnxl	187	3	,	,	,
cord-314500-89ovdnxl	187	4	there	there	EX
cord-314500-89ovdnxl	187	5	is	be	VBZ
cord-314500-89ovdnxl	187	6	emerging	emerge	VBG
cord-314500-89ovdnxl	187	7	evidence	evidence	NN
cord-314500-89ovdnxl	187	8	for	for	IN
cord-314500-89ovdnxl	187	9	beneficial	beneficial	JJ
cord-314500-89ovdnxl	187	10	infection	infection	NN
cord-314500-89ovdnxl	187	11	outcomes	outcome	NNS
cord-314500-89ovdnxl	187	12	in	in	IN
cord-314500-89ovdnxl	187	13	people	people	NNS
cord-314500-89ovdnxl	187	14	with	with	IN
cord-314500-89ovdnxl	187	15	diabetes	diabete	NNS
cord-314500-89ovdnxl	187	16	taking	take	VBG
cord-314500-89ovdnxl	187	17	metformin	metformin	NN
cord-314500-89ovdnxl	187	18	compared	compare	VBN
cord-314500-89ovdnxl	187	19	with	with	IN
cord-314500-89ovdnxl	187	20	other	other	JJ
cord-314500-89ovdnxl	187	21	therapies	therapy	NNS
cord-314500-89ovdnxl	187	22	,	,	,
cord-314500-89ovdnxl	187	23	[	[	-LRB-
cord-314500-89ovdnxl	187	24	102	102	CD
cord-314500-89ovdnxl	187	25	]	]	-RRB-
cord-314500-89ovdnxl	187	26	[	[	-LRB-
cord-314500-89ovdnxl	187	27	103	103	CD
cord-314500-89ovdnxl	187	28	]	]	-RRB-
cord-314500-89ovdnxl	187	29	[	[	-LRB-
cord-314500-89ovdnxl	187	30	104	104	CD
cord-314500-89ovdnxl	187	31	]	]	-RRB-
cord-314500-89ovdnxl	187	32	and	and	CC
cord-314500-89ovdnxl	188	1	glyburide	glyburide	NNP
cord-314500-89ovdnxl	188	2	/	/	SYM
cord-314500-89ovdnxl	188	3	glibenclamide	glibenclamide	NNP
cord-314500-89ovdnxl	188	4	has	have	VBZ
cord-314500-89ovdnxl	188	5	been	be	VBN
cord-314500-89ovdnxl	188	6	associated	associate	VBN
cord-314500-89ovdnxl	188	7	with	with	IN
cord-314500-89ovdnxl	188	8	anti	anti	JJ
cord-314500-89ovdnxl	188	9	-	-	JJ
cord-314500-89ovdnxl	188	10	inflammatory	inflammatory	JJ
cord-314500-89ovdnxl	188	11	properties	property	NNS
cord-314500-89ovdnxl	188	12	and	and	CC
cord-314500-89ovdnxl	188	13	lower	low	JJR
cord-314500-89ovdnxl	188	14	mortality	mortality	NN
cord-314500-89ovdnxl	188	15	in	in	IN
cord-314500-89ovdnxl	188	16	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	188	17	.	.	.
cord-314500-89ovdnxl	189	1	105	105	CD
cord-314500-89ovdnxl	189	2	Vaccination	vaccination	NN
cord-314500-89ovdnxl	189	3	remains	remain	VBZ
cord-314500-89ovdnxl	189	4	the	the	DT
cord-314500-89ovdnxl	189	5	cornerstone	cornerstone	NN
cord-314500-89ovdnxl	189	6	in	in	IN
cord-314500-89ovdnxl	189	7	controlling	control	VBG
cord-314500-89ovdnxl	189	8	infectious	infectious	JJ
cord-314500-89ovdnxl	189	9	diseases	disease	NNS
cord-314500-89ovdnxl	189	10	,	,	,
cord-314500-89ovdnxl	189	11	and	and	CC
cord-314500-89ovdnxl	189	12	people	people	NNS
cord-314500-89ovdnxl	189	13	with	with	IN
cord-314500-89ovdnxl	189	14	diabetes	diabete	NNS
cord-314500-89ovdnxl	189	15	are	be	VBP
cord-314500-89ovdnxl	189	16	prioritised	prioritise	VBN
cord-314500-89ovdnxl	189	17	as	as	IN
cord-314500-89ovdnxl	189	18	a	a	DT
cord-314500-89ovdnxl	189	19	high	high	JJ
cord-314500-89ovdnxl	189	20	-	-	HYPH
cord-314500-89ovdnxl	189	21	risk	risk	NN
cord-314500-89ovdnxl	189	22	group	group	NN
cord-314500-89ovdnxl	189	23	for	for	IN
cord-314500-89ovdnxl	189	24	vaccination	vaccination	NN
cord-314500-89ovdnxl	189	25	against	against	IN
cord-314500-89ovdnxl	189	26	a	a	DT
cord-314500-89ovdnxl	189	27	range	range	NN
cord-314500-89ovdnxl	189	28	of	of	IN
cord-314500-89ovdnxl	189	29	pathogens	pathogen	NNS
cord-314500-89ovdnxl	189	30	including	include	VBG
cord-314500-89ovdnxl	189	31	pneumococcus	pneumococcus	NN
cord-314500-89ovdnxl	189	32	,	,	,
cord-314500-89ovdnxl	189	33	influenza	influenza	NN
cord-314500-89ovdnxl	189	34	and	and	CC
cord-314500-89ovdnxl	189	35	VZV	VZV	NNP
cord-314500-89ovdnxl	189	36	.	.	.
cord-314500-89ovdnxl	190	1	Development	development	NN
cord-314500-89ovdnxl	190	2	of	of	IN
cord-314500-89ovdnxl	190	3	highly	highly	RB
cord-314500-89ovdnxl	190	4	efficacious	efficacious	JJ
cord-314500-89ovdnxl	190	5	vaccines	vaccine	NNS
cord-314500-89ovdnxl	190	6	against	against	IN
cord-314500-89ovdnxl	190	7	intracellular	intracellular	JJ
cord-314500-89ovdnxl	190	8	infections	infection	NNS
cord-314500-89ovdnxl	190	9	such	such	JJ
cord-314500-89ovdnxl	190	10	as	as	IN
cord-314500-89ovdnxl	190	11	TB	TB	NNP
cord-314500-89ovdnxl	190	12	,	,	,
cord-314500-89ovdnxl	190	13	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	190	14	and	and	CC
cord-314500-89ovdnxl	190	15	leishmaniasis	leishmaniasis	NN
cord-314500-89ovdnxl	190	16	,	,	,
cord-314500-89ovdnxl	190	17	to	to	TO
cord-314500-89ovdnxl	190	18	which	which	WDT
cord-314500-89ovdnxl	190	19	people	people	NNS
cord-314500-89ovdnxl	190	20	with	with	IN
cord-314500-89ovdnxl	190	21	diabetes	diabete	NNS
cord-314500-89ovdnxl	190	22	are	be	VBP
cord-314500-89ovdnxl	190	23	at	at	IN
cord-314500-89ovdnxl	190	24	greater	great	JJR
cord-314500-89ovdnxl	190	25	risk	risk	NN
cord-314500-89ovdnxl	190	26	,	,	,
cord-314500-89ovdnxl	190	27	is	be	VBZ
cord-314500-89ovdnxl	190	28	an	an	DT
cord-314500-89ovdnxl	190	29	important	important	JJ
cord-314500-89ovdnxl	190	30	priority	priority	NN
cord-314500-89ovdnxl	190	31	,	,	,
cord-314500-89ovdnxl	190	32	and	and	CC
cord-314500-89ovdnxl	190	33	progress	progress	NN
cord-314500-89ovdnxl	190	34	requires	require	VBZ
cord-314500-89ovdnxl	190	35	consideration	consideration	NN
cord-314500-89ovdnxl	190	36	of	of	IN
cord-314500-89ovdnxl	190	37	how	how	WRB
cord-314500-89ovdnxl	190	38	to	to	TO
cord-314500-89ovdnxl	190	39	overcome	overcome	VB
cord-314500-89ovdnxl	190	40	the	the	DT
cord-314500-89ovdnxl	190	41	specific	specific	JJ
cord-314500-89ovdnxl	190	42	immune	immune	JJ
cord-314500-89ovdnxl	190	43	impairments	impairment	NNS
cord-314500-89ovdnxl	190	44	seen	see	VBN
cord-314500-89ovdnxl	190	45	in	in	IN
cord-314500-89ovdnxl	190	46	diabetes	diabetes	NN
cord-314500-89ovdnxl	190	47	.	.	.
cord-314500-89ovdnxl	191	1	Characterising	characterise	VBG
cord-314500-89ovdnxl	191	2	the	the	DT
cord-314500-89ovdnxl	191	3	impact	impact	NN
cord-314500-89ovdnxl	191	4	of	of	IN
cord-314500-89ovdnxl	191	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	191	6	on	on	IN
cord-314500-89ovdnxl	191	7	protective	protective	JJ
cord-314500-89ovdnxl	191	8	immunity	immunity	NN
cord-314500-89ovdnxl	191	9	is	be	VBZ
cord-314500-89ovdnxl	191	10	particularly	particularly	RB
cord-314500-89ovdnxl	191	11	important	important	JJ
cord-314500-89ovdnxl	191	12	for	for	IN
cord-314500-89ovdnxl	191	13	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	191	14	,	,	,
cord-314500-89ovdnxl	191	15	where	where	WRB
cord-314500-89ovdnxl	191	16	more	more	JJR
cord-314500-89ovdnxl	191	17	than	than	IN
cord-314500-89ovdnxl	191	18	half	half	NN
cord-314500-89ovdnxl	191	19	of	of	IN
cord-314500-89ovdnxl	191	20	all	all	DT
cord-314500-89ovdnxl	191	21	cases	case	NNS
cord-314500-89ovdnxl	191	22	occur	occur	VBP
cord-314500-89ovdnxl	191	23	in	in	IN
cord-314500-89ovdnxl	191	24	people	people	NNS
cord-314500-89ovdnxl	191	25	with	with	IN
cord-314500-89ovdnxl	191	26	diabetes	diabetes	NN
cord-314500-89ovdnxl	191	27	,	,	,
cord-314500-89ovdnxl	191	28	and	and	CC
cord-314500-89ovdnxl	191	29	cost	cost	NN
cord-314500-89ovdnxl	191	30	-	-	HYPH
cord-314500-89ovdnxl	191	31	effective	effective	JJ
cord-314500-89ovdnxl	191	32	implementation	implementation	NN
cord-314500-89ovdnxl	191	33	of	of	IN
cord-314500-89ovdnxl	191	34	a	a	DT
cord-314500-89ovdnxl	191	35	successful	successful	JJ
cord-314500-89ovdnxl	191	36	vaccine	vaccine	NN
cord-314500-89ovdnxl	191	37	is	be	VBZ
cord-314500-89ovdnxl	191	38	likely	likely	JJ
cord-314500-89ovdnxl	191	39	to	to	TO
cord-314500-89ovdnxl	191	40	involve	involve	VB
cord-314500-89ovdnxl	191	41	targeting	target	VBG
cord-314500-89ovdnxl	191	42	this	this	DT
cord-314500-89ovdnxl	191	43	group	group	NN
cord-314500-89ovdnxl	191	44	.	.	.
cord-314500-89ovdnxl	192	1	106	106	CD
cord-314500-89ovdnxl	192	2	B.	B.	NNP
cord-314500-89ovdnxl	192	3	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	192	4	therefore	therefore	RB
cord-314500-89ovdnxl	192	5	represents	represent	VBZ
cord-314500-89ovdnxl	192	6	an	an	DT
cord-314500-89ovdnxl	192	7	exemplar	exemplar	JJ
cord-314500-89ovdnxl	192	8	pathogen	pathogen	NN
cord-314500-89ovdnxl	192	9	for	for	IN
cord-314500-89ovdnxl	192	10	defining	define	VBG
cord-314500-89ovdnxl	192	11	the	the	DT
cord-314500-89ovdnxl	192	12	immune	immune	JJ
cord-314500-89ovdnxl	192	13	deficits	deficit	NNS
cord-314500-89ovdnxl	192	14	in	in	IN
cord-314500-89ovdnxl	192	15	diabetes	diabetes	NN
cord-314500-89ovdnxl	192	16	,	,	,
cord-314500-89ovdnxl	192	17	and	and	CC
cord-314500-89ovdnxl	192	18	how	how	WRB
cord-314500-89ovdnxl	192	19	to	to	TO
cord-314500-89ovdnxl	192	20	overcome	overcome	VB
cord-314500-89ovdnxl	192	21	them	-PRON-	PRP
cord-314500-89ovdnxl	192	22	.	.	.
cord-314500-89ovdnxl	193	1	The	the	DT
cord-314500-89ovdnxl	193	2	collision	collision	NN
cord-314500-89ovdnxl	193	3	of	of	IN
cord-314500-89ovdnxl	193	4	diabetes	diabetes	NN
cord-314500-89ovdnxl	193	5	and	and	CC
cord-314500-89ovdnxl	193	6	the	the	DT
cord-314500-89ovdnxl	193	7	world	world	NN
cord-314500-89ovdnxl	193	8	's	's	POS
cord-314500-89ovdnxl	193	9	global	global	JJ
cord-314500-89ovdnxl	193	10	infections	infection	NNS
cord-314500-89ovdnxl	193	11	is	be	VBZ
cord-314500-89ovdnxl	193	12	a	a	DT
cord-314500-89ovdnxl	193	13	highly	highly	RB
cord-314500-89ovdnxl	193	14	neglected	neglect	VBN
cord-314500-89ovdnxl	193	15	area	area	NN
cord-314500-89ovdnxl	193	16	.	.	.
cord-314500-89ovdnxl	194	1	More	More	JJR
cord-314500-89ovdnxl	194	2	research	research	NN
cord-314500-89ovdnxl	194	3	to	to	TO
cord-314500-89ovdnxl	194	4	clearly	clearly	RB
cord-314500-89ovdnxl	194	5	define	define	VB
cord-314500-89ovdnxl	194	6	the	the	DT
cord-314500-89ovdnxl	194	7	epidemiology	epidemiology	NN
cord-314500-89ovdnxl	194	8	and	and	CC
cord-314500-89ovdnxl	194	9	illuminate	illuminate	VB
cord-314500-89ovdnxl	194	10	successful	successful	JJ
cord-314500-89ovdnxl	194	11	interventions	intervention	NNS
cord-314500-89ovdnxl	194	12	needs	need	VBZ
cord-314500-89ovdnxl	194	13	prioritising	prioritise	VBG
cord-314500-89ovdnxl	194	14	.	.	.
cord-314500-89ovdnxl	195	1	The	the	DT
cord-314500-89ovdnxl	195	2	majority	majority	NN
cord-314500-89ovdnxl	195	3	of	of	IN
cord-314500-89ovdnxl	195	4	the	the	DT
cord-314500-89ovdnxl	195	5	evidence	evidence	NN
cord-314500-89ovdnxl	195	6	for	for	IN
cord-314500-89ovdnxl	195	7	associations	association	NNS
cord-314500-89ovdnxl	195	8	between	between	IN
cord-314500-89ovdnxl	195	9	diabetes	diabetes	NN
cord-314500-89ovdnxl	195	10	and	and	CC
cord-314500-89ovdnxl	195	11	specific	specific	JJ
cord-314500-89ovdnxl	195	12	infections	infection	NNS
cord-314500-89ovdnxl	195	13	relies	rely	VBZ
cord-314500-89ovdnxl	195	14	on	on	IN
cord-314500-89ovdnxl	195	15	the	the	DT
cord-314500-89ovdnxl	195	16	use	use	NN
cord-314500-89ovdnxl	195	17	of	of	IN
cord-314500-89ovdnxl	195	18	relatively	relatively	RB
cord-314500-89ovdnxl	195	19	small	small	JJ
cord-314500-89ovdnxl	195	20	retrospective	retrospective	JJ
cord-314500-89ovdnxl	195	21	case	case	NN
cord-314500-89ovdnxl	195	22	-	-	HYPH
cord-314500-89ovdnxl	195	23	control	control	NN
cord-314500-89ovdnxl	195	24	studies	study	NNS
cord-314500-89ovdnxl	195	25	,	,	,
cord-314500-89ovdnxl	195	26	and	and	CC
cord-314500-89ovdnxl	195	27	meta	meta	NNP
cord-314500-89ovdnxl	195	28	-	-	HYPH
cord-314500-89ovdnxl	195	29	analysis	analysis	NN
cord-314500-89ovdnxl	195	30	approaches	approach	NNS
cord-314500-89ovdnxl	195	31	are	be	VBP
cord-314500-89ovdnxl	195	32	limited	limit	VBN
cord-314500-89ovdnxl	195	33	by	by	IN
cord-314500-89ovdnxl	195	34	the	the	DT
cord-314500-89ovdnxl	195	35	heterogeneity	heterogeneity	NN
cord-314500-89ovdnxl	195	36	of	of	IN
cord-314500-89ovdnxl	195	37	patient	patient	JJ
cord-314500-89ovdnxl	195	38	-	-	HYPH
cord-314500-89ovdnxl	195	39	level	level	NN
cord-314500-89ovdnxl	195	40	factors	factor	NNS
cord-314500-89ovdnxl	195	41	across	across	IN
cord-314500-89ovdnxl	195	42	studies	study	NNS
cord-314500-89ovdnxl	195	43	.	.	.
cord-314500-89ovdnxl	196	1	Diabetes	diabetes	NN
cord-314500-89ovdnxl	196	2	is	be	VBZ
cord-314500-89ovdnxl	196	3	interrelated	interrelate	VBN
cord-314500-89ovdnxl	196	4	with	with	IN
cord-314500-89ovdnxl	196	5	obesity	obesity	NN
cord-314500-89ovdnxl	196	6	,	,	,
cord-314500-89ovdnxl	196	7	hypertension	hypertension	NN
cord-314500-89ovdnxl	196	8	and	and	CC
cord-314500-89ovdnxl	196	9	cardiovascular	cardiovascular	JJ
cord-314500-89ovdnxl	196	10	diseases	disease	NNS
cord-314500-89ovdnxl	196	11	that	that	WDT
cord-314500-89ovdnxl	196	12	share	share	VBP
cord-314500-89ovdnxl	196	13	similar	similar	JJ
cord-314500-89ovdnxl	196	14	risk	risk	NN
cord-314500-89ovdnxl	196	15	factors	factor	NNS
cord-314500-89ovdnxl	196	16	and	and	CC
cord-314500-89ovdnxl	196	17	are	be	VBP
cord-314500-89ovdnxl	196	18	each	each	DT
cord-314500-89ovdnxl	196	19	linked	link	VBN
cord-314500-89ovdnxl	196	20	to	to	IN
cord-314500-89ovdnxl	196	21	adverse	adverse	JJ
cord-314500-89ovdnxl	196	22	disease	disease	NN
cord-314500-89ovdnxl	196	23	outcomes	outcome	NNS
cord-314500-89ovdnxl	196	24	,	,	,
cord-314500-89ovdnxl	196	25	rendering	render	VBG
cord-314500-89ovdnxl	196	26	elucidation	elucidation	NN
cord-314500-89ovdnxl	196	27	of	of	IN
cord-314500-89ovdnxl	196	28	the	the	DT
cord-314500-89ovdnxl	196	29	precise	precise	JJ
cord-314500-89ovdnxl	196	30	contribution	contribution	NN
cord-314500-89ovdnxl	196	31	of	of	IN
cord-314500-89ovdnxl	196	32	diabetes	diabete	NNS
cord-314500-89ovdnxl	196	33	to	to	IN
cord-314500-89ovdnxl	196	34	excess	excess	JJ
cord-314500-89ovdnxl	196	35	morbidity	morbidity	NN
cord-314500-89ovdnxl	196	36	and	and	CC
cord-314500-89ovdnxl	196	37	mortality	mortality	NN
cord-314500-89ovdnxl	196	38	difficult	difficult	JJ
cord-314500-89ovdnxl	196	39	.	.	.
cord-314500-89ovdnxl	197	1	The	the	DT
cord-314500-89ovdnxl	197	2	causal	causal	JJ
cord-314500-89ovdnxl	197	3	interaction	interaction	NN
cord-314500-89ovdnxl	197	4	between	between	IN
cord-314500-89ovdnxl	197	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	197	6	and	and	CC
cord-314500-89ovdnxl	197	7	infection	infection	NN
cord-314500-89ovdnxl	197	8	rates	rate	NNS
cord-314500-89ovdnxl	197	9	and	and	CC
cord-314500-89ovdnxl	197	10	outcomes	outcome	NNS
cord-314500-89ovdnxl	197	11	is	be	VBZ
cord-314500-89ovdnxl	197	12	also	also	RB
cord-314500-89ovdnxl	197	13	challenging	challenging	JJ
cord-314500-89ovdnxl	197	14	.	.	.
cord-314500-89ovdnxl	198	1	For	for	IN
cord-314500-89ovdnxl	198	2	some	some	DT
cord-314500-89ovdnxl	198	3	chronic	chronic	JJ
cord-314500-89ovdnxl	198	4	viruses	virus	NNS
cord-314500-89ovdnxl	198	5	such	such	JJ
cord-314500-89ovdnxl	198	6	as	as	IN
cord-314500-89ovdnxl	198	7	HBV	HBV	NNP
cord-314500-89ovdnxl	198	8	and	and	CC
cord-314500-89ovdnxl	198	9	HIV	HIV	NNP
cord-314500-89ovdnxl	198	10	,	,	,
cord-314500-89ovdnxl	198	11	the	the	DT
cord-314500-89ovdnxl	198	12	association	association	NN
cord-314500-89ovdnxl	198	13	with	with	IN
cord-314500-89ovdnxl	198	14	diabetes	diabete	NNS
cord-314500-89ovdnxl	198	15	may	may	MD
cord-314500-89ovdnxl	198	16	represent	represent	VB
cord-314500-89ovdnxl	198	17	increased	increase	VBN
cord-314500-89ovdnxl	198	18	risk	risk	NN
cord-314500-89ovdnxl	198	19	of	of	IN
cord-314500-89ovdnxl	198	20	diabetes	diabetes	NN
cord-314500-89ovdnxl	198	21	by	by	IN
cord-314500-89ovdnxl	198	22	pathogenesis	pathogenesis	NN
cord-314500-89ovdnxl	198	23	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	198	24	resulting	result	VBG
cord-314500-89ovdnxl	198	25	in	in	IN
cord-314500-89ovdnxl	198	26	insulin	insulin	NN
cord-314500-89ovdnxl	198	27	resistance	resistance	NN
cord-314500-89ovdnxl	198	28	related	relate	VBN
cord-314500-89ovdnxl	198	29	to	to	IN
cord-314500-89ovdnxl	198	30	chronic	chronic	JJ
cord-314500-89ovdnxl	198	31	inflammation	inflammation	NN
cord-314500-89ovdnxl	198	32	,	,	,
cord-314500-89ovdnxl	198	33	rather	rather	RB
cord-314500-89ovdnxl	198	34	than	than	IN
cord-314500-89ovdnxl	198	35	the	the	DT
cord-314500-89ovdnxl	198	36	other	other	JJ
cord-314500-89ovdnxl	198	37	way	way	NN
cord-314500-89ovdnxl	198	38	around	around	RB
cord-314500-89ovdnxl	198	39	.	.	.
cord-314500-89ovdnxl	199	1	High	high	JJ
cord-314500-89ovdnxl	199	2	-	-	HYPH
cord-314500-89ovdnxl	199	3	quality	quality	NN
cord-314500-89ovdnxl	199	4	,	,	,
cord-314500-89ovdnxl	199	5	large	large	JJ
cord-314500-89ovdnxl	199	6	prospective	prospective	JJ
cord-314500-89ovdnxl	199	7	epidemiology	epidemiology	NN
cord-314500-89ovdnxl	199	8	studies	study	NNS
cord-314500-89ovdnxl	199	9	are	be	VBP
cord-314500-89ovdnxl	199	10	needed	need	VBN
cord-314500-89ovdnxl	199	11	to	to	TO
cord-314500-89ovdnxl	199	12	quantitate	quantitate	VB
cord-314500-89ovdnxl	199	13	the	the	DT
cord-314500-89ovdnxl	199	14	problem	problem	NN
cord-314500-89ovdnxl	199	15	,	,	,
cord-314500-89ovdnxl	199	16	alongside	alongside	IN
cord-314500-89ovdnxl	199	17	randomised	randomised	JJ
cord-314500-89ovdnxl	199	18	controlled	control	VBN
cord-314500-89ovdnxl	199	19	trials	trial	NNS
cord-314500-89ovdnxl	199	20	of	of	IN
cord-314500-89ovdnxl	199	21	interventions	intervention	NNS
cord-314500-89ovdnxl	199	22	to	to	TO
cord-314500-89ovdnxl	199	23	define	define	VB
cord-314500-89ovdnxl	199	24	optimal	optimal	JJ
cord-314500-89ovdnxl	199	25	treatment	treatment	NN
cord-314500-89ovdnxl	199	26	strategies	strategy	NNS
cord-314500-89ovdnxl	199	27	in	in	IN
cord-314500-89ovdnxl	199	28	diabetes	diabetes	NN
cord-314500-89ovdnxl	199	29	.	.	.
cord-314500-89ovdnxl	200	1	Raising	raise	VBG
cord-314500-89ovdnxl	200	2	awareness	awareness	NN
cord-314500-89ovdnxl	200	3	of	of	IN
cord-314500-89ovdnxl	200	4	the	the	DT
cord-314500-89ovdnxl	200	5	interaction	interaction	NN
cord-314500-89ovdnxl	200	6	of	of	IN
cord-314500-89ovdnxl	200	7	diabetes	diabetes	NN
cord-314500-89ovdnxl	200	8	and	and	CC
cord-314500-89ovdnxl	200	9	infection	infection	NN
cord-314500-89ovdnxl	200	10	with	with	IN
cord-314500-89ovdnxl	200	11	policy	policy	NN
cord-314500-89ovdnxl	200	12	-	-	HYPH
cord-314500-89ovdnxl	200	13	makers	maker	NNS
cord-314500-89ovdnxl	200	14	,	,	,
cord-314500-89ovdnxl	200	15	and	and	CC
cord-314500-89ovdnxl	200	16	ensuring	ensure	VBG
cord-314500-89ovdnxl	200	17	the	the	DT
cord-314500-89ovdnxl	200	18	engagement	engagement	NN
cord-314500-89ovdnxl	200	19	of	of	IN
cord-314500-89ovdnxl	200	20	social	social	JJ
cord-314500-89ovdnxl	200	21	scientists	scientist	NNS
cord-314500-89ovdnxl	200	22	,	,	,
cord-314500-89ovdnxl	200	23	health	health	NN
cord-314500-89ovdnxl	200	24	economists	economist	NNS
cord-314500-89ovdnxl	200	25	and	and	CC
cord-314500-89ovdnxl	200	26	the	the	DT
cord-314500-89ovdnxl	200	27	pharmaceutical	pharmaceutical	JJ
cord-314500-89ovdnxl	200	28	industry	industry	NN
cord-314500-89ovdnxl	200	29	in	in	IN
cord-314500-89ovdnxl	200	30	developing	develop	VBG
cord-314500-89ovdnxl	200	31	new	new	JJ
cord-314500-89ovdnxl	200	32	strategies	strategy	NNS
cord-314500-89ovdnxl	200	33	to	to	TO
cord-314500-89ovdnxl	200	34	fight	fight	VB
cord-314500-89ovdnxl	200	35	this	this	DT
cord-314500-89ovdnxl	200	36	double	double	JJ
cord-314500-89ovdnxl	200	37	burden	burden	NN
cord-314500-89ovdnxl	200	38	in	in	IN
cord-314500-89ovdnxl	200	39	LMIC	LMIC	NNP
cord-314500-89ovdnxl	200	40	is	be	VBZ
cord-314500-89ovdnxl	200	41	vital	vital	JJ
cord-314500-89ovdnxl	200	42	.	.	.
cord-314500-89ovdnxl	201	1	Authors	author	NNS
cord-314500-89ovdnxl	201	2	'	'	POS
cord-314500-89ovdnxl	201	3	contributions	contribution	NNS
cord-314500-89ovdnxl	201	4	:	:	:
cord-314500-89ovdnxl	201	5	SD	SD	NNP
cord-314500-89ovdnxl	201	6	and	and	CC
cord-314500-89ovdnxl	201	7	PC	PC	NNP
cord-314500-89ovdnxl	201	8	wrote	write	VBD
cord-314500-89ovdnxl	201	9	and	and	CC
cord-314500-89ovdnxl	201	10	reviewed	review	VBD
cord-314500-89ovdnxl	201	11	the	the	DT
cord-314500-89ovdnxl	201	12	manuscript	manuscript	NN
cord-314500-89ovdnxl	201	13	together	together	RB
cord-314500-89ovdnxl	201	14	.	.	.
cord-314500-89ovdnxl	202	1	International	International	NNP
cord-314500-89ovdnxl	202	2	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	202	3	Federation	Federation	NNP
cord-314500-89ovdnxl	202	4	Worldwide	Worldwide	NNP
cord-314500-89ovdnxl	202	5	trends	trend	NNS
cord-314500-89ovdnxl	202	6	in	in	IN
cord-314500-89ovdnxl	202	7	diabetes	diabete	NNS
cord-314500-89ovdnxl	202	8	since	since	IN
cord-314500-89ovdnxl	202	9	1980	1980	CD
cord-314500-89ovdnxl	202	10	:	:	:
cord-314500-89ovdnxl	202	11	a	a	DT
cord-314500-89ovdnxl	202	12	pooled	pool	VBN
cord-314500-89ovdnxl	202	13	analysis	analysis	NN
cord-314500-89ovdnxl	202	14	of	of	IN
cord-314500-89ovdnxl	202	15	751	751	CD
cord-314500-89ovdnxl	202	16	population	population	NN
cord-314500-89ovdnxl	202	17	-	-	HYPH
cord-314500-89ovdnxl	202	18	based	base	VBN
cord-314500-89ovdnxl	202	19	studies	study	NNS
cord-314500-89ovdnxl	202	20	with	with	IN
cord-314500-89ovdnxl	202	21	4.4	4.4	CD
cord-314500-89ovdnxl	202	22	million	million	CD
cord-314500-89ovdnxl	202	23	participants	participant	NNS
cord-314500-89ovdnxl	202	24	Diabetes	diabetes	NN
cord-314500-89ovdnxl	202	25	mellitus	mellitus	NN
cord-314500-89ovdnxl	202	26	increases	increase	VBZ
cord-314500-89ovdnxl	202	27	the	the	DT
cord-314500-89ovdnxl	202	28	risk	risk	NN
cord-314500-89ovdnxl	202	29	of	of	IN
cord-314500-89ovdnxl	202	30	active	active	JJ
cord-314500-89ovdnxl	202	31	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	202	32	:	:	:
cord-314500-89ovdnxl	202	33	a	a	DT
cord-314500-89ovdnxl	202	34	systematic	systematic	JJ
cord-314500-89ovdnxl	202	35	review	review	NN
cord-314500-89ovdnxl	202	36	of	of	IN
cord-314500-89ovdnxl	202	37	13	13	CD
cord-314500-89ovdnxl	202	38	observational	observational	JJ
cord-314500-89ovdnxl	202	39	studies	study	NNS
cord-314500-89ovdnxl	203	1	The	the	DT
cord-314500-89ovdnxl	203	2	epidemiology	epidemiology	NN
cord-314500-89ovdnxl	203	3	of	of	IN
cord-314500-89ovdnxl	203	4	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	203	5	in	in	IN
cord-314500-89ovdnxl	203	6	Ubon	Ubon	NNP
cord-314500-89ovdnxl	203	7	Ratchatani	Ratchatani	NNP
cord-314500-89ovdnxl	203	8	,	,	,
cord-314500-89ovdnxl	203	9	northeast	northeast	NN
cord-314500-89ovdnxl	203	10	Thailand	Thailand	NNP
cord-314500-89ovdnxl	203	11	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	203	12	epidemiology	epidemiology	NN
cord-314500-89ovdnxl	203	13	and	and	CC
cord-314500-89ovdnxl	203	14	risk	risk	NN
cord-314500-89ovdnxl	203	15	factors	factor	NNS
cord-314500-89ovdnxl	203	16	from	from	IN
cord-314500-89ovdnxl	203	17	a	a	DT
cord-314500-89ovdnxl	203	18	prospective	prospective	JJ
cord-314500-89ovdnxl	203	19	whole	whole	JJ
cord-314500-89ovdnxl	203	20	-	-	HYPH
cord-314500-89ovdnxl	203	21	population	population	NN
cord-314500-89ovdnxl	203	22	study	study	NN
cord-314500-89ovdnxl	203	23	in	in	IN
cord-314500-89ovdnxl	203	24	northern	northern	JJ
cord-314500-89ovdnxl	203	25	Australia	Australia	NNP
cord-314500-89ovdnxl	203	26	GBD	GBD	NNP
cord-314500-89ovdnxl	203	27	Causes	cause	NNS
cord-314500-89ovdnxl	203	28	of	of	IN
cord-314500-89ovdnxl	203	29	Death	Death	NNP
cord-314500-89ovdnxl	203	30	Collaborators	Collaborators	NNPS
cord-314500-89ovdnxl	203	31	.	.	.
cord-314500-89ovdnxl	204	1	Global	global	JJ
cord-314500-89ovdnxl	204	2	,	,	,
cord-314500-89ovdnxl	204	3	regional	regional	JJ
cord-314500-89ovdnxl	204	4	,	,	,
cord-314500-89ovdnxl	204	5	and	and	CC
cord-314500-89ovdnxl	204	6	national	national	JJ
cord-314500-89ovdnxl	204	7	age	age	NN
cord-314500-89ovdnxl	204	8	-	-	HYPH
cord-314500-89ovdnxl	204	9	sex	sex	NN
cord-314500-89ovdnxl	204	10	specific	specific	JJ
cord-314500-89ovdnxl	204	11	mortality	mortality	NN
cord-314500-89ovdnxl	204	12	for	for	IN
cord-314500-89ovdnxl	204	13	264	264	CD
cord-314500-89ovdnxl	204	14	causes	cause	NNS
cord-314500-89ovdnxl	204	15	of	of	IN
cord-314500-89ovdnxl	204	16	death	death	NN
cord-314500-89ovdnxl	204	17	,	,	,
cord-314500-89ovdnxl	204	18	1980	1980	CD
cord-314500-89ovdnxl	204	19	-	-	SYM
cord-314500-89ovdnxl	204	20	2016	2016	CD
cord-314500-89ovdnxl	204	21	:	:	:
cord-314500-89ovdnxl	204	22	a	a	DT
cord-314500-89ovdnxl	204	23	systematic	systematic	JJ
cord-314500-89ovdnxl	204	24	analysis	analysis	NN
cord-314500-89ovdnxl	204	25	for	for	IN
cord-314500-89ovdnxl	204	26	the	the	DT
cord-314500-89ovdnxl	204	27	Global	Global	NNP
cord-314500-89ovdnxl	204	28	Burden	Burden	NNP
cord-314500-89ovdnxl	204	29	of	of	IN
cord-314500-89ovdnxl	204	30	Disease	Disease	NNP
cord-314500-89ovdnxl	204	31	Study	Study	NNP
cord-314500-89ovdnxl	204	32	World	World	NNP
cord-314500-89ovdnxl	204	33	Health	Health	NNP
cord-314500-89ovdnxl	204	34	Organization	Organization	NNP
cord-314500-89ovdnxl	204	35	.	.	.
cord-314500-89ovdnxl	205	1	Definition	definition	NN
cord-314500-89ovdnxl	205	2	and	and	CC
cord-314500-89ovdnxl	205	3	diagnosis	diagnosis	NN
cord-314500-89ovdnxl	205	4	of	of	IN
cord-314500-89ovdnxl	205	5	diabetes	diabetes	NN
cord-314500-89ovdnxl	205	6	mellitus	mellitus	NN
cord-314500-89ovdnxl	205	7	and	and	CC
cord-314500-89ovdnxl	205	8	intermediate	intermediate	JJ
cord-314500-89ovdnxl	205	9	hyperglycaemia	hyperglycaemia	NNP
cord-314500-89ovdnxl	205	10	.	.	.
cord-314500-89ovdnxl	206	1	Geneva	Geneva	NNP
cord-314500-89ovdnxl	206	2	:	:	:
cord-314500-89ovdnxl	207	1	World	World	NNP
cord-314500-89ovdnxl	207	2	Health	Health	NNP
cord-314500-89ovdnxl	207	3	Organization	Organization	NNP
cord-314500-89ovdnxl	207	4	American	American	NNP
cord-314500-89ovdnxl	207	5	Diabetes	diabetes	NN
cord-314500-89ovdnxl	208	1	A.	A.	NNP
cord-314500-89ovdnxl	208	2	2	2	CD
cord-314500-89ovdnxl	208	3	.	.	.
cord-314500-89ovdnxl	209	1	Classification	classification	NN
cord-314500-89ovdnxl	209	2	and	and	CC
cord-314500-89ovdnxl	209	3	Diagnosis	Diagnosis	NNP
cord-314500-89ovdnxl	209	4	of	of	IN
cord-314500-89ovdnxl	209	5	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	209	6	International	International	NNP
cord-314500-89ovdnxl	209	7	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	209	8	Federation	Federation	NNP
cord-314500-89ovdnxl	209	9	:	:	:
cord-314500-89ovdnxl	209	10	a	a	DT
cord-314500-89ovdnxl	209	11	consensus	consensus	NN
cord-314500-89ovdnxl	209	12	on	on	IN
cord-314500-89ovdnxl	209	13	Type	type	NN
cord-314500-89ovdnxl	209	14	2	2	CD
cord-314500-89ovdnxl	209	15	diabetes	diabetes	NN
cord-314500-89ovdnxl	209	16	prevention	prevention	NN
cord-314500-89ovdnxl	209	17	Influence	influence	NN
cord-314500-89ovdnxl	209	18	of	of	IN
cord-314500-89ovdnxl	209	19	diabetes	diabetes	NN
cord-314500-89ovdnxl	209	20	and	and	CC
cord-314500-89ovdnxl	209	21	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	209	22	on	on	IN
cord-314500-89ovdnxl	209	23	infectious	infectious	JJ
cord-314500-89ovdnxl	209	24	disease	disease	NN
cord-314500-89ovdnxl	209	25	hospitalisation	hospitalisation	NN
cord-314500-89ovdnxl	209	26	and	and	CC
cord-314500-89ovdnxl	209	27	outcome	outcome	NN
cord-314500-89ovdnxl	209	28	Increased	increase	VBN
cord-314500-89ovdnxl	209	29	Risk	Risk	NNP
cord-314500-89ovdnxl	209	30	of	of	IN
cord-314500-89ovdnxl	209	31	Common	Common	NNP
cord-314500-89ovdnxl	209	32	Infections	Infections	NNPS
cord-314500-89ovdnxl	209	33	in	in	IN
cord-314500-89ovdnxl	209	34	Patients	patient	NNS
cord-314500-89ovdnxl	209	35	with	with	IN
cord-314500-89ovdnxl	209	36	Type	type	NN
cord-314500-89ovdnxl	209	37	1	1	CD
cord-314500-89ovdnxl	209	38	and	and	CC
cord-314500-89ovdnxl	209	39	Type	type	NN
cord-314500-89ovdnxl	209	40	2	2	CD
cord-314500-89ovdnxl	209	41	Diabetes	diabetes	NN
cord-314500-89ovdnxl	209	42	Mellitus	Mellitus	NNP
cord-314500-89ovdnxl	209	43	Impact	Impact	NNP
cord-314500-89ovdnxl	209	44	of	of	IN
cord-314500-89ovdnxl	209	45	diabetes	diabetes	NN
cord-314500-89ovdnxl	209	46	mellitus	mellitus	NN
cord-314500-89ovdnxl	209	47	on	on	IN
cord-314500-89ovdnxl	209	48	treatment	treatment	NN
cord-314500-89ovdnxl	209	49	outcomes	outcome	NNS
cord-314500-89ovdnxl	209	50	of	of	IN
cord-314500-89ovdnxl	209	51	patients	patient	NNS
cord-314500-89ovdnxl	209	52	with	with	IN
cord-314500-89ovdnxl	209	53	active	active	JJ
cord-314500-89ovdnxl	209	54	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	210	1	The	the	DT
cord-314500-89ovdnxl	210	2	global	global	JJ
cord-314500-89ovdnxl	210	3	burden	burden	NN
cord-314500-89ovdnxl	210	4	of	of	IN
cord-314500-89ovdnxl	210	5	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	210	6	:	:	:
cord-314500-89ovdnxl	210	7	results	result	NNS
cord-314500-89ovdnxl	210	8	from	from	IN
cord-314500-89ovdnxl	210	9	the	the	DT
cord-314500-89ovdnxl	210	10	Global	Global	NNP
cord-314500-89ovdnxl	210	11	Burden	Burden	NNP
cord-314500-89ovdnxl	210	12	of	of	IN
cord-314500-89ovdnxl	210	13	Disease	Disease	NNP
cord-314500-89ovdnxl	210	14	Study	Study	NNP
cord-314500-89ovdnxl	210	15	Geneva	Geneva	NNP
cord-314500-89ovdnxl	210	16	:	:	:
cord-314500-89ovdnxl	211	1	World	World	NNP
cord-314500-89ovdnxl	211	2	Health	Health	NNP
cord-314500-89ovdnxl	211	3	Organization	Organization	NNP
cord-314500-89ovdnxl	211	4	Stress	Stress	NNP
cord-314500-89ovdnxl	211	5	Hyperglycemia	hyperglycemia	NN
cord-314500-89ovdnxl	211	6	in	in	IN
cord-314500-89ovdnxl	211	7	Patients	patient	NNS
cord-314500-89ovdnxl	211	8	with	with	IN
cord-314500-89ovdnxl	211	9	Tuberculosis	Tuberculosis	NNP
cord-314500-89ovdnxl	211	10	Disease	Disease	NNP
cord-314500-89ovdnxl	211	11	:	:	:
cord-314500-89ovdnxl	211	12	Epidemiology	Epidemiology	NNP
cord-314500-89ovdnxl	211	13	and	and	CC
cord-314500-89ovdnxl	211	14	Clinical	Clinical	NNP
cord-314500-89ovdnxl	211	15	Implications	implication	NNS
cord-314500-89ovdnxl	212	1	Addressing	address	VBG
cord-314500-89ovdnxl	212	2	diabetes	diabetes	NN
cord-314500-89ovdnxl	212	3	mellitus	mellitus	NN
cord-314500-89ovdnxl	212	4	as	as	IN
cord-314500-89ovdnxl	212	5	part	part	NN
cord-314500-89ovdnxl	212	6	of	of	IN
cord-314500-89ovdnxl	212	7	the	the	DT
cord-314500-89ovdnxl	212	8	strategy	strategy	NN
cord-314500-89ovdnxl	212	9	for	for	IN
cord-314500-89ovdnxl	212	10	ending	end	VBG
cord-314500-89ovdnxl	212	11	TB	TB	NNP
cord-314500-89ovdnxl	212	12	Diabetic	diabetic	JJ
cord-314500-89ovdnxl	212	13	status	status	NN
cord-314500-89ovdnxl	212	14	in	in	IN
cord-314500-89ovdnxl	212	15	leprosy	leprosy	NN
cord-314500-89ovdnxl	212	16	Diabetic	diabetic	JJ
cord-314500-89ovdnxl	212	17	status	status	NN
cord-314500-89ovdnxl	212	18	of	of	IN
cord-314500-89ovdnxl	212	19	patients	patient	NNS
cord-314500-89ovdnxl	212	20	with	with	IN
cord-314500-89ovdnxl	212	21	leprosy	leprosy	NN
cord-314500-89ovdnxl	212	22	in	in	IN
cord-314500-89ovdnxl	212	23	Kuwait	Kuwait	NNP
cord-314500-89ovdnxl	212	24	T	T	NNP
cord-314500-89ovdnxl	212	25	-	-	HYPH
cord-314500-89ovdnxl	212	26	Cell	cell	NN
cord-314500-89ovdnxl	212	27	Responses	response	NNS
cord-314500-89ovdnxl	212	28	Are	be	VBP
cord-314500-89ovdnxl	212	29	Associated	associate	VBN
cord-314500-89ovdnxl	212	30	with	with	IN
cord-314500-89ovdnxl	212	31	Survival	Survival	NNP
cord-314500-89ovdnxl	212	32	in	in	IN
cord-314500-89ovdnxl	212	33	Acute	Acute	NNP
cord-314500-89ovdnxl	212	34	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	212	35	Patients	Patients	NNP
cord-314500-89ovdnxl	212	36	Activities	Activities	NNPS
cord-314500-89ovdnxl	212	37	of	of	IN
cord-314500-89ovdnxl	212	38	Daily	Daily	NNP
cord-314500-89ovdnxl	212	39	Living	Living	NNP
cord-314500-89ovdnxl	212	40	Associated	Associated	NNP
cord-314500-89ovdnxl	212	41	with	with	IN
cord-314500-89ovdnxl	212	42	Acquisition	Acquisition	NNP
cord-314500-89ovdnxl	212	43	of	of	IN
cord-314500-89ovdnxl	212	44	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	212	45	in	in	IN
cord-314500-89ovdnxl	212	46	Northeast	Northeast	NNP
cord-314500-89ovdnxl	212	47	Thailand	Thailand	NNP
cord-314500-89ovdnxl	212	48	:	:	:
cord-314500-89ovdnxl	213	1	A	a	DT
cord-314500-89ovdnxl	213	2	Matched	match	VBN
cord-314500-89ovdnxl	213	3	Case	Case	NNP
cord-314500-89ovdnxl	213	4	-	-	HYPH
cord-314500-89ovdnxl	213	5	Control	Control	NNP
cord-314500-89ovdnxl	213	6	Study	Study	NNP
cord-314500-89ovdnxl	213	7	Predicted	predict	VBD
cord-314500-89ovdnxl	213	8	global	global	JJ
cord-314500-89ovdnxl	213	9	distribution	distribution	NN
cord-314500-89ovdnxl	213	10	of	of	IN
cord-314500-89ovdnxl	213	11	Burkholderia	Burkholderia	NNP
cord-314500-89ovdnxl	213	12	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	213	13	and	and	CC
cord-314500-89ovdnxl	213	14	burden	burden	NN
cord-314500-89ovdnxl	213	15	of	of	IN
cord-314500-89ovdnxl	213	16	melioidosis	melioidosis	NN
cord-314500-89ovdnxl	213	17	Bacteremia	Bacteremia	NNP
cord-314500-89ovdnxl	213	18	in	in	IN
cord-314500-89ovdnxl	213	19	diabetic	diabetic	JJ
cord-314500-89ovdnxl	213	20	patients	patient	NNS
cord-314500-89ovdnxl	213	21	:	:	:
cord-314500-89ovdnxl	213	22	comparison	comparison	NN
cord-314500-89ovdnxl	213	23	of	of	IN
cord-314500-89ovdnxl	213	24	incidence	incidence	NN
cord-314500-89ovdnxl	213	25	and	and	CC
cord-314500-89ovdnxl	213	26	mortality	mortality	NN
cord-314500-89ovdnxl	213	27	with	with	IN
cord-314500-89ovdnxl	213	28	nondiabetic	nondiabetic	JJ
cord-314500-89ovdnxl	213	29	patients	patient	NNS
cord-314500-89ovdnxl	213	30	Risk	risk	NN
cord-314500-89ovdnxl	213	31	factors	factor	NNS
cord-314500-89ovdnxl	213	32	and	and	CC
cord-314500-89ovdnxl	213	33	mortality	mortality	NN
cord-314500-89ovdnxl	213	34	of	of	IN
cord-314500-89ovdnxl	213	35	healthcare	healthcare	NN
cord-314500-89ovdnxl	213	36	-	-	HYPH
cord-314500-89ovdnxl	213	37	associated	associate	VBN
cord-314500-89ovdnxl	213	38	and	and	CC
cord-314500-89ovdnxl	213	39	community	community	NN
cord-314500-89ovdnxl	213	40	-	-	HYPH
cord-314500-89ovdnxl	213	41	acquired	acquire	VBN
cord-314500-89ovdnxl	213	42	Staphylococcus	Staphylococcus	NNP
cord-314500-89ovdnxl	213	43	aureus	aureus	NN
cord-314500-89ovdnxl	213	44	bacteraemia	bacteraemia	NNP
cord-314500-89ovdnxl	213	45	Tropical	tropical	JJ
cord-314500-89ovdnxl	213	46	pyomyositis	pyomyositis	NN
cord-314500-89ovdnxl	213	47	(	(	-LRB-
cord-314500-89ovdnxl	213	48	myositis	myositis	NN
cord-314500-89ovdnxl	213	49	tropicans	tropicans	NNPS
cord-314500-89ovdnxl	213	50	)	)	-RRB-
cord-314500-89ovdnxl	214	1	:	:	:
cord-314500-89ovdnxl	214	2	current	current	JJ
cord-314500-89ovdnxl	214	3	perspective	perspective	NN
cord-314500-89ovdnxl	214	4	Case	Case	NNP
cord-314500-89ovdnxl	214	5	report	report	NN
cord-314500-89ovdnxl	214	6	:	:	:
cord-314500-89ovdnxl	214	7	diabetes	diabetes	NN
cord-314500-89ovdnxl	214	8	mellitus	mellitus	NN
cord-314500-89ovdnxl	214	9	as	as	IN
cord-314500-89ovdnxl	214	10	a	a	DT
cord-314500-89ovdnxl	214	11	predisposing	predispose	VBG
cord-314500-89ovdnxl	214	12	factor	factor	NN
cord-314500-89ovdnxl	214	13	in	in	IN
cord-314500-89ovdnxl	214	14	the	the	DT
cord-314500-89ovdnxl	214	15	development	development	NN
cord-314500-89ovdnxl	214	16	of	of	IN
cord-314500-89ovdnxl	214	17	pyomyositis	pyomyositis	NNP
cord-314500-89ovdnxl	214	18	Bacterial	bacterial	JJ
cord-314500-89ovdnxl	214	19	pyomyositis	pyomyositis	NN
cord-314500-89ovdnxl	214	20	in	in	IN
cord-314500-89ovdnxl	214	21	the	the	DT
cord-314500-89ovdnxl	214	22	United	United	NNP
cord-314500-89ovdnxl	214	23	States	States	NNP
cord-314500-89ovdnxl	214	24	Primary	Primary	NNP
cord-314500-89ovdnxl	214	25	pyomyositis	pyomyositis	NN
cord-314500-89ovdnxl	214	26	in	in	IN
cord-314500-89ovdnxl	214	27	North	North	NNP
cord-314500-89ovdnxl	214	28	India	India	NNP
cord-314500-89ovdnxl	214	29	:	:	:
cord-314500-89ovdnxl	215	1	a	a	DT
cord-314500-89ovdnxl	215	2	clinical	clinical	JJ
cord-314500-89ovdnxl	215	3	,	,	,
cord-314500-89ovdnxl	215	4	microbiological	microbiological	JJ
cord-314500-89ovdnxl	215	5	,	,	,
cord-314500-89ovdnxl	215	6	and	and	CC
cord-314500-89ovdnxl	215	7	outcome	outcome	NN
cord-314500-89ovdnxl	215	8	study	study	NN
cord-314500-89ovdnxl	215	9	Salmonella	Salmonella	NNP
cord-314500-89ovdnxl	215	10	infections	infection	NNS
cord-314500-89ovdnxl	215	11	:	:	:
cord-314500-89ovdnxl	215	12	a	a	DT
cord-314500-89ovdnxl	215	13	retrospective	retrospective	JJ
cord-314500-89ovdnxl	215	14	10-year	10-year	CD
cord-314500-89ovdnxl	215	15	analysis	analysis	NN
cord-314500-89ovdnxl	215	16	of	of	IN
cord-314500-89ovdnxl	215	17	134	134	CD
cord-314500-89ovdnxl	215	18	cases	case	NNS
cord-314500-89ovdnxl	215	19	in	in	IN
cord-314500-89ovdnxl	215	20	a	a	DT
cord-314500-89ovdnxl	215	21	regional	regional	JJ
cord-314500-89ovdnxl	215	22	hospital	hospital	NN
cord-314500-89ovdnxl	215	23	in	in	IN
cord-314500-89ovdnxl	215	24	Taiwan	Taiwan	NNP
cord-314500-89ovdnxl	215	25	Diabetes	diabetes	NN
cord-314500-89ovdnxl	215	26	mellitus	mellitus	NN
cord-314500-89ovdnxl	215	27	-	-	:
cord-314500-89ovdnxl	215	28	a	a	DT
cord-314500-89ovdnxl	215	29	newly	newly	RB
cord-314500-89ovdnxl	215	30	described	describe	VBN
cord-314500-89ovdnxl	215	31	risk	risk	NN
cord-314500-89ovdnxl	215	32	factor	factor	NN
cord-314500-89ovdnxl	215	33	for	for	IN
cord-314500-89ovdnxl	215	34	infection	infection	NN
cord-314500-89ovdnxl	215	35	from	from	IN
cord-314500-89ovdnxl	215	36	Salmonella	Salmonella	NNP
cord-314500-89ovdnxl	215	37	enteritidis	enteritidis	NN
cord-314500-89ovdnxl	215	38	Bacteremia	Bacteremia	NNP
cord-314500-89ovdnxl	215	39	in	in	IN
cord-314500-89ovdnxl	215	40	adult	adult	JJ
cord-314500-89ovdnxl	215	41	diabetic	diabetic	JJ
cord-314500-89ovdnxl	215	42	patients	patient	NNS
cord-314500-89ovdnxl	215	43	Comparison	Comparison	NNP
cord-314500-89ovdnxl	215	44	of	of	IN
cord-314500-89ovdnxl	215	45	pyogenic	pyogenic	JJ
cord-314500-89ovdnxl	215	46	liver	liver	NN
cord-314500-89ovdnxl	215	47	abscess	abscess	NN
cord-314500-89ovdnxl	215	48	caused	cause	VBN
cord-314500-89ovdnxl	215	49	by	by	IN
cord-314500-89ovdnxl	215	50	non	non	JJ
cord-314500-89ovdnxl	215	51	-	-	JJ
cord-314500-89ovdnxl	215	52	Klebsiella	klebsiella	JJ
cord-314500-89ovdnxl	215	53	pneumoniae	pneumoniae	NN
cord-314500-89ovdnxl	215	54	and	and	CC
cord-314500-89ovdnxl	215	55	Klebsiella	Klebsiella	NNP
cord-314500-89ovdnxl	215	56	pneumoniae	pneumoniae	NN
cord-314500-89ovdnxl	215	57	Distribution	distribution	NN
cord-314500-89ovdnxl	215	58	of	of	IN
cord-314500-89ovdnxl	215	59	common	common	JJ
cord-314500-89ovdnxl	215	60	pathogens	pathogen	NNS
cord-314500-89ovdnxl	215	61	in	in	IN
cord-314500-89ovdnxl	215	62	patients	patient	NNS
cord-314500-89ovdnxl	215	63	with	with	IN
cord-314500-89ovdnxl	215	64	pyogenic	pyogenic	JJ
cord-314500-89ovdnxl	215	65	liver	liver	NN
cord-314500-89ovdnxl	215	66	abscess	abscess	NN
cord-314500-89ovdnxl	215	67	in	in	IN
cord-314500-89ovdnxl	215	68	China	China	NNP
cord-314500-89ovdnxl	215	69	:	:	:
cord-314500-89ovdnxl	215	70	a	a	DT
cord-314500-89ovdnxl	215	71	meta	meta	JJ
cord-314500-89ovdnxl	215	72	-	-	HYPH
cord-314500-89ovdnxl	215	73	analysis	analysis	NNP
cord-314500-89ovdnxl	215	74	Review	Review	NNP
cord-314500-89ovdnxl	215	75	article	article	NN
cord-314500-89ovdnxl	215	76	:	:	:
cord-314500-89ovdnxl	216	1	Unresolved	unresolved	JJ
cord-314500-89ovdnxl	216	2	problems	problem	NNS
cord-314500-89ovdnxl	216	3	related	relate	VBN
cord-314500-89ovdnxl	216	4	to	to	TO
cord-314500-89ovdnxl	216	5	scrub	scrub	VB
cord-314500-89ovdnxl	216	6	typhus	typhus	NN
cord-314500-89ovdnxl	216	7	:	:	:
cord-314500-89ovdnxl	216	8	A	a	DT
cord-314500-89ovdnxl	216	9	seriously	seriously	RB
cord-314500-89ovdnxl	216	10	neglected	neglect	VBN
cord-314500-89ovdnxl	216	11	life	life	NN
cord-314500-89ovdnxl	216	12	-	-	HYPH
cord-314500-89ovdnxl	216	13	threatening	threaten	VBG
cord-314500-89ovdnxl	216	14	disease	disease	NN
cord-314500-89ovdnxl	217	1	A	a	DT
cord-314500-89ovdnxl	217	2	Systematic	Systematic	NNP
cord-314500-89ovdnxl	217	3	Review	Review	NNP
cord-314500-89ovdnxl	217	4	of	of	IN
cord-314500-89ovdnxl	217	5	Mortality	Mortality	NNP
cord-314500-89ovdnxl	217	6	from	from	IN
cord-314500-89ovdnxl	217	7	Untreated	untreated	JJ
cord-314500-89ovdnxl	217	8	Scrub	Scrub	NNP
cord-314500-89ovdnxl	217	9	Typhus	Typhus	NNP
cord-314500-89ovdnxl	217	10	(	(	-LRB-
cord-314500-89ovdnxl	217	11	Orientia	Orientia	NNP
cord-314500-89ovdnxl	217	12	tsutsugamushi	tsutsugamushi	NNP
cord-314500-89ovdnxl	217	13	)	)	-RRB-
cord-314500-89ovdnxl	218	1	Severity	severity	NN
cord-314500-89ovdnxl	218	2	predictors	predictor	NNS
cord-314500-89ovdnxl	218	3	in	in	IN
cord-314500-89ovdnxl	218	4	eschar	eschar	NN
cord-314500-89ovdnxl	218	5	-	-	HYPH
cord-314500-89ovdnxl	218	6	positive	positive	JJ
cord-314500-89ovdnxl	218	7	scrub	scrub	NN
cord-314500-89ovdnxl	218	8	typhus	typhus	NN
cord-314500-89ovdnxl	218	9	and	and	CC
cord-314500-89ovdnxl	218	10	role	role	NN
cord-314500-89ovdnxl	218	11	of	of	IN
cord-314500-89ovdnxl	218	12	serum	serum	NN
cord-314500-89ovdnxl	218	13	osteopontin	osteopontin	NNP
cord-314500-89ovdnxl	218	14	Diabetes	diabetes	NN
cord-314500-89ovdnxl	218	15	and	and	CC
cord-314500-89ovdnxl	218	16	Other	other	JJ
cord-314500-89ovdnxl	218	17	Risk	Risk	NNP
cord-314500-89ovdnxl	218	18	Factors	Factors	NNPS
cord-314500-89ovdnxl	218	19	for	for	IN
cord-314500-89ovdnxl	218	20	Multi	multi	JJ
cord-314500-89ovdnxl	218	21	-	-	JJ
cord-314500-89ovdnxl	218	22	drug	drug	NN
cord-314500-89ovdnxl	218	23	Resistant	Resistant	NNP
cord-314500-89ovdnxl	218	24	Tuberculosis	Tuberculosis	NNP
cord-314500-89ovdnxl	218	25	in	in	IN
cord-314500-89ovdnxl	218	26	a	a	DT
cord-314500-89ovdnxl	218	27	Mexican	Mexican	NNP
cord-314500-89ovdnxl	218	28	Population	population	NN
cord-314500-89ovdnxl	218	29	with	with	IN
cord-314500-89ovdnxl	218	30	Pulmonary	Pulmonary	NNP
cord-314500-89ovdnxl	218	31	Tuberculosis	Tuberculosis	NNP
cord-314500-89ovdnxl	219	1	:	:	:
cord-314500-89ovdnxl	219	2	Case	Case	NNP
cord-314500-89ovdnxl	219	3	Control	Control	NNP
cord-314500-89ovdnxl	219	4	Study	Study	NNP
cord-314500-89ovdnxl	220	1	The	the	DT
cord-314500-89ovdnxl	220	2	effect	effect	NN
cord-314500-89ovdnxl	220	3	size	size	NN
cord-314500-89ovdnxl	220	4	of	of	IN
cord-314500-89ovdnxl	220	5	type	type	NN
cord-314500-89ovdnxl	220	6	2	2	CD
cord-314500-89ovdnxl	220	7	diabetes	diabetes	NN
cord-314500-89ovdnxl	220	8	mellitus	mellitus	NN
cord-314500-89ovdnxl	220	9	on	on	IN
cord-314500-89ovdnxl	220	10	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	220	11	drug	drug	NN
cord-314500-89ovdnxl	220	12	resistance	resistance	NN
cord-314500-89ovdnxl	220	13	and	and	CC
cord-314500-89ovdnxl	220	14	adverse	adverse	JJ
cord-314500-89ovdnxl	220	15	treatment	treatment	NN
cord-314500-89ovdnxl	220	16	outcomes	outcome	NNS
cord-314500-89ovdnxl	220	17	Epidemiology	Epidemiology	NNP
cord-314500-89ovdnxl	220	18	of	of	IN
cord-314500-89ovdnxl	220	19	Carbapenem	Carbapenem	NNP
cord-314500-89ovdnxl	220	20	-	-	HYPH
cord-314500-89ovdnxl	220	21	Resistant	Resistant	NNP
cord-314500-89ovdnxl	220	22	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-314500-89ovdnxl	220	23	in	in	IN
cord-314500-89ovdnxl	220	24	7	7	CD
cord-314500-89ovdnxl	220	25	US	US	NNP
cord-314500-89ovdnxl	220	26	Communities	Communities	NNPS
cord-314500-89ovdnxl	221	1	The	the	DT
cord-314500-89ovdnxl	221	2	Example	example	NN
cord-314500-89ovdnxl	221	3	of	of	IN
cord-314500-89ovdnxl	221	4	Dengue	Dengue	NNP
cord-314500-89ovdnxl	221	5	Fever	Fever	NNP
cord-314500-89ovdnxl	221	6	Is	be	VBZ
cord-314500-89ovdnxl	221	7	diabetes	diabetes	NN
cord-314500-89ovdnxl	221	8	a	a	DT
cord-314500-89ovdnxl	221	9	risk	risk	NN
cord-314500-89ovdnxl	221	10	factor	factor	NN
cord-314500-89ovdnxl	221	11	for	for	IN
cord-314500-89ovdnxl	221	12	a	a	DT
cord-314500-89ovdnxl	221	13	severe	severe	JJ
cord-314500-89ovdnxl	221	14	clinical	clinical	JJ
cord-314500-89ovdnxl	221	15	presentation	presentation	NN
cord-314500-89ovdnxl	221	16	of	of	IN
cord-314500-89ovdnxl	221	17	dengue?-review	dengue?-review	NFP
cord-314500-89ovdnxl	221	18	and	and	CC
cord-314500-89ovdnxl	221	19	meta	meta	NNP
cord-314500-89ovdnxl	221	20	-	-	HYPH
cord-314500-89ovdnxl	221	21	analysis	analysis	NN
cord-314500-89ovdnxl	221	22	Clinico	Clinico	NNP
cord-314500-89ovdnxl	221	23	-	-	HYPH
cord-314500-89ovdnxl	221	24	laboratory	laboratory	NN
cord-314500-89ovdnxl	221	25	spectrum	spectrum	NN
cord-314500-89ovdnxl	221	26	of	of	IN
cord-314500-89ovdnxl	221	27	dengue	dengue	NN
cord-314500-89ovdnxl	221	28	viral	viral	JJ
cord-314500-89ovdnxl	221	29	infection	infection	NN
cord-314500-89ovdnxl	221	30	and	and	CC
cord-314500-89ovdnxl	221	31	risk	risk	NN
cord-314500-89ovdnxl	221	32	factors	factor	NNS
cord-314500-89ovdnxl	221	33	associated	associate	VBN
cord-314500-89ovdnxl	221	34	with	with	IN
cord-314500-89ovdnxl	221	35	dengue	dengue	NN
cord-314500-89ovdnxl	221	36	hemorrhagic	hemorrhagic	JJ
cord-314500-89ovdnxl	221	37	fever	fever	NN
cord-314500-89ovdnxl	221	38	:	:	:
cord-314500-89ovdnxl	221	39	a	a	DT
cord-314500-89ovdnxl	221	40	retrospective	retrospective	JJ
cord-314500-89ovdnxl	221	41	study	study	NN
cord-314500-89ovdnxl	221	42	Analysis	analysis	NN
cord-314500-89ovdnxl	221	43	of	of	IN
cord-314500-89ovdnxl	221	44	clinical	clinical	JJ
cord-314500-89ovdnxl	221	45	characteristic	characteristic	NN
cord-314500-89ovdnxl	221	46	of	of	IN
cord-314500-89ovdnxl	221	47	158	158	CD
cord-314500-89ovdnxl	221	48	inpatients	inpatient	NNS
cord-314500-89ovdnxl	221	49	with	with	IN
cord-314500-89ovdnxl	221	50	dengue	dengue	NN
cord-314500-89ovdnxl	221	51	fever	fever	NN
cord-314500-89ovdnxl	221	52	Relevance	relevance	NN
cord-314500-89ovdnxl	221	53	of	of	IN
cord-314500-89ovdnxl	221	54	Non	non	JJ
cord-314500-89ovdnxl	221	55	-	-	JJ
cord-314500-89ovdnxl	221	56	communicable	communicable	JJ
cord-314500-89ovdnxl	221	57	Comorbidities	Comorbidities	NNPS
cord-314500-89ovdnxl	221	58	for	for	IN
cord-314500-89ovdnxl	221	59	the	the	DT
cord-314500-89ovdnxl	221	60	Development	Development	NNP
cord-314500-89ovdnxl	221	61	of	of	IN
cord-314500-89ovdnxl	221	62	the	the	DT
cord-314500-89ovdnxl	221	63	Severe	severe	JJ
cord-314500-89ovdnxl	221	64	Forms	form	NNS
cord-314500-89ovdnxl	221	65	of	of	IN
cord-314500-89ovdnxl	221	66	Dengue	dengue	NN
cord-314500-89ovdnxl	221	67	:	:	:
cord-314500-89ovdnxl	221	68	A	a	DT
cord-314500-89ovdnxl	221	69	Systematic	Systematic	NNP
cord-314500-89ovdnxl	221	70	Literature	literature	NN
cord-314500-89ovdnxl	221	71	Review	review	NN
cord-314500-89ovdnxl	221	72	Prevalence	prevalence	NN
cord-314500-89ovdnxl	221	73	of	of	IN
cord-314500-89ovdnxl	221	74	chronic	chronic	JJ
cord-314500-89ovdnxl	221	75	comorbidities	comorbiditie	NNS
cord-314500-89ovdnxl	221	76	in	in	IN
cord-314500-89ovdnxl	221	77	dengue	dengue	NN
cord-314500-89ovdnxl	221	78	fever	fever	NN
cord-314500-89ovdnxl	221	79	and	and	CC
cord-314500-89ovdnxl	221	80	West	West	NNP
cord-314500-89ovdnxl	221	81	Nile	Nile	NNP
cord-314500-89ovdnxl	221	82	virus	virus	NN
cord-314500-89ovdnxl	221	83	:	:	:
cord-314500-89ovdnxl	221	84	A	a	DT
cord-314500-89ovdnxl	221	85	systematic	systematic	JJ
cord-314500-89ovdnxl	221	86	review	review	NN
cord-314500-89ovdnxl	221	87	and	and	CC
cord-314500-89ovdnxl	221	88	meta	meta	NNP
cord-314500-89ovdnxl	221	89	-	-	HYPH
cord-314500-89ovdnxl	221	90	analysis	analysis	NN
cord-314500-89ovdnxl	221	91	Medical	medical	JJ
cord-314500-89ovdnxl	221	92	risk	risk	NN
cord-314500-89ovdnxl	221	93	factors	factor	NNS
cord-314500-89ovdnxl	221	94	for	for	IN
cord-314500-89ovdnxl	221	95	severe	severe	JJ
cord-314500-89ovdnxl	221	96	West	West	NNP
cord-314500-89ovdnxl	221	97	Nile	Nile	NNP
cord-314500-89ovdnxl	221	98	Virus	Virus	NNP
cord-314500-89ovdnxl	221	99	disease	disease	NN
cord-314500-89ovdnxl	221	100	Chikungunya	Chikungunya	NNP
cord-314500-89ovdnxl	221	101	Virus	virus	NN
cord-314500-89ovdnxl	221	102	Infection	infection	NN
cord-314500-89ovdnxl	221	103	and	and	CC
cord-314500-89ovdnxl	221	104	Diabetes	diabetes	NN
cord-314500-89ovdnxl	221	105	Mellitus	mellitus	NN
cord-314500-89ovdnxl	221	106	:	:	:
cord-314500-89ovdnxl	222	1	A	a	DT
cord-314500-89ovdnxl	222	2	Double	double	JJ
cord-314500-89ovdnxl	222	3	Negative	negative	JJ
cord-314500-89ovdnxl	222	4	Impact	Impact	NNP
cord-314500-89ovdnxl	222	5	Influenza	Influenza	NNP
cord-314500-89ovdnxl	222	6	Virus	Virus	NNP
cord-314500-89ovdnxl	222	7	and	and	CC
cord-314500-89ovdnxl	222	8	Glycemic	Glycemic	NNP
cord-314500-89ovdnxl	222	9	Variability	Variability	NNP
cord-314500-89ovdnxl	222	10	in	in	IN
cord-314500-89ovdnxl	222	11	Diabetes	diabetes	NN
cord-314500-89ovdnxl	222	12	:	:	:
cord-314500-89ovdnxl	222	13	A	a	DT
cord-314500-89ovdnxl	222	14	Killer	killer	NN
cord-314500-89ovdnxl	222	15	Combination	combination	NN
cord-314500-89ovdnxl	222	16	?	?	.
cord-314500-89ovdnxl	223	1	Front	Front	NNP
cord-314500-89ovdnxl	223	2	Microbiol	Microbiol	NNP
cord-314500-89ovdnxl	223	3	Populations	Populations	NNPS
cord-314500-89ovdnxl	223	4	at	at	IN
cord-314500-89ovdnxl	223	5	risk	risk	NN
cord-314500-89ovdnxl	223	6	for	for	IN
cord-314500-89ovdnxl	223	7	severe	severe	JJ
cord-314500-89ovdnxl	223	8	or	or	CC
cord-314500-89ovdnxl	223	9	complicated	complicated	JJ
cord-314500-89ovdnxl	223	10	influenza	influenza	NN
cord-314500-89ovdnxl	223	11	illness	illness	NN
cord-314500-89ovdnxl	223	12	:	:	:
cord-314500-89ovdnxl	223	13	systematic	systematic	JJ
cord-314500-89ovdnxl	223	14	review	review	NN
cord-314500-89ovdnxl	223	15	and	and	CC
cord-314500-89ovdnxl	223	16	meta	meta	NNP
cord-314500-89ovdnxl	223	17	-	-	HYPH
cord-314500-89ovdnxl	223	18	analysis	analysis	NN
cord-314500-89ovdnxl	223	19	World	World	NNP
cord-314500-89ovdnxl	223	20	Health	Health	NNP
cord-314500-89ovdnxl	223	21	Organisation	Organisation	NNP
cord-314500-89ovdnxl	223	22	.	.	.
cord-314500-89ovdnxl	224	1	WHO	who	WP
cord-314500-89ovdnxl	224	2	Hepatitis	Hepatitis	NNP
cord-314500-89ovdnxl	224	3	B	B	NNP
cord-314500-89ovdnxl	224	4	Fact	Fact	NNP
cord-314500-89ovdnxl	224	5	Sheet	Sheet	NNP
cord-314500-89ovdnxl	224	6	Hepatitis	Hepatitis	NNP
cord-314500-89ovdnxl	224	7	B	B	NNP
cord-314500-89ovdnxl	224	8	virus	virus	NN
cord-314500-89ovdnxl	224	9	infection	infection	NN
cord-314500-89ovdnxl	224	10	as	as	IN
cord-314500-89ovdnxl	224	11	a	a	DT
cord-314500-89ovdnxl	224	12	neglected	neglect	VBN
cord-314500-89ovdnxl	224	13	tropical	tropical	JJ
cord-314500-89ovdnxl	224	14	disease	disease	NN
cord-314500-89ovdnxl	224	15	Serological	serological	JJ
cord-314500-89ovdnxl	224	16	and	and	CC
cord-314500-89ovdnxl	224	17	molecular	molecular	JJ
cord-314500-89ovdnxl	224	18	analysis	analysis	NN
cord-314500-89ovdnxl	224	19	on	on	IN
cord-314500-89ovdnxl	224	20	the	the	DT
cord-314500-89ovdnxl	224	21	relationships	relationship	NNS
cord-314500-89ovdnxl	224	22	between	between	IN
cord-314500-89ovdnxl	224	23	type	type	NN
cord-314500-89ovdnxl	224	24	2	2	CD
cord-314500-89ovdnxl	224	25	diabetes	diabetes	NN
cord-314500-89ovdnxl	224	26	mellitus	mellitus	NN
cord-314500-89ovdnxl	224	27	and	and	CC
cord-314500-89ovdnxl	224	28	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	224	29	B	B	NNP
cord-314500-89ovdnxl	224	30	virus	virus	NN
cord-314500-89ovdnxl	224	31	infection	infection	NN
cord-314500-89ovdnxl	225	1	The	the	DT
cord-314500-89ovdnxl	225	2	prevalence	prevalence	NN
cord-314500-89ovdnxl	225	3	of	of	IN
cord-314500-89ovdnxl	225	4	occult	occult	JJ
cord-314500-89ovdnxl	225	5	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	225	6	B	B	NNP
cord-314500-89ovdnxl	225	7	virus	virus	NN
cord-314500-89ovdnxl	225	8	infection	infection	NN
cord-314500-89ovdnxl	225	9	in	in	IN
cord-314500-89ovdnxl	225	10	type	type	NN
cord-314500-89ovdnxl	225	11	2	2	CD
cord-314500-89ovdnxl	225	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	225	13	mellitus	mellitus	NN
cord-314500-89ovdnxl	225	14	patients	patient	NNS
cord-314500-89ovdnxl	225	15	Increased	increase	VBD
cord-314500-89ovdnxl	225	16	risk	risk	NN
cord-314500-89ovdnxl	225	17	of	of	IN
cord-314500-89ovdnxl	225	18	acute	acute	JJ
cord-314500-89ovdnxl	225	19	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	225	20	B	b	NN
cord-314500-89ovdnxl	225	21	among	among	IN
cord-314500-89ovdnxl	225	22	adults	adult	NNS
cord-314500-89ovdnxl	225	23	with	with	IN
cord-314500-89ovdnxl	225	24	diagnosed	diagnosed	JJ
cord-314500-89ovdnxl	225	25	diabetes	diabetes	NN
cord-314500-89ovdnxl	225	26	mellitus	mellitus	NN
cord-314500-89ovdnxl	225	27	Hepatitis	Hepatitis	NNP
cord-314500-89ovdnxl	225	28	B	B	NNP
cord-314500-89ovdnxl	225	29	and	and	CC
cord-314500-89ovdnxl	225	30	C	c	NN
cord-314500-89ovdnxl	225	31	virus	virus	NN
cord-314500-89ovdnxl	225	32	infection	infection	NN
cord-314500-89ovdnxl	225	33	and	and	CC
cord-314500-89ovdnxl	225	34	diabetes	diabetes	NN
cord-314500-89ovdnxl	225	35	mellitus	mellitus	NN
cord-314500-89ovdnxl	225	36	:	:	:
cord-314500-89ovdnxl	226	1	A	a	DT
cord-314500-89ovdnxl	226	2	cohort	cohort	NN
cord-314500-89ovdnxl	226	3	study	study	NN
cord-314500-89ovdnxl	226	4	Prevalence	prevalence	NN
cord-314500-89ovdnxl	226	5	of	of	IN
cord-314500-89ovdnxl	226	6	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	226	7	B	B	NNP
cord-314500-89ovdnxl	226	8	virus	virus	NN
cord-314500-89ovdnxl	226	9	in	in	IN
cord-314500-89ovdnxl	226	10	patients	patient	NNS
cord-314500-89ovdnxl	226	11	with	with	IN
cord-314500-89ovdnxl	226	12	diabetes	diabetes	NN
cord-314500-89ovdnxl	226	13	mellitus	mellitus	NN
cord-314500-89ovdnxl	226	14	:	:	:
cord-314500-89ovdnxl	227	1	a	a	DT
cord-314500-89ovdnxl	227	2	comparative	comparative	JJ
cord-314500-89ovdnxl	227	3	cross	cross	JJ
cord-314500-89ovdnxl	227	4	sectional	sectional	JJ
cord-314500-89ovdnxl	227	5	study	study	NN
cord-314500-89ovdnxl	227	6	at	at	IN
cord-314500-89ovdnxl	227	7	Woldiya	Woldiya	NNP
cord-314500-89ovdnxl	227	8	General	General	NNP
cord-314500-89ovdnxl	227	9	Hospital	Hospital	NNP
cord-314500-89ovdnxl	227	10	,	,	,
cord-314500-89ovdnxl	227	11	Ethiopia	Ethiopia	NNP
cord-314500-89ovdnxl	227	12	Prevalence	prevalence	NN
cord-314500-89ovdnxl	227	13	of	of	IN
cord-314500-89ovdnxl	227	14	serological	serological	JJ
cord-314500-89ovdnxl	227	15	markers	marker	NNS
cord-314500-89ovdnxl	227	16	of	of	IN
cord-314500-89ovdnxl	227	17	chronic	chronic	JJ
cord-314500-89ovdnxl	227	18	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	227	19	B	b	NN
cord-314500-89ovdnxl	227	20	virus	virus	NN
cord-314500-89ovdnxl	227	21	infection	infection	NN
cord-314500-89ovdnxl	227	22	in	in	IN
cord-314500-89ovdnxl	227	23	diabetics	diabetic	NNS
cord-314500-89ovdnxl	227	24	in	in	IN
cord-314500-89ovdnxl	227	25	the	the	DT
cord-314500-89ovdnxl	227	26	Lagos	Lagos	NNP
cord-314500-89ovdnxl	227	27	University	University	NNP
cord-314500-89ovdnxl	227	28	Teaching	Teaching	NNP
cord-314500-89ovdnxl	227	29	Hospital	Hospital	NNP
cord-314500-89ovdnxl	227	30	Diabetes	diabete	VBZ
cord-314500-89ovdnxl	227	31	mellitus	mellitus	NN
cord-314500-89ovdnxl	227	32	as	as	IN
cord-314500-89ovdnxl	227	33	a	a	DT
cord-314500-89ovdnxl	227	34	risk	risk	NN
cord-314500-89ovdnxl	227	35	factor	factor	NN
cord-314500-89ovdnxl	227	36	of	of	IN
cord-314500-89ovdnxl	227	37	liver	liver	NN
cord-314500-89ovdnxl	227	38	cirrhosis	cirrhosis	NN
cord-314500-89ovdnxl	227	39	in	in	IN
cord-314500-89ovdnxl	227	40	patients	patient	NNS
cord-314500-89ovdnxl	227	41	with	with	IN
cord-314500-89ovdnxl	227	42	chronic	chronic	JJ
cord-314500-89ovdnxl	227	43	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	227	44	B	b	NN
cord-314500-89ovdnxl	227	45	virus	virus	NN
cord-314500-89ovdnxl	227	46	infection	infection	NN
cord-314500-89ovdnxl	227	47	Increased	increase	VBD
cord-314500-89ovdnxl	227	48	risk	risk	NN
cord-314500-89ovdnxl	227	49	of	of	IN
cord-314500-89ovdnxl	227	50	cirrhosis	cirrhosis	NN
cord-314500-89ovdnxl	227	51	and	and	CC
cord-314500-89ovdnxl	227	52	its	-PRON-	PRP$
cord-314500-89ovdnxl	227	53	decompensation	decompensation	NN
cord-314500-89ovdnxl	227	54	in	in	IN
cord-314500-89ovdnxl	227	55	chronic	chronic	JJ
cord-314500-89ovdnxl	227	56	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	227	57	B	B	NNP
cord-314500-89ovdnxl	227	58	patients	patient	NNS
cord-314500-89ovdnxl	227	59	with	with	IN
cord-314500-89ovdnxl	227	60	newly	newly	RB
cord-314500-89ovdnxl	227	61	diagnosed	diagnose	VBN
cord-314500-89ovdnxl	227	62	diabetes	diabetes	NN
cord-314500-89ovdnxl	227	63	:	:	:
cord-314500-89ovdnxl	228	1	a	a	DT
cord-314500-89ovdnxl	228	2	nationwide	nationwide	JJ
cord-314500-89ovdnxl	228	3	cohort	cohort	NN
cord-314500-89ovdnxl	228	4	study	study	NN
cord-314500-89ovdnxl	228	5	Increased	increase	VBD
cord-314500-89ovdnxl	228	6	risk	risk	NN
cord-314500-89ovdnxl	228	7	of	of	IN
cord-314500-89ovdnxl	228	8	hepatocellular	hepatocellular	JJ
cord-314500-89ovdnxl	228	9	carcinoma	carcinoma	NN
cord-314500-89ovdnxl	228	10	in	in	IN
cord-314500-89ovdnxl	228	11	chronic	chronic	JJ
cord-314500-89ovdnxl	228	12	hepatitis	hepatitis	NN
cord-314500-89ovdnxl	228	13	B	B	NNP
cord-314500-89ovdnxl	228	14	patients	patient	NNS
cord-314500-89ovdnxl	228	15	with	with	IN
cord-314500-89ovdnxl	228	16	new	new	JJ
cord-314500-89ovdnxl	228	17	onset	onset	NN
cord-314500-89ovdnxl	228	18	diabetes	diabetes	NN
cord-314500-89ovdnxl	228	19	:	:	:
cord-314500-89ovdnxl	228	20	a	a	DT
cord-314500-89ovdnxl	228	21	nationwide	nationwide	JJ
cord-314500-89ovdnxl	228	22	cohort	cohort	NN
cord-314500-89ovdnxl	228	23	study	study	NN
cord-314500-89ovdnxl	228	24	Hepatitis	Hepatitis	NNP
cord-314500-89ovdnxl	228	25	C	C	NNP
cord-314500-89ovdnxl	228	26	virus	virus	NN
cord-314500-89ovdnxl	228	27	infection	infection	NN
cord-314500-89ovdnxl	228	28	and	and	CC
cord-314500-89ovdnxl	228	29	type	type	NN
cord-314500-89ovdnxl	228	30	1	1	CD
cord-314500-89ovdnxl	228	31	and	and	CC
cord-314500-89ovdnxl	228	32	type	type	NN
cord-314500-89ovdnxl	228	33	2	2	CD
cord-314500-89ovdnxl	228	34	diabetes	diabetes	NN
cord-314500-89ovdnxl	228	35	mellitus	mellitus	NN
cord-314500-89ovdnxl	228	36	Risk	Risk	NNP
cord-314500-89ovdnxl	228	37	Factors	Factors	NNP
cord-314500-89ovdnxl	228	38	for	for	IN
cord-314500-89ovdnxl	228	39	Herpes	Herpes	NNP
cord-314500-89ovdnxl	228	40	Zoster	Zoster	NNP
cord-314500-89ovdnxl	228	41	:	:	:
cord-314500-89ovdnxl	229	1	A	a	DT
cord-314500-89ovdnxl	229	2	Systematic	Systematic	NNP
cord-314500-89ovdnxl	229	3	Review	Review	NNP
cord-314500-89ovdnxl	229	4	and	and	CC
cord-314500-89ovdnxl	229	5	Meta	Meta	NNP
cord-314500-89ovdnxl	229	6	-	-	HYPH
cord-314500-89ovdnxl	229	7	analysis	analysis	NN
cord-314500-89ovdnxl	229	8	Diabetes	diabetes	NN
cord-314500-89ovdnxl	229	9	as	as	IN
cord-314500-89ovdnxl	229	10	a	a	DT
cord-314500-89ovdnxl	229	11	Risk	Risk	NNP
cord-314500-89ovdnxl	229	12	Factor	factor	NN
cord-314500-89ovdnxl	229	13	for	for	IN
cord-314500-89ovdnxl	229	14	Herpes	Herpes	NNP
cord-314500-89ovdnxl	229	15	Zoster	Zoster	NNP
cord-314500-89ovdnxl	229	16	Infection	infection	NN
cord-314500-89ovdnxl	229	17	:	:	:
cord-314500-89ovdnxl	229	18	Results	result	NNS
cord-314500-89ovdnxl	229	19	of	of	IN
cord-314500-89ovdnxl	229	20	a	a	DT
cord-314500-89ovdnxl	229	21	Population	population	NN
cord-314500-89ovdnxl	229	22	-	-	HYPH
cord-314500-89ovdnxl	229	23	Based	Based	NNP
cord-314500-89ovdnxl	229	24	Study	Study	NNP
cord-314500-89ovdnxl	229	25	in	in	IN
cord-314500-89ovdnxl	229	26	Israel	Israel	NNP
cord-314500-89ovdnxl	229	27	MERS	MERS	NNP
cord-314500-89ovdnxl	229	28	transmission	transmission	NN
cord-314500-89ovdnxl	229	29	and	and	CC
cord-314500-89ovdnxl	229	30	risk	risk	NN
cord-314500-89ovdnxl	229	31	factors	factor	NNS
cord-314500-89ovdnxl	229	32	:	:	:
cord-314500-89ovdnxl	229	33	a	a	DT
cord-314500-89ovdnxl	229	34	systematic	systematic	JJ
cord-314500-89ovdnxl	229	35	review	review	NN
cord-314500-89ovdnxl	229	36	A	a	DT
cord-314500-89ovdnxl	229	37	comparison	comparison	NN
cord-314500-89ovdnxl	229	38	of	of	IN
cord-314500-89ovdnxl	229	39	factors	factor	NNS
cord-314500-89ovdnxl	229	40	associated	associate	VBN
cord-314500-89ovdnxl	229	41	with	with	IN
cord-314500-89ovdnxl	229	42	prevalent	prevalent	JJ
cord-314500-89ovdnxl	229	43	diabetes	diabetes	NN
cord-314500-89ovdnxl	229	44	mellitus	mellitus	NN
cord-314500-89ovdnxl	229	45	among	among	IN
cord-314500-89ovdnxl	229	46	HIV	HIV	NNP
cord-314500-89ovdnxl	229	47	-	-	HYPH
cord-314500-89ovdnxl	229	48	Infected	infect	VBN
cord-314500-89ovdnxl	229	49	antiretroviralnaive	antiretroviralnaive	JJ
cord-314500-89ovdnxl	229	50	individuals	individual	NNS
cord-314500-89ovdnxl	229	51	versus	versus	IN
cord-314500-89ovdnxl	229	52	individuals	individual	NNS
cord-314500-89ovdnxl	229	53	in	in	IN
cord-314500-89ovdnxl	229	54	the	the	DT
cord-314500-89ovdnxl	229	55	National	National	NNP
cord-314500-89ovdnxl	229	56	Health	Health	NNP
cord-314500-89ovdnxl	229	57	and	and	CC
cord-314500-89ovdnxl	229	58	Nutritional	Nutritional	NNP
cord-314500-89ovdnxl	229	59	Examination	Examination	NNP
cord-314500-89ovdnxl	229	60	Survey	Survey	NNP
cord-314500-89ovdnxl	229	61	cohort	cohort	NN
cord-314500-89ovdnxl	230	1	What	what	WP
cord-314500-89ovdnxl	230	2	We	-PRON-	PRP
cord-314500-89ovdnxl	230	3	Know	know	VBP
cord-314500-89ovdnxl	230	4	From	from	IN
cord-314500-89ovdnxl	230	5	Low	Low	NNP
cord-314500-89ovdnxl	230	6	-	-	:
cord-314500-89ovdnxl	230	7	and	and	CC
cord-314500-89ovdnxl	231	1	Middle	Middle	NNP
cord-314500-89ovdnxl	231	2	-	-	HYPH
cord-314500-89ovdnxl	231	3	Income	Income	NNP
cord-314500-89ovdnxl	231	4	Countries	Countries	NNPS
cord-314500-89ovdnxl	231	5	Risk	Risk	NNP
cord-314500-89ovdnxl	231	6	factors	factor	NNS
cord-314500-89ovdnxl	231	7	for	for	IN
cord-314500-89ovdnxl	231	8	incident	incident	NN
cord-314500-89ovdnxl	231	9	diabetes	diabetes	NN
cord-314500-89ovdnxl	231	10	mellitus	mellitus	NN
cord-314500-89ovdnxl	231	11	among	among	IN
cord-314500-89ovdnxl	231	12	HIV	HIV	NNP
cord-314500-89ovdnxl	231	13	-	-	HYPH
cord-314500-89ovdnxl	231	14	infected	infect	VBN
cord-314500-89ovdnxl	231	15	patients	patient	NNS
cord-314500-89ovdnxl	231	16	receiving	receive	VBG
cord-314500-89ovdnxl	231	17	combination	combination	NN
cord-314500-89ovdnxl	231	18	antiretroviral	antiretroviral	JJ
cord-314500-89ovdnxl	231	19	therapy	therapy	NN
cord-314500-89ovdnxl	231	20	in	in	IN
cord-314500-89ovdnxl	231	21	Taiwan	Taiwan	NNP
cord-314500-89ovdnxl	231	22	:	:	:
cord-314500-89ovdnxl	231	23	a	a	DT
cord-314500-89ovdnxl	231	24	case	case	NN
cord-314500-89ovdnxl	231	25	-	-	HYPH
cord-314500-89ovdnxl	231	26	control	control	NN
cord-314500-89ovdnxl	231	27	study	study	NN
cord-314500-89ovdnxl	231	28	New	new	JJ
cord-314500-89ovdnxl	231	29	-	-	HYPH
cord-314500-89ovdnxl	231	30	onset	onset	NN
cord-314500-89ovdnxl	231	31	diabetes	diabetes	NN
cord-314500-89ovdnxl	231	32	in	in	IN
cord-314500-89ovdnxl	231	33	HIV	HIV	NNP
cord-314500-89ovdnxl	231	34	-	-	HYPH
cord-314500-89ovdnxl	231	35	treated	treat	VBN
cord-314500-89ovdnxl	231	36	adults	adult	NNS
cord-314500-89ovdnxl	231	37	:	:	:
cord-314500-89ovdnxl	231	38	predictors	predictor	NNS
cord-314500-89ovdnxl	231	39	,	,	,
cord-314500-89ovdnxl	231	40	long	long	JJ
cord-314500-89ovdnxl	231	41	-	-	HYPH
cord-314500-89ovdnxl	231	42	term	term	NN
cord-314500-89ovdnxl	231	43	renal	renal	JJ
cord-314500-89ovdnxl	231	44	and	and	CC
cord-314500-89ovdnxl	231	45	cardiovascular	cardiovascular	JJ
cord-314500-89ovdnxl	231	46	outcomes	outcome	NNS
cord-314500-89ovdnxl	231	47	Changes	change	NNS
cord-314500-89ovdnxl	231	48	in	in	IN
cord-314500-89ovdnxl	231	49	blood	blood	NN
cord-314500-89ovdnxl	231	50	pressure	pressure	NN
cord-314500-89ovdnxl	231	51	,	,	,
cord-314500-89ovdnxl	231	52	glucose	glucose	NN
cord-314500-89ovdnxl	231	53	levels	level	NNS
cord-314500-89ovdnxl	231	54	,	,	,
cord-314500-89ovdnxl	231	55	insulin	insulin	NN
cord-314500-89ovdnxl	231	56	secretion	secretion	NN
cord-314500-89ovdnxl	231	57	and	and	CC
cord-314500-89ovdnxl	231	58	anthropometry	anthropometry	NN
cord-314500-89ovdnxl	231	59	after	after	IN
cord-314500-89ovdnxl	231	60	long	long	JJ
cord-314500-89ovdnxl	231	61	term	term	NN
cord-314500-89ovdnxl	231	62	exposure	exposure	NN
cord-314500-89ovdnxl	231	63	to	to	IN
cord-314500-89ovdnxl	231	64	antiretroviral	antiretroviral	JJ
cord-314500-89ovdnxl	231	65	therapy	therapy	NN
cord-314500-89ovdnxl	231	66	in	in	IN
cord-314500-89ovdnxl	231	67	South	south	JJ
cord-314500-89ovdnxl	231	68	African	african	JJ
cord-314500-89ovdnxl	231	69	women	woman	NNS
cord-314500-89ovdnxl	231	70	Glucose	glucose	VBP
cord-314500-89ovdnxl	231	71	Metabolism	metabolism	NN
cord-314500-89ovdnxl	231	72	Disorders	Disorders	NNPS
cord-314500-89ovdnxl	231	73	,	,	,
cord-314500-89ovdnxl	231	74	HIV	HIV	NNP
cord-314500-89ovdnxl	231	75	and	and	CC
cord-314500-89ovdnxl	231	76	Antiretroviral	Antiretroviral	NNP
cord-314500-89ovdnxl	231	77	Therapy	Therapy	NNP
cord-314500-89ovdnxl	231	78	among	among	IN
cord-314500-89ovdnxl	231	79	Tanzanian	Tanzanian	NNP
cord-314500-89ovdnxl	231	80	Adults	Adults	NNPS
cord-314500-89ovdnxl	231	81	Type	Type	NNP
cord-314500-89ovdnxl	231	82	2	2	CD
cord-314500-89ovdnxl	231	83	diabetes	diabetes	NN
cord-314500-89ovdnxl	231	84	mellitus	mellitus	NN
cord-314500-89ovdnxl	231	85	and	and	CC
cord-314500-89ovdnxl	231	86	increased	increase	VBN
cord-314500-89ovdnxl	231	87	risk	risk	NN
cord-314500-89ovdnxl	231	88	for	for	IN
cord-314500-89ovdnxl	231	89	malaria	malaria	NN
cord-314500-89ovdnxl	231	90	infection	infection	NN
cord-314500-89ovdnxl	231	91	Epidemiology	Epidemiology	NNP
cord-314500-89ovdnxl	231	92	of	of	IN
cord-314500-89ovdnxl	231	93	Plasmodium	Plasmodium	NNP
cord-314500-89ovdnxl	231	94	vivax	vivax	NN
cord-314500-89ovdnxl	231	95	Malaria	Malaria	NNP
cord-314500-89ovdnxl	231	96	in	in	IN
cord-314500-89ovdnxl	231	97	India	India	NNP
cord-314500-89ovdnxl	231	98	Risk	Risk	NNP
cord-314500-89ovdnxl	231	99	factors	factor	NNS
cord-314500-89ovdnxl	231	100	for	for	IN
cord-314500-89ovdnxl	231	101	anthroponotic	anthroponotic	JJ
cord-314500-89ovdnxl	231	102	cutaneous	cutaneous	JJ
cord-314500-89ovdnxl	231	103	leishmaniasis	leishmaniasis	NN
cord-314500-89ovdnxl	231	104	in	in	IN
cord-314500-89ovdnxl	231	105	unresponsive	unresponsive	JJ
cord-314500-89ovdnxl	231	106	and	and	CC
cord-314500-89ovdnxl	231	107	responsive	responsive	JJ
cord-314500-89ovdnxl	231	108	patients	patient	NNS
cord-314500-89ovdnxl	231	109	in	in	IN
cord-314500-89ovdnxl	231	110	a	a	DT
cord-314500-89ovdnxl	231	111	major	major	JJ
cord-314500-89ovdnxl	231	112	focus	focus	NN
cord-314500-89ovdnxl	231	113	,	,	,
cord-314500-89ovdnxl	231	114	southeast	southeast	NN
cord-314500-89ovdnxl	231	115	of	of	IN
cord-314500-89ovdnxl	231	116	Iran	Iran	NNP
cord-314500-89ovdnxl	231	117	Reinfestation	Reinfestation	NNP
cord-314500-89ovdnxl	231	118	in	in	IN
cord-314500-89ovdnxl	231	119	cutaneous	cutaneous	JJ
cord-314500-89ovdnxl	231	120	leishmaniasis	leishmaniasis	NN
cord-314500-89ovdnxl	231	121	:	:	:
cord-314500-89ovdnxl	231	122	a	a	DT
cord-314500-89ovdnxl	231	123	new	new	JJ
cord-314500-89ovdnxl	231	124	look	look	NN
cord-314500-89ovdnxl	231	125	at	at	IN
cord-314500-89ovdnxl	231	126	predisposing	predispose	VBG
cord-314500-89ovdnxl	231	127	conditions	condition	NNS
cord-314500-89ovdnxl	231	128	Visceral	visceral	JJ
cord-314500-89ovdnxl	231	129	leishmaniasis	leishmaniasis	NN
cord-314500-89ovdnxl	231	130	:	:	:
cord-314500-89ovdnxl	231	131	a	a	DT
cord-314500-89ovdnxl	231	132	threat	threat	NN
cord-314500-89ovdnxl	231	133	to	to	IN
cord-314500-89ovdnxl	231	134	immunocompromised	immunocompromised	JJ
cord-314500-89ovdnxl	231	135	patients	patient	NNS
cord-314500-89ovdnxl	231	136	in	in	IN
cord-314500-89ovdnxl	231	137	non	non	JJ
cord-314500-89ovdnxl	231	138	-	-	JJ
cord-314500-89ovdnxl	231	139	endemic	endemic	JJ
cord-314500-89ovdnxl	231	140	areas	area	NNS
cord-314500-89ovdnxl	231	141	?	?	.
cord-314500-89ovdnxl	232	1	Freqüência	Freqüência	NNP
cord-314500-89ovdnxl	232	2	de	de	IN
cord-314500-89ovdnxl	232	3	diabetes	diabetes	NN
cord-314500-89ovdnxl	233	1	mellitus	mellitus	NN
cord-314500-89ovdnxl	233	2	e	e	NN
cord-314500-89ovdnxl	233	3	hiperglicemia	hiperglicemia	NN
cord-314500-89ovdnxl	233	4	em	-PRON-	PRP
cord-314500-89ovdnxl	234	1	mulheres	mulhere	NNS
cord-314500-89ovdnxl	235	1	chagásicas	chagásicas	NNP
cord-314500-89ovdnxl	235	2	e	e	NNP
cord-314500-89ovdnxl	235	3	não	não	NNP
cord-314500-89ovdnxl	235	4	-	-	HYPH
cord-314500-89ovdnxl	235	5	chagásicas	chagásicas	NNP
cord-314500-89ovdnxl	236	1	The	the	DT
cord-314500-89ovdnxl	236	2	global	global	JJ
cord-314500-89ovdnxl	236	3	diabetes	diabetes	NN
cord-314500-89ovdnxl	236	4	epidemic	epidemic	NN
cord-314500-89ovdnxl	236	5	:	:	:
cord-314500-89ovdnxl	236	6	what	what	WP
cord-314500-89ovdnxl	236	7	does	do	VBZ
cord-314500-89ovdnxl	236	8	it	-PRON-	PRP
cord-314500-89ovdnxl	236	9	mean	mean	VB
cord-314500-89ovdnxl	236	10	for	for	IN
cord-314500-89ovdnxl	236	11	infectious	infectious	JJ
cord-314500-89ovdnxl	236	12	diseases	disease	NNS
cord-314500-89ovdnxl	236	13	in	in	IN
cord-314500-89ovdnxl	236	14	tropical	tropical	JJ
cord-314500-89ovdnxl	236	15	countries	country	NNS
cord-314500-89ovdnxl	236	16	?	?	.
cord-314500-89ovdnxl	237	1	Parasitic	parasitic	JJ
cord-314500-89ovdnxl	237	2	helminths	helminth	NNS
cord-314500-89ovdnxl	237	3	and	and	CC
cord-314500-89ovdnxl	237	4	their	-PRON-	PRP$
cord-314500-89ovdnxl	237	5	beneficial	beneficial	JJ
cord-314500-89ovdnxl	237	6	impact	impact	NN
cord-314500-89ovdnxl	237	7	on	on	IN
cord-314500-89ovdnxl	237	8	type	type	NN
cord-314500-89ovdnxl	237	9	1	1	CD
cord-314500-89ovdnxl	237	10	and	and	CC
cord-314500-89ovdnxl	237	11	type	type	NN
cord-314500-89ovdnxl	237	12	2	2	CD
cord-314500-89ovdnxl	237	13	diabetes	diabetes	NN
cord-314500-89ovdnxl	237	14	Chronic	chronic	JJ
cord-314500-89ovdnxl	237	15	helminth	helminth	JJ
cord-314500-89ovdnxl	237	16	infection	infection	NN
cord-314500-89ovdnxl	237	17	and	and	CC
cord-314500-89ovdnxl	237	18	helminth	helminth	NN
cord-314500-89ovdnxl	237	19	-	-	HYPH
cord-314500-89ovdnxl	237	20	derived	derive	VBN
cord-314500-89ovdnxl	237	21	egg	egg	NN
cord-314500-89ovdnxl	237	22	antigens	antigen	NNS
cord-314500-89ovdnxl	237	23	promote	promote	VBP
cord-314500-89ovdnxl	237	24	adipose	adipose	JJ
cord-314500-89ovdnxl	237	25	tissue	tissue	NN
cord-314500-89ovdnxl	237	26	Transactions	transaction	NNS
cord-314500-89ovdnxl	237	27	of	of	IN
cord-314500-89ovdnxl	237	28	the	the	DT
cord-314500-89ovdnxl	237	29	Royal	Royal	NNP
cord-314500-89ovdnxl	237	30	Society	Society	NNP
cord-314500-89ovdnxl	237	31	of	of	IN
cord-314500-89ovdnxl	237	32	Tropical	Tropical	NNP
cord-314500-89ovdnxl	237	33	Medicine	Medicine	NNP
cord-314500-89ovdnxl	237	34	and	and	CC
cord-314500-89ovdnxl	237	35	Hygiene	Hygiene	NNP
cord-314500-89ovdnxl	237	36	M2	M2	NNP
cord-314500-89ovdnxl	237	37	macrophages	macrophage	NNS
cord-314500-89ovdnxl	237	38	and	and	CC
cord-314500-89ovdnxl	237	39	improve	improve	VB
cord-314500-89ovdnxl	237	40	insulin	insulin	NN
cord-314500-89ovdnxl	237	41	sensitivity	sensitivity	NN
cord-314500-89ovdnxl	237	42	in	in	IN
cord-314500-89ovdnxl	237	43	obese	obese	JJ
cord-314500-89ovdnxl	237	44	mice	mouse	NNS
cord-314500-89ovdnxl	238	1	Schistosoma	Schistosoma	NNP
cord-314500-89ovdnxl	238	2	Infection	Infection	NNP
cord-314500-89ovdnxl	238	3	and	and	CC
cord-314500-89ovdnxl	238	4	Schistosoma	Schistosoma	NNP
cord-314500-89ovdnxl	238	5	-	-	HYPH
cord-314500-89ovdnxl	238	6	Derived	derive	VBN
cord-314500-89ovdnxl	238	7	Products	product	NNS
cord-314500-89ovdnxl	238	8	Modulate	modulate	VBP
cord-314500-89ovdnxl	238	9	the	the	DT
cord-314500-89ovdnxl	238	10	Immune	Immune	NNP
cord-314500-89ovdnxl	238	11	Responses	response	NNS
cord-314500-89ovdnxl	238	12	Associated	Associated	NNP
cord-314500-89ovdnxl	238	13	with	with	IN
cord-314500-89ovdnxl	238	14	Protection	Protection	NNP
cord-314500-89ovdnxl	238	15	against	against	IN
cord-314500-89ovdnxl	238	16	Type	Type	NNP
cord-314500-89ovdnxl	238	17	2	2	CD
cord-314500-89ovdnxl	238	18	Diabetes	Diabetes	NNP
cord-314500-89ovdnxl	238	19	Helminth	Helminth	NNP
cord-314500-89ovdnxl	238	20	infections	infection	NNS
cord-314500-89ovdnxl	238	21	and	and	CC
cord-314500-89ovdnxl	238	22	type	type	NN
cord-314500-89ovdnxl	238	23	2	2	CD
cord-314500-89ovdnxl	238	24	diabetes	diabetes	NN
cord-314500-89ovdnxl	238	25	:	:	:
cord-314500-89ovdnxl	238	26	a	a	DT
cord-314500-89ovdnxl	238	27	cluster	cluster	NN
cord-314500-89ovdnxl	238	28	-	-	HYPH
cord-314500-89ovdnxl	238	29	randomized	randomized	JJ
cord-314500-89ovdnxl	238	30	placebo	placebo	NN
cord-314500-89ovdnxl	238	31	controlled	control	VBN
cord-314500-89ovdnxl	238	32	SUGARSPIN	SUGARSPIN	NNP
cord-314500-89ovdnxl	238	33	trial	trial	NN
cord-314500-89ovdnxl	238	34	in	in	IN
cord-314500-89ovdnxl	238	35	Nangapanda	Nangapanda	NNP
cord-314500-89ovdnxl	238	36	Nasal	Nasal	NNP
cord-314500-89ovdnxl	238	37	colonization	colonization	NN
cord-314500-89ovdnxl	238	38	with	with	IN
cord-314500-89ovdnxl	238	39	Staphylococcus	Staphylococcus	NNP
cord-314500-89ovdnxl	238	40	aureus	aureus	NN
cord-314500-89ovdnxl	238	41	in	in	IN
cord-314500-89ovdnxl	238	42	patients	patient	NNS
cord-314500-89ovdnxl	238	43	with	with	IN
cord-314500-89ovdnxl	238	44	diabetes	diabetes	NN
cord-314500-89ovdnxl	238	45	mellitus	mellitus	NN
cord-314500-89ovdnxl	238	46	Disentangling	disentangle	VBG
cord-314500-89ovdnxl	238	47	type	type	NN
cord-314500-89ovdnxl	238	48	2	2	CD
cord-314500-89ovdnxl	238	49	diabetes	diabete	NNS
cord-314500-89ovdnxl	238	50	and	and	CC
cord-314500-89ovdnxl	238	51	metformin	metformin	NNP
cord-314500-89ovdnxl	238	52	treatment	treatment	NN
cord-314500-89ovdnxl	238	53	signatures	signature	NNS
cord-314500-89ovdnxl	238	54	in	in	IN
cord-314500-89ovdnxl	238	55	the	the	DT
cord-314500-89ovdnxl	238	56	human	human	JJ
cord-314500-89ovdnxl	238	57	gut	gut	NN
cord-314500-89ovdnxl	238	58	microbiota	microbiota	NN
cord-314500-89ovdnxl	238	59	Interactions	interaction	NNS
cord-314500-89ovdnxl	238	60	Between	between	IN
cord-314500-89ovdnxl	238	61	the	the	DT
cord-314500-89ovdnxl	238	62	Microbiota	Microbiota	NNP
cord-314500-89ovdnxl	238	63	and	and	CC
cord-314500-89ovdnxl	238	64	the	the	DT
cord-314500-89ovdnxl	238	65	Immune	Immune	NNP
cord-314500-89ovdnxl	238	66	System	System	NNP
cord-314500-89ovdnxl	239	1	The	the	DT
cord-314500-89ovdnxl	239	2	effect	effect	NN
cord-314500-89ovdnxl	239	3	of	of	IN
cord-314500-89ovdnxl	239	4	hyperglycaemia	hyperglycaemia	NN
cord-314500-89ovdnxl	239	5	on	on	IN
cord-314500-89ovdnxl	239	6	in	in	IN
cord-314500-89ovdnxl	239	7	vitro	vitro	FW
cord-314500-89ovdnxl	239	8	cytokine	cytokine	JJ
cord-314500-89ovdnxl	239	9	production	production	NN
cord-314500-89ovdnxl	239	10	and	and	CC
cord-314500-89ovdnxl	239	11	macrophage	macrophage	NN
cord-314500-89ovdnxl	239	12	infection	infection	NN
cord-314500-89ovdnxl	239	13	with	with	IN
cord-314500-89ovdnxl	239	14	Mycobacterium	Mycobacterium	NNP
cord-314500-89ovdnxl	239	15	tuberculosis	tuberculosis	NN
cord-314500-89ovdnxl	239	16	Cellular	cellular	JJ
cord-314500-89ovdnxl	239	17	and	and	CC
cord-314500-89ovdnxl	239	18	molecular	molecular	JJ
cord-314500-89ovdnxl	239	19	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	239	20	of	of	IN
cord-314500-89ovdnxl	239	21	endothelial	endothelial	JJ
cord-314500-89ovdnxl	239	22	dysfunction	dysfunction	NN
cord-314500-89ovdnxl	239	23	in	in	IN
cord-314500-89ovdnxl	239	24	diabetes	diabetes	NN
cord-314500-89ovdnxl	240	1	Chronic	chronic	JJ
cord-314500-89ovdnxl	240	2	granulomatous	granulomatous	JJ
cord-314500-89ovdnxl	240	3	disease	disease	NN
cord-314500-89ovdnxl	240	4	Human	human	JJ
cord-314500-89ovdnxl	240	5	polymorphonuclear	polymorphonuclear	NN
cord-314500-89ovdnxl	240	6	neutrophil	neutrophil	NN
cord-314500-89ovdnxl	240	7	responses	response	NNS
cord-314500-89ovdnxl	240	8	to	to	IN
cord-314500-89ovdnxl	240	9	Burkholderia	Burkholderia	NNP
cord-314500-89ovdnxl	240	10	pseudomallei	pseudomallei	NN
cord-314500-89ovdnxl	240	11	in	in	IN
cord-314500-89ovdnxl	240	12	healthy	healthy	JJ
cord-314500-89ovdnxl	240	13	and	and	CC
cord-314500-89ovdnxl	240	14	diabetic	diabetic	JJ
cord-314500-89ovdnxl	240	15	subjects	subject	NNS
cord-314500-89ovdnxl	240	16	Effects	effect	NNS
cord-314500-89ovdnxl	240	17	of	of	IN
cord-314500-89ovdnxl	240	18	Risk	Risk	NNP
cord-314500-89ovdnxl	240	19	Factors	Factors	NNP
cord-314500-89ovdnxl	240	20	on	on	IN
cord-314500-89ovdnxl	240	21	Anti	Anti	NNP
cord-314500-89ovdnxl	240	22	-	-	NNP
cord-314500-89ovdnxl	240	23	HBs	HBs	NNP
cord-314500-89ovdnxl	240	24	Development	Development	NNP
cord-314500-89ovdnxl	240	25	in	in	IN
cord-314500-89ovdnxl	240	26	Hepatitis	Hepatitis	NNP
cord-314500-89ovdnxl	240	27	B	B	NNP
cord-314500-89ovdnxl	241	1	Vaccinated	vaccinated	JJ
cord-314500-89ovdnxl	241	2	and	and	CC
cord-314500-89ovdnxl	241	3	Nonvaccinated	Nonvaccinated	NNP
cord-314500-89ovdnxl	241	4	Populations	Populations	NNPS
cord-314500-89ovdnxl	242	1	Prospective	prospective	JJ
cord-314500-89ovdnxl	242	2	clinical	clinical	JJ
cord-314500-89ovdnxl	242	3	trial	trial	NN
cord-314500-89ovdnxl	242	4	of	of	IN
cord-314500-89ovdnxl	242	5	hepatitis	hepatitis	NNP
cord-314500-89ovdnxl	242	6	B	B	NNP
cord-314500-89ovdnxl	242	7	vaccination	vaccination	NN
cord-314500-89ovdnxl	242	8	in	in	IN
cord-314500-89ovdnxl	242	9	adults	adult	NNS
cord-314500-89ovdnxl	242	10	with	with	IN
cord-314500-89ovdnxl	242	11	and	and	CC
cord-314500-89ovdnxl	242	12	without	without	IN
cord-314500-89ovdnxl	242	13	type-2	type-2	NN
cord-314500-89ovdnxl	242	14	diabetes	diabetes	NN
cord-314500-89ovdnxl	242	15	mellitus	mellitus	NN
cord-314500-89ovdnxl	242	16	Safety	Safety	NNP
cord-314500-89ovdnxl	242	17	,	,	,
cord-314500-89ovdnxl	242	18	humoral	humoral	JJ
cord-314500-89ovdnxl	242	19	and	and	CC
cord-314500-89ovdnxl	242	20	cellmediated	cellmediate	VBN
cord-314500-89ovdnxl	242	21	immune	immune	JJ
cord-314500-89ovdnxl	242	22	responses	response	NNS
cord-314500-89ovdnxl	242	23	to	to	IN
cord-314500-89ovdnxl	242	24	herpes	herpes	NNP
cord-314500-89ovdnxl	242	25	zoster	zoster	NNP
cord-314500-89ovdnxl	242	26	vaccine	vaccine	NN
cord-314500-89ovdnxl	242	27	in	in	IN
cord-314500-89ovdnxl	242	28	subjects	subject	NNS
cord-314500-89ovdnxl	242	29	with	with	IN
cord-314500-89ovdnxl	242	30	diabetes	diabetes	NN
cord-314500-89ovdnxl	242	31	mellitus	mellitus	NN
cord-314500-89ovdnxl	242	32	Young	young	JJ
cord-314500-89ovdnxl	242	33	and	and	CC
cord-314500-89ovdnxl	242	34	elderly	elderly	JJ
cord-314500-89ovdnxl	242	35	patients	patient	NNS
cord-314500-89ovdnxl	242	36	with	with	IN
cord-314500-89ovdnxl	242	37	type	type	NN
cord-314500-89ovdnxl	242	38	2	2	CD
cord-314500-89ovdnxl	242	39	diabetes	diabete	NNS
cord-314500-89ovdnxl	242	40	have	have	VBP
cord-314500-89ovdnxl	242	41	optimal	optimal	JJ
cord-314500-89ovdnxl	242	42	B	b	NN
cord-314500-89ovdnxl	242	43	cell	cell	NN
cord-314500-89ovdnxl	242	44	responses	response	NNS
cord-314500-89ovdnxl	242	45	to	to	IN
cord-314500-89ovdnxl	242	46	the	the	DT
cord-314500-89ovdnxl	242	47	seasonal	seasonal	JJ
cord-314500-89ovdnxl	242	48	influenza	influenza	NN
cord-314500-89ovdnxl	242	49	vaccine	vaccine	NN
cord-314500-89ovdnxl	242	50	Antibodies	Antibodies	NNP
cord-314500-89ovdnxl	242	51	in	in	IN
cord-314500-89ovdnxl	242	52	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	242	53	:	:	:
cord-314500-89ovdnxl	243	1	The	the	DT
cord-314500-89ovdnxl	243	2	Role	role	NN
cord-314500-89ovdnxl	243	3	of	of	IN
cord-314500-89ovdnxl	243	4	the	the	DT
cord-314500-89ovdnxl	243	5	Indirect	Indirect	NNP
cord-314500-89ovdnxl	243	6	Hemagglutination	Hemagglutination	NNP
cord-314500-89ovdnxl	243	7	Assay	Assay	NNP
cord-314500-89ovdnxl	243	8	in	in	IN
cord-314500-89ovdnxl	243	9	Evaluating	evaluate	VBG
cord-314500-89ovdnxl	243	10	Patients	Patients	NNPS
cord-314500-89ovdnxl	243	11	and	and	CC
cord-314500-89ovdnxl	243	12	Exposed	Exposed	NNP
cord-314500-89ovdnxl	243	13	Populations	Populations	NNPS
cord-314500-89ovdnxl	243	14	Elevated	Elevated	NNP
cord-314500-89ovdnxl	243	15	B	B	NNP
cord-314500-89ovdnxl	243	16	Cell	cell	NN
cord-314500-89ovdnxl	243	17	Activation	Activation	NNP
cord-314500-89ovdnxl	243	18	is	be	VBZ
cord-314500-89ovdnxl	243	19	Associated	associate	VBN
cord-314500-89ovdnxl	243	20	with	with	IN
cord-314500-89ovdnxl	243	21	Type	type	NN
cord-314500-89ovdnxl	243	22	2	2	CD
cord-314500-89ovdnxl	243	23	Diabetes	diabetes	NN
cord-314500-89ovdnxl	243	24	Development	development	NN
cord-314500-89ovdnxl	243	25	in	in	IN
cord-314500-89ovdnxl	243	26	Obese	obese	JJ
cord-314500-89ovdnxl	243	27	Subjects	subject	NNS
cord-314500-89ovdnxl	243	28	Immunological	immunological	JJ
cord-314500-89ovdnxl	243	29	mechanisms	mechanism	NNS
cord-314500-89ovdnxl	243	30	contributing	contribute	VBG
cord-314500-89ovdnxl	243	31	to	to	IN
cord-314500-89ovdnxl	243	32	the	the	DT
cord-314500-89ovdnxl	243	33	double	double	JJ
cord-314500-89ovdnxl	243	34	burden	burden	NN
cord-314500-89ovdnxl	243	35	of	of	IN
cord-314500-89ovdnxl	243	36	diabetes	diabetes	NN
cord-314500-89ovdnxl	243	37	and	and	CC
cord-314500-89ovdnxl	243	38	intracellular	intracellular	JJ
cord-314500-89ovdnxl	243	39	bacterial	bacterial	JJ
cord-314500-89ovdnxl	243	40	infections	infection	NNS
cord-314500-89ovdnxl	243	41	Comparison	comparison	NN
cord-314500-89ovdnxl	243	42	of	of	IN
cord-314500-89ovdnxl	243	43	Varicella	varicella	NN
cord-314500-89ovdnxl	243	44	-	-	HYPH
cord-314500-89ovdnxl	243	45	Zoster	Zoster	NNP
cord-314500-89ovdnxl	243	46	Virus	virus	NN
cord-314500-89ovdnxl	243	47	-	-	HYPH
cord-314500-89ovdnxl	243	48	Specific	specific	JJ
cord-314500-89ovdnxl	243	49	Immunity	immunity	NN
cord-314500-89ovdnxl	243	50	of	of	IN
cord-314500-89ovdnxl	243	51	Patients	patient	NNS
cord-314500-89ovdnxl	243	52	with	with	IN
cord-314500-89ovdnxl	243	53	Diabetes	diabetes	NN
cord-314500-89ovdnxl	243	54	Mellitus	Mellitus	NNP
cord-314500-89ovdnxl	243	55	and	and	CC
cord-314500-89ovdnxl	243	56	Healthy	Healthy	NNP
cord-314500-89ovdnxl	243	57	Individuals	Individuals	NNPS
cord-314500-89ovdnxl	243	58	Increased	increase	VBD
cord-314500-89ovdnxl	243	59	Production	production	NN
cord-314500-89ovdnxl	243	60	of	of	IN
cord-314500-89ovdnxl	243	61	Interleukin-4	Interleukin-4	NNP
cord-314500-89ovdnxl	243	62	,	,	,
cord-314500-89ovdnxl	243	63	Interleukin-10	interleukin-10	NN
cord-314500-89ovdnxl	243	64	,	,	,
cord-314500-89ovdnxl	243	65	and	and	CC
cord-314500-89ovdnxl	244	1	Granulocyte	Granulocyte	NNP
cord-314500-89ovdnxl	244	2	-	-	HYPH
cord-314500-89ovdnxl	244	3	Macrophage	Macrophage	NNP
cord-314500-89ovdnxl	244	4	Colony	Colony	NNP
cord-314500-89ovdnxl	244	5	-	-	HYPH
cord-314500-89ovdnxl	244	6	Stimulating	stimulate	VBG
cord-314500-89ovdnxl	244	7	Factor	factor	NN
cord-314500-89ovdnxl	244	8	by	by	IN
cord-314500-89ovdnxl	244	9	Type	type	NN
cord-314500-89ovdnxl	244	10	2	2	CD
cord-314500-89ovdnxl	244	11	Diabetes	diabetes	NN
cord-314500-89ovdnxl	245	1	'	'	``
cord-314500-89ovdnxl	245	2	Mononuclear	Mononuclear	NNP
cord-314500-89ovdnxl	245	3	Cells	cell	NNS
cord-314500-89ovdnxl	245	4	Infected	infect	VBN
cord-314500-89ovdnxl	245	5	with	with	IN
cord-314500-89ovdnxl	245	6	Dengue	Dengue	NNP
cord-314500-89ovdnxl	245	7	Virus	Virus	NNP
cord-314500-89ovdnxl	245	8	,	,	,
cord-314500-89ovdnxl	245	9	but	but	CC
cord-314500-89ovdnxl	245	10	Not	not	RB
cord-314500-89ovdnxl	245	11	Increased	increase	VBN
cord-314500-89ovdnxl	245	12	Intracellular	Intracellular	NNP
cord-314500-89ovdnxl	245	13	Viral	Viral	NNP
cord-314500-89ovdnxl	245	14	Multiplication	multiplication	NN
cord-314500-89ovdnxl	246	1	The	the	DT
cord-314500-89ovdnxl	246	2	impact	impact	NN
cord-314500-89ovdnxl	246	3	of	of	IN
cord-314500-89ovdnxl	246	4	diabetes	diabetes	NN
cord-314500-89ovdnxl	246	5	on	on	IN
cord-314500-89ovdnxl	246	6	the	the	DT
cord-314500-89ovdnxl	246	7	pathogenesis	pathogenesis	NN
cord-314500-89ovdnxl	246	8	of	of	IN
cord-314500-89ovdnxl	246	9	sepsis	sepsis	NN
cord-314500-89ovdnxl	246	10	Hyperglycemia	hyperglycemia	NN
cord-314500-89ovdnxl	246	11	in	in	IN
cord-314500-89ovdnxl	246	12	sepsis	sepsis	NN
cord-314500-89ovdnxl	246	13	is	be	VBZ
cord-314500-89ovdnxl	246	14	a	a	DT
cord-314500-89ovdnxl	246	15	risk	risk	NN
cord-314500-89ovdnxl	246	16	factor	factor	NN
cord-314500-89ovdnxl	246	17	for	for	IN
cord-314500-89ovdnxl	246	18	development	development	NN
cord-314500-89ovdnxl	246	19	of	of	IN
cord-314500-89ovdnxl	246	20	type	type	NN
cord-314500-89ovdnxl	246	21	II	ii	CD
cord-314500-89ovdnxl	246	22	diabetes	diabetes	NN
cord-314500-89ovdnxl	246	23	Metformin	Metformin	NNP
cord-314500-89ovdnxl	246	24	and	and	CC
cord-314500-89ovdnxl	246	25	other	other	JJ
cord-314500-89ovdnxl	246	26	glucoselowering	glucoselowering	NN
cord-314500-89ovdnxl	246	27	drug	drug	NN
cord-314500-89ovdnxl	246	28	initiation	initiation	NN
cord-314500-89ovdnxl	246	29	and	and	CC
cord-314500-89ovdnxl	246	30	rates	rate	NNS
cord-314500-89ovdnxl	246	31	of	of	IN
cord-314500-89ovdnxl	246	32	community	community	NN
cord-314500-89ovdnxl	246	33	-	-	HYPH
cord-314500-89ovdnxl	246	34	based	base	VBN
cord-314500-89ovdnxl	246	35	antibiotic	antibiotic	JJ
cord-314500-89ovdnxl	246	36	use	use	NN
cord-314500-89ovdnxl	246	37	and	and	CC
cord-314500-89ovdnxl	246	38	hospital	hospital	NN
cord-314500-89ovdnxl	246	39	-	-	HYPH
cord-314500-89ovdnxl	246	40	treated	treat	VBN
cord-314500-89ovdnxl	246	41	infections	infection	NNS
cord-314500-89ovdnxl	246	42	in	in	IN
cord-314500-89ovdnxl	246	43	patients	patient	NNS
cord-314500-89ovdnxl	246	44	with	with	IN
cord-314500-89ovdnxl	246	45	type	type	NN
cord-314500-89ovdnxl	246	46	2	2	CD
cord-314500-89ovdnxl	246	47	diabetes	diabetes	NN
cord-314500-89ovdnxl	246	48	:	:	:
cord-314500-89ovdnxl	246	49	a	a	DT
cord-314500-89ovdnxl	246	50	Danish	danish	JJ
cord-314500-89ovdnxl	246	51	nationwide	nationwide	JJ
cord-314500-89ovdnxl	246	52	population	population	NN
cord-314500-89ovdnxl	246	53	-	-	HYPH
cord-314500-89ovdnxl	246	54	based	base	VBN
cord-314500-89ovdnxl	246	55	cohort	cohort	NN
cord-314500-89ovdnxl	246	56	study	study	NN
cord-314500-89ovdnxl	246	57	Metformin	Metformin	NNP
cord-314500-89ovdnxl	246	58	as	as	IN
cord-314500-89ovdnxl	246	59	adjunct	adjunct	NN
cord-314500-89ovdnxl	246	60	antituberculosis	antituberculosis	NN
cord-314500-89ovdnxl	246	61	therapy	therapy	NN
cord-314500-89ovdnxl	246	62	Metformin	Metformin	NNP
cord-314500-89ovdnxl	246	63	Use	Use	NNP
cord-314500-89ovdnxl	246	64	and	and	CC
cord-314500-89ovdnxl	246	65	Severe	severe	JJ
cord-314500-89ovdnxl	246	66	Dengue	dengue	NN
cord-314500-89ovdnxl	246	67	in	in	IN
cord-314500-89ovdnxl	246	68	Diabetic	diabetic	JJ
cord-314500-89ovdnxl	246	69	Adults	Adults	NNPS
cord-314500-89ovdnxl	247	1	Glyburide	Glyburide	NNP
cord-314500-89ovdnxl	247	2	Is	be	VBZ
cord-314500-89ovdnxl	247	3	Antiinflammatory	antiinflammatory	JJ
cord-314500-89ovdnxl	247	4	and	and	CC
cord-314500-89ovdnxl	247	5	Associated	associate	VBN
cord-314500-89ovdnxl	247	6	with	with	IN
cord-314500-89ovdnxl	247	7	Reduced	Reduced	NNP
cord-314500-89ovdnxl	247	8	Mortality	Mortality	NNP
cord-314500-89ovdnxl	247	9	in	in	IN
cord-314500-89ovdnxl	247	10	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	247	11	Melioidosis	Melioidosis	NNP
cord-314500-89ovdnxl	247	12	vaccines	vaccine	NNS
cord-314500-89ovdnxl	247	13	:	:	:
cord-314500-89ovdnxl	248	1	A	a	DT
cord-314500-89ovdnxl	248	2	systematic	systematic	JJ
cord-314500-89ovdnxl	248	3	review	review	NN
cord-314500-89ovdnxl	248	4	and	and	CC
cord-314500-89ovdnxl	248	5	appraisal	appraisal	NN
cord-314500-89ovdnxl	248	6	of	of	IN
cord-314500-89ovdnxl	248	7	the	the	DT
cord-314500-89ovdnxl	248	8	potential	potential	NN
cord-314500-89ovdnxl	248	9	to	to	TO
cord-314500-89ovdnxl	248	10	exploit	exploit	VB
cord-314500-89ovdnxl	248	11	biodefense	biodefense	NN
cord-314500-89ovdnxl	248	12	vaccines	vaccine	NNS
cord-314500-89ovdnxl	248	13	for	for	IN
cord-314500-89ovdnxl	248	14	public	public	JJ
cord-314500-89ovdnxl	248	15	health	health	NN
cord-314500-89ovdnxl	248	16	purposes	purpose	NNS
cord-314500-89ovdnxl	248	17	Acknowledgements	acknowledgement	NNS
cord-314500-89ovdnxl	248	18	:	:	:
cord-314500-89ovdnxl	248	19	None	none	NN
cord-314500-89ovdnxl	248	20	.	.	.
cord-314500-89ovdnxl	248	21	 	 	_SP
cord-314500-89ovdnxl	249	1	Ethical	ethical	JJ
cord-314500-89ovdnxl	249	2	approval	approval	NN
cord-314500-89ovdnxl	249	3	:	:	:
cord-314500-89ovdnxl	249	4	Not	not	RB
cord-314500-89ovdnxl	249	5	required	require	VBN
cord-314500-89ovdnxl	249	6	.	.	.